data_2m6q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m6q _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.644 0.259 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -167.27 179.35 5.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.78 0.832 . . . . 0.0 111.125 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.9 mt -72.41 115.84 13.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.107 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.2 mm -84.74 -45.65 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.3 p -154.65 133.44 12.19 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.12 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.7 mm -78.37 105.6 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 169.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.556 ' HB3' ' HG3' ' A' ' 16' ' ' LYS . 38.2 t . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 122.956 0.502 . . . . 0.0 110.804 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 25.6 t-20 -66.59 -64.76 0.79 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.536 0.734 . . . . 0.0 110.618 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.4 t -106.84 126.9 52.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.532 0.333 . . . . 0.0 110.121 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.408 ' HE3' HD23 ' A' ' 75' ' ' LEU . 25.4 ptt? -122.35 143.33 49.71 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.29 0.567 . . . . 0.0 110.457 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.556 ' HG3' ' HB3' ' A' ' 7' ' ' SER . 20.3 ptmt -88.38 140.53 29.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.84 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.1 mt -130.0 114.93 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.499 1.12 . . . . 0.0 109.317 -172.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.8 m -71.66 119.96 16.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.645 0.778 . . . . 0.0 110.322 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.9 mt -87.41 169.88 11.86 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.222 0.609 . . . . 0.0 110.696 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 p -74.7 -26.72 60.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.399 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HB2' ' SD ' ' A' ' 26' ' ' MET . 24.5 mm-40 -84.2 128.42 34.55 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.267 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.6 p -153.37 166.8 31.51 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.216 0.606 . . . . 0.0 111.334 -174.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 71.04 156.13 0.15 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.875 1.67 . . . . 0.0 112.437 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 69.28 -75.97 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.803 1.641 . . . . 0.0 110.853 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.02 116.45 1.06 Allowed Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.535 -0.302 . . . . 0.0 112.505 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.449 ' SD ' ' HB2' ' A' ' 21' ' ' GLU . 82.5 mtp -75.32 -167.59 0.67 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.302 1.041 . . . . 0.0 109.748 170.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.0 p -59.19 112.9 1.88 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.298 0.639 . . . . 0.0 110.991 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.1 p -94.59 84.87 4.36 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -144.78 141.74 29.44 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.828 0.851 . . . . 0.0 111.237 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 23.2 m -89.29 106.41 18.42 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -80.21 101.17 8.69 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -146.01 -33.7 0.32 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.948 0.499 . . . . 0.0 111.874 -171.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.428 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 46.9 pttt -88.85 4.87 46.26 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -169.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.4 t 65.02 126.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 125.448 1.499 . . . . 0.0 110.533 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 t70 72.01 47.34 0.31 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.927 1.291 . . . . 0.0 109.26 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.428 ' OD2' ' HG2' ' A' ' 33' ' ' LYS . 2.7 m-20 -84.31 47.91 1.41 Allowed 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.882 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.0 p 58.05 19.29 5.85 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.843 1.657 . . . . 0.0 113.249 -174.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.32 147.01 34.12 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 123.789 0.836 . . . . 0.0 109.966 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -52.43 155.19 10.15 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.739 2.959 . . . . 0.0 113.809 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.86 -31.35 49.29 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.253 1.021 . . . . 0.0 112.107 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -56.73 -44.98 82.19 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.216 1.006 . . . . 0.0 111.257 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mm -71.55 -28.86 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.381 0.672 . . . . 0.0 109.958 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 28.8 m-80 -72.07 -32.93 67.52 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.91 0.484 . . . . 0.0 110.068 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 48' ' ' VAL . 28.0 t70 -63.43 -41.78 98.7 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 124.145 0.903 . . . . 0.0 109.8 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.0 mt -59.74 -44.84 94.69 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 O-C-N 124.267 0.979 . . . . 0.0 109.882 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.48 -36.68 74.12 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.132 0.573 . . . . 0.0 111.223 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 43' ' ' ASN . 96.2 mttt -79.45 -19.72 49.2 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.658 0.783 . . . . 0.0 112.09 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 44' ' ' ASP . 55.9 t -60.44 121.83 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.65 89.47 0.05 OUTLIER 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.353 1.033 . . . . 0.0 109.581 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.15 -32.07 0.45 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.184 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.89 131.4 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.476 0.71 . . . . 0.0 109.7 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -87.05 -52.05 5.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.331 0.652 . . . . 0.0 109.26 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.6 p -163.31 173.0 13.84 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.584 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.454 HG22 HG23 ' A' ' 63' ' ' VAL . 74.0 mt -132.03 101.04 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 28.8 t80 -81.98 146.27 29.83 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -135.54 135.03 40.04 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.12 124.64 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.538 0.735 . . . . 0.0 110.241 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 45.6 ttm 55.78 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.263 1.425 . . . . 0.0 112.821 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -120.31 -39.32 2.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.131 0.572 . . . . 0.0 110.6 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -98.26 138.79 35.01 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.644 0.735 . . . . 0.0 110.807 -167.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.5 mt -85.61 163.78 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.801 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -143.44 86.31 1.89 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 54' ' ' ILE . 40.7 t -80.01 114.63 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.27 131.15 34.32 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.097 0.959 . . . . 0.0 108.69 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 13' ' ' ASN . 21.5 pttp -101.72 -173.86 2.45 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 173.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -89.39 162.71 15.64 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -59.13 -48.19 82.51 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.295 0.638 . . . . 0.0 112.631 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -80.55 -33.8 35.94 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.36 0.664 . . . . 0.0 111.597 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.35 140.94 12.59 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.591 1.156 . . . . 0.0 112.666 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -110.24 130.47 55.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.799 0.84 . . . . 0.0 110.302 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -60.35 -18.32 49.25 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.448 0.699 . . . . 0.0 112.027 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -56.73 -35.31 68.44 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.537 0.735 . . . . 0.0 110.732 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 t -101.06 -42.59 6.33 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.012 0.525 . . . . 0.0 110.884 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.1 t -70.73 -45.87 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.312 1.045 . . . . 0.0 113.358 -170.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.408 HD23 ' HE3' ' A' ' 15' ' ' MET . 32.6 tp -60.64 -43.74 93.22 Favored Pre-proline 0 N--CA 1.492 1.66 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.65 -176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -46.45 -34.31 14.32 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.415 2.077 . . . . 0.0 114.38 170.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -75.1 -41.45 58.64 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.337 0.655 . . . . 0.0 111.118 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -65.02 -58.12 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-O 121.638 0.732 . . . . 0.0 109.237 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.67 -31.17 67.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.73 1.612 . . . . 0.0 112.26 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.14 55.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.383 1.073 . . . . 0.0 112.876 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.3 -49.54 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.203 0.601 . . . . 0.0 110.816 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -69.28 -25.22 64.15 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.351 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -122.49 77.16 1.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.726 0.81 . . . . 0.0 109.534 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--O 1.243 0.754 0 C-N-CA 124.097 0.959 . . . . 0.0 108.565 171.01 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -145.28 144.45 30.78 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.452 0.701 . . . . 0.0 110.424 -175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.5 mt -73.58 95.04 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.4 0.68 . . . . 0.0 109.728 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 mm -83.54 -35.51 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.698 0.799 . . . . 0.0 110.138 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.7 t -134.31 146.75 50.28 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.824 0.45 . . . . 0.0 111.123 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.436 HG23 ' HG2' ' A' ' 15' ' ' MET . 72.6 mt -128.76 133.95 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.775 1.63 . . . . 0.0 108.252 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 121.226 0.536 . . . . 0.0 111.285 -179.279 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 69.64 20.29 7.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.553 1.141 . . . . 0.0 111.912 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 13.2 t -161.01 143.1 12.29 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.097 0.959 . . . . 0.0 108.832 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.5 ' O ' ' HA ' ' A' ' 62' ' ' SER . 57.7 mtm -115.68 110.76 19.61 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HZ2' ' HB3' ' A' ' 60' ' ' PHE . 35.5 tptt -75.74 85.89 2.75 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 165.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.442 HD11 ' HE1' ' A' ' 15' ' ' MET . 68.2 mt -77.31 93.29 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.0 m -77.94 116.89 18.77 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.1 mt -84.88 -150.49 0.12 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 p -76.65 15.17 0.67 Allowed 'General case' 0 CA--C 1.558 1.269 0 O-C-N 121.93 -0.481 . . . . 0.0 112.114 173.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 42.4 mt-10 67.82 92.4 0.08 Allowed 'General case' 0 C--N 1.358 0.944 0 C-N-CA 125.903 1.681 . . . . 0.0 110.798 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -73.07 131.92 42.69 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -76.11 78.91 2.94 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.549 0.531 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 62.17 13.27 5.7 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.497 1.119 . . . . 0.0 111.874 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.12 -26.7 61.43 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.156 -173.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.0 mmt -80.46 107.13 13.01 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.5 p -75.12 154.54 37.74 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.579 0.352 . . . . 0.0 110.916 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.0 p -69.48 96.06 0.88 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.241 0.543 . . . . 0.0 110.815 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -119.2 111.06 17.76 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.258 1.023 . . . . 0.0 109.565 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.3 m -91.1 97.23 11.03 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -81.98 103.78 11.87 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.0 p -99.47 49.81 0.94 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.753 1.221 . . . . 0.0 109.307 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HA ' HD12 ' A' ' 46' ' ' LEU 0.298 0.9 OUTLIER 56.72 99.55 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 127.427 2.291 . . . . 0.0 113.727 179.372 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t 50.54 80.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 125.53 1.532 . . . . 0.0 111.215 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -151.78 -50.08 0.11 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -164.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -105.07 -96.64 0.33 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.856 0.462 . . . . 0.0 110.783 -169.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.6 t -161.81 87.54 0.67 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.1 pm0 -139.77 144.36 38.56 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.627 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -53.34 150.65 25.42 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.837 2.358 . . . . 0.0 112.326 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.33 -34.43 57.41 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.581 0.753 . . . . 0.0 111.057 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.414 ' HB3' HG11 ' A' ' 81' ' ' VAL . 91.0 m-85 -56.82 -46.94 81.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.422 1.089 . . . . 0.0 111.499 176.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.0 mm -67.31 -32.35 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.202 0.601 . . . . 0.0 110.296 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.452 ' HA ' HD13 ' A' ' 46' ' ' LEU . 64.6 m-20 -70.5 -32.01 69.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.509 0.724 . . . . 0.0 110.702 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.418 ' O ' HG21 ' A' ' 48' ' ' VAL . 1.1 m-20 -65.63 -38.11 88.47 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.237 0.615 . . . . 0.0 111.221 175.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.43 HG22 HG21 ' A' ' 78' ' ' VAL . 59.7 mt -61.99 -44.6 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.794 0.807 . . . . 0.0 109.931 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 33' ' ' LYS . 58.7 mt -61.89 -34.55 76.23 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.725 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -82.32 -8.67 59.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.559 0.744 . . . . 0.0 112.562 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 74' ' ' VAL . 65.9 t -70.5 105.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 171.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.69 94.31 0.2 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.694 0.798 . . . . 0.0 110.451 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 161.44 -35.81 0.39 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.0 129.73 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.825 0.85 . . . . 0.0 109.024 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.503 ' HZ1' ' HB2' ' A' ' 52' ' ' LYS . 5.1 ttmp? -78.6 -57.04 3.97 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 p -163.61 178.49 7.92 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.975 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.5 mt -132.27 117.64 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.084 0.954 . . . . 0.0 109.221 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -103.67 97.54 7.54 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.697 0.76 . . . . 0.0 109.621 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -87.86 131.35 34.59 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.652 1.181 . . . . 0.0 109.88 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.4 p -172.52 155.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 118.433 0.56 . . . . 0.0 111.715 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 27.5 ttt 65.09 -83.81 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.5 1.92 . . . . 0.0 112.918 171.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.439 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 7.1 p-10 -132.71 -16.19 2.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.977 0.911 . . . . 0.0 110.561 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.424 ' HB3' ' HZ2' ' A' ' 16' ' ' LYS . 37.6 p90 -122.54 171.13 9.33 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 122.129 0.966 . . . . 0.0 112.446 -162.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -126.06 103.67 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.616 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 15' ' ' MET . 28.5 t -86.0 89.08 7.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.3 t -88.54 107.72 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 4.8 p-10 -106.58 158.19 17.12 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.894 0.478 . . . . 0.0 111.035 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -139.44 -167.97 2.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.815 0.846 . . . . 0.0 111.889 -165.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -88.19 161.13 17.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.33 1.052 . . . . 0.0 110.826 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.87 -27.02 67.91 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.731 0.812 . . . . 0.0 113.048 -172.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -97.1 -28.26 14.21 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.813 0.845 . . . . 0.0 111.734 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.28 130.89 23.74 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.817 0.847 . . . . 0.0 112.282 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -104.6 127.43 52.33 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.242 0.617 . . . . 0.0 110.443 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 63.3 m95 -71.87 -16.72 62.15 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.531 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.92 -34.54 71.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.083 0.468 . . . . 0.0 110.787 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.1 m -82.96 -44.7 14.99 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.74 0.816 . . . . 0.0 110.536 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 48' ' ' VAL . 48.2 t -74.61 -39.51 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.944 0.898 . . . . 0.0 112.538 -170.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 71' ' ' TRP . 3.0 tt -59.14 -44.25 98.29 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-O 117.125 -1.417 . . . . 0.0 112.509 -168.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -48.96 -31.21 19.69 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.441 2.094 . . . . 0.0 114.676 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.08 -40.81 21.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.515 0.726 . . . . 0.0 110.029 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.43 HG21 HG22 ' A' ' 45' ' ' ILE . 56.2 t -63.81 -38.45 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 123.914 0.885 . . . . 0.0 109.936 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.68 -47.64 82.77 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.73 1.612 . . . . 0.0 109.868 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.51 -31.1 61.78 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.854 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 41' ' ' PHE . 56.1 t -68.34 -55.48 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.41 0.684 . . . . 0.0 110.683 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 1' ' ' MET . 17.9 m-85 -65.04 -29.05 69.92 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -80.14 -38.59 31.12 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.029 0.532 . . . . 0.0 112.07 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 124.055 0.942 . . . . 0.0 109.504 -164.676 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.66 ' SD ' ' HE1' ' A' ' 26' ' ' MET . 54.9 mtm . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -127.94 -174.75 3.28 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.9 mt -76.1 108.1 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -82.16 -51.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -162.79 147.88 11.93 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.558 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mt -89.74 97.29 6.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 168.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.549 0.911 0 C-N-CA 123.531 0.732 . . . . 0.0 111.782 -174.489 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.2 t60 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 77.56 -51.22 0.53 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.234 1.414 . . . . 0.0 111.254 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.4 t -105.71 112.04 24.96 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.866 0.466 . . . . 0.0 110.635 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.9 mtm -98.98 142.85 29.95 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.187 0.518 . . . . 0.0 110.048 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HZ1' ' HB3' ' A' ' 60' ' ' PHE . 52.5 tttp -89.59 113.73 25.2 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.936 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.8 mt -93.32 111.39 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.4 m -76.59 122.89 25.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.579 0.752 . . . . 0.0 109.832 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.2 mt -101.99 -171.3 1.95 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.489 0.715 . . . . 0.0 109.727 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 p -76.72 6.76 5.48 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 63.86 -171.29 0.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.427 1.091 . . . . 0.0 112.122 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 t -151.28 -162.81 1.62 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -69.68 89.56 0.55 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.244 0.618 . . . . 0.0 109.576 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 65.49 -74.0 0.06 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.453 1.501 . . . . 0.0 110.482 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.85 148.68 20.43 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.034 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.66 ' HE1' ' SD ' ' A' ' 1' ' ' MET . 23.8 ptt? -131.64 127.53 37.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.236 1.014 . . . . 0.0 109.447 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 t 46.64 176.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 126.609 1.964 . . . . 0.0 115.365 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 p -155.61 98.37 1.94 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.624 0.769 . . . . 0.0 109.46 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.49 164.24 14.86 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.108 0.963 . . . . 0.0 110.866 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 m -141.41 98.02 3.28 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 161.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.573 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 40.4 m-85 -82.16 111.97 18.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 p -122.38 -71.29 0.73 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.079 0.552 . . . . 0.0 110.134 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -110.02 46.88 0.99 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.683 0.793 . . . . 0.0 108.994 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.4 t 67.6 120.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 125.139 1.376 . . . . 0.0 111.704 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.17 -81.41 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.903 1.281 . . . . 0.0 110.4 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 166.06 -66.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.299 1.44 . . . . 0.0 108.611 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t -90.98 -2.4 57.71 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.117 0.967 . . . . 0.0 111.802 -169.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -63.08 149.84 89.86 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 123.693 0.797 . . . . 0.0 111.257 173.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -53.61 148.21 36.31 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.556 2.837 . . . . 0.0 113.731 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.02 69.81 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.029 0.931 . . . . 0.0 111.364 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.441 ' HB3' HG12 ' A' ' 81' ' ' VAL . 31.5 m-85 -61.48 -36.69 81.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.983 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.3 mm -75.69 -25.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -69.1 -37.26 78.3 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.15 -39.17 92.62 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.6 0.76 . . . . 0.0 110.358 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.528 HG21 HG12 ' A' ' 51' ' ' VAL . 29.2 mt -66.42 -34.55 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 123.533 0.521 . . . . 0.0 110.04 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.532 HD13 ' HB3' ' A' ' 31' ' ' TYR . 88.9 mt -64.32 -35.54 81.19 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.838 0.455 . . . . 0.0 111.804 174.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.36 -15.37 61.87 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.896 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.49 97.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.82 87.48 0.06 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 109.904 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.46 -17.22 0.08 OUTLIER Glycine 0 C--O 1.221 -0.714 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.881 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.528 HG12 HG21 ' A' ' 45' ' ' ILE . 35.6 m -85.77 -27.86 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.56 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 22.2 ttmm 48.59 -77.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.94 2.096 . . . . 0.0 113.217 -173.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 49.9 m -122.89 98.06 5.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.945 0.898 . . . . 0.0 110.172 -171.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 66.0 mt -83.93 84.08 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.43 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 92.5 t80 -81.49 140.32 34.65 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.429 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -137.02 134.41 36.56 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.15 143.32 9.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 171.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.2 ttt 62.31 -80.45 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 O-C-N 124.651 1.22 . . . . 0.0 111.837 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.59 -38.01 1.55 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.636 0.774 . . . . 0.0 111.327 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.465 ' HB3' ' HZ1' ' A' ' 16' ' ' LYS . 33.7 p90 -103.44 165.14 11.21 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.305 0.642 . . . . 0.0 112.625 -163.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.3 mt -120.19 111.53 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.989 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 50.1 m -85.83 95.37 9.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.358 0.663 . . . . 0.0 109.61 173.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 14' ' ' THR . 52.4 t -85.07 99.95 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.56 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 1.8 m-20 -84.7 98.3 10.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.683 1.193 . . . . 0.0 108.58 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.624 ' HD2' ' HB3' ' A' ' 69' ' ' ALA . 57.9 pttt -66.25 177.09 1.54 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -175.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.557 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 47.7 mm-40 -64.09 -177.39 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.499 0.719 . . . . 0.0 112.274 174.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -61.0 -25.1 66.65 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.528 0.731 . . . . 0.0 111.732 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.13 -58.27 0.9 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.412 0.685 . . . . 0.0 109.772 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.624 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . 49.6 -164.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.85 1.26 . . . . 0.0 113.053 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -156.8 114.21 3.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -68.69 -28.07 66.53 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.064 0.546 . . . . 0.0 111.832 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.63 -21.65 64.46 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 120.982 0.42 . . . . 0.0 110.505 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.7 m -86.0 -45.14 11.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.115 0.566 . . . . 0.0 110.396 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.44 -58.14 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.845 0.858 . . . . 0.0 112.571 -173.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.36 -47.01 99.73 Favored Pre-proline 0 N--CA 1.491 1.599 0 CA-C-O 117.362 -1.304 . . . . 0.0 114.321 -170.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.49 -33.99 60.03 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 122.14 1.893 . . . . 0.0 113.974 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -77.25 -39.02 49.82 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.811 0.844 . . . . 0.0 110.435 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.94 -41.23 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.765 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.93 -36.88 84.87 Favored 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 123.75 0.82 . . . . 0.0 110.837 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.71 -30.49 67.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.415 0.686 . . . . 0.0 111.917 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.453 HG21 HD11 ' A' ' 45' ' ' ILE . 40.6 t -65.83 -58.96 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.848 0.859 . . . . 0.0 111.928 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -73.75 -42.93 60.41 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.261 0.624 . . . . 0.0 110.914 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.5 70.36 2.26 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.483 1.191 0 C-N-CA 123.558 0.743 . . . . 0.0 110.915 175.72 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 121.132 0.491 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 50.9 pttt -145.14 -170.72 3.49 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.195 0.998 . . . . 0.0 108.984 173.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.51 HD13 HD11 ' A' ' 6' ' ' ILE . 59.5 mt -78.12 116.65 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 163.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.656 HD12 ' HA ' ' A' ' 19' ' ' LEU . 1.6 mp -83.43 -52.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 t -159.32 124.39 4.13 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.432 0.458 . . . . 0.0 110.881 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.559 HG21 ' HB2' ' A' ' 15' ' ' MET . 59.8 mt -92.25 90.6 3.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 123.959 0.904 . . . . 0.0 112.532 171.075 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.9 t60 . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.559 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 1.6 m120 -72.28 -22.29 61.23 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.03 1.287 . . . . 0.0 111.469 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 11.9 t -140.31 162.44 35.29 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.225 1.01 . . . . 0.0 109.292 171.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.559 ' HB2' HG21 ' A' ' 6' ' ' ILE . 6.9 ptp -136.36 125.49 24.55 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.285 0.564 . . . . 0.0 110.929 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -80.32 92.39 5.77 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.008 0.923 . . . . 0.0 109.356 170.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.482 HG12 HG12 ' A' ' 6' ' ' ILE . 71.1 mt -80.04 95.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 m -82.75 141.32 32.47 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.519 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.656 ' HA ' HD12 ' A' ' 4' ' ' ILE . 75.5 mt -111.98 160.85 17.06 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.141 0.976 . . . . 0.0 110.069 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.4 p -76.31 -15.81 59.91 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.205 1.002 . . . . 0.0 111.886 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.39 61.62 6.72 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 122.078 0.942 . . . . 0.0 110.244 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.3 m -90.12 66.41 6.71 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.768 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -154.25 -56.43 0.11 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.882 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.57 -19.89 66.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -170.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.7 63.15 4.44 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.491 0.494 . . . . 0.0 112.457 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.9 mtt -48.7 149.55 1.7 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.28 1.432 . . . . 0.0 112.821 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.7 p -66.08 148.6 51.56 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.024 0.93 . . . . 0.0 111.926 -174.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 p -89.05 105.3 17.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.655 0.782 . . . . 0.0 110.223 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -138.39 138.23 38.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.471 0.708 . . . . 0.0 111.193 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.4 m -103.31 98.91 8.75 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.1 0.96 . . . . 0.0 109.552 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -83.98 116.08 22.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.465 1.106 . . . . 0.0 109.683 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.3 p -137.42 -75.79 0.41 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.365 0.666 . . . . 0.0 112.514 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -91.47 18.66 6.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -164.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t 61.86 90.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.369 1.068 . . . . 0.0 109.485 -170.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -163.0 155.68 18.89 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.563 0.745 . . . . 0.0 110.347 -171.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.8 t70 67.17 -80.56 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.471 1.509 . . . . 0.0 112.129 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.5 t -154.28 69.99 0.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.295 0.569 . . . . 0.0 110.006 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -108.74 104.74 55.47 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.485 0.714 . . . . 0.0 109.358 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.79 152.34 42.93 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.765 2.31 . . . . 0.0 112.221 173.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.46 -37.91 51.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.928 0.891 . . . . 0.0 111.612 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.57 ' HB3' HG12 ' A' ' 81' ' ' VAL . 59.1 m-85 -62.91 -39.48 94.64 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.126 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -74.73 -29.69 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.127 0.971 . . . . 0.0 110.587 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -41.12 91.87 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 48' ' ' VAL . 22.1 t70 -56.92 -49.23 76.24 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.297 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.484 HG23 HG23 ' A' ' 78' ' ' VAL . 61.1 mt -57.27 -46.26 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 124.148 0.905 . . . . 0.0 110.278 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.74 -36.91 82.37 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.719 0.808 . . . . 0.0 111.856 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -77.49 -13.36 59.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.405 0.682 . . . . 0.0 111.536 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 44' ' ' ASP . 96.9 t -71.0 125.9 30.27 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -61.97 92.11 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.109 1.364 . . . . 0.0 111.367 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.52 -52.13 0.38 Allowed Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.098 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.98 120.88 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.53 0.732 . . . . 0.0 110.985 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HZ1' ' HB3' ' A' ' 52' ' ' LYS . 7.7 ttpm? -95.55 -50.86 4.79 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.373 0.669 . . . . 0.0 110.074 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.3 t -143.06 152.68 42.14 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.79 0.436 . . . . 0.0 111.286 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.429 HG12 HG11 ' A' ' 63' ' ' VAL . 46.7 mt -125.2 94.59 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.773 1.229 . . . . 0.0 108.615 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -96.18 100.11 11.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.893 -0.504 . . . . 0.0 110.088 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.33 129.71 35.83 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 p -161.59 141.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.445 0.698 . . . . 0.0 111.086 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 65.08 -73.25 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.976 1.71 . . . . 0.0 113.594 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -155.16 8.84 0.29 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.78 0.432 . . . . 0.0 111.166 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -142.52 165.97 25.96 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.1 0.56 . . . . 0.0 110.213 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.59 102.27 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 15' ' ' MET . 19.3 p -81.98 89.07 6.37 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.429 HG11 HG12 ' A' ' 54' ' ' ILE . 43.8 t -89.27 116.04 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.244 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 4.1 p30 -99.75 163.72 12.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.941 0.496 . . . . 0.0 111.293 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -136.37 173.07 12.1 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.342 -175.348 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.07 125.06 32.45 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 166.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -54.68 -21.18 9.95 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.715 1.206 . . . . 0.0 113.347 -167.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -51.76 -47.9 63.95 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.598 1.159 . . . . 0.0 112.159 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.09 130.54 35.52 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.61 0.764 . . . . 0.0 111.389 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -84.94 155.94 21.41 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.103 0.561 . . . . 0.0 109.56 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.419 ' CD2' ' HE3' ' A' ' 15' ' ' MET . 49.4 m95 -76.58 -31.38 57.48 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -28.62 44.14 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -171.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -81.12 -39.59 25.36 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.889 0.876 . . . . 0.0 110.011 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.65 -36.04 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 124.93 1.292 . . . . 0.0 111.703 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.473 HD21 ' HE2' ' A' ' 15' ' ' MET . 77.0 mt -50.12 -49.12 77.4 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 125.194 1.398 . . . . 0.0 114.59 -172.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.85 -31.16 88.04 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.885 1.723 . . . . 0.0 113.555 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -80.13 -40.18 27.96 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.862 0.865 . . . . 0.0 110.387 -176.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.484 HG23 HG23 ' A' ' 45' ' ' ILE . 59.8 t -65.81 -48.91 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.22 -31.26 72.38 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.966 0.906 . . . . 0.0 111.339 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.67 -34.83 69.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.892 0.877 . . . . 0.0 111.119 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.57 HG12 ' HB3' ' A' ' 41' ' ' PHE . 43.2 t -57.82 -46.99 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.914 0.886 . . . . 0.0 111.059 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.596 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 18.1 m-85 -87.69 19.56 3.38 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.693 0.797 . . . . 0.0 112.684 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -157.05 5.75 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 111.306 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.609 0.242 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.75 157.8 16.71 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.464 HG22 HG13 ' A' ' 6' ' ' ILE . 32.8 mt -76.93 129.85 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.983 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.4 mm -87.56 -48.02 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.935 0.894 . . . . 0.0 109.849 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 p -142.25 128.73 20.15 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.369 0.667 . . . . 0.0 109.673 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.464 HG13 HG22 ' A' ' 3' ' ' ILE . 3.8 mp -90.53 86.92 2.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.537 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 97.5 p . . . . . 0 N--CA 1.484 1.266 0 C-N-CA 125.531 1.533 . . . . 0.0 113.901 171.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.58 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 76.9 m-20 -102.82 8.79 39.25 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.161 0.584 . . . . 0.0 112.191 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 t -159.89 95.07 1.16 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.545 0.738 . . . . 0.0 110.135 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.1 mtp -82.65 125.77 31.57 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 121.713 -0.617 . . . . 0.0 111.802 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 7' ' ' SER . 23.0 ttmm -79.92 89.73 5.31 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.743 1.217 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.459 HD13 HG22 ' A' ' 63' ' ' VAL . 70.9 mt -85.6 95.63 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 174.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 60' ' ' PHE . 49.3 m -77.06 124.16 27.4 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.265 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.3 mt -87.55 164.52 16.06 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.118 0.485 . . . . 0.0 110.785 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -76.02 -19.89 58.28 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.872 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -96.73 101.57 13.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 109.664 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.774 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 29.3 t -79.41 107.94 12.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.536 0.734 . . . . 0.0 109.291 173.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 46.08 -154.94 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.712 1.605 . . . . 0.0 113.326 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.22 40.88 32.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.137 0.975 . . . . 0.0 112.078 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.79 -32.29 1.45 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.804 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.8 mmt -90.34 101.91 14.64 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.547 0.739 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.7 m -80.11 166.82 21.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.016 0.926 . . . . 0.0 111.057 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 67.8 p -80.87 74.35 7.85 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.937 0.895 . . . . 0.0 109.784 170.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -87.15 153.99 21.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.584 1.154 . . . . 0.0 110.387 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -128.54 101.25 6.09 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.453 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 37.4 m-85 -88.01 119.62 28.56 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.2 p -118.19 -62.44 1.54 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.52 0.6 . . . . 0.0 112.132 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.65 26.97 7.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -157.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.5 t 62.11 83.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -166.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.76 -77.21 0.26 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.567 -162.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -169.31 -77.2 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.02 0.373 . . . . 0.0 111.337 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 m -89.15 68.48 8.18 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.089 0.956 . . . . 0.0 110.727 -171.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -151.65 154.22 32.91 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.594 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.489 ' HB2' ' HB2' ' A' ' 41' ' ' PHE . 21.5 Cg_exo -66.2 150.89 84.68 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 122.669 2.246 . . . . 0.0 112.215 169.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.02 -23.76 63.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.865 0.866 . . . . 0.0 111.389 171.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.552 ' HB3' HG13 ' A' ' 81' ' ' VAL . 25.3 m-85 -46.97 -51.4 17.16 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.374 1.47 . . . . 0.0 110.82 170.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.1 mm -72.62 -29.25 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.625 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.421 HD21 HD12 ' A' ' 46' ' ' LEU . 14.0 m120 -67.97 -32.94 73.71 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.362 0.665 . . . . 0.0 111.945 -175.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -59.08 -46.8 87.35 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.492 0.495 . . . . 0.0 110.22 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.8 mt -66.07 -38.75 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.609 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.421 HD12 HD21 ' A' ' 43' ' ' ASN . 76.7 mt -60.71 -39.53 88.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.36 0.664 . . . . 0.0 111.709 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -85.62 4.13 37.69 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.267 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.2 t -78.84 123.53 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 169.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.13 130.39 34.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.571 0.748 . . . . 0.0 110.931 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.63 -32.67 7.3 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.644 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.37 109.36 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -78.94 -55.24 5.29 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.427 0.691 . . . . 0.0 110.568 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.1 t -158.88 157.29 31.19 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.567 0.698 . . . . 0.0 110.716 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 67.6 mt -114.4 87.26 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 58.3 t80 -84.26 90.75 7.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.546 0.689 . . . . 0.0 109.841 -175.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -80.75 117.37 21.36 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 2.5 p -140.97 125.25 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.129 0.422 . . . . 0.0 110.556 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 62.84 -71.98 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.446 1.498 . . . . 0.0 110.59 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.774 ' HB3' ' HA ' ' A' ' 22' ' ' SER . 2.0 p30 -148.46 -33.08 0.24 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.849 1.259 . . . . 0.0 110.08 172.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 29.0 p90 -83.86 129.31 34.93 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -174.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.26 113.78 39.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -176.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 10.9 m -82.37 81.84 8.07 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.643 0.777 . . . . 0.0 109.64 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 17' ' ' ILE . 48.7 t -78.85 92.89 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -82.41 151.2 26.71 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.265 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' A' ' 13' ' ' ASN . 39.0 pttt -137.17 -178.2 5.1 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.746 -173.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.84 140.88 30.85 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.95 -38.57 62.16 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.708 0.803 . . . . 0.0 112.163 -169.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.52 -32.62 72.7 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.702 0.801 . . . . 0.0 112.956 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . -56.31 111.33 0.94 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.936 0.894 . . . . 0.0 111.945 -175.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.496 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 15.8 m120 -82.47 126.4 32.19 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -70.59 -13.99 62.31 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.821 0.448 . . . . 0.0 112.101 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 70' ' ' ASN . 12.6 pt-20 -60.65 -28.4 68.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.302 0.641 . . . . 0.0 111.549 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.2 t -96.49 -40.68 8.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.761 0.824 . . . . 0.0 111.307 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.6 t -66.1 -47.23 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.094 0.958 . . . . 0.0 111.659 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.84 -43.33 97.59 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.858 -171.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.12 -39.51 20.49 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.732 2.288 . . . . 0.0 113.742 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -75.59 -41.32 54.92 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.036 0.534 . . . . 0.0 111.391 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.421 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 76.0 t -60.01 -55.52 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.317 0.647 . . . . 0.0 110.643 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -60.12 -39.11 85.08 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.035 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.59 -33.12 72.27 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.53 0.732 . . . . 0.0 111.655 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 41' ' ' PHE . 8.2 t -58.85 -48.56 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.295 0.638 . . . . 0.0 110.88 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -74.44 -30.48 61.91 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.932 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -107.0 20.39 19.11 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.419 HD21 ' HA ' ' A' ' 81' ' ' VAL . 4.5 pp . . . . . 0 N--CA 1.493 1.698 0 O-C-N 122.176 -0.328 . . . . 0.0 111.417 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.488 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -122.76 179.31 4.67 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.607 0.763 . . . . 0.0 109.969 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.523 HD13 ' HG2' ' A' ' 79' ' ' GLU . 27.6 mt -71.92 104.11 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.405 HD12 ' HG ' ' A' ' 20' ' ' SER . 48.1 mm -84.23 -48.73 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.185 0.594 . . . . 0.0 109.808 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.1 p -155.81 125.99 6.63 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.017 0.527 . . . . 0.0 110.243 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.92 153.01 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 47.6 t . . . . . 0 N--CA 1.48 1.033 0 C-N-CA 123.141 0.576 . . . . 0.0 112.369 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 42.6 m170 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.0 m120 72.63 -61.4 0.5 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.136 1.774 . . . . 0.0 112.237 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.46 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 6.7 t -140.92 136.75 32.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.996 0.426 . . . . 0.0 111.201 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 62' ' ' SER . 6.7 ptp -104.49 153.35 21.24 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.533 174.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 32.2 ttmt -95.47 125.01 39.78 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 171.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.21 97.1 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.1 m -70.37 113.0 7.09 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.298 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 86.9 mt -81.71 -178.67 7.07 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.029 0.532 . . . . 0.0 111.081 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.443 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 7.4 m -73.63 0.8 11.68 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.203 0.601 . . . . 0.0 111.537 172.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.94 130.72 48.13 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.199 1.4 . . . . 0.0 110.121 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -61.98 -30.58 71.04 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.113 1.365 . . . . 0.0 112.327 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.534 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 44.4 ttt85 103.9 132.96 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 129.067 2.947 . . . . 0.0 109.186 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.59 ' HA ' ' SD ' ' A' ' 58' ' ' MET . 28.4 tt0 80.62 -4.53 1.79 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.064 1.746 . . . . 0.0 111.788 175.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.18 -33.73 53.4 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.41 ' SD ' ' CE1' ' A' ' 56' ' ' HIS . 64.4 mtt -107.42 -179.6 3.97 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.268 1.027 . . . . 0.0 109.635 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 t -124.56 179.2 5.05 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.297 0.639 . . . . 0.0 111.276 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 33.9 p -89.43 132.93 34.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.667 1.187 . . . . 0.0 110.709 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -155.57 158.19 38.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.422 ' HB ' ' HD1' ' A' ' 55' ' ' PHE . 5.7 t -129.17 102.68 6.57 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.709 0.766 . . . . 0.0 109.38 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.506 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 68.6 m-85 -83.11 109.39 17.11 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.7 p -113.17 -69.64 0.85 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.531 0.732 . . . . 0.0 111.145 -172.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -100.23 22.94 10.73 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.244 0.618 . . . . 0.0 112.106 -168.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.601 HG22 ' HZ2' ' A' ' 47' ' ' LYS . 67.9 t 69.23 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 124.718 1.207 . . . . 0.0 112.509 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 66.26 90.3 0.09 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.028 1.731 . . . . 0.0 112.065 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -168.7 74.07 0.1 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 0.0 109.039 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.1 p 46.89 46.63 15.56 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.112 1.365 . . . . 0.0 112.508 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.07 125.04 17.85 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 123.992 0.917 . . . . 0.0 109.22 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.97 155.07 6.33 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 124.05 3.167 . . . . 0.0 114.412 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.5 -33.1 43.4 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.403 1.081 . . . . 0.0 112.519 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -60.87 -40.72 94.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.095 0.958 . . . . 0.0 111.479 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.1 mm -70.98 -27.6 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.787 0.835 . . . . 0.0 110.024 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.415 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -69.79 -34.75 74.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.293 0.637 . . . . 0.0 110.391 177.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -64.62 -43.64 93.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.538 0.735 . . . . 0.0 111.105 175.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.508 HG21 HG21 ' A' ' 78' ' ' VAL . 54.9 mt -60.22 -37.63 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.038 0.447 . . . . 0.0 110.376 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.69 -34.21 77.35 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.39 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.601 ' HZ2' HG22 ' A' ' 34' ' ' VAL . 11.9 mptt -87.77 0.57 55.58 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.768 0.827 . . . . 0.0 112.551 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 44' ' ' ASP . 91.6 t -72.09 127.22 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.73 132.57 53.68 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.091 0.956 . . . . 0.0 111.358 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.23 -47.4 1.11 Allowed Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.617 -173.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.72 135.88 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 124.305 1.042 . . . . 0.0 112.243 -171.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -113.21 -47.03 3.04 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.811 1.244 . . . . 0.0 110.09 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 12.6 m -146.35 157.68 43.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.239 0.542 . . . . 0.0 111.007 -174.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 82.0 mt -123.09 82.68 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 173.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.422 ' HD1' ' HB ' ' A' ' 30' ' ' THR . 32.2 t80 -82.98 88.04 6.86 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 9.6 t-160 -84.5 87.95 7.28 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 p -92.62 105.8 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.712 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.59 ' SD ' ' HA ' ' A' ' 24' ' ' GLU . 44.5 tpp 65.45 -91.19 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.916 1.287 . . . . 0.0 111.276 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.534 ' HB3' ' HA ' ' A' ' 23' ' ' ARG . 6.7 p-10 -116.2 -7.36 11.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.734 0.814 . . . . 0.0 111.933 -170.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -133.61 136.78 45.07 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.071 0.548 . . . . 0.0 111.011 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 56' ' ' HIS . 43.5 mt -94.06 106.65 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.787 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 15' ' ' MET . 10.7 t -81.99 90.98 6.53 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 172.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.82 98.18 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.16 0.584 . . . . 0.0 109.647 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 53' ' ' SER . 3.2 m-20 -79.78 150.12 30.85 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.505 0.722 . . . . 0.0 110.567 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.401 ' HZ3' HG21 ' A' ' 74' ' ' VAL . 12.3 ptpt -152.99 -159.49 1.01 Allowed 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.717 0.807 . . . . 0.0 109.091 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -63.11 -175.88 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.147 0.979 . . . . 0.0 111.947 168.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -51.33 -43.45 61.75 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.966 0.906 . . . . 0.0 111.828 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -158.3 -46.72 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.434 0.694 . . . . 0.0 110.467 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 51.68 -97.05 0.05 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.995 0.918 . . . . 0.0 109.171 -169.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -158.73 127.53 5.41 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 160.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.425 ' CH2' ' HG2' ' A' ' 15' ' ' MET . 94.3 m95 -80.72 -13.52 58.92 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.979 -0.451 . . . . 0.0 110.295 171.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -50.99 -45.19 60.96 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.397 1.079 . . . . 0.0 111.854 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -75.64 -41.72 53.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.631 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.401 HG21 ' HZ3' ' A' ' 65' ' ' LYS . 84.6 t -64.29 -50.78 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.917 0.887 . . . . 0.0 113.359 -166.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.36 -50.4 85.17 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-O 117.772 -1.109 . . . . 0.0 113.135 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -43.9 -41.0 11.98 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.867 2.378 . . . . 0.0 114.83 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.61 -46.45 26.02 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.939 0.496 . . . . 0.0 110.874 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.508 HG21 HG21 ' A' ' 45' ' ' ILE . 89.2 t -64.53 -52.85 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.661 0.784 . . . . 0.0 110.768 -175.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.523 ' HG2' HD13 ' A' ' 3' ' ' ILE . 49.5 mt-10 -58.9 -34.66 71.92 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.53 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.68 -34.04 72.36 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.878 0.871 . . . . 0.0 112.005 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.84 -42.13 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.672 0.789 . . . . 0.0 110.679 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -84.61 7.63 19.53 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.617 0.767 . . . . 0.0 112.927 173.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -133.28 52.97 2.04 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.191 0.996 . . . . 0.0 109.172 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.487 1.38 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.326 -178.644 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -88.7 41.01 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.367 0.667 . . . . 0.0 112.295 -173.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.466 HG21 HG21 ' A' ' 17' ' ' ILE . 43.3 mt 53.79 103.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 124.57 1.148 . . . . 0.0 112.061 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.0 mm -82.66 -49.59 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.678 0.791 . . . . 0.0 110.677 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 t -149.3 148.17 29.22 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 120.88 0.371 . . . . 0.0 110.586 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.8 mm -96.01 106.86 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.481 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.475 0.824 0 C-N-CA 126.093 1.757 . . . . 0.0 115.537 168.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -64.95 -56.47 13.03 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 9.8 t -115.66 126.78 54.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.804 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.525 ' HE1' HD11 ' A' ' 75' ' ' LEU . 34.2 mtm -110.69 136.57 49.58 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.253 0.549 . . . . 0.0 110.857 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.506 ' NZ ' ' HB3' ' A' ' 60' ' ' PHE . 6.4 tmtm? -79.22 94.56 5.44 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.059 174.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.466 HG21 HG21 ' A' ' 3' ' ' ILE . 58.3 mt -77.8 96.33 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 m -63.03 129.89 42.33 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.964 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.2 mt -116.15 149.18 39.47 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -75.37 -13.75 60.42 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.06 0.544 . . . . 0.0 110.54 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -92.05 63.08 4.34 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.564 1.146 . . . . 0.0 108.712 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.54 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 26.5 m -78.43 -172.93 3.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.611 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 72.39 171.63 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.562 1.145 . . . . 0.0 110.398 -172.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 68.36 -75.84 0.06 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.309 1.443 . . . . 0.0 111.966 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.7 -25.2 0.21 Allowed Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.009 -175.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 43.5 tpp 41.56 66.46 0.69 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.579 1.552 . . . . 0.0 111.444 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.5 p 48.44 100.57 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.976 1.71 . . . . 0.0 112.883 -171.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.5 p -88.48 70.75 8.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.823 0.821 . . . . 0.0 108.985 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.64 168.52 11.68 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.039 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.435 HG23 HG22 ' A' ' 32' ' ' THR . 7.4 m -126.36 97.11 4.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.283 -1.326 . . . . 0.0 107.864 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.466 ' HB3' HD11 ' A' ' 46' ' ' LEU . 44.0 m-85 -83.25 98.43 9.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.933 0.893 . . . . 0.0 108.842 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.435 HG22 HG23 ' A' ' 30' ' ' THR . 28.6 p -124.34 -64.47 1.12 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.733 0.813 . . . . 0.0 110.102 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -79.88 -4.09 50.77 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -168.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 t 63.88 164.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 C-N-CA 125.161 1.384 . . . . 0.0 110.599 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 65.54 96.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.285 1.034 . . . . 0.0 110.892 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -152.99 -74.95 0.13 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.6 t -165.62 23.44 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.495 0.718 . . . . 0.0 109.46 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.531 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -107.56 140.95 22.04 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.141 0.577 . . . . 0.0 109.668 -177.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.22 148.42 3.13 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.934 3.089 . . . . 0.0 114.563 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.06 -32.96 62.31 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.996 0.918 . . . . 0.0 110.714 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.555 ' HB3' HG12 ' A' ' 81' ' ' VAL . 82.3 m-85 -52.69 -48.65 66.42 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.704 1.201 . . . . 0.0 111.037 172.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -71.42 -31.05 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.254 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.531 ' ND2' ' HG2' ' A' ' 38' ' ' GLN . 0.9 OUTLIER -67.81 -37.71 82.33 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 48' ' ' VAL . 25.0 t70 -65.1 -41.82 94.58 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.635 0.774 . . . . 0.0 110.1 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 81' ' ' VAL . 64.3 mt -57.26 -47.32 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 123.891 0.744 . . . . 0.0 109.831 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 31' ' ' TYR . 88.8 mt -60.47 -36.92 79.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.212 0.605 . . . . 0.0 111.178 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.92 -8.93 59.52 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.6 0.76 . . . . 0.0 112.094 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.593 HG23 ' HZ2' ' A' ' 77' ' ' LYS . 97.2 t -65.17 107.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 171.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.56 107.19 0.31 Allowed 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.983 0.802 . . . . 0.0 110.398 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.5 -45.38 0.86 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.183 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.511 HG11 HG12 ' A' ' 63' ' ' VAL . 40.2 t -60.55 -40.51 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 125.085 1.354 . . . . 0.0 113.655 -171.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 38.5 ttmt 64.13 -72.25 0.06 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.389 1.876 . . . . 0.0 111.587 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 p -144.95 156.33 43.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.157 0.583 . . . . 0.0 111.156 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.1 mt -131.64 131.48 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.463 1.105 . . . . 0.0 108.245 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -118.14 104.77 11.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -96.62 128.08 43.22 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 p -163.9 151.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 56.6 tpp 68.46 -69.77 0.14 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.367 1.467 . . . . 0.0 110.692 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.54 ' HB3' ' HA ' ' A' ' 22' ' ' SER . 8.7 p-10 -148.16 -36.41 0.2 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.591 1.157 . . . . 0.0 110.401 173.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.506 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . 55.3 p90 -87.47 149.69 24.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -158.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 66.8 mt -98.77 97.17 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 113.616 -1.629 . . . . 0.0 107.921 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.1 t -83.94 86.97 7.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.116 0.566 . . . . 0.0 109.625 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.511 HG12 HG11 ' A' ' 51' ' ' VAL . 44.2 t -80.87 103.55 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 36.3 t70 -95.01 95.53 8.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.971 0.908 . . . . 0.0 109.875 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.615 ' HD2' ' HB2' ' A' ' 69' ' ' ALA . 17.3 pttp -86.05 -172.17 3.94 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.904 0.881 . . . . 0.0 112.359 -175.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.45 167.56 1.88 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.768 0.827 . . . . 0.0 111.45 167.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -51.25 -68.76 0.14 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.219 1.007 . . . . 0.0 111.496 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -94.35 -57.23 2.56 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.35 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.615 ' HB2' ' HD2' ' A' ' 65' ' ' LYS . . . 40.39 -157.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.309 1.443 . . . . 0.0 113.578 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -141.68 108.59 5.42 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.478 0.711 . . . . 0.0 109.477 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -61.18 -32.86 72.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.038 0.535 . . . . 0.0 110.041 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -62.91 -22.04 66.46 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.977 0.911 . . . . 0.0 111.614 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.3 m -92.36 -44.86 8.48 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.619 0.767 . . . . 0.0 110.962 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.3 t -72.69 -51.6 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.834 0.854 . . . . 0.0 112.398 -172.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.525 HD11 ' HE1' ' A' ' 15' ' ' MET . 91.3 mt -56.44 -41.34 90.68 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-O 117.368 -1.301 . . . . 0.0 114.389 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -40.33 -41.83 3.5 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.067 2.511 . . . . 0.0 114.596 170.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.593 ' HZ2' HG23 ' A' ' 48' ' ' VAL . 36.6 mtpt -75.92 -43.04 47.01 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.683 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.08 -50.18 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.261 0.624 . . . . 0.0 110.042 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG2' HD13 ' A' ' 3' ' ' ILE . 42.9 mt-10 -57.21 -44.18 83.45 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.342 1.057 . . . . 0.0 110.968 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.08 67.76 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.48 1.112 . . . . 0.0 112.703 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 41' ' ' PHE . 52.6 t -61.55 -49.4 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.267 0.627 . . . . 0.0 110.977 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -78.54 -27.71 45.99 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.967 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.46 71.34 4.35 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.476 0.846 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.849 173.522 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.569 ' HG2' HD11 ' A' ' 19' ' ' LEU . 3.3 mpp? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.069 0.461 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -116.81 -175.57 2.8 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.83 1.252 . . . . 0.0 109.766 174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.6 mt -102.49 109.66 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 170.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mm -84.19 -46.02 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.0 m -146.53 127.27 14.32 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.172 0.589 . . . . 0.0 110.272 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -86.78 75.35 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 165.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.476 ' HG ' ' HB2' ' A' ' 16' ' ' LYS . 11.7 p . . . . . 0 CA--C 1.541 0.608 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.352 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -59.21 -36.81 76.05 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.904 0.881 . . . . 0.0 109.542 163.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -123.78 159.25 29.92 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.796 0.839 . . . . 0.0 110.966 -177.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 37.7 mtm -136.45 143.06 43.68 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.553 1.141 . . . . 0.0 108.569 169.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.476 ' HB2' ' HG ' ' A' ' 7' ' ' SER . 51.2 mtpt -95.25 116.68 29.07 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.411 0.685 . . . . 0.0 109.597 175.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.519 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 64.6 mt -90.58 96.11 6.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 172.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 m -66.29 120.53 13.44 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.476 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.569 HD11 ' HG2' ' A' ' 1' ' ' MET . 77.0 mt -87.8 -160.56 0.63 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.216 0.607 . . . . 0.0 110.238 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -68.97 8.26 0.56 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 66.33 106.62 0.04 OUTLIER 'General case' 0 C--N 1.362 1.115 0 C-N-CA 125.352 1.461 . . . . 0.0 110.742 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -140.49 174.24 10.71 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.364 0.666 . . . . 0.0 110.827 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -56.48 133.04 52.96 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.222 0.609 . . . . 0.0 109.711 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -54.37 91.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.807 1.317 . . . . 0.0 112.519 -170.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.455 ' N ' ' HA ' ' A' ' 58' ' ' MET . . . -164.65 -73.2 0.03 OUTLIER Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 60.4 tpp 51.29 21.6 1.18 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.304 1.442 . . . . 0.0 112.381 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m 67.61 135.17 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.503 1.521 . . . . 0.0 110.513 -168.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 p -102.32 114.46 28.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.009 0.923 . . . . 0.0 108.746 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 56' ' ' HIS . 15.7 m-20 -138.21 158.57 44.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.198 0.999 . . . . 0.0 110.194 -170.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 t -151.21 93.96 1.98 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -95.56 92.34 6.59 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.876 0.87 . . . . 0.0 110.566 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.402 ' HA ' ' HB3' ' A' ' 53' ' ' SER . 81.3 p -92.31 -23.47 19.26 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.219 0.533 . . . . 0.0 109.585 174.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.621 ' HG2' ' H ' ' A' ' 34' ' ' VAL . 20.6 ttmm -106.58 -161.91 0.82 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.78 1.232 . . . . 0.0 108.272 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.621 ' H ' ' HG2' ' A' ' 33' ' ' LYS . 58.4 t -149.01 83.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 105.645 -1.984 . . . . 0.0 105.645 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -164.74 -138.0 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.694 -170.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 64.01 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.359 1.019 0 C-N-CA 124.891 1.276 . . . . 0.0 110.527 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.1 p -172.9 20.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.11 1.364 . . . . 0.0 109.386 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' HG3' ' ND2' ' A' ' 43' ' ' ASN . 12.9 pt20 -65.1 142.86 98.73 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.028 0.931 . . . . 0.0 110.369 -176.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.82 141.18 28.92 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.597 2.865 . . . . 0.0 113.347 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -58.97 -31.81 69.07 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.981 0.912 . . . . 0.0 111.74 -178.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.487 ' HB3' HG11 ' A' ' 81' ' ' VAL . 62.5 m-85 -65.4 -36.49 84.13 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.268 0.627 . . . . 0.0 110.911 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.3 mm -73.66 -27.1 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.525 0.73 . . . . 0.0 110.136 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -62.27 -41.79 98.77 Favored 'General case' 0 C--N 1.368 1.392 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.265 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -57.72 -46.12 84.83 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.502 1.126 . . . . 0.0 111.418 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.528 HG23 HG23 ' A' ' 78' ' ' VAL . 57.4 mt -55.42 -49.27 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 123.801 0.688 . . . . 0.0 110.064 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.4 mt -65.15 -32.69 74.51 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.51 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -72.04 -18.94 61.91 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.764 0.826 . . . . 0.0 112.278 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.05 117.94 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -57.05 99.99 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.229 0.956 . . . . 0.0 109.168 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.52 -56.09 0.48 Allowed Glycine 0 C--O 1.225 -0.437 0 N-CA-C 110.071 -1.211 . . . . 0.0 110.071 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.73 127.71 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.844 0.858 . . . . 0.0 111.719 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.512 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 8.0 ttpm? -92.2 -46.56 7.68 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.063 0.945 . . . . 0.0 108.48 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.402 ' HB3' ' HA ' ' A' ' 32' ' ' THR . 20.1 p -166.43 178.89 5.86 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 123.702 0.626 . . . . 0.0 111.599 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.4 mt -131.63 111.25 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.178 0.991 . . . . 0.0 109.377 176.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -90.35 125.79 35.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 169.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 29' ' ' ASP . 11.1 t-160 -132.78 123.38 26.06 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.61 0.764 . . . . 0.0 109.233 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -168.03 161.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 123.164 0.29 . . . . 0.0 110.458 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.455 ' HA ' ' N ' ' A' ' 25' ' ' GLY 0.27 27.2 ptm 56.64 -61.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 128.412 2.685 . . . . 0.0 114.973 175.251 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -150.88 -31.54 0.17 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.584 0.753 . . . . 0.0 111.0 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -95.51 155.38 16.77 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.337 0.589 . . . . 0.0 112.205 -167.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.519 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 42.7 mt -108.89 94.2 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 t -82.82 88.96 6.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.7 t -80.15 122.2 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.27 156.47 23.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.896 0.478 . . . . 0.0 110.006 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.512 ' HA ' ' H ' ' A' ' 52' ' ' LYS . 16.8 pttm -132.11 -162.09 1.2 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.109 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.94 165.64 2.32 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.535 0.734 . . . . 0.0 111.403 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -39.2 -44.82 1.26 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.539 1.536 . . . . 0.0 114.692 -164.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -133.36 -59.04 0.88 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 173.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.483 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . . . 49.91 -163.08 0.05 OUTLIER 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 125.782 1.633 . . . . 0.0 113.79 171.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -131.39 120.85 23.65 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.159 0.584 . . . . 0.0 111.536 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -73.81 -10.78 60.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.302 0.641 . . . . 0.0 110.935 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -61.93 -26.92 68.48 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.76 0.824 . . . . 0.0 110.575 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 m -91.84 -43.91 9.24 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.506 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.9 t -80.3 -50.21 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.631 0.772 . . . . 0.0 112.793 -172.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.25 -46.98 83.45 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-O 117.29 -1.338 . . . . 0.0 113.093 -171.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.19 -38.52 81.35 Favored 'Trans proline' 0 C--N 1.4 3.278 0 C-N-CA 122.232 1.955 . . . . 0.0 112.979 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.26 -40.56 70.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.067 0.547 . . . . 0.0 111.337 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.528 HG23 HG23 ' A' ' 45' ' ' ILE . 41.4 t -65.47 -40.14 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.022 0.529 . . . . 0.0 109.97 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.15 -45.5 87.29 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.804 1.242 . . . . 0.0 110.463 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.0 -31.73 51.95 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.642 1.177 . . . . 0.0 112.708 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 41' ' ' PHE . 56.0 t -65.77 -51.68 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 124.068 0.947 . . . . 0.0 111.279 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -72.66 -25.53 61.3 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -79.67 -69.76 0.56 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.375 0.27 . . . . 0.0 111.321 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 N--CA 1.495 1.824 0 C-N-CA 125.976 1.71 . . . . 0.0 111.813 -175.07 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -160.99 167.28 26.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.636 0.774 . . . . 0.0 109.981 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.3 mt -65.21 96.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.504 HG13 ' HB2' ' A' ' 20' ' ' SER . 33.3 mm -93.26 -40.98 12.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 C-N-CA 123.889 0.876 . . . . 0.0 109.786 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.582 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 10.9 t -150.5 158.74 44.49 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.428 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -117.06 134.13 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.118 0.967 . . . . 0.0 109.087 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.535 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 7.3 m . . . . . 0 C--O 1.245 0.84 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.7 m170 . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.409 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 17.0 m120 76.82 -66.42 0.25 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.988 1.715 . . . . 0.0 110.363 -176.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 10.0 t -105.15 135.47 46.44 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.847 0.356 . . . . 0.0 111.573 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 62' ' ' SER . 13.0 ptp -133.24 149.29 51.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.723 169.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 84.3 tttt -91.06 100.26 13.14 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.534 1.134 . . . . 0.0 110.58 -175.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.86 111.15 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.582 ' HB ' ' HB3' ' A' ' 5' ' ' SER . 86.2 m -75.35 131.27 40.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.601 0.76 . . . . 0.0 110.98 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.5 mt -102.35 166.56 10.5 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.764 0.825 . . . . 0.0 109.239 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.504 ' HB2' HG13 ' A' ' 4' ' ' ILE . 29.4 t -76.19 -26.77 56.5 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.702 0.401 . . . . 0.0 111.501 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -82.0 76.67 8.88 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.28 0.562 . . . . 0.0 109.976 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -87.5 166.53 14.7 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.996 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 68.92 173.44 0.29 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.506 1.122 . . . . 0.0 110.586 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 57.05 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.702 1.201 . . . . 0.0 111.061 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.72 143.43 5.71 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.8 mtt -92.35 -165.93 1.44 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.525 0.73 . . . . 0.0 109.7 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.1 m -90.65 153.27 20.43 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.039 0.447 . . . . 0.0 110.048 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 p -87.09 104.71 16.6 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.26 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -123.55 97.5 5.41 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.88 0.872 . . . . 0.0 110.49 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 m -89.45 83.49 6.37 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.583 ' HB3' HD12 ' A' ' 46' ' ' LEU . 25.0 m-85 -81.87 110.46 17.18 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.477 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.3 p -121.55 -39.91 2.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.969 0.908 . . . . 0.0 110.472 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.619 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -141.14 40.0 1.78 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.883 -176.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.7 t 65.86 126.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 125.003 1.321 . . . . 0.0 113.133 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -93.69 -88.31 0.23 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 171.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 t70 169.51 -42.3 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.362 1.065 . . . . 0.0 109.294 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.5 p -63.42 -38.27 90.51 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.412 1.085 . . . . 0.0 111.806 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -60.51 141.9 91.44 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.945 0.898 . . . . 0.0 111.598 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.93 154.47 7.11 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.225 2.617 . . . . 0.0 113.815 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.14 67.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.973 0.909 . . . . 0.0 111.095 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.432 ' HB3' HG13 ' A' ' 81' ' ' VAL . 55.3 m-85 -62.3 -34.31 76.36 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.217 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.527 HD12 HG12 ' A' ' 81' ' ' VAL . 13.0 mm -79.76 -23.17 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 122.906 0.482 . . . . 0.0 110.52 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -68.27 -36.26 79.14 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.87 -41.84 92.4 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.71 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.573 HG23 HG13 ' A' ' 51' ' ' VAL . 54.3 mt -56.45 -46.6 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 123.994 0.809 . . . . 0.0 110.416 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' A' ' 31' ' ' TYR . 96.7 mt -64.04 -36.4 83.88 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -79.34 -1.93 39.16 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.163 0.585 . . . . 0.0 112.059 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.6 t -70.87 115.52 10.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 165.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -62.96 89.06 0.03 OUTLIER 'General case' 0 C--N 1.348 0.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.28 -52.48 0.25 Allowed Glycine 0 C--O 1.218 -0.872 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.056 -172.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.573 HG13 HG23 ' A' ' 45' ' ' ILE . 74.2 t -69.9 -40.83 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -168.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 19.6 ttmt 65.63 -72.69 0.07 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.857 1.663 . . . . 0.0 111.823 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 35.9 t -133.29 151.86 51.91 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.641 0.776 . . . . 0.0 111.24 -174.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 75.1 mt -129.68 107.01 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.469 1.508 . . . . 0.0 107.401 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.505 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 72.0 t80 -99.59 91.44 4.89 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -94.13 134.49 36.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.138 0.975 . . . . 0.0 109.649 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 p -171.02 153.32 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.433 0.693 . . . . 0.0 109.48 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.489 ' HG3' ' H ' ' A' ' 59' ' ' ASP 0.269 18.3 ptp 43.93 -84.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 126.698 1.999 . . . . 0.0 115.231 -175.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.489 ' H ' ' HG3' ' A' ' 58' ' ' MET . 9.5 p-10 -138.82 20.88 2.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.022 -1.049 . . . . 0.0 111.853 -172.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -147.54 167.37 24.68 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.439 HG21 HG21 ' A' ' 54' ' ' ILE . 68.4 mt -132.14 101.89 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.406 1.483 . . . . 0.0 108.118 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 68.4 m -82.78 94.65 7.68 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.764 0.426 . . . . 0.0 110.121 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.487 HG13 HG11 ' A' ' 51' ' ' VAL . 97.5 t -79.15 105.21 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 18.7 t0 -93.71 85.57 4.88 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.273 1.029 . . . . 0.0 109.966 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 13' ' ' ASN . 16.8 pttp -75.73 174.09 10.26 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.074 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -75.54 176.25 7.76 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.946 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -70.46 -66.02 0.66 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.521 0.328 . . . . 0.0 110.531 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -69.81 -44.22 70.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.021 0.528 . . . . 0.0 111.348 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.53 121.48 8.48 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.244 0.965 . . . . 0.0 110.476 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -94.94 154.9 16.98 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.752 0.821 . . . . 0.0 111.311 -168.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -62.88 -20.11 64.81 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.094 0.558 . . . . 0.0 112.459 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -70.07 -19.34 63.27 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.565 0.346 . . . . 0.0 111.311 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.2 m -95.28 -47.18 6.43 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.409 0.683 . . . . 0.0 110.469 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.461 HG13 HG23 ' A' ' 51' ' ' VAL . 93.5 t -70.32 -59.99 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.934 0.893 . . . . 0.0 112.364 -171.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.3 tt -56.78 -50.27 88.97 Favored Pre-proline 0 CA--C 1.57 1.725 0 CA-C-O 117.773 -1.108 . . . . 0.0 112.902 -171.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -59.2 -31.25 94.96 Favored 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.409 2.072 . . . . 0.0 112.894 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -71.9 -41.25 68.16 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.659 0.784 . . . . 0.0 111.227 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.64 -48.51 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.96 -38.38 85.72 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.228 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.92 -29.1 70.31 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.13 0.972 . . . . 0.0 111.844 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.527 HG12 HD12 ' A' ' 42' ' ' ILE . 38.0 t -68.32 -39.4 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.686 0.394 . . . . 0.0 110.991 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -70.9 -40.79 71.97 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.469 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.0 79.14 1.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 124.658 1.183 . . . . 0.0 111.854 -177.682 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.464 0.649 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 10.8 mtmp? -137.55 -175.72 4.16 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.258 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -92.27 93.83 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.592 HG13 ' HB3' ' A' ' 20' ' ' SER . 49.1 mm -90.41 -42.13 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.364 0.666 . . . . 0.0 110.027 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -142.84 156.29 44.92 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.15 0.98 . . . . 0.0 108.87 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -111.51 -75.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.462 0.705 . . . . 0.0 110.196 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.6 t . . . . . 0 N--CA 1.484 1.25 0 C-N-CA 124.813 1.245 . . . . 0.0 110.79 -176.858 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.2 m80 . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.19 -48.27 18.05 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -128.04 141.65 51.45 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.472 0.653 . . . . 0.0 111.863 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.598 ' SD ' HD23 ' A' ' 75' ' ' LEU . 13.2 ptp -130.63 148.79 52.47 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 108.765 167.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 59.3 mttp -94.42 158.26 15.64 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.319 0.648 . . . . 0.0 109.538 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.1 mt -132.66 94.87 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.1 m -60.11 109.46 0.97 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.767 0.827 . . . . 0.0 109.983 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.9 mt -79.38 -26.76 41.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.939 0.496 . . . . 0.0 111.625 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.592 ' HB3' HG13 ' A' ' 4' ' ' ILE . 54.5 p 98.82 -6.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 127.876 2.47 . . . . 0.0 112.849 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -89.86 62.94 5.88 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.139 0.427 . . . . 0.0 109.887 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.3 m -65.22 84.47 0.05 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.586 0.707 . . . . 0.0 111.024 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -104.73 5.23 33.21 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.324 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 66.74 -71.1 0.1 Allowed 'General case' 0 C--N 1.37 1.497 0 C-N-CA 125.823 1.649 . . . . 0.0 111.075 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.29 56.34 4.25 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.288 -0.414 . . . . 0.0 112.246 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.9 ttt -94.92 46.95 1.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 m 68.47 155.2 0.12 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 125.752 1.621 . . . . 0.0 111.997 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.1 p -135.27 78.87 1.75 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.85 1.26 . . . . 0.0 108.309 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -124.52 144.68 49.98 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.434 0.694 . . . . 0.0 111.329 -165.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -99.92 149.73 23.12 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.989 0.916 . . . . 0.0 109.978 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 59.5 m-85 -141.35 113.99 8.32 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.156 1.383 . . . . 0.0 107.782 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.4 p -136.71 -43.06 0.59 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.564 0.746 . . . . 0.0 110.262 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -106.61 32.76 4.28 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.983 0.913 . . . . 0.0 112.076 -164.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 43' ' ' ASN . 58.9 t 55.58 64.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 122.756 1.265 . . . . 0.0 109.194 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.3 135.21 42.57 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.481 -1.69 . . . . 0.0 111.321 -170.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -77.09 91.89 3.72 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 p -177.96 -61.83 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.685 1.194 . . . . 0.0 108.662 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.473 ' HG3' ' ND2' ' A' ' 43' ' ' ASN . 25.2 pt20 -60.08 149.69 73.56 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.904 1.282 . . . . 0.0 111.91 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.6 150.93 11.18 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.262 2.642 . . . . 0.0 112.542 168.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.87 -37.33 63.58 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 123.687 0.617 . . . . 0.0 111.253 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -55.69 -40.31 72.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.89 1.276 . . . . 0.0 111.937 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.4 mm -75.63 -28.96 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.435 0.694 . . . . 0.0 110.304 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.473 ' ND2' ' HG3' ' A' ' 38' ' ' GLN . 55.5 m-80 -70.86 -34.94 72.15 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -64.61 -34.89 79.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.071 0.548 . . . . 0.0 110.93 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.9 mt -60.55 -45.24 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 123.728 0.642 . . . . 0.0 110.091 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.2 -35.74 78.01 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.921 0.488 . . . . 0.0 111.883 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.58 -14.12 60.38 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.212 0.605 . . . . 0.0 111.647 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.39 109.77 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -59.12 104.64 0.26 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.041 0.838 . . . . 0.0 111.003 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 146.88 -45.3 0.78 Allowed Glycine 0 C--N 1.344 1.015 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.5 121.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.791 0.836 . . . . 0.0 109.897 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.405 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 26.2 ttpp -104.96 -32.58 8.69 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.84 0.856 . . . . 0.0 110.965 -172.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 t -151.99 161.62 42.35 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.73 0.412 . . . . 0.0 111.062 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 79.1 mt -148.02 116.84 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.658 1.583 . . . . 0.0 107.252 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -119.59 110.23 16.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.798 0.439 . . . . 0.0 110.083 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -95.16 119.94 34.52 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.29 147.81 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.074 0.55 . . . . 0.0 110.336 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 67.55 -68.46 0.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.529 1.532 . . . . 0.0 110.883 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -160.06 -25.44 0.06 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.87 1.268 . . . . 0.0 110.234 169.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -81.27 143.11 32.51 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-O 120.922 0.391 . . . . 0.0 111.259 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.16 103.18 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 15.0 t -83.32 89.25 6.98 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.6 t -77.48 126.13 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -120.21 149.4 42.32 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.275 1.03 . . . . 0.0 110.457 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.405 ' HA ' ' H ' ' A' ' 52' ' ' LYS . 17.8 pttp -140.22 179.88 6.38 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.681 1.192 . . . . 0.0 109.441 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.9 167.04 22.51 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.828 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.11 -48.38 71.07 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.976 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.96 -32.88 74.57 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.507 -172.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.83 161.99 27.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.705 0.802 . . . . 0.0 111.933 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -118.25 146.23 44.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.679 0.792 . . . . 0.0 110.074 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.497 ' HB3' HD21 ' A' ' 75' ' ' LEU . 66.1 m95 -69.66 -17.14 63.48 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.048 0.539 . . . . 0.0 111.031 172.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.59 -24.81 67.76 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.969 0.908 . . . . 0.0 111.792 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.7 m -84.75 -45.3 12.53 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.019 0.928 . . . . 0.0 110.397 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.8 t -73.5 -60.92 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.068 -169.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.598 HD23 ' SD ' ' A' ' 15' ' ' MET . 3.9 mm? -49.32 -47.62 76.33 Favored Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -172.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -55.51 -33.85 87.69 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.078 1.852 . . . . 0.0 113.876 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -80.96 -41.98 21.99 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.696 0.798 . . . . 0.0 110.5 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.1 t -74.42 -31.77 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.331 1.052 . . . . 0.0 111.523 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.5 -41.35 80.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.872 0.869 . . . . 0.0 110.987 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.33 -32.34 71.15 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.045 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -63.11 -40.19 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.901 0.88 . . . . 0.0 111.663 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.648 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 27.2 m-85 -91.2 25.08 2.63 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -145.62 -58.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.055 0.455 . . . . 0.0 109.904 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.487 1.381 0 C-N-CA 125.397 1.479 . . . . 0.0 111.091 -174.38 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.644 0.259 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -167.27 179.35 5.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.78 0.832 . . . . 0.0 111.125 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.9 mt -72.41 115.84 13.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.107 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.2 mm -84.74 -45.65 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.3 p -154.65 133.44 12.19 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.12 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.7 mm -78.37 105.6 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 169.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.556 ' HB3' ' HG3' ' A' ' 16' ' ' LYS . 38.2 t -77.97 160.56 28.11 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 122.956 0.502 . . . . 0.0 110.804 -176.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -72.79 163.27 28.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.357 0.663 . . . . 0.0 111.607 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -154.27 144.17 15.47 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.709 0.804 . . . . 0.0 109.761 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.93 -11.6 8.81 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.465 2.11 . . . . 0.0 112.523 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -117.32 115.79 25.95 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -67.71 -19.83 65.2 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.85 0.86 . . . . 0.0 111.81 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 25.6 t-20 -66.59 -64.76 0.79 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.536 0.734 . . . . 0.0 110.618 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.4 t -106.84 126.9 52.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.532 0.333 . . . . 0.0 110.121 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.408 ' HE3' HD23 ' A' ' 75' ' ' LEU . 25.4 ptt? -122.35 143.33 49.71 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.29 0.567 . . . . 0.0 110.457 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.556 ' HG3' ' HB3' ' A' ' 7' ' ' SER . 20.3 ptmt -88.38 140.53 29.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.84 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.1 mt -130.0 114.93 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.499 1.12 . . . . 0.0 109.317 -172.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.8 m -71.66 119.96 16.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.645 0.778 . . . . 0.0 110.322 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.9 mt -87.41 169.88 11.86 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.222 0.609 . . . . 0.0 110.696 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 p -74.7 -26.72 60.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.399 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HB2' ' SD ' ' A' ' 26' ' ' MET . 24.5 mm-40 -84.2 128.42 34.55 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.267 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.6 p -153.37 166.8 31.51 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.216 0.606 . . . . 0.0 111.334 -174.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 71.04 156.13 0.15 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.875 1.67 . . . . 0.0 112.437 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 69.28 -75.97 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.803 1.641 . . . . 0.0 110.853 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.02 116.45 1.06 Allowed Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.535 -0.302 . . . . 0.0 112.505 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.449 ' SD ' ' HB2' ' A' ' 21' ' ' GLU . 82.5 mtp -75.32 -167.59 0.67 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.302 1.041 . . . . 0.0 109.748 170.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.0 p -59.19 112.9 1.88 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.298 0.639 . . . . 0.0 110.991 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.1 p -94.59 84.87 4.36 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -144.78 141.74 29.44 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.828 0.851 . . . . 0.0 111.237 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 23.2 m -89.29 106.41 18.42 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -80.21 101.17 8.69 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -146.01 -33.7 0.32 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.948 0.499 . . . . 0.0 111.874 -171.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.428 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 46.9 pttt -88.85 4.87 46.26 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -169.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.4 t 65.02 126.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 125.448 1.499 . . . . 0.0 110.533 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 t70 72.01 47.34 0.31 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.927 1.291 . . . . 0.0 109.26 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.428 ' OD2' ' HG2' ' A' ' 33' ' ' LYS . 2.7 m-20 -84.31 47.91 1.41 Allowed 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.882 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.0 p 58.05 19.29 5.85 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.843 1.657 . . . . 0.0 113.249 -174.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.32 147.01 34.12 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 123.789 0.836 . . . . 0.0 109.966 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -52.43 155.19 10.15 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.739 2.959 . . . . 0.0 113.809 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.86 -31.35 49.29 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.253 1.021 . . . . 0.0 112.107 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -56.73 -44.98 82.19 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.216 1.006 . . . . 0.0 111.257 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mm -71.55 -28.86 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.381 0.672 . . . . 0.0 109.958 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 28.8 m-80 -72.07 -32.93 67.52 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.91 0.484 . . . . 0.0 110.068 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 48' ' ' VAL . 28.0 t70 -63.43 -41.78 98.7 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 124.145 0.903 . . . . 0.0 109.8 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.0 mt -59.74 -44.84 94.69 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 O-C-N 124.267 0.979 . . . . 0.0 109.882 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.48 -36.68 74.12 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.132 0.573 . . . . 0.0 111.223 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 43' ' ' ASN . 96.2 mttt -79.45 -19.72 49.2 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.658 0.783 . . . . 0.0 112.09 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 44' ' ' ASP . 55.9 t -60.44 121.83 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.65 89.47 0.05 OUTLIER 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.353 1.033 . . . . 0.0 109.581 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.15 -32.07 0.45 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.184 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.89 131.4 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.476 0.71 . . . . 0.0 109.7 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -87.05 -52.05 5.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.331 0.652 . . . . 0.0 109.26 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.6 p -163.31 173.0 13.84 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.584 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.454 HG22 HG23 ' A' ' 63' ' ' VAL . 74.0 mt -132.03 101.04 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 28.8 t80 -81.98 146.27 29.83 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -135.54 135.03 40.04 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.12 124.64 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.538 0.735 . . . . 0.0 110.241 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 45.6 ttm 55.78 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.263 1.425 . . . . 0.0 112.821 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -120.31 -39.32 2.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.131 0.572 . . . . 0.0 110.6 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -98.26 138.79 35.01 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.644 0.735 . . . . 0.0 110.807 -167.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.5 mt -85.61 163.78 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.801 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -143.44 86.31 1.89 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 54' ' ' ILE . 40.7 t -80.01 114.63 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.27 131.15 34.32 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.097 0.959 . . . . 0.0 108.69 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 13' ' ' ASN . 21.5 pttp -101.72 -173.86 2.45 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 173.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -89.39 162.71 15.64 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -59.13 -48.19 82.51 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.295 0.638 . . . . 0.0 112.631 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -80.55 -33.8 35.94 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.36 0.664 . . . . 0.0 111.597 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.35 140.94 12.59 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.591 1.156 . . . . 0.0 112.666 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -110.24 130.47 55.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.799 0.84 . . . . 0.0 110.302 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -60.35 -18.32 49.25 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.448 0.699 . . . . 0.0 112.027 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -56.73 -35.31 68.44 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.537 0.735 . . . . 0.0 110.732 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 t -101.06 -42.59 6.33 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.012 0.525 . . . . 0.0 110.884 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.1 t -70.73 -45.87 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.312 1.045 . . . . 0.0 113.358 -170.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.408 HD23 ' HE3' ' A' ' 15' ' ' MET . 32.6 tp -60.64 -43.74 93.22 Favored Pre-proline 0 N--CA 1.492 1.66 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.65 -176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -46.45 -34.31 14.32 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.415 2.077 . . . . 0.0 114.38 170.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -75.1 -41.45 58.64 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.337 0.655 . . . . 0.0 111.118 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -65.02 -58.12 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-O 121.638 0.732 . . . . 0.0 109.237 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.67 -31.17 67.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.73 1.612 . . . . 0.0 112.26 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.14 55.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.383 1.073 . . . . 0.0 112.876 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.3 -49.54 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.203 0.601 . . . . 0.0 110.816 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -69.28 -25.22 64.15 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.351 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -122.49 77.16 1.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.726 0.81 . . . . 0.0 109.534 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -142.87 168.75 18.97 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.097 0.959 . . . . 0.0 108.565 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -68.38 98.07 0.8 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.23 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -82.68 104.93 13.3 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.92 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -136.31 155.82 49.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.093 0.957 . . . . 0.0 109.044 167.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -78.13 143.96 36.84 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.528 0.731 . . . . 0.0 110.068 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -123.72 119.76 30.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.044 0.938 . . . . 0.0 109.333 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -152.25 -48.5 0.11 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.388 0.675 . . . . 0.0 110.215 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 CA--C 1.561 1.374 0 O-C-N 124.763 1.289 . . . . 0.0 110.244 -172.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -145.28 144.45 30.78 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.452 0.701 . . . . 0.0 110.424 -175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.5 mt -73.58 95.04 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.4 0.68 . . . . 0.0 109.728 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 mm -83.54 -35.51 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.698 0.799 . . . . 0.0 110.138 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.7 t -134.31 146.75 50.28 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.824 0.45 . . . . 0.0 111.123 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.436 HG23 ' HG2' ' A' ' 15' ' ' MET . 72.6 mt -128.76 133.95 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.775 1.63 . . . . 0.0 108.252 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.4 p -98.64 53.67 1.02 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.226 0.536 . . . . 0.0 111.285 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -103.2 -17.4 15.37 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.098 0.559 . . . . 0.0 112.388 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 m -89.21 -53.23 0.34 Allowed Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 123.721 0.809 . . . . 0.0 110.009 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -82.86 -10.69 10.42 Favored 'Trans proline' 0 C--N 1.395 2.991 0 C-N-CA 121.773 1.649 . . . . 0.0 113.288 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -145.65 -161.86 1.39 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -168.33 148.87 4.8 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.828 0.74 . . . . 0.0 109.736 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 69.64 20.29 7.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.553 1.141 . . . . 0.0 111.912 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 13.2 t -161.01 143.1 12.29 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.097 0.959 . . . . 0.0 108.832 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.5 ' O ' ' HA ' ' A' ' 62' ' ' SER . 57.7 mtm -115.68 110.76 19.61 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HZ2' ' HB3' ' A' ' 60' ' ' PHE . 35.5 tptt -75.74 85.89 2.75 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 165.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.442 HD11 ' HE1' ' A' ' 15' ' ' MET . 68.2 mt -77.31 93.29 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.0 m -77.94 116.89 18.77 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.1 mt -84.88 -150.49 0.12 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 p -76.65 15.17 0.67 Allowed 'General case' 0 CA--C 1.558 1.269 0 O-C-N 121.93 -0.481 . . . . 0.0 112.114 173.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 42.4 mt-10 67.82 92.4 0.08 Allowed 'General case' 0 C--N 1.358 0.944 0 C-N-CA 125.903 1.681 . . . . 0.0 110.798 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -73.07 131.92 42.69 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -76.11 78.91 2.94 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.549 0.531 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 62.17 13.27 5.7 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.497 1.119 . . . . 0.0 111.874 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.12 -26.7 61.43 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.156 -173.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.0 mmt -80.46 107.13 13.01 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.5 p -75.12 154.54 37.74 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.579 0.352 . . . . 0.0 110.916 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.0 p -69.48 96.06 0.88 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.241 0.543 . . . . 0.0 110.815 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -119.2 111.06 17.76 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.258 1.023 . . . . 0.0 109.565 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.3 m -91.1 97.23 11.03 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -81.98 103.78 11.87 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.0 p -99.47 49.81 0.94 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.753 1.221 . . . . 0.0 109.307 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HA ' HD12 ' A' ' 46' ' ' LEU 0.298 0.9 OUTLIER 56.72 99.55 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 127.427 2.291 . . . . 0.0 113.727 179.372 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t 50.54 80.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 125.53 1.532 . . . . 0.0 111.215 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -151.78 -50.08 0.11 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -164.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -105.07 -96.64 0.33 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.856 0.462 . . . . 0.0 110.783 -169.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.6 t -161.81 87.54 0.67 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.1 pm0 -139.77 144.36 38.56 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.627 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -53.34 150.65 25.42 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.837 2.358 . . . . 0.0 112.326 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.33 -34.43 57.41 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.581 0.753 . . . . 0.0 111.057 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.414 ' HB3' HG11 ' A' ' 81' ' ' VAL . 91.0 m-85 -56.82 -46.94 81.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.422 1.089 . . . . 0.0 111.499 176.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.0 mm -67.31 -32.35 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.202 0.601 . . . . 0.0 110.296 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.452 ' HA ' HD13 ' A' ' 46' ' ' LEU . 64.6 m-20 -70.5 -32.01 69.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.509 0.724 . . . . 0.0 110.702 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.418 ' O ' HG21 ' A' ' 48' ' ' VAL . 1.1 m-20 -65.63 -38.11 88.47 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.237 0.615 . . . . 0.0 111.221 175.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.43 HG22 HG21 ' A' ' 78' ' ' VAL . 59.7 mt -61.99 -44.6 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.794 0.807 . . . . 0.0 109.931 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 33' ' ' LYS . 58.7 mt -61.89 -34.55 76.23 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.725 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -82.32 -8.67 59.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.559 0.744 . . . . 0.0 112.562 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 74' ' ' VAL . 65.9 t -70.5 105.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 171.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.69 94.31 0.2 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.694 0.798 . . . . 0.0 110.451 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 161.44 -35.81 0.39 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.0 129.73 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.825 0.85 . . . . 0.0 109.024 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.503 ' HZ1' ' HB2' ' A' ' 52' ' ' LYS . 5.1 ttmp? -78.6 -57.04 3.97 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 p -163.61 178.49 7.92 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.975 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.5 mt -132.27 117.64 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.084 0.954 . . . . 0.0 109.221 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -103.67 97.54 7.54 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.697 0.76 . . . . 0.0 109.621 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -87.86 131.35 34.59 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.652 1.181 . . . . 0.0 109.88 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.4 p -172.52 155.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 118.433 0.56 . . . . 0.0 111.715 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 27.5 ttt 65.09 -83.81 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.5 1.92 . . . . 0.0 112.918 171.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.439 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 7.1 p-10 -132.71 -16.19 2.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.977 0.911 . . . . 0.0 110.561 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.424 ' HB3' ' HZ2' ' A' ' 16' ' ' LYS . 37.6 p90 -122.54 171.13 9.33 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 122.129 0.966 . . . . 0.0 112.446 -162.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -126.06 103.67 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.616 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 15' ' ' MET . 28.5 t -86.0 89.08 7.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.3 t -88.54 107.72 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 4.8 p-10 -106.58 158.19 17.12 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.894 0.478 . . . . 0.0 111.035 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -139.44 -167.97 2.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.815 0.846 . . . . 0.0 111.889 -165.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -88.19 161.13 17.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.33 1.052 . . . . 0.0 110.826 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.87 -27.02 67.91 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.731 0.812 . . . . 0.0 113.048 -172.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -97.1 -28.26 14.21 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.813 0.845 . . . . 0.0 111.734 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.28 130.89 23.74 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.817 0.847 . . . . 0.0 112.282 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -104.6 127.43 52.33 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.242 0.617 . . . . 0.0 110.443 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 63.3 m95 -71.87 -16.72 62.15 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.531 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.92 -34.54 71.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.083 0.468 . . . . 0.0 110.787 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.1 m -82.96 -44.7 14.99 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.74 0.816 . . . . 0.0 110.536 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 48' ' ' VAL . 48.2 t -74.61 -39.51 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.944 0.898 . . . . 0.0 112.538 -170.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 71' ' ' TRP . 3.0 tt -59.14 -44.25 98.29 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-O 117.125 -1.417 . . . . 0.0 112.509 -168.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -48.96 -31.21 19.69 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.441 2.094 . . . . 0.0 114.676 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.08 -40.81 21.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.515 0.726 . . . . 0.0 110.029 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.43 HG21 HG22 ' A' ' 45' ' ' ILE . 56.2 t -63.81 -38.45 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 123.914 0.885 . . . . 0.0 109.936 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.68 -47.64 82.77 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.73 1.612 . . . . 0.0 109.868 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.51 -31.1 61.78 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.854 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 41' ' ' PHE . 56.1 t -68.34 -55.48 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.41 0.684 . . . . 0.0 110.683 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 1' ' ' MET . 17.9 m-85 -65.04 -29.05 69.92 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -80.14 -38.59 31.12 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.029 0.532 . . . . 0.0 112.07 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 84.0 mt 55.27 37.58 29.11 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.055 0.942 . . . . 0.0 109.504 -164.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.44 ' HB2' ' HD2' ' A' ' 87' ' ' HIS . 2.3 mp0 53.17 -136.61 1.34 Allowed 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.242 -168.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -117.76 51.38 1.05 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 165.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.44 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 89.0 m-70 -83.31 -166.56 1.4 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.135 172.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -71.57 79.82 0.81 Allowed 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.474 1.131 . . . . 0.0 109.947 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -102.69 21.87 14.66 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.984 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 65.84 6.32 3.91 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.534 1.533 . . . . 0.0 112.31 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.1 t60 . . . . . 0 C--O 1.25 1.081 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -174.498 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.66 ' SD ' ' HE1' ' A' ' 26' ' ' MET . 54.9 mtm . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -127.94 -174.75 3.28 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.9 mt -76.1 108.1 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -82.16 -51.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -162.79 147.88 11.93 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.558 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mt -89.74 97.29 6.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 168.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -83.74 -166.16 1.32 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.531 0.732 . . . . 0.0 111.782 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -58.01 154.69 12.11 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.034 0.933 . . . . 0.0 113.424 -168.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 t -155.61 64.63 4.05 Favored Pre-proline 0 CA--C 1.556 1.187 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.003 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.5 -13.01 32.42 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.534 2.156 . . . . 0.0 112.663 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -85.3 -32.82 22.31 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.192 0.597 . . . . 0.0 110.052 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.2 t60 71.03 165.57 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.971 1.308 . . . . 0.0 109.974 -171.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 77.56 -51.22 0.53 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.234 1.414 . . . . 0.0 111.254 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.4 t -105.71 112.04 24.96 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.866 0.466 . . . . 0.0 110.635 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.9 mtm -98.98 142.85 29.95 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.187 0.518 . . . . 0.0 110.048 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HZ1' ' HB3' ' A' ' 60' ' ' PHE . 52.5 tttp -89.59 113.73 25.2 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.936 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.8 mt -93.32 111.39 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.4 m -76.59 122.89 25.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.579 0.752 . . . . 0.0 109.832 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.2 mt -101.99 -171.3 1.95 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.489 0.715 . . . . 0.0 109.727 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 p -76.72 6.76 5.48 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 63.86 -171.29 0.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.427 1.091 . . . . 0.0 112.122 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 t -151.28 -162.81 1.62 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -69.68 89.56 0.55 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.244 0.618 . . . . 0.0 109.576 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 65.49 -74.0 0.06 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.453 1.501 . . . . 0.0 110.482 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.85 148.68 20.43 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.034 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.66 ' HE1' ' SD ' ' A' ' 1' ' ' MET . 23.8 ptt? -131.64 127.53 37.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.236 1.014 . . . . 0.0 109.447 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 t 46.64 176.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 126.609 1.964 . . . . 0.0 115.365 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 p -155.61 98.37 1.94 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.624 0.769 . . . . 0.0 109.46 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.49 164.24 14.86 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.108 0.963 . . . . 0.0 110.866 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 m -141.41 98.02 3.28 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 161.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.573 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 40.4 m-85 -82.16 111.97 18.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 p -122.38 -71.29 0.73 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.079 0.552 . . . . 0.0 110.134 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -110.02 46.88 0.99 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.683 0.793 . . . . 0.0 108.994 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.4 t 67.6 120.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 125.139 1.376 . . . . 0.0 111.704 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.17 -81.41 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.903 1.281 . . . . 0.0 110.4 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 166.06 -66.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.299 1.44 . . . . 0.0 108.611 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t -90.98 -2.4 57.71 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.117 0.967 . . . . 0.0 111.802 -169.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -63.08 149.84 89.86 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 123.693 0.797 . . . . 0.0 111.257 173.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -53.61 148.21 36.31 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.556 2.837 . . . . 0.0 113.731 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.02 69.81 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.029 0.931 . . . . 0.0 111.364 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.441 ' HB3' HG12 ' A' ' 81' ' ' VAL . 31.5 m-85 -61.48 -36.69 81.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.983 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.3 mm -75.69 -25.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -69.1 -37.26 78.3 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.15 -39.17 92.62 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.6 0.76 . . . . 0.0 110.358 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.528 HG21 HG12 ' A' ' 51' ' ' VAL . 29.2 mt -66.42 -34.55 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 123.533 0.521 . . . . 0.0 110.04 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.532 HD13 ' HB3' ' A' ' 31' ' ' TYR . 88.9 mt -64.32 -35.54 81.19 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.838 0.455 . . . . 0.0 111.804 174.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.36 -15.37 61.87 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.896 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.49 97.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.82 87.48 0.06 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 109.904 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.46 -17.22 0.08 OUTLIER Glycine 0 C--O 1.221 -0.714 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.881 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.528 HG12 HG21 ' A' ' 45' ' ' ILE . 35.6 m -85.77 -27.86 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.56 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 22.2 ttmm 48.59 -77.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.94 2.096 . . . . 0.0 113.217 -173.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 49.9 m -122.89 98.06 5.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.945 0.898 . . . . 0.0 110.172 -171.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 66.0 mt -83.93 84.08 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.43 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 92.5 t80 -81.49 140.32 34.65 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.429 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -137.02 134.41 36.56 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.15 143.32 9.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 171.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.2 ttt 62.31 -80.45 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 O-C-N 124.651 1.22 . . . . 0.0 111.837 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.59 -38.01 1.55 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.636 0.774 . . . . 0.0 111.327 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.465 ' HB3' ' HZ1' ' A' ' 16' ' ' LYS . 33.7 p90 -103.44 165.14 11.21 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.305 0.642 . . . . 0.0 112.625 -163.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.3 mt -120.19 111.53 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.989 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 50.1 m -85.83 95.37 9.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.358 0.663 . . . . 0.0 109.61 173.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 14' ' ' THR . 52.4 t -85.07 99.95 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.56 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 1.8 m-20 -84.7 98.3 10.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.683 1.193 . . . . 0.0 108.58 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.624 ' HD2' ' HB3' ' A' ' 69' ' ' ALA . 57.9 pttt -66.25 177.09 1.54 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -175.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.557 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 47.7 mm-40 -64.09 -177.39 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.499 0.719 . . . . 0.0 112.274 174.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -61.0 -25.1 66.65 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.528 0.731 . . . . 0.0 111.732 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.13 -58.27 0.9 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.412 0.685 . . . . 0.0 109.772 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.624 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . 49.6 -164.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.85 1.26 . . . . 0.0 113.053 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -156.8 114.21 3.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -68.69 -28.07 66.53 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.064 0.546 . . . . 0.0 111.832 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.63 -21.65 64.46 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 120.982 0.42 . . . . 0.0 110.505 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.7 m -86.0 -45.14 11.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.115 0.566 . . . . 0.0 110.396 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.44 -58.14 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.845 0.858 . . . . 0.0 112.571 -173.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.36 -47.01 99.73 Favored Pre-proline 0 N--CA 1.491 1.599 0 CA-C-O 117.362 -1.304 . . . . 0.0 114.321 -170.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.49 -33.99 60.03 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 122.14 1.893 . . . . 0.0 113.974 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -77.25 -39.02 49.82 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.811 0.844 . . . . 0.0 110.435 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.94 -41.23 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.765 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.93 -36.88 84.87 Favored 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 123.75 0.82 . . . . 0.0 110.837 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.71 -30.49 67.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.415 0.686 . . . . 0.0 111.917 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.453 HG21 HD11 ' A' ' 45' ' ' ILE . 40.6 t -65.83 -58.96 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.848 0.859 . . . . 0.0 111.928 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -73.75 -42.93 60.41 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.261 0.624 . . . . 0.0 110.914 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.5 70.36 2.26 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.18 -32.17 64.09 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.558 0.743 . . . . 0.0 110.915 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.68 164.12 28.98 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.721 1.209 . . . . 0.0 109.682 174.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -78.0 109.24 11.89 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -57.16 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.209 1.004 . . . . 0.0 112.01 -170.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -172.2 66.04 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.7 0.8 . . . . 0.0 109.218 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -86.47 -42.97 13.14 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -138.29 161.46 36.84 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.626 1.17 . . . . 0.0 108.865 169.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 71.1 t60 . . . . . 0 CA--C 1.557 1.246 0 C-N-CA 123.915 0.886 . . . . 0.0 109.776 -174.518 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 121.132 0.491 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 50.9 pttt -145.14 -170.72 3.49 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.195 0.998 . . . . 0.0 108.984 173.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.51 HD13 HD11 ' A' ' 6' ' ' ILE . 59.5 mt -78.12 116.65 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 163.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.656 HD12 ' HA ' ' A' ' 19' ' ' LEU . 1.6 mp -83.43 -52.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 t -159.32 124.39 4.13 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.432 0.458 . . . . 0.0 110.881 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.559 HG21 ' HB2' ' A' ' 15' ' ' MET . 59.8 mt -92.25 90.6 3.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m 55.99 -160.93 0.19 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.959 0.904 . . . . 0.0 112.532 171.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -83.98 -32.66 24.87 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.402 0.62 . . . . 0.0 110.892 170.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 t -130.8 134.49 26.05 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.449 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.07 -52.49 7.19 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.91 2.407 . . . . 0.0 113.044 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.499 ' HA ' ' HD1' ' A' ' 71' ' ' TRP . 63.2 t30 -83.88 124.55 31.09 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.121 0.486 . . . . 0.0 110.837 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -172.69 171.01 4.57 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.559 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 1.6 m120 -72.28 -22.29 61.23 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.03 1.287 . . . . 0.0 111.469 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 11.9 t -140.31 162.44 35.29 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.225 1.01 . . . . 0.0 109.292 171.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.559 ' HB2' HG21 ' A' ' 6' ' ' ILE . 6.9 ptp -136.36 125.49 24.55 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.285 0.564 . . . . 0.0 110.929 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -80.32 92.39 5.77 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.008 0.923 . . . . 0.0 109.356 170.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.482 HG12 HG12 ' A' ' 6' ' ' ILE . 71.1 mt -80.04 95.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 m -82.75 141.32 32.47 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.519 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.656 ' HA ' HD12 ' A' ' 4' ' ' ILE . 75.5 mt -111.98 160.85 17.06 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.141 0.976 . . . . 0.0 110.069 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.4 p -76.31 -15.81 59.91 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.205 1.002 . . . . 0.0 111.886 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.39 61.62 6.72 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 122.078 0.942 . . . . 0.0 110.244 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.3 m -90.12 66.41 6.71 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.768 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -154.25 -56.43 0.11 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.882 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.57 -19.89 66.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -170.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.7 63.15 4.44 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.491 0.494 . . . . 0.0 112.457 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.9 mtt -48.7 149.55 1.7 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.28 1.432 . . . . 0.0 112.821 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.7 p -66.08 148.6 51.56 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.024 0.93 . . . . 0.0 111.926 -174.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 p -89.05 105.3 17.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.655 0.782 . . . . 0.0 110.223 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -138.39 138.23 38.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.471 0.708 . . . . 0.0 111.193 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.4 m -103.31 98.91 8.75 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.1 0.96 . . . . 0.0 109.552 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -83.98 116.08 22.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.465 1.106 . . . . 0.0 109.683 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.3 p -137.42 -75.79 0.41 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.365 0.666 . . . . 0.0 112.514 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -91.47 18.66 6.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -164.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t 61.86 90.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.369 1.068 . . . . 0.0 109.485 -170.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -163.0 155.68 18.89 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.563 0.745 . . . . 0.0 110.347 -171.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.8 t70 67.17 -80.56 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.471 1.509 . . . . 0.0 112.129 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.5 t -154.28 69.99 0.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.295 0.569 . . . . 0.0 110.006 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -108.74 104.74 55.47 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.485 0.714 . . . . 0.0 109.358 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.79 152.34 42.93 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.765 2.31 . . . . 0.0 112.221 173.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.46 -37.91 51.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.928 0.891 . . . . 0.0 111.612 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.57 ' HB3' HG12 ' A' ' 81' ' ' VAL . 59.1 m-85 -62.91 -39.48 94.64 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.126 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -74.73 -29.69 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.127 0.971 . . . . 0.0 110.587 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -41.12 91.87 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 48' ' ' VAL . 22.1 t70 -56.92 -49.23 76.24 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.297 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.484 HG23 HG23 ' A' ' 78' ' ' VAL . 61.1 mt -57.27 -46.26 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 124.148 0.905 . . . . 0.0 110.278 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.74 -36.91 82.37 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.719 0.808 . . . . 0.0 111.856 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -77.49 -13.36 59.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.405 0.682 . . . . 0.0 111.536 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 44' ' ' ASP . 96.9 t -71.0 125.9 30.27 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -61.97 92.11 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.109 1.364 . . . . 0.0 111.367 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.52 -52.13 0.38 Allowed Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.098 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.98 120.88 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.53 0.732 . . . . 0.0 110.985 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HZ1' ' HB3' ' A' ' 52' ' ' LYS . 7.7 ttpm? -95.55 -50.86 4.79 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.373 0.669 . . . . 0.0 110.074 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.3 t -143.06 152.68 42.14 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.79 0.436 . . . . 0.0 111.286 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.429 HG12 HG11 ' A' ' 63' ' ' VAL . 46.7 mt -125.2 94.59 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.773 1.229 . . . . 0.0 108.615 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -96.18 100.11 11.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.893 -0.504 . . . . 0.0 110.088 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.33 129.71 35.83 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 p -161.59 141.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.445 0.698 . . . . 0.0 111.086 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 65.08 -73.25 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.976 1.71 . . . . 0.0 113.594 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -155.16 8.84 0.29 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.78 0.432 . . . . 0.0 111.166 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -142.52 165.97 25.96 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.1 0.56 . . . . 0.0 110.213 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.59 102.27 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 15' ' ' MET . 19.3 p -81.98 89.07 6.37 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.429 HG11 HG12 ' A' ' 54' ' ' ILE . 43.8 t -89.27 116.04 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.244 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 4.1 p30 -99.75 163.72 12.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.941 0.496 . . . . 0.0 111.293 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -136.37 173.07 12.1 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.342 -175.348 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.07 125.06 32.45 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 166.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -54.68 -21.18 9.95 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.715 1.206 . . . . 0.0 113.347 -167.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -51.76 -47.9 63.95 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.598 1.159 . . . . 0.0 112.159 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.09 130.54 35.52 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.61 0.764 . . . . 0.0 111.389 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -84.94 155.94 21.41 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.103 0.561 . . . . 0.0 109.56 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.499 ' HD1' ' HA ' ' A' ' 11' ' ' ASN . 49.4 m95 -76.58 -31.38 57.48 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -28.62 44.14 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -171.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -81.12 -39.59 25.36 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.889 0.876 . . . . 0.0 110.011 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.65 -36.04 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 124.93 1.292 . . . . 0.0 111.703 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.473 HD21 ' HE2' ' A' ' 15' ' ' MET . 77.0 mt -50.12 -49.12 77.4 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 125.194 1.398 . . . . 0.0 114.59 -172.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.85 -31.16 88.04 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.885 1.723 . . . . 0.0 113.555 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -80.13 -40.18 27.96 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.862 0.865 . . . . 0.0 110.387 -176.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.484 HG23 HG23 ' A' ' 45' ' ' ILE . 59.8 t -65.81 -48.91 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.22 -31.26 72.38 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.966 0.906 . . . . 0.0 111.339 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.67 -34.83 69.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.892 0.877 . . . . 0.0 111.119 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.57 HG12 ' HB3' ' A' ' 41' ' ' PHE . 43.2 t -57.82 -46.99 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.914 0.886 . . . . 0.0 111.059 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.596 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 18.1 m-85 -87.69 19.56 3.38 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.693 0.797 . . . . 0.0 112.684 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -157.05 5.75 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.89 -31.44 66.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 111.306 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 53.39 43.55 31.22 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.45 1.094 . . . . 0.0 112.791 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -80.53 73.25 7.46 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.461 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -171.54 115.04 0.38 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.549 1.54 . . . . 0.0 107.378 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -68.99 -33.03 73.01 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.564 0.746 . . . . 0.0 111.184 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -70.75 152.27 43.98 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 167.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -87.13 139.92 30.08 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.2 m170 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 124.882 1.273 . . . . 0.0 110.481 -178.64 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.609 0.242 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.75 157.8 16.71 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.464 HG22 HG13 ' A' ' 6' ' ' ILE . 32.8 mt -76.93 129.85 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.983 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.4 mm -87.56 -48.02 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.935 0.894 . . . . 0.0 109.849 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 p -142.25 128.73 20.15 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.369 0.667 . . . . 0.0 109.673 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.464 HG13 HG22 ' A' ' 3' ' ' ILE . 3.8 mp -90.53 86.92 2.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.581 ' HB2' HD22 ' A' ' 11' ' ' ASN . 97.5 p 60.52 176.57 0.1 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.531 1.533 . . . . 0.0 113.901 171.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.439 ' HB2' ' OD1' ' A' ' 11' ' ' ASN . 40.8 mt-10 -115.1 -166.01 1.08 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.332 1.053 . . . . 0.0 108.335 168.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.4 p -87.13 -48.97 0.47 Allowed Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 118.275 -0.869 . . . . 0.0 113.232 -176.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.67 -9.9 21.48 Favored 'Trans proline' 0 C--N 1.396 3.031 0 CA-C-N 121.374 1.526 . . . . 0.0 112.817 -166.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.581 HD22 ' HB2' ' A' ' 7' ' ' SER . 3.7 p-10 -99.03 50.62 0.95 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.629 1.171 . . . . 0.0 110.156 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -64.25 -27.38 69.01 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.977 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.58 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 76.9 m-20 -102.82 8.79 39.25 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.161 0.584 . . . . 0.0 112.191 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 3.1 t -159.89 95.07 1.16 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.545 0.738 . . . . 0.0 110.135 176.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.1 mtp -82.65 125.77 31.57 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 121.713 -0.617 . . . . 0.0 111.802 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 7' ' ' SER . 23.0 ttmm -79.92 89.73 5.31 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.743 1.217 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.459 HD13 HG22 ' A' ' 63' ' ' VAL . 70.9 mt -85.6 95.63 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 174.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 60' ' ' PHE . 49.3 m -77.06 124.16 27.4 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.265 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.3 mt -87.55 164.52 16.06 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.118 0.485 . . . . 0.0 110.785 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -76.02 -19.89 58.28 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.872 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -96.73 101.57 13.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 109.664 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.774 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 29.3 t -79.41 107.94 12.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.536 0.734 . . . . 0.0 109.291 173.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 46.08 -154.94 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.712 1.605 . . . . 0.0 113.326 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.22 40.88 32.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.137 0.975 . . . . 0.0 112.078 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.79 -32.29 1.45 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.804 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.8 mmt -90.34 101.91 14.64 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.547 0.739 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.7 m -80.11 166.82 21.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.016 0.926 . . . . 0.0 111.057 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 67.8 p -80.87 74.35 7.85 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.937 0.895 . . . . 0.0 109.784 170.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -87.15 153.99 21.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.584 1.154 . . . . 0.0 110.387 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -128.54 101.25 6.09 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.453 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 37.4 m-85 -88.01 119.62 28.56 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.2 p -118.19 -62.44 1.54 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.52 0.6 . . . . 0.0 112.132 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.65 26.97 7.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -157.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.5 t 62.11 83.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -166.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.76 -77.21 0.26 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.567 -162.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -169.31 -77.2 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.02 0.373 . . . . 0.0 111.337 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 m -89.15 68.48 8.18 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.089 0.956 . . . . 0.0 110.727 -171.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -151.65 154.22 32.91 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.594 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.489 ' HB2' ' HB2' ' A' ' 41' ' ' PHE . 21.5 Cg_exo -66.2 150.89 84.68 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 122.669 2.246 . . . . 0.0 112.215 169.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.02 -23.76 63.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.865 0.866 . . . . 0.0 111.389 171.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.552 ' HB3' HG13 ' A' ' 81' ' ' VAL . 25.3 m-85 -46.97 -51.4 17.16 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.374 1.47 . . . . 0.0 110.82 170.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.1 mm -72.62 -29.25 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.625 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.421 HD21 HD12 ' A' ' 46' ' ' LEU . 14.0 m120 -67.97 -32.94 73.71 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.362 0.665 . . . . 0.0 111.945 -175.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -59.08 -46.8 87.35 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.492 0.495 . . . . 0.0 110.22 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.8 mt -66.07 -38.75 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.609 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.421 HD12 HD21 ' A' ' 43' ' ' ASN . 76.7 mt -60.71 -39.53 88.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.36 0.664 . . . . 0.0 111.709 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -85.62 4.13 37.69 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.267 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.2 t -78.84 123.53 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 169.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.13 130.39 34.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.571 0.748 . . . . 0.0 110.931 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.63 -32.67 7.3 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.644 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.37 109.36 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -78.94 -55.24 5.29 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.427 0.691 . . . . 0.0 110.568 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.1 t -158.88 157.29 31.19 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.567 0.698 . . . . 0.0 110.716 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 67.6 mt -114.4 87.26 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 58.3 t80 -84.26 90.75 7.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.546 0.689 . . . . 0.0 109.841 -175.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -80.75 117.37 21.36 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 2.5 p -140.97 125.25 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.129 0.422 . . . . 0.0 110.556 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 62.84 -71.98 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.446 1.498 . . . . 0.0 110.59 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.774 ' HB3' ' HA ' ' A' ' 22' ' ' SER . 2.0 p30 -148.46 -33.08 0.24 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.849 1.259 . . . . 0.0 110.08 172.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 29.0 p90 -83.86 129.31 34.93 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -174.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.26 113.78 39.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -176.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 10.9 m -82.37 81.84 8.07 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.643 0.777 . . . . 0.0 109.64 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 17' ' ' ILE . 48.7 t -78.85 92.89 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -82.41 151.2 26.71 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.265 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' A' ' 13' ' ' ASN . 39.0 pttt -137.17 -178.2 5.1 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.746 -173.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.84 140.88 30.85 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.95 -38.57 62.16 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.708 0.803 . . . . 0.0 112.163 -169.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.52 -32.62 72.7 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.702 0.801 . . . . 0.0 112.956 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . -56.31 111.33 0.94 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.936 0.894 . . . . 0.0 111.945 -175.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.496 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 15.8 m120 -82.47 126.4 32.19 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -70.59 -13.99 62.31 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.821 0.448 . . . . 0.0 112.101 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 70' ' ' ASN . 12.6 pt-20 -60.65 -28.4 68.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.302 0.641 . . . . 0.0 111.549 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.2 t -96.49 -40.68 8.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.761 0.824 . . . . 0.0 111.307 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.6 t -66.1 -47.23 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.094 0.958 . . . . 0.0 111.659 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.84 -43.33 97.59 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.858 -171.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.12 -39.51 20.49 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.732 2.288 . . . . 0.0 113.742 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -75.59 -41.32 54.92 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.036 0.534 . . . . 0.0 111.391 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.421 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 76.0 t -60.01 -55.52 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.317 0.647 . . . . 0.0 110.643 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -60.12 -39.11 85.08 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.035 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.59 -33.12 72.27 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.53 0.732 . . . . 0.0 111.655 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 41' ' ' PHE . 8.2 t -58.85 -48.56 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.295 0.638 . . . . 0.0 110.88 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -74.44 -30.48 61.91 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.932 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -107.0 20.39 19.11 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.419 HD21 ' HA ' ' A' ' 81' ' ' VAL . 4.5 pp -84.38 5.92 25.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 122.176 -0.328 . . . . 0.0 111.417 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -52.41 150.8 4.52 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 123.698 0.799 . . . . 0.0 110.332 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -49.56 110.54 0.39 Allowed 'General case' 0 N--CA 1.477 0.893 0 O-C-N 124.585 1.178 . . . . 0.0 110.087 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -60.49 -48.28 82.46 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.546 0.738 . . . . 0.0 111.603 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 66.74 150.78 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.752 1.221 . . . . 0.0 111.644 -175.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -80.35 -11.18 59.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.222 167.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -75.5 75.4 2.55 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 164.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 . . . . . 0 C--O 1.252 1.191 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.282 -175.76 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.488 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -122.76 179.31 4.67 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.607 0.763 . . . . 0.0 109.969 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.523 HD13 ' HG2' ' A' ' 79' ' ' GLU . 27.6 mt -71.92 104.11 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.405 HD12 ' HG ' ' A' ' 20' ' ' SER . 48.1 mm -84.23 -48.73 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.185 0.594 . . . . 0.0 109.808 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.1 p -155.81 125.99 6.63 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.017 0.527 . . . . 0.0 110.243 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.92 153.01 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 47.6 t -66.52 171.72 4.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.141 0.576 . . . . 0.0 112.369 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -59.54 -23.52 62.93 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.021 1.328 . . . . 0.0 111.35 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -104.99 96.33 10.74 Favored Pre-proline 0 CA--C 1.56 1.338 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.135 169.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -88.93 10.24 3.36 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.825 2.35 . . . . 0.0 112.239 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -149.15 -158.14 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.519 1.127 . . . . 0.0 109.873 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 42.6 m170 65.14 73.97 0.4 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.567 1.147 . . . . 0.0 110.182 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.0 m120 72.63 -61.4 0.5 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.136 1.774 . . . . 0.0 112.237 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.46 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 6.7 t -140.92 136.75 32.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.996 0.426 . . . . 0.0 111.201 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 62' ' ' SER . 6.7 ptp -104.49 153.35 21.24 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.533 174.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 32.2 ttmt -95.47 125.01 39.78 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 171.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.21 97.1 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.1 m -70.37 113.0 7.09 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.298 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 86.9 mt -81.71 -178.67 7.07 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.029 0.532 . . . . 0.0 111.081 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.443 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 7.4 m -73.63 0.8 11.68 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.203 0.601 . . . . 0.0 111.537 172.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.94 130.72 48.13 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.199 1.4 . . . . 0.0 110.121 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -61.98 -30.58 71.04 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.113 1.365 . . . . 0.0 112.327 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.534 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 44.4 ttt85 103.9 132.96 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 129.067 2.947 . . . . 0.0 109.186 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.59 ' HA ' ' SD ' ' A' ' 58' ' ' MET . 28.4 tt0 80.62 -4.53 1.79 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.064 1.746 . . . . 0.0 111.788 175.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.18 -33.73 53.4 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.41 ' SD ' ' CE1' ' A' ' 56' ' ' HIS . 64.4 mtt -107.42 -179.6 3.97 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.268 1.027 . . . . 0.0 109.635 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 t -124.56 179.2 5.05 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.297 0.639 . . . . 0.0 111.276 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 33.9 p -89.43 132.93 34.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.667 1.187 . . . . 0.0 110.709 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -155.57 158.19 38.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.422 ' HB ' ' HD1' ' A' ' 55' ' ' PHE . 5.7 t -129.17 102.68 6.57 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.709 0.766 . . . . 0.0 109.38 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.506 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 68.6 m-85 -83.11 109.39 17.11 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.7 p -113.17 -69.64 0.85 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.531 0.732 . . . . 0.0 111.145 -172.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -100.23 22.94 10.73 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.244 0.618 . . . . 0.0 112.106 -168.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.601 HG22 ' HZ2' ' A' ' 47' ' ' LYS . 67.9 t 69.23 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 124.718 1.207 . . . . 0.0 112.509 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 66.26 90.3 0.09 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.028 1.731 . . . . 0.0 112.065 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -168.7 74.07 0.1 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 0.0 109.039 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.1 p 46.89 46.63 15.56 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.112 1.365 . . . . 0.0 112.508 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.07 125.04 17.85 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 123.992 0.917 . . . . 0.0 109.22 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.97 155.07 6.33 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 124.05 3.167 . . . . 0.0 114.412 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.5 -33.1 43.4 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.403 1.081 . . . . 0.0 112.519 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -60.87 -40.72 94.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.095 0.958 . . . . 0.0 111.479 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.1 mm -70.98 -27.6 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.787 0.835 . . . . 0.0 110.024 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.415 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -69.79 -34.75 74.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.293 0.637 . . . . 0.0 110.391 177.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -64.62 -43.64 93.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.538 0.735 . . . . 0.0 111.105 175.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.508 HG21 HG21 ' A' ' 78' ' ' VAL . 54.9 mt -60.22 -37.63 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.038 0.447 . . . . 0.0 110.376 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.69 -34.21 77.35 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.39 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.601 ' HZ2' HG22 ' A' ' 34' ' ' VAL . 11.9 mptt -87.77 0.57 55.58 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.768 0.827 . . . . 0.0 112.551 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 44' ' ' ASP . 91.6 t -72.09 127.22 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.73 132.57 53.68 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.091 0.956 . . . . 0.0 111.358 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.23 -47.4 1.11 Allowed Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.617 -173.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.72 135.88 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 124.305 1.042 . . . . 0.0 112.243 -171.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -113.21 -47.03 3.04 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.811 1.244 . . . . 0.0 110.09 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 12.6 m -146.35 157.68 43.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.239 0.542 . . . . 0.0 111.007 -174.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 82.0 mt -123.09 82.68 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 173.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.422 ' HD1' ' HB ' ' A' ' 30' ' ' THR . 32.2 t80 -82.98 88.04 6.86 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 9.6 t-160 -84.5 87.95 7.28 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 p -92.62 105.8 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.712 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.59 ' SD ' ' HA ' ' A' ' 24' ' ' GLU . 44.5 tpp 65.45 -91.19 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.916 1.287 . . . . 0.0 111.276 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.534 ' HB3' ' HA ' ' A' ' 23' ' ' ARG . 6.7 p-10 -116.2 -7.36 11.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.734 0.814 . . . . 0.0 111.933 -170.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -133.61 136.78 45.07 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.071 0.548 . . . . 0.0 111.011 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 56' ' ' HIS . 43.5 mt -94.06 106.65 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.787 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 15' ' ' MET . 10.7 t -81.99 90.98 6.53 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 172.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.82 98.18 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.16 0.584 . . . . 0.0 109.647 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 53' ' ' SER . 3.2 m-20 -79.78 150.12 30.85 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.505 0.722 . . . . 0.0 110.567 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.401 ' HZ3' HG21 ' A' ' 74' ' ' VAL . 12.3 ptpt -152.99 -159.49 1.01 Allowed 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.717 0.807 . . . . 0.0 109.091 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -63.11 -175.88 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.147 0.979 . . . . 0.0 111.947 168.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -51.33 -43.45 61.75 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.966 0.906 . . . . 0.0 111.828 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -158.3 -46.72 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.434 0.694 . . . . 0.0 110.467 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 51.68 -97.05 0.05 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.995 0.918 . . . . 0.0 109.171 -169.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -158.73 127.53 5.41 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 160.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.425 ' CH2' ' HG2' ' A' ' 15' ' ' MET . 94.3 m95 -80.72 -13.52 58.92 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.979 -0.451 . . . . 0.0 110.295 171.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -50.99 -45.19 60.96 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.397 1.079 . . . . 0.0 111.854 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -75.64 -41.72 53.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.631 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.401 HG21 ' HZ3' ' A' ' 65' ' ' LYS . 84.6 t -64.29 -50.78 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.917 0.887 . . . . 0.0 113.359 -166.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.36 -50.4 85.17 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-O 117.772 -1.109 . . . . 0.0 113.135 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -43.9 -41.0 11.98 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.867 2.378 . . . . 0.0 114.83 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.61 -46.45 26.02 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.939 0.496 . . . . 0.0 110.874 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.508 HG21 HG21 ' A' ' 45' ' ' ILE . 89.2 t -64.53 -52.85 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.661 0.784 . . . . 0.0 110.768 -175.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.523 ' HG2' HD13 ' A' ' 3' ' ' ILE . 49.5 mt-10 -58.9 -34.66 71.92 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.53 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.68 -34.04 72.36 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.878 0.871 . . . . 0.0 112.005 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.84 -42.13 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.672 0.789 . . . . 0.0 110.679 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -84.61 7.63 19.53 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.617 0.767 . . . . 0.0 112.927 173.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -133.28 52.97 2.04 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.191 0.996 . . . . 0.0 109.172 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.65 30.51 0.72 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.326 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -72.27 106.63 4.52 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 167.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -93.77 -39.74 10.58 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.222 0.609 . . . . 0.0 110.045 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -160.39 -42.92 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.899 0.88 . . . . 0.0 109.283 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -88.99 133.08 34.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.049 0.94 . . . . 0.0 109.614 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -74.57 150.44 39.71 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.408 0.683 . . . . 0.0 110.081 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -139.28 97.52 3.31 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.952 0.501 . . . . 0.0 109.784 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.245 0.837 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.084 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -88.7 41.01 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.367 0.667 . . . . 0.0 112.295 -173.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.466 HG21 HG21 ' A' ' 17' ' ' ILE . 43.3 mt 53.79 103.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 124.57 1.148 . . . . 0.0 112.061 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.0 mm -82.66 -49.59 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.678 0.791 . . . . 0.0 110.677 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 t -149.3 148.17 29.22 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 120.88 0.371 . . . . 0.0 110.586 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.8 mm -96.01 106.86 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.481 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 t 66.63 140.23 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.093 1.757 . . . . 0.0 115.537 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.511 ' H ' ' HB3' ' A' ' 16' ' ' LYS . 21.4 mm-40 -115.25 -6.91 12.41 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.948 1.299 . . . . 0.0 110.555 168.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 m -104.94 129.75 24.32 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 125.384 1.474 . . . . 0.0 108.975 -174.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.0 -4.64 15.53 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.137 1.891 . . . . 0.0 113.014 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -78.38 121.09 24.04 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.526 0.73 . . . . 0.0 109.624 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -74.92 -18.63 60.37 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.609 0.764 . . . . 0.0 112.024 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -64.95 -56.47 13.03 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 9.8 t -115.66 126.78 54.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.804 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.525 ' HE1' HD11 ' A' ' 75' ' ' LEU . 34.2 mtm -110.69 136.57 49.58 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.253 0.549 . . . . 0.0 110.857 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.511 ' HB3' ' H ' ' A' ' 8' ' ' GLU . 6.4 tmtm? -79.22 94.56 5.44 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.059 174.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.466 HG21 HG21 ' A' ' 3' ' ' ILE . 58.3 mt -77.8 96.33 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 m -63.03 129.89 42.33 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.964 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.2 mt -116.15 149.18 39.47 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -75.37 -13.75 60.42 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.06 0.544 . . . . 0.0 110.54 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -92.05 63.08 4.34 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.564 1.146 . . . . 0.0 108.712 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.54 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 26.5 m -78.43 -172.93 3.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.611 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 72.39 171.63 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.562 1.145 . . . . 0.0 110.398 -172.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 68.36 -75.84 0.06 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.309 1.443 . . . . 0.0 111.966 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.7 -25.2 0.21 Allowed Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.009 -175.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 43.5 tpp 41.56 66.46 0.69 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.579 1.552 . . . . 0.0 111.444 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.5 p 48.44 100.57 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.976 1.71 . . . . 0.0 112.883 -171.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.5 p -88.48 70.75 8.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.823 0.821 . . . . 0.0 108.985 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.64 168.52 11.68 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.039 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.435 HG23 HG22 ' A' ' 32' ' ' THR . 7.4 m -126.36 97.11 4.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.283 -1.326 . . . . 0.0 107.864 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.466 ' HB3' HD11 ' A' ' 46' ' ' LEU . 44.0 m-85 -83.25 98.43 9.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.933 0.893 . . . . 0.0 108.842 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.435 HG22 HG23 ' A' ' 30' ' ' THR . 28.6 p -124.34 -64.47 1.12 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.733 0.813 . . . . 0.0 110.102 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -79.88 -4.09 50.77 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -168.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 t 63.88 164.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 C-N-CA 125.161 1.384 . . . . 0.0 110.599 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 65.54 96.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.285 1.034 . . . . 0.0 110.892 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -152.99 -74.95 0.13 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.6 t -165.62 23.44 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.495 0.718 . . . . 0.0 109.46 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.531 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -107.56 140.95 22.04 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.141 0.577 . . . . 0.0 109.668 -177.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.22 148.42 3.13 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.934 3.089 . . . . 0.0 114.563 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.06 -32.96 62.31 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.996 0.918 . . . . 0.0 110.714 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.555 ' HB3' HG12 ' A' ' 81' ' ' VAL . 82.3 m-85 -52.69 -48.65 66.42 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.704 1.201 . . . . 0.0 111.037 172.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -71.42 -31.05 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.254 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.531 ' ND2' ' HG2' ' A' ' 38' ' ' GLN . 0.9 OUTLIER -67.81 -37.71 82.33 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 48' ' ' VAL . 25.0 t70 -65.1 -41.82 94.58 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.635 0.774 . . . . 0.0 110.1 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 81' ' ' VAL . 64.3 mt -57.26 -47.32 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 123.891 0.744 . . . . 0.0 109.831 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 31' ' ' TYR . 88.8 mt -60.47 -36.92 79.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.212 0.605 . . . . 0.0 111.178 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.92 -8.93 59.52 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.6 0.76 . . . . 0.0 112.094 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.593 HG23 ' HZ2' ' A' ' 77' ' ' LYS . 97.2 t -65.17 107.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 171.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.56 107.19 0.31 Allowed 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.983 0.802 . . . . 0.0 110.398 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.5 -45.38 0.86 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.183 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.511 HG11 HG12 ' A' ' 63' ' ' VAL . 40.2 t -60.55 -40.51 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 125.085 1.354 . . . . 0.0 113.655 -171.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 38.5 ttmt 64.13 -72.25 0.06 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.389 1.876 . . . . 0.0 111.587 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 p -144.95 156.33 43.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.157 0.583 . . . . 0.0 111.156 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.1 mt -131.64 131.48 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.463 1.105 . . . . 0.0 108.245 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -118.14 104.77 11.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -96.62 128.08 43.22 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 p -163.9 151.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 56.6 tpp 68.46 -69.77 0.14 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.367 1.467 . . . . 0.0 110.692 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.54 ' HB3' ' HA ' ' A' ' 22' ' ' SER . 8.7 p-10 -148.16 -36.41 0.2 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.591 1.157 . . . . 0.0 110.401 173.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.506 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . 55.3 p90 -87.47 149.69 24.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -158.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 66.8 mt -98.77 97.17 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 113.616 -1.629 . . . . 0.0 107.921 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.1 t -83.94 86.97 7.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.116 0.566 . . . . 0.0 109.625 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.511 HG12 HG11 ' A' ' 51' ' ' VAL . 44.2 t -80.87 103.55 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 36.3 t70 -95.01 95.53 8.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.971 0.908 . . . . 0.0 109.875 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.615 ' HD2' ' HB2' ' A' ' 69' ' ' ALA . 17.3 pttp -86.05 -172.17 3.94 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.904 0.881 . . . . 0.0 112.359 -175.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.45 167.56 1.88 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.768 0.827 . . . . 0.0 111.45 167.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -51.25 -68.76 0.14 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.219 1.007 . . . . 0.0 111.496 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -94.35 -57.23 2.56 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.35 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.615 ' HB2' ' HD2' ' A' ' 65' ' ' LYS . . . 40.39 -157.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.309 1.443 . . . . 0.0 113.578 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -141.68 108.59 5.42 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.478 0.711 . . . . 0.0 109.477 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -61.18 -32.86 72.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.038 0.535 . . . . 0.0 110.041 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -62.91 -22.04 66.46 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.977 0.911 . . . . 0.0 111.614 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.3 m -92.36 -44.86 8.48 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.619 0.767 . . . . 0.0 110.962 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.3 t -72.69 -51.6 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.834 0.854 . . . . 0.0 112.398 -172.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.525 HD11 ' HE1' ' A' ' 15' ' ' MET . 91.3 mt -56.44 -41.34 90.68 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-O 117.368 -1.301 . . . . 0.0 114.389 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -40.33 -41.83 3.5 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.067 2.511 . . . . 0.0 114.596 170.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.593 ' HZ2' HG23 ' A' ' 48' ' ' VAL . 36.6 mtpt -75.92 -43.04 47.01 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.683 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.08 -50.18 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.261 0.624 . . . . 0.0 110.042 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG2' HD13 ' A' ' 3' ' ' ILE . 42.9 mt-10 -57.21 -44.18 83.45 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.342 1.057 . . . . 0.0 110.968 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.08 67.76 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.48 1.112 . . . . 0.0 112.703 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 41' ' ' PHE . 52.6 t -61.55 -49.4 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.267 0.627 . . . . 0.0 110.977 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -78.54 -27.71 45.99 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.967 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.46 71.34 4.35 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.6 mt -85.12 51.19 2.11 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.849 173.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 23.68 76.37 0.02 OUTLIER 'General case' 0 C--N 1.374 1.644 0 C-N-CA 126.539 1.936 . . . . 0.0 113.352 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -60.79 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.444 1.097 . . . . 0.0 111.582 -169.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -109.13 -42.17 4.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.03 0.932 . . . . 0.0 109.299 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -65.18 161.15 19.77 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 171.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -74.6 -160.2 0.1 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.072 0.549 . . . . 0.0 110.22 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -65.74 137.81 57.52 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.369 -0.832 . . . . 0.0 110.064 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 . . . . . 0 CA--C 1.553 1.096 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.417 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.569 ' HG2' HD11 ' A' ' 19' ' ' LEU . 3.3 mpp? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.069 0.461 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -116.81 -175.57 2.8 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.83 1.252 . . . . 0.0 109.766 174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.6 mt -102.49 109.66 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 170.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mm -84.19 -46.02 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.0 m -146.53 127.27 14.32 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.172 0.589 . . . . 0.0 110.272 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -86.78 75.35 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 165.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.476 ' HG ' ' HB2' ' A' ' 16' ' ' LYS . 11.7 p -77.6 90.69 3.94 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.352 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.45 -179.17 2.85 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.404 1.081 . . . . 0.0 111.047 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 p -137.64 151.65 71.23 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.591 1.157 . . . . 0.0 108.463 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.7 -37.95 84.21 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.745 2.297 . . . . 0.0 111.024 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -79.56 73.74 6.24 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 166.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -77.44 25.53 0.18 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.177 -167.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -59.21 -36.81 76.05 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.904 0.881 . . . . 0.0 109.542 163.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -123.78 159.25 29.92 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.796 0.839 . . . . 0.0 110.966 -177.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 37.7 mtm -136.45 143.06 43.68 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.553 1.141 . . . . 0.0 108.569 169.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.476 ' HB2' ' HG ' ' A' ' 7' ' ' SER . 51.2 mtpt -95.25 116.68 29.07 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.411 0.685 . . . . 0.0 109.597 175.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.519 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 64.6 mt -90.58 96.11 6.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 172.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 m -66.29 120.53 13.44 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.476 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.569 HD11 ' HG2' ' A' ' 1' ' ' MET . 77.0 mt -87.8 -160.56 0.63 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.216 0.607 . . . . 0.0 110.238 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -68.97 8.26 0.56 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 66.33 106.62 0.04 OUTLIER 'General case' 0 C--N 1.362 1.115 0 C-N-CA 125.352 1.461 . . . . 0.0 110.742 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -140.49 174.24 10.71 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.364 0.666 . . . . 0.0 110.827 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -56.48 133.04 52.96 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.222 0.609 . . . . 0.0 109.711 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -54.37 91.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.807 1.317 . . . . 0.0 112.519 -170.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.455 ' N ' ' HA ' ' A' ' 58' ' ' MET . . . -164.65 -73.2 0.03 OUTLIER Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 60.4 tpp 51.29 21.6 1.18 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.304 1.442 . . . . 0.0 112.381 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m 67.61 135.17 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.503 1.521 . . . . 0.0 110.513 -168.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 p -102.32 114.46 28.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.009 0.923 . . . . 0.0 108.746 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 56' ' ' HIS . 15.7 m-20 -138.21 158.57 44.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.198 0.999 . . . . 0.0 110.194 -170.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 t -151.21 93.96 1.98 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -95.56 92.34 6.59 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.876 0.87 . . . . 0.0 110.566 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.402 ' HA ' ' HB3' ' A' ' 53' ' ' SER . 81.3 p -92.31 -23.47 19.26 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.219 0.533 . . . . 0.0 109.585 174.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.621 ' HG2' ' H ' ' A' ' 34' ' ' VAL . 20.6 ttmm -106.58 -161.91 0.82 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.78 1.232 . . . . 0.0 108.272 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.621 ' H ' ' HG2' ' A' ' 33' ' ' LYS . 58.4 t -149.01 83.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 105.645 -1.984 . . . . 0.0 105.645 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -164.74 -138.0 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.694 -170.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 64.01 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.359 1.019 0 C-N-CA 124.891 1.276 . . . . 0.0 110.527 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.1 p -172.9 20.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.11 1.364 . . . . 0.0 109.386 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' HG3' ' ND2' ' A' ' 43' ' ' ASN . 12.9 pt20 -65.1 142.86 98.73 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.028 0.931 . . . . 0.0 110.369 -176.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.82 141.18 28.92 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.597 2.865 . . . . 0.0 113.347 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -58.97 -31.81 69.07 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.981 0.912 . . . . 0.0 111.74 -178.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.487 ' HB3' HG11 ' A' ' 81' ' ' VAL . 62.5 m-85 -65.4 -36.49 84.13 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.268 0.627 . . . . 0.0 110.911 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.3 mm -73.66 -27.1 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.525 0.73 . . . . 0.0 110.136 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -62.27 -41.79 98.77 Favored 'General case' 0 C--N 1.368 1.392 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.265 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -57.72 -46.12 84.83 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.502 1.126 . . . . 0.0 111.418 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.528 HG23 HG23 ' A' ' 78' ' ' VAL . 57.4 mt -55.42 -49.27 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 123.801 0.688 . . . . 0.0 110.064 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.4 mt -65.15 -32.69 74.51 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.51 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -72.04 -18.94 61.91 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.764 0.826 . . . . 0.0 112.278 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.05 117.94 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -57.05 99.99 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.229 0.956 . . . . 0.0 109.168 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.52 -56.09 0.48 Allowed Glycine 0 C--O 1.225 -0.437 0 N-CA-C 110.071 -1.211 . . . . 0.0 110.071 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.73 127.71 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.844 0.858 . . . . 0.0 111.719 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.512 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 8.0 ttpm? -92.2 -46.56 7.68 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.063 0.945 . . . . 0.0 108.48 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.402 ' HB3' ' HA ' ' A' ' 32' ' ' THR . 20.1 p -166.43 178.89 5.86 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 123.702 0.626 . . . . 0.0 111.599 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.4 mt -131.63 111.25 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.178 0.991 . . . . 0.0 109.377 176.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -90.35 125.79 35.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 169.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 29' ' ' ASP . 11.1 t-160 -132.78 123.38 26.06 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.61 0.764 . . . . 0.0 109.233 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -168.03 161.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 123.164 0.29 . . . . 0.0 110.458 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.455 ' HA ' ' N ' ' A' ' 25' ' ' GLY 0.27 27.2 ptm 56.64 -61.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 128.412 2.685 . . . . 0.0 114.973 175.251 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -150.88 -31.54 0.17 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.584 0.753 . . . . 0.0 111.0 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -95.51 155.38 16.77 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.337 0.589 . . . . 0.0 112.205 -167.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.519 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 42.7 mt -108.89 94.2 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 t -82.82 88.96 6.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.7 t -80.15 122.2 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.27 156.47 23.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.896 0.478 . . . . 0.0 110.006 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.512 ' HA ' ' H ' ' A' ' 52' ' ' LYS . 16.8 pttm -132.11 -162.09 1.2 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.109 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.94 165.64 2.32 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.535 0.734 . . . . 0.0 111.403 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -39.2 -44.82 1.26 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.539 1.536 . . . . 0.0 114.692 -164.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -133.36 -59.04 0.88 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 173.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.483 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . . . 49.91 -163.08 0.05 OUTLIER 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 125.782 1.633 . . . . 0.0 113.79 171.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -131.39 120.85 23.65 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.159 0.584 . . . . 0.0 111.536 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -73.81 -10.78 60.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.302 0.641 . . . . 0.0 110.935 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -61.93 -26.92 68.48 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.76 0.824 . . . . 0.0 110.575 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 m -91.84 -43.91 9.24 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.506 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.9 t -80.3 -50.21 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.631 0.772 . . . . 0.0 112.793 -172.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.25 -46.98 83.45 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-O 117.29 -1.338 . . . . 0.0 113.093 -171.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.19 -38.52 81.35 Favored 'Trans proline' 0 C--N 1.4 3.278 0 C-N-CA 122.232 1.955 . . . . 0.0 112.979 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.26 -40.56 70.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.067 0.547 . . . . 0.0 111.337 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.528 HG23 HG23 ' A' ' 45' ' ' ILE . 41.4 t -65.47 -40.14 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.022 0.529 . . . . 0.0 109.97 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.15 -45.5 87.29 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.804 1.242 . . . . 0.0 110.463 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.0 -31.73 51.95 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.642 1.177 . . . . 0.0 112.708 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 41' ' ' PHE . 56.0 t -65.77 -51.68 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 124.068 0.947 . . . . 0.0 111.279 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -72.66 -25.53 61.3 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -79.67 -69.76 0.56 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.375 0.27 . . . . 0.0 111.321 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.3 mt 73.38 -45.57 0.62 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.976 1.71 . . . . 0.0 111.813 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.59 144.54 42.57 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.627 1.171 . . . . 0.0 109.184 170.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -70.3 73.21 0.49 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.742 0.782 . . . . 0.0 110.409 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -67.92 108.4 3.02 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.6 0.76 . . . . 0.0 110.36 -173.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -103.67 149.87 24.54 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.515 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -67.55 -25.47 65.82 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.319 0.647 . . . . 0.0 111.113 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -117.36 154.24 31.63 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.435 0.694 . . . . 0.0 109.236 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 . . . . . 0 C--O 1.249 1.076 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 172.65 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -160.99 167.28 26.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.636 0.774 . . . . 0.0 109.981 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.3 mt -65.21 96.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.504 HG13 ' HB2' ' A' ' 20' ' ' SER . 33.3 mm -93.26 -40.98 12.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 C-N-CA 123.889 0.876 . . . . 0.0 109.786 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.582 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 10.9 t -150.5 158.74 44.49 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.428 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -117.06 134.13 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.118 0.967 . . . . 0.0 109.087 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.535 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 7.3 m -118.06 81.52 1.69 Allowed 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.75 -179.13 6.75 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.22 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 11' ' ' ASN . 2.0 t -160.11 154.77 20.62 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.778 0.831 . . . . 0.0 109.417 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.22 -18.95 65.05 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 122.529 2.153 . . . . 0.0 111.818 171.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.49 ' O ' HG22 ' A' ' 9' ' ' THR . 49.8 t30 -78.21 148.03 34.18 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 169.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -116.51 -171.71 2.05 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 122.116 -0.365 . . . . 0.0 111.413 -168.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.409 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 17.0 m120 76.82 -66.42 0.25 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.988 1.715 . . . . 0.0 110.363 -176.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 10.0 t -105.15 135.47 46.44 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.847 0.356 . . . . 0.0 111.573 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 62' ' ' SER . 13.0 ptp -133.24 149.29 51.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.723 169.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 84.3 tttt -91.06 100.26 13.14 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.534 1.134 . . . . 0.0 110.58 -175.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.86 111.15 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.582 ' HB ' ' HB3' ' A' ' 5' ' ' SER . 86.2 m -75.35 131.27 40.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.601 0.76 . . . . 0.0 110.98 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.5 mt -102.35 166.56 10.5 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.764 0.825 . . . . 0.0 109.239 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.504 ' HB2' HG13 ' A' ' 4' ' ' ILE . 29.4 t -76.19 -26.77 56.5 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.702 0.401 . . . . 0.0 111.501 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -82.0 76.67 8.88 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.28 0.562 . . . . 0.0 109.976 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -87.5 166.53 14.7 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.996 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 68.92 173.44 0.29 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.506 1.122 . . . . 0.0 110.586 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 57.05 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.702 1.201 . . . . 0.0 111.061 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.72 143.43 5.71 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.8 mtt -92.35 -165.93 1.44 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.525 0.73 . . . . 0.0 109.7 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.1 m -90.65 153.27 20.43 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.039 0.447 . . . . 0.0 110.048 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 p -87.09 104.71 16.6 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.26 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -123.55 97.5 5.41 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.88 0.872 . . . . 0.0 110.49 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 m -89.45 83.49 6.37 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.583 ' HB3' HD12 ' A' ' 46' ' ' LEU . 25.0 m-85 -81.87 110.46 17.18 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.477 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.3 p -121.55 -39.91 2.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.969 0.908 . . . . 0.0 110.472 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.619 ' HE3' ' HA ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -141.14 40.0 1.78 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.883 -176.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.7 t 65.86 126.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 125.003 1.321 . . . . 0.0 113.133 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -93.69 -88.31 0.23 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 171.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 t70 169.51 -42.3 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.362 1.065 . . . . 0.0 109.294 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.5 p -63.42 -38.27 90.51 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.412 1.085 . . . . 0.0 111.806 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -60.51 141.9 91.44 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.945 0.898 . . . . 0.0 111.598 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.93 154.47 7.11 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.225 2.617 . . . . 0.0 113.815 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.14 67.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.973 0.909 . . . . 0.0 111.095 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.432 ' HB3' HG13 ' A' ' 81' ' ' VAL . 55.3 m-85 -62.3 -34.31 76.36 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.217 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.527 HD12 HG12 ' A' ' 81' ' ' VAL . 13.0 mm -79.76 -23.17 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 122.906 0.482 . . . . 0.0 110.52 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -68.27 -36.26 79.14 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.87 -41.84 92.4 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.71 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.573 HG23 HG13 ' A' ' 51' ' ' VAL . 54.3 mt -56.45 -46.6 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 123.994 0.809 . . . . 0.0 110.416 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' A' ' 31' ' ' TYR . 96.7 mt -64.04 -36.4 83.88 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -79.34 -1.93 39.16 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.163 0.585 . . . . 0.0 112.059 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.6 t -70.87 115.52 10.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 165.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -62.96 89.06 0.03 OUTLIER 'General case' 0 C--N 1.348 0.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.28 -52.48 0.25 Allowed Glycine 0 C--O 1.218 -0.872 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.056 -172.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.573 HG13 HG23 ' A' ' 45' ' ' ILE . 74.2 t -69.9 -40.83 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -168.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 19.6 ttmt 65.63 -72.69 0.07 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.857 1.663 . . . . 0.0 111.823 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 35.9 t -133.29 151.86 51.91 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.641 0.776 . . . . 0.0 111.24 -174.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 75.1 mt -129.68 107.01 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.469 1.508 . . . . 0.0 107.401 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.505 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 72.0 t80 -99.59 91.44 4.89 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -94.13 134.49 36.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.138 0.975 . . . . 0.0 109.649 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 p -171.02 153.32 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.433 0.693 . . . . 0.0 109.48 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.489 ' HG3' ' H ' ' A' ' 59' ' ' ASP 0.269 18.3 ptp 43.93 -84.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 126.698 1.999 . . . . 0.0 115.231 -175.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.489 ' H ' ' HG3' ' A' ' 58' ' ' MET . 9.5 p-10 -138.82 20.88 2.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.022 -1.049 . . . . 0.0 111.853 -172.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -147.54 167.37 24.68 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.439 HG21 HG21 ' A' ' 54' ' ' ILE . 68.4 mt -132.14 101.89 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.406 1.483 . . . . 0.0 108.118 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 68.4 m -82.78 94.65 7.68 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.764 0.426 . . . . 0.0 110.121 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.487 HG13 HG11 ' A' ' 51' ' ' VAL . 97.5 t -79.15 105.21 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 18.7 t0 -93.71 85.57 4.88 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.273 1.029 . . . . 0.0 109.966 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 13' ' ' ASN . 16.8 pttp -75.73 174.09 10.26 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.074 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -75.54 176.25 7.76 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.946 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -70.46 -66.02 0.66 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.521 0.328 . . . . 0.0 110.531 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -69.81 -44.22 70.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.021 0.528 . . . . 0.0 111.348 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.53 121.48 8.48 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.244 0.965 . . . . 0.0 110.476 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -94.94 154.9 16.98 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.752 0.821 . . . . 0.0 111.311 -168.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -62.88 -20.11 64.81 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.094 0.558 . . . . 0.0 112.459 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -70.07 -19.34 63.27 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.565 0.346 . . . . 0.0 111.311 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.2 m -95.28 -47.18 6.43 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.409 0.683 . . . . 0.0 110.469 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.461 HG13 HG23 ' A' ' 51' ' ' VAL . 93.5 t -70.32 -59.99 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.934 0.893 . . . . 0.0 112.364 -171.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.3 tt -56.78 -50.27 88.97 Favored Pre-proline 0 CA--C 1.57 1.725 0 CA-C-O 117.773 -1.108 . . . . 0.0 112.902 -171.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -59.2 -31.25 94.96 Favored 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.409 2.072 . . . . 0.0 112.894 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -71.9 -41.25 68.16 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.659 0.784 . . . . 0.0 111.227 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.64 -48.51 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.96 -38.38 85.72 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.228 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.92 -29.1 70.31 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.13 0.972 . . . . 0.0 111.844 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.527 HG12 HD12 ' A' ' 42' ' ' ILE . 38.0 t -68.32 -39.4 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.686 0.394 . . . . 0.0 110.991 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -70.9 -40.79 71.97 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.469 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.0 79.14 1.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.9 mt -80.04 40.04 0.46 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.658 1.183 . . . . 0.0 111.854 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 66.93 172.31 0.25 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.06 0.944 . . . . 0.0 109.164 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -80.07 62.36 4.23 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.997 -1.064 . . . . 0.0 108.157 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -169.66 91.25 0.21 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.568 1.547 . . . . 0.0 107.309 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -69.43 -12.17 61.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.853 0.861 . . . . 0.0 111.766 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 80.99 -61.34 0.22 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.048 1.739 . . . . 0.0 111.827 173.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 50.43 -165.03 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.517 1.527 . . . . 0.0 112.53 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 28.8 p80 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 123.181 0.592 . . . . 0.0 109.479 170.903 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.464 0.649 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 10.8 mtmp? -137.55 -175.72 4.16 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.258 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -92.27 93.83 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.592 HG13 ' HB3' ' A' ' 20' ' ' SER . 49.1 mm -90.41 -42.13 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.364 0.666 . . . . 0.0 110.027 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -142.84 156.29 44.92 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.15 0.98 . . . . 0.0 108.87 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -111.51 -75.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.462 0.705 . . . . 0.0 110.196 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.6 t 57.12 84.06 0.1 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.813 1.245 . . . . 0.0 110.79 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -168.7 2.32 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.029 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.2 p -112.65 149.39 41.09 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.2 -33.79 97.89 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.912 2.408 . . . . 0.0 113.836 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -78.61 -11.71 59.98 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.694 0.797 . . . . 0.0 111.124 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.2 m80 64.98 29.94 12.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.133 1.373 . . . . 0.0 112.423 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.19 -48.27 18.05 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -128.04 141.65 51.45 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.472 0.653 . . . . 0.0 111.863 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.598 ' SD ' HD23 ' A' ' 75' ' ' LEU . 13.2 ptp -130.63 148.79 52.47 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 108.765 167.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 59.3 mttp -94.42 158.26 15.64 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.319 0.648 . . . . 0.0 109.538 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.1 mt -132.66 94.87 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.1 m -60.11 109.46 0.97 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.767 0.827 . . . . 0.0 109.983 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.9 mt -79.38 -26.76 41.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.939 0.496 . . . . 0.0 111.625 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.592 ' HB3' HG13 ' A' ' 4' ' ' ILE . 54.5 p 98.82 -6.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 127.876 2.47 . . . . 0.0 112.849 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -89.86 62.94 5.88 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.139 0.427 . . . . 0.0 109.887 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.3 m -65.22 84.47 0.05 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.586 0.707 . . . . 0.0 111.024 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -104.73 5.23 33.21 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.324 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 66.74 -71.1 0.1 Allowed 'General case' 0 C--N 1.37 1.497 0 C-N-CA 125.823 1.649 . . . . 0.0 111.075 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.29 56.34 4.25 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.288 -0.414 . . . . 0.0 112.246 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.9 ttt -94.92 46.95 1.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 m 68.47 155.2 0.12 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 125.752 1.621 . . . . 0.0 111.997 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.1 p -135.27 78.87 1.75 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.85 1.26 . . . . 0.0 108.309 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -124.52 144.68 49.98 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.434 0.694 . . . . 0.0 111.329 -165.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -99.92 149.73 23.12 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.989 0.916 . . . . 0.0 109.978 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 59.5 m-85 -141.35 113.99 8.32 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.156 1.383 . . . . 0.0 107.782 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.4 p -136.71 -43.06 0.59 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.564 0.746 . . . . 0.0 110.262 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -106.61 32.76 4.28 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.983 0.913 . . . . 0.0 112.076 -164.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 43' ' ' ASN . 58.9 t 55.58 64.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 122.756 1.265 . . . . 0.0 109.194 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.3 135.21 42.57 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.481 -1.69 . . . . 0.0 111.321 -170.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -77.09 91.89 3.72 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 p -177.96 -61.83 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.685 1.194 . . . . 0.0 108.662 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.473 ' HG3' ' ND2' ' A' ' 43' ' ' ASN . 25.2 pt20 -60.08 149.69 73.56 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.904 1.282 . . . . 0.0 111.91 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.6 150.93 11.18 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.262 2.642 . . . . 0.0 112.542 168.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.87 -37.33 63.58 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 123.687 0.617 . . . . 0.0 111.253 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -55.69 -40.31 72.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.89 1.276 . . . . 0.0 111.937 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.4 mm -75.63 -28.96 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.435 0.694 . . . . 0.0 110.304 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.473 ' ND2' ' HG3' ' A' ' 38' ' ' GLN . 55.5 m-80 -70.86 -34.94 72.15 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -64.61 -34.89 79.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.071 0.548 . . . . 0.0 110.93 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.9 mt -60.55 -45.24 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 123.728 0.642 . . . . 0.0 110.091 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.2 -35.74 78.01 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.921 0.488 . . . . 0.0 111.883 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.58 -14.12 60.38 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.212 0.605 . . . . 0.0 111.647 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.39 109.77 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -59.12 104.64 0.26 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.041 0.838 . . . . 0.0 111.003 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 146.88 -45.3 0.78 Allowed Glycine 0 C--N 1.344 1.015 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.5 121.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.791 0.836 . . . . 0.0 109.897 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.405 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 26.2 ttpp -104.96 -32.58 8.69 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.84 0.856 . . . . 0.0 110.965 -172.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 t -151.99 161.62 42.35 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.73 0.412 . . . . 0.0 111.062 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 79.1 mt -148.02 116.84 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.658 1.583 . . . . 0.0 107.252 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -119.59 110.23 16.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.798 0.439 . . . . 0.0 110.083 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -95.16 119.94 34.52 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.29 147.81 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.074 0.55 . . . . 0.0 110.336 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 67.55 -68.46 0.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.529 1.532 . . . . 0.0 110.883 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -160.06 -25.44 0.06 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.87 1.268 . . . . 0.0 110.234 169.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -81.27 143.11 32.51 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-O 120.922 0.391 . . . . 0.0 111.259 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.16 103.18 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 15.0 t -83.32 89.25 6.98 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.6 t -77.48 126.13 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -120.21 149.4 42.32 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.275 1.03 . . . . 0.0 110.457 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.405 ' HA ' ' H ' ' A' ' 52' ' ' LYS . 17.8 pttp -140.22 179.88 6.38 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.681 1.192 . . . . 0.0 109.441 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.9 167.04 22.51 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.828 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.11 -48.38 71.07 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.976 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.96 -32.88 74.57 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.507 -172.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.83 161.99 27.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.705 0.802 . . . . 0.0 111.933 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -118.25 146.23 44.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.679 0.792 . . . . 0.0 110.074 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.497 ' HB3' HD21 ' A' ' 75' ' ' LEU . 66.1 m95 -69.66 -17.14 63.48 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.048 0.539 . . . . 0.0 111.031 172.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.59 -24.81 67.76 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.969 0.908 . . . . 0.0 111.792 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.7 m -84.75 -45.3 12.53 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.019 0.928 . . . . 0.0 110.397 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.8 t -73.5 -60.92 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.068 -169.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.598 HD23 ' SD ' ' A' ' 15' ' ' MET . 3.9 mm? -49.32 -47.62 76.33 Favored Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -172.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -55.51 -33.85 87.69 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.078 1.852 . . . . 0.0 113.876 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -80.96 -41.98 21.99 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.696 0.798 . . . . 0.0 110.5 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.1 t -74.42 -31.77 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.331 1.052 . . . . 0.0 111.523 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.5 -41.35 80.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.872 0.869 . . . . 0.0 110.987 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.33 -32.34 71.15 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.045 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -63.11 -40.19 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.901 0.88 . . . . 0.0 111.663 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.648 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 27.2 m-85 -91.2 25.08 2.63 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 85' ' ' GLU . 57.8 mt-10 -145.62 -58.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.055 0.455 . . . . 0.0 109.904 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 62.82 30.73 16.66 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.397 1.479 . . . . 0.0 111.091 -174.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 83' ' ' GLU . 10.2 mm-40 -72.89 93.71 1.75 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.633 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -116.37 125.3 51.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.273 1.029 . . . . 0.0 108.988 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 60.35 27.18 16.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.028 0.931 . . . . 0.0 111.566 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.33 124.41 27.47 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.778 0.831 . . . . 0.0 110.988 -173.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -125.61 91.56 3.43 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.238 1.015 . . . . 0.0 108.67 175.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -93.39 -68.99 0.77 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.9 p80 . . . . . 0 CA--C 1.557 1.24 0 C-N-CA 123.778 0.831 . . . . 0.0 109.584 178.455 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.644 0.259 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -167.27 179.35 5.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.78 0.832 . . . . 0.0 111.125 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.9 mt -72.41 115.84 13.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.107 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.2 mm -84.74 -45.65 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.3 p -154.65 133.44 12.19 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.12 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.7 mm -78.37 105.6 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 169.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.538 ' HB3' ' HG3' ' A' ' 16' ' ' LYS . 38.2 t . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 122.956 0.502 . . . . 0.0 110.804 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.447 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 25.6 t-20 -66.59 -64.76 0.79 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.536 0.734 . . . . 0.0 110.618 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.4 t -106.84 126.9 52.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.532 0.333 . . . . 0.0 110.121 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -122.35 143.33 49.71 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.29 0.567 . . . . 0.0 110.457 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HG3' ' HB3' ' A' ' 7' ' ' SER . 20.3 ptmt -88.38 140.53 29.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.84 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.1 mt -130.0 114.93 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.499 1.12 . . . . 0.0 109.317 -172.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.8 m -71.66 119.96 16.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.645 0.778 . . . . 0.0 110.322 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.9 mt -87.41 169.88 11.86 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.222 0.609 . . . . 0.0 110.696 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 p -74.7 -26.72 60.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.399 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HB2' ' SD ' ' A' ' 26' ' ' MET . 24.5 mm-40 -84.2 128.42 34.55 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.267 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.6 p -153.37 166.8 31.51 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.216 0.606 . . . . 0.0 111.334 -174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 71.04 156.13 0.15 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.875 1.67 . . . . 0.0 112.437 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 69.28 -75.97 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.803 1.641 . . . . 0.0 110.853 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.02 116.45 1.06 Allowed Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.535 -0.302 . . . . 0.0 112.505 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 21' ' ' GLU . 82.5 mtp -75.32 -167.59 0.67 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.302 1.041 . . . . 0.0 109.748 170.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.0 p -59.19 112.9 1.88 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.298 0.639 . . . . 0.0 110.991 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.1 p -94.59 84.87 4.36 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -144.78 141.74 29.44 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.828 0.851 . . . . 0.0 111.237 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.469 ' HG1' ' HD1' ' A' ' 55' ' ' PHE . 23.2 m -89.29 106.41 18.42 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -80.21 101.17 8.69 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -146.01 -33.7 0.32 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.948 0.499 . . . . 0.0 111.874 -171.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.427 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 46.9 pttt -88.85 4.87 46.26 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -169.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.4 t 65.02 126.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 125.448 1.499 . . . . 0.0 110.533 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 t70 72.01 47.34 0.31 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.927 1.291 . . . . 0.0 109.26 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' A' ' 33' ' ' LYS . 2.7 m-20 -84.31 47.91 1.41 Allowed 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.882 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.0 p 58.05 19.29 5.85 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.843 1.657 . . . . 0.0 113.249 -174.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.32 147.01 34.12 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 123.789 0.836 . . . . 0.0 109.966 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -52.43 155.19 10.15 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.739 2.959 . . . . 0.0 113.809 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.86 -31.35 49.29 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.253 1.021 . . . . 0.0 112.107 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -56.73 -44.98 82.19 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.216 1.006 . . . . 0.0 111.257 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mm -71.55 -28.86 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.381 0.672 . . . . 0.0 109.958 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.417 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 28.8 m-80 -72.07 -32.93 67.52 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.91 0.484 . . . . 0.0 110.068 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 48' ' ' VAL . 28.0 t70 -63.43 -41.78 98.7 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 124.145 0.903 . . . . 0.0 109.8 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.0 mt -59.74 -44.84 94.69 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 O-C-N 124.267 0.979 . . . . 0.0 109.882 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.48 -36.68 74.12 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.132 0.573 . . . . 0.0 111.223 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 43' ' ' ASN . 96.2 mttt -79.45 -19.72 49.2 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.658 0.783 . . . . 0.0 112.09 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 44' ' ' ASP . 55.9 t -60.44 121.83 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.65 89.47 0.05 OUTLIER 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.353 1.033 . . . . 0.0 109.581 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.15 -32.07 0.45 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.184 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.89 131.4 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.476 0.71 . . . . 0.0 109.7 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -87.05 -52.05 5.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.331 0.652 . . . . 0.0 109.26 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.6 p -163.31 173.0 13.84 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.584 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.461 HG23 HG22 ' A' ' 63' ' ' VAL . 74.0 mt -132.03 101.04 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.469 ' HD1' ' HG1' ' A' ' 30' ' ' THR . 28.8 t80 -81.98 146.27 29.83 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -135.54 135.03 40.04 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.12 124.64 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.538 0.735 . . . . 0.0 110.241 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 45.6 ttm 55.78 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.263 1.425 . . . . 0.0 112.821 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -120.31 -39.32 2.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.131 0.572 . . . . 0.0 110.6 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -98.26 138.79 35.01 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.644 0.735 . . . . 0.0 110.807 -167.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 53.5 mt -85.61 163.78 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.801 173.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -143.44 86.31 1.89 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.461 HG22 HG23 ' A' ' 54' ' ' ILE . 40.7 t -80.01 114.63 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.27 131.15 34.32 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.097 0.959 . . . . 0.0 108.69 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 13' ' ' ASN . 21.5 pttp -101.72 -173.86 2.45 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 173.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -89.39 162.71 15.64 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -59.13 -48.19 82.51 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.295 0.638 . . . . 0.0 112.631 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -80.55 -33.8 35.94 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.36 0.664 . . . . 0.0 111.597 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.35 140.94 12.59 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.591 1.156 . . . . 0.0 112.666 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -110.24 130.47 55.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.799 0.84 . . . . 0.0 110.302 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -60.35 -18.32 49.25 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.448 0.699 . . . . 0.0 112.027 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -56.73 -35.31 68.44 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.537 0.735 . . . . 0.0 110.732 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 t -101.06 -42.59 6.33 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.012 0.525 . . . . 0.0 110.884 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.1 t -70.73 -45.87 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.312 1.045 . . . . 0.0 113.358 -170.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.6 tp -60.64 -43.74 93.22 Favored Pre-proline 0 N--CA 1.492 1.66 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.65 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -46.45 -34.31 14.32 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.415 2.077 . . . . 0.0 114.38 170.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -75.1 -41.45 58.64 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.337 0.655 . . . . 0.0 111.118 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -65.02 -58.12 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-O 121.638 0.732 . . . . 0.0 109.237 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.67 -31.17 67.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.73 1.612 . . . . 0.0 112.26 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.14 55.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.383 1.073 . . . . 0.0 112.876 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.3 -49.54 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.203 0.601 . . . . 0.0 110.816 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -69.28 -25.22 64.15 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.351 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -122.49 77.16 1.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.726 0.81 . . . . 0.0 109.534 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--O 1.243 0.754 0 C-N-CA 124.097 0.959 . . . . 0.0 108.565 171.01 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -145.28 144.45 30.78 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.452 0.701 . . . . 0.0 110.424 -175.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.5 mt -73.58 95.04 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.4 0.68 . . . . 0.0 109.728 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 mm -83.54 -35.51 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.698 0.799 . . . . 0.0 110.138 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.7 t -134.31 146.75 50.28 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.824 0.45 . . . . 0.0 111.123 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.422 HG23 ' HG2' ' A' ' 15' ' ' MET . 72.6 mt -128.76 133.95 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.775 1.63 . . . . 0.0 108.252 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 121.226 0.536 . . . . 0.0 111.285 -179.279 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 69.64 20.29 7.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.553 1.141 . . . . 0.0 111.912 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 13.2 t -161.01 143.1 12.29 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.097 0.959 . . . . 0.0 108.832 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 62' ' ' SER . 57.7 mtm -115.68 110.76 19.61 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -75.74 85.89 2.75 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 165.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.2 mt -77.31 93.29 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.0 m -77.94 116.89 18.77 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.1 mt -84.88 -150.49 0.12 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 p -76.65 15.17 0.67 Allowed 'General case' 0 CA--C 1.558 1.269 0 O-C-N 121.93 -0.481 . . . . 0.0 112.114 173.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 42.4 mt-10 67.82 92.4 0.08 Allowed 'General case' 0 C--N 1.358 0.944 0 C-N-CA 125.903 1.681 . . . . 0.0 110.798 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -73.07 131.92 42.69 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -76.11 78.91 2.94 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.549 0.531 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 62.17 13.27 5.7 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.497 1.119 . . . . 0.0 111.874 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.12 -26.7 61.43 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.156 -173.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.0 mmt -80.46 107.13 13.01 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.5 p -75.12 154.54 37.74 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.579 0.352 . . . . 0.0 110.916 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.0 p -69.48 96.06 0.88 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.241 0.543 . . . . 0.0 110.815 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -119.2 111.06 17.76 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.258 1.023 . . . . 0.0 109.565 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.3 m -91.1 97.23 11.03 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -81.98 103.78 11.87 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.0 p -99.47 49.81 0.94 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.753 1.221 . . . . 0.0 109.307 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.463 ' HA ' HD13 ' A' ' 46' ' ' LEU 0.298 0.9 OUTLIER 56.72 99.55 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 127.427 2.291 . . . . 0.0 113.727 179.372 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t 50.54 80.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 125.53 1.532 . . . . 0.0 111.215 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -151.78 -50.08 0.11 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -164.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -105.07 -96.64 0.33 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.856 0.462 . . . . 0.0 110.783 -169.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.6 t -161.81 87.54 0.67 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.1 pm0 -139.77 144.36 38.56 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.627 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -53.34 150.65 25.42 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.837 2.358 . . . . 0.0 112.326 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.33 -34.43 57.41 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.581 0.753 . . . . 0.0 111.057 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.468 ' HB3' HG13 ' A' ' 81' ' ' VAL . 91.0 m-85 -56.82 -46.94 81.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.422 1.089 . . . . 0.0 111.499 176.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.0 mm -67.31 -32.35 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.202 0.601 . . . . 0.0 110.296 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.455 ' HA ' HD12 ' A' ' 46' ' ' LEU . 64.6 m-20 -70.5 -32.01 69.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.509 0.724 . . . . 0.0 110.702 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 48' ' ' VAL . 1.1 m-20 -65.63 -38.11 88.47 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.237 0.615 . . . . 0.0 111.221 175.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 78' ' ' VAL . 59.7 mt -61.99 -44.6 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.794 0.807 . . . . 0.0 109.931 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 33' ' ' LYS . 58.7 mt -61.89 -34.55 76.23 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.725 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -82.32 -8.67 59.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.559 0.744 . . . . 0.0 112.562 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.498 HG11 HG13 ' A' ' 74' ' ' VAL . 65.9 t -70.5 105.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 171.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.69 94.31 0.2 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.694 0.798 . . . . 0.0 110.451 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 161.44 -35.81 0.39 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.0 129.73 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.825 0.85 . . . . 0.0 109.024 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -78.6 -57.04 3.97 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 p -163.61 178.49 7.92 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.975 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.403 HG12 HG13 ' A' ' 63' ' ' VAL . 75.5 mt -132.27 117.64 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.084 0.954 . . . . 0.0 109.221 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -103.67 97.54 7.54 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.697 0.76 . . . . 0.0 109.621 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -87.86 131.35 34.59 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.652 1.181 . . . . 0.0 109.88 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.4 p -172.52 155.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 118.433 0.56 . . . . 0.0 111.715 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 27.5 ttt 65.09 -83.81 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.5 1.92 . . . . 0.0 112.918 171.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 7.1 p-10 -132.71 -16.19 2.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.977 0.911 . . . . 0.0 110.561 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.408 ' HE2' ' HB2' ' A' ' 62' ' ' SER . 37.6 p90 -122.54 171.13 9.33 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 122.129 0.966 . . . . 0.0 112.446 -162.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -126.06 103.67 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.616 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 15' ' ' MET . 28.5 t -86.0 89.08 7.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.403 HG13 HG12 ' A' ' 54' ' ' ILE . 26.3 t -88.54 107.72 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 4.8 p-10 -106.58 158.19 17.12 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.894 0.478 . . . . 0.0 111.035 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -139.44 -167.97 2.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.815 0.846 . . . . 0.0 111.889 -165.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -88.19 161.13 17.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.33 1.052 . . . . 0.0 110.826 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.87 -27.02 67.91 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.731 0.812 . . . . 0.0 113.048 -172.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -97.1 -28.26 14.21 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.813 0.845 . . . . 0.0 111.734 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.28 130.89 23.74 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.817 0.847 . . . . 0.0 112.282 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -104.6 127.43 52.33 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.242 0.617 . . . . 0.0 110.443 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.425 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 63.3 m95 -71.87 -16.72 62.15 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.531 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.92 -34.54 71.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.083 0.468 . . . . 0.0 110.787 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.1 m -82.96 -44.7 14.99 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.74 0.816 . . . . 0.0 110.536 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.498 HG13 HG11 ' A' ' 48' ' ' VAL . 48.2 t -74.61 -39.51 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.944 0.898 . . . . 0.0 112.538 -170.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 71' ' ' TRP . 3.0 tt -59.14 -44.25 98.29 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-O 117.125 -1.417 . . . . 0.0 112.509 -168.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -48.96 -31.21 19.69 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.441 2.094 . . . . 0.0 114.676 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -82.08 -40.81 21.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.515 0.726 . . . . 0.0 110.029 -179.391 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 45' ' ' ILE . 56.2 t -63.81 -38.45 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 123.914 0.885 . . . . 0.0 109.936 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.68 -47.64 82.77 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.73 1.612 . . . . 0.0 109.868 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.51 -31.1 61.78 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.854 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 41' ' ' PHE . 56.1 t -68.34 -55.48 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.41 0.684 . . . . 0.0 110.683 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 1' ' ' MET . 17.9 m-85 -65.04 -29.05 69.92 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -80.14 -38.59 31.12 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.029 0.532 . . . . 0.0 112.07 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 124.055 0.942 . . . . 0.0 109.504 -164.676 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 mtm . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -127.94 -174.75 3.28 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.9 mt -76.1 108.1 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -82.16 -51.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -162.79 147.88 11.93 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.558 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mt -89.74 97.29 6.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 168.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.549 0.911 0 C-N-CA 123.531 0.732 . . . . 0.0 111.782 -174.489 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 77.56 -51.22 0.53 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.234 1.414 . . . . 0.0 111.254 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.4 t -105.71 112.04 24.96 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.866 0.466 . . . . 0.0 110.635 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.9 mtm -98.98 142.85 29.95 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.187 0.518 . . . . 0.0 110.048 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -89.59 113.73 25.2 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.936 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.8 mt -93.32 111.39 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.4 m -76.59 122.89 25.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.579 0.752 . . . . 0.0 109.832 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.2 mt -101.99 -171.3 1.95 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.489 0.715 . . . . 0.0 109.727 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 p -76.72 6.76 5.48 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 63.86 -171.29 0.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.427 1.091 . . . . 0.0 112.122 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 t -151.28 -162.81 1.62 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -69.68 89.56 0.55 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.244 0.618 . . . . 0.0 109.576 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 65.49 -74.0 0.06 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.453 1.501 . . . . 0.0 110.482 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.85 148.68 20.43 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.034 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -131.64 127.53 37.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.236 1.014 . . . . 0.0 109.447 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 t 46.64 176.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 126.609 1.964 . . . . 0.0 115.365 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 p -155.61 98.37 1.94 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.624 0.769 . . . . 0.0 109.46 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.49 164.24 14.86 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.108 0.963 . . . . 0.0 110.866 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 m -141.41 98.02 3.28 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 161.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 40.4 m-85 -82.16 111.97 18.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 p -122.38 -71.29 0.73 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.079 0.552 . . . . 0.0 110.134 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -110.02 46.88 0.99 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.683 0.793 . . . . 0.0 108.994 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.4 t 67.6 120.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 125.139 1.376 . . . . 0.0 111.704 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.17 -81.41 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.903 1.281 . . . . 0.0 110.4 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 166.06 -66.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.299 1.44 . . . . 0.0 108.611 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t -90.98 -2.4 57.71 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.117 0.967 . . . . 0.0 111.802 -169.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -63.08 149.84 89.86 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 123.693 0.797 . . . . 0.0 111.257 173.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -53.61 148.21 36.31 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.556 2.837 . . . . 0.0 113.731 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.02 69.81 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.029 0.931 . . . . 0.0 111.364 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.505 ' HB3' HG13 ' A' ' 81' ' ' VAL . 31.5 m-85 -61.48 -36.69 81.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.983 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.3 mm -75.69 -25.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -69.1 -37.26 78.3 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.15 -39.17 92.62 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.6 0.76 . . . . 0.0 110.358 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.523 HG22 HG11 ' A' ' 51' ' ' VAL . 29.2 mt -66.42 -34.55 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 123.533 0.521 . . . . 0.0 110.04 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 31' ' ' TYR . 88.9 mt -64.32 -35.54 81.19 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.838 0.455 . . . . 0.0 111.804 174.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.36 -15.37 61.87 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.896 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.49 97.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.82 87.48 0.06 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 109.904 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.46 -17.22 0.08 OUTLIER Glycine 0 C--O 1.221 -0.714 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.881 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.523 HG11 HG22 ' A' ' 45' ' ' ILE . 35.6 m -85.77 -27.86 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 22.2 ttmm 48.59 -77.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.94 2.096 . . . . 0.0 113.217 -173.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 49.9 m -122.89 98.06 5.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.945 0.898 . . . . 0.0 110.172 -171.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 66.0 mt -83.93 84.08 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.447 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 92.5 t80 -81.49 140.32 34.65 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.429 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -137.02 134.41 36.56 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.15 143.32 9.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 171.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.2 ttt 62.31 -80.45 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 O-C-N 124.651 1.22 . . . . 0.0 111.837 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.59 -38.01 1.55 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.636 0.774 . . . . 0.0 111.327 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -103.44 165.14 11.21 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.305 0.642 . . . . 0.0 112.625 -163.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.3 mt -120.19 111.53 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.989 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 50.1 m -85.83 95.37 9.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.358 0.663 . . . . 0.0 109.61 173.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 14' ' ' THR . 52.4 t -85.07 99.95 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.571 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 1.8 m-20 -84.7 98.3 10.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.683 1.193 . . . . 0.0 108.58 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.631 ' HD2' ' HB3' ' A' ' 69' ' ' ALA . 57.9 pttt -66.25 177.09 1.54 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -175.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 47.7 mm-40 -64.09 -177.39 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.499 0.719 . . . . 0.0 112.274 174.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -61.0 -25.1 66.65 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.528 0.731 . . . . 0.0 111.732 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.13 -58.27 0.9 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.412 0.685 . . . . 0.0 109.772 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.631 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . 49.6 -164.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.85 1.26 . . . . 0.0 113.053 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -156.8 114.21 3.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -68.69 -28.07 66.53 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.064 0.546 . . . . 0.0 111.832 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.63 -21.65 64.46 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 120.982 0.42 . . . . 0.0 110.505 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.7 m -86.0 -45.14 11.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.115 0.566 . . . . 0.0 110.396 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.44 -58.14 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.845 0.858 . . . . 0.0 112.571 -173.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.36 -47.01 99.73 Favored Pre-proline 0 N--CA 1.491 1.599 0 CA-C-O 117.362 -1.304 . . . . 0.0 114.321 -170.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.49 -33.99 60.03 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 122.14 1.893 . . . . 0.0 113.974 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -77.25 -39.02 49.82 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.811 0.844 . . . . 0.0 110.435 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.94 -41.23 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.765 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.93 -36.88 84.87 Favored 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 123.75 0.82 . . . . 0.0 110.837 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.71 -30.49 67.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.415 0.686 . . . . 0.0 111.917 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 41' ' ' PHE . 40.6 t -65.83 -58.96 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.848 0.859 . . . . 0.0 111.928 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -73.75 -42.93 60.41 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.261 0.624 . . . . 0.0 110.914 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.5 70.36 2.26 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.483 1.191 0 C-N-CA 123.558 0.743 . . . . 0.0 110.915 175.72 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 121.132 0.491 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.602 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 50.9 pttt -145.14 -170.72 3.49 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.195 0.998 . . . . 0.0 108.984 173.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 6' ' ' ILE . 59.5 mt -78.12 116.65 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 163.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 19' ' ' LEU . 1.6 mp -83.43 -52.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 t -159.32 124.39 4.13 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.432 0.458 . . . . 0.0 110.881 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.632 HG21 ' HE2' ' A' ' 15' ' ' MET . 59.8 mt -92.25 90.6 3.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 123.959 0.904 . . . . 0.0 112.532 171.075 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.572 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 1.6 m120 -72.28 -22.29 61.23 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.03 1.287 . . . . 0.0 111.469 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 11.9 t -140.31 162.44 35.29 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.225 1.01 . . . . 0.0 109.292 171.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.632 ' HE2' HG21 ' A' ' 6' ' ' ILE . 6.9 ptp -136.36 125.49 24.55 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.285 0.564 . . . . 0.0 110.929 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -80.32 92.39 5.77 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.008 0.923 . . . . 0.0 109.356 170.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 6' ' ' ILE . 71.1 mt -80.04 95.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 m -82.75 141.32 32.47 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.519 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.682 ' HA ' HD13 ' A' ' 4' ' ' ILE . 75.5 mt -111.98 160.85 17.06 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.141 0.976 . . . . 0.0 110.069 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.4 p -76.31 -15.81 59.91 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.205 1.002 . . . . 0.0 111.886 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.39 61.62 6.72 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 122.078 0.942 . . . . 0.0 110.244 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.3 m -90.12 66.41 6.71 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.768 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -154.25 -56.43 0.11 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.882 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.57 -19.89 66.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -170.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.7 63.15 4.44 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.491 0.494 . . . . 0.0 112.457 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.9 mtt -48.7 149.55 1.7 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.28 1.432 . . . . 0.0 112.821 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.7 p -66.08 148.6 51.56 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.024 0.93 . . . . 0.0 111.926 -174.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 p -89.05 105.3 17.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.655 0.782 . . . . 0.0 110.223 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -138.39 138.23 38.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.471 0.708 . . . . 0.0 111.193 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.4 m -103.31 98.91 8.75 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.1 0.96 . . . . 0.0 109.552 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -83.98 116.08 22.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.465 1.106 . . . . 0.0 109.683 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.3 p -137.42 -75.79 0.41 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.365 0.666 . . . . 0.0 112.514 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -91.47 18.66 6.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -164.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t 61.86 90.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.369 1.068 . . . . 0.0 109.485 -170.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -163.0 155.68 18.89 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.563 0.745 . . . . 0.0 110.347 -171.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.8 t70 67.17 -80.56 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.471 1.509 . . . . 0.0 112.129 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.5 t -154.28 69.99 0.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.295 0.569 . . . . 0.0 110.006 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -108.74 104.74 55.47 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.485 0.714 . . . . 0.0 109.358 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.79 152.34 42.93 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.765 2.31 . . . . 0.0 112.221 173.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.46 -37.91 51.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.928 0.891 . . . . 0.0 111.612 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.632 ' HB3' HG13 ' A' ' 81' ' ' VAL . 59.1 m-85 -62.91 -39.48 94.64 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.126 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -74.73 -29.69 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.127 0.971 . . . . 0.0 110.587 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -41.12 91.87 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 22.1 t70 -56.92 -49.23 76.24 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.297 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.481 HG23 HG22 ' A' ' 78' ' ' VAL . 61.1 mt -57.27 -46.26 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 124.148 0.905 . . . . 0.0 110.278 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.74 -36.91 82.37 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.719 0.808 . . . . 0.0 111.856 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -77.49 -13.36 59.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.405 0.682 . . . . 0.0 111.536 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 44' ' ' ASP . 96.9 t -71.0 125.9 30.27 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -61.97 92.11 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.109 1.364 . . . . 0.0 111.367 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.52 -52.13 0.38 Allowed Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.098 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.98 120.88 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.53 0.732 . . . . 0.0 110.985 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -95.55 -50.86 4.79 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.373 0.669 . . . . 0.0 110.074 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.3 t -143.06 152.68 42.14 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.79 0.436 . . . . 0.0 111.286 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.422 HG12 HG13 ' A' ' 63' ' ' VAL . 46.7 mt -125.2 94.59 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.773 1.229 . . . . 0.0 108.615 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -96.18 100.11 11.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.893 -0.504 . . . . 0.0 110.088 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.33 129.71 35.83 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 p -161.59 141.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.445 0.698 . . . . 0.0 111.086 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 65.08 -73.25 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.976 1.71 . . . . 0.0 113.594 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -155.16 8.84 0.29 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.78 0.432 . . . . 0.0 111.166 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -142.52 165.97 25.96 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.1 0.56 . . . . 0.0 110.213 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.59 102.27 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 15' ' ' MET . 19.3 p -81.98 89.07 6.37 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.422 HG13 HG12 ' A' ' 54' ' ' ILE . 43.8 t -89.27 116.04 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.244 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 4.1 p30 -99.75 163.72 12.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.941 0.496 . . . . 0.0 111.293 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -136.37 173.07 12.1 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.342 -175.348 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.07 125.06 32.45 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 166.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -54.68 -21.18 9.95 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.715 1.206 . . . . 0.0 113.347 -167.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -51.76 -47.9 63.95 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.598 1.159 . . . . 0.0 112.159 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.09 130.54 35.52 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.61 0.764 . . . . 0.0 111.389 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -84.94 155.94 21.41 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.103 0.561 . . . . 0.0 109.56 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.41 ' HH2' HG12 ' A' ' 63' ' ' VAL . 49.4 m95 -76.58 -31.38 57.48 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -28.62 44.14 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -171.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -81.12 -39.59 25.36 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.889 0.876 . . . . 0.0 110.011 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.65 -36.04 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 124.93 1.292 . . . . 0.0 111.703 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 77.0 mt -50.12 -49.12 77.4 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 125.194 1.398 . . . . 0.0 114.59 -172.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.85 -31.16 88.04 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.885 1.723 . . . . 0.0 113.555 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -80.13 -40.18 27.96 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.862 0.865 . . . . 0.0 110.387 -176.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 45' ' ' ILE . 59.8 t -65.81 -48.91 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.22 -31.26 72.38 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.966 0.906 . . . . 0.0 111.339 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.67 -34.83 69.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.892 0.877 . . . . 0.0 111.119 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 41' ' ' PHE . 43.2 t -57.82 -46.99 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.914 0.886 . . . . 0.0 111.059 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.602 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 18.1 m-85 -87.69 19.56 3.38 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.693 0.797 . . . . 0.0 112.684 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -157.05 5.75 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 111.306 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.609 0.242 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.75 157.8 16.71 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.451 HG21 HG13 ' A' ' 6' ' ' ILE . 32.8 mt -76.93 129.85 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.983 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.4 mm -87.56 -48.02 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.935 0.894 . . . . 0.0 109.849 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 p -142.25 128.73 20.15 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.369 0.667 . . . . 0.0 109.673 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.451 HG13 HG21 ' A' ' 3' ' ' ILE . 3.8 mp -90.53 86.92 2.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.552 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 97.5 p . . . . . 0 N--CA 1.484 1.266 0 C-N-CA 125.531 1.533 . . . . 0.0 113.901 171.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.602 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 76.9 m-20 -102.82 8.79 39.25 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.161 0.584 . . . . 0.0 112.191 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 t -159.89 95.07 1.16 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.545 0.738 . . . . 0.0 110.135 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.1 mtp -82.65 125.77 31.57 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 121.713 -0.617 . . . . 0.0 111.802 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 7' ' ' SER . 23.0 ttmm -79.92 89.73 5.31 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.743 1.217 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.494 HD12 HG21 ' A' ' 63' ' ' VAL . 70.9 mt -85.6 95.63 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 174.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 60' ' ' PHE . 49.3 m -77.06 124.16 27.4 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.265 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.3 mt -87.55 164.52 16.06 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.118 0.485 . . . . 0.0 110.785 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -76.02 -19.89 58.28 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.872 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -96.73 101.57 13.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 109.664 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.778 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 29.3 t -79.41 107.94 12.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.536 0.734 . . . . 0.0 109.291 173.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 46.08 -154.94 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.712 1.605 . . . . 0.0 113.326 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.22 40.88 32.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.137 0.975 . . . . 0.0 112.078 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.79 -32.29 1.45 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.804 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.8 mmt -90.34 101.91 14.64 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.547 0.739 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.7 m -80.11 166.82 21.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.016 0.926 . . . . 0.0 111.057 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 67.8 p -80.87 74.35 7.85 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.937 0.895 . . . . 0.0 109.784 170.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -87.15 153.99 21.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.584 1.154 . . . . 0.0 110.387 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -128.54 101.25 6.09 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.453 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 37.4 m-85 -88.01 119.62 28.56 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.2 p -118.19 -62.44 1.54 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.52 0.6 . . . . 0.0 112.132 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.65 26.97 7.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -157.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.459 ' H ' HD13 ' A' ' 46' ' ' LEU . 87.5 t 62.11 83.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -166.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.76 -77.21 0.26 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.567 -162.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -169.31 -77.2 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.02 0.373 . . . . 0.0 111.337 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 m -89.15 68.48 8.18 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.089 0.956 . . . . 0.0 110.727 -171.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.444 HE22 HD11 ' A' ' 46' ' ' LEU . 4.1 pt20 -151.65 154.22 32.91 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.594 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.488 ' HB2' ' HB2' ' A' ' 41' ' ' PHE . 21.5 Cg_exo -66.2 150.89 84.68 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 122.669 2.246 . . . . 0.0 112.215 169.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HA ' HD21 ' A' ' 43' ' ' ASN . . . -60.02 -23.76 63.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.865 0.866 . . . . 0.0 111.389 171.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.591 ' HB3' HG13 ' A' ' 81' ' ' VAL . 25.3 m-85 -46.97 -51.4 17.16 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.374 1.47 . . . . 0.0 110.82 170.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.1 mm -72.62 -29.25 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.625 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.474 HD21 ' HA ' ' A' ' 40' ' ' ALA . 93.7 m-20 -67.97 -32.94 73.71 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.362 0.665 . . . . 0.0 111.945 -175.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -59.08 -46.8 87.35 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.492 0.495 . . . . 0.0 110.22 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.8 mt -66.07 -38.75 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.609 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.459 HD13 ' H ' ' A' ' 34' ' ' VAL . 76.7 mt -60.71 -39.53 88.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.36 0.664 . . . . 0.0 111.709 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -85.62 4.13 37.69 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.267 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.2 t -78.84 123.53 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 169.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.13 130.39 34.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.571 0.748 . . . . 0.0 110.931 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.63 -32.67 7.3 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.644 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.37 109.36 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 24.3 ttmm -78.94 -55.24 5.29 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.427 0.691 . . . . 0.0 110.568 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.1 t -158.88 157.29 31.19 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.567 0.698 . . . . 0.0 110.716 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 67.6 mt -114.4 87.26 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.442 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 58.3 t80 -84.26 90.75 7.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.546 0.689 . . . . 0.0 109.841 -175.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -80.75 117.37 21.36 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 2.5 p -140.97 125.25 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.129 0.422 . . . . 0.0 110.556 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 62.84 -71.98 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.446 1.498 . . . . 0.0 110.59 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.778 ' HB3' ' HA ' ' A' ' 22' ' ' SER . 2.0 p30 -148.46 -33.08 0.24 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.849 1.259 . . . . 0.0 110.08 172.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 29.0 p90 -83.86 129.31 34.93 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -174.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.26 113.78 39.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -176.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 10.9 m -82.37 81.84 8.07 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.643 0.777 . . . . 0.0 109.64 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.494 HG21 HD12 ' A' ' 17' ' ' ILE . 48.7 t -78.85 92.89 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -82.41 151.2 26.71 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.265 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.602 ' HE2' ' HA ' ' A' ' 13' ' ' ASN . 39.0 pttt -137.17 -178.2 5.1 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.746 -173.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.84 140.88 30.85 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.95 -38.57 62.16 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.708 0.803 . . . . 0.0 112.163 -169.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.52 -32.62 72.7 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.702 0.801 . . . . 0.0 112.956 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.497 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . -56.31 111.33 0.94 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.936 0.894 . . . . 0.0 111.945 -175.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.512 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 15.8 m120 -82.47 126.4 32.19 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -70.59 -13.99 62.31 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.821 0.448 . . . . 0.0 112.101 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 70' ' ' ASN . 12.6 pt-20 -60.65 -28.4 68.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.302 0.641 . . . . 0.0 111.549 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.2 t -96.49 -40.68 8.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.761 0.824 . . . . 0.0 111.307 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.6 t -66.1 -47.23 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.094 0.958 . . . . 0.0 111.659 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.84 -43.33 97.59 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.858 -171.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.12 -39.51 20.49 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.732 2.288 . . . . 0.0 113.742 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -75.59 -41.32 54.92 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.036 0.534 . . . . 0.0 111.391 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.421 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 76.0 t -60.01 -55.52 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.317 0.647 . . . . 0.0 110.643 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -60.12 -39.11 85.08 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.035 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.59 -33.12 72.27 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.53 0.732 . . . . 0.0 111.655 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 41' ' ' PHE . 8.2 t -58.85 -48.56 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.295 0.638 . . . . 0.0 110.88 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -74.44 -30.48 61.91 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.932 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -107.0 20.39 19.11 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 81' ' ' VAL . 4.5 pp . . . . . 0 N--CA 1.493 1.698 0 O-C-N 122.176 -0.328 . . . . 0.0 111.417 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.488 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -122.76 179.31 4.67 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.607 0.763 . . . . 0.0 109.969 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.527 HD12 ' HG2' ' A' ' 79' ' ' GLU . 27.6 mt -71.92 104.11 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.1 mm -84.23 -48.73 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.185 0.594 . . . . 0.0 109.808 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.1 p -155.81 125.99 6.63 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.017 0.527 . . . . 0.0 110.243 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.92 153.01 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.611 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 47.6 t . . . . . 0 N--CA 1.48 1.033 0 C-N-CA 123.141 0.576 . . . . 0.0 112.369 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 42.6 m170 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 72.63 -61.4 0.5 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.136 1.774 . . . . 0.0 112.237 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.448 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 6.7 t -140.92 136.75 32.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.996 0.426 . . . . 0.0 111.201 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.448 ' O ' ' HA ' ' A' ' 62' ' ' SER . 6.7 ptp -104.49 153.35 21.24 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.533 174.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 32.2 ttmt -95.47 125.01 39.78 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 171.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.21 97.1 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.1 m -70.37 113.0 7.09 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.298 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 86.9 mt -81.71 -178.67 7.07 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.029 0.532 . . . . 0.0 111.081 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.434 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 7.4 m -73.63 0.8 11.68 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.203 0.601 . . . . 0.0 111.537 172.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.94 130.72 48.13 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.199 1.4 . . . . 0.0 110.121 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -61.98 -30.58 71.04 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.113 1.365 . . . . 0.0 112.327 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.575 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 44.4 ttt85 103.9 132.96 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 129.067 2.947 . . . . 0.0 109.186 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.581 ' HA ' ' SD ' ' A' ' 58' ' ' MET . 28.4 tt0 80.62 -4.53 1.79 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.064 1.746 . . . . 0.0 111.788 175.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.18 -33.73 53.4 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 58' ' ' MET . 64.4 mtt -107.42 -179.6 3.97 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.268 1.027 . . . . 0.0 109.635 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 t -124.56 179.2 5.05 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.297 0.639 . . . . 0.0 111.276 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 33.9 p -89.43 132.93 34.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.667 1.187 . . . . 0.0 110.709 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -155.57 158.19 38.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.438 ' HB ' ' HD1' ' A' ' 55' ' ' PHE . 5.7 t -129.17 102.68 6.57 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.709 0.766 . . . . 0.0 109.38 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.514 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 68.6 m-85 -83.11 109.39 17.11 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.7 p -113.17 -69.64 0.85 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.531 0.732 . . . . 0.0 111.145 -172.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -100.23 22.94 10.73 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.244 0.618 . . . . 0.0 112.106 -168.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.9 t 69.23 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 124.718 1.207 . . . . 0.0 112.509 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 66.26 90.3 0.09 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.028 1.731 . . . . 0.0 112.065 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -168.7 74.07 0.1 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 0.0 109.039 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.1 p 46.89 46.63 15.56 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.112 1.365 . . . . 0.0 112.508 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.07 125.04 17.85 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 123.992 0.917 . . . . 0.0 109.22 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.97 155.07 6.33 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 124.05 3.167 . . . . 0.0 114.412 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.5 -33.1 43.4 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.403 1.081 . . . . 0.0 112.519 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -60.87 -40.72 94.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.095 0.958 . . . . 0.0 111.479 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.1 mm -70.98 -27.6 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.787 0.835 . . . . 0.0 110.024 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.79 -34.75 74.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.293 0.637 . . . . 0.0 110.391 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -64.62 -43.64 93.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.538 0.735 . . . . 0.0 111.105 175.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.528 HG23 HG22 ' A' ' 78' ' ' VAL . 54.9 mt -60.22 -37.63 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.038 0.447 . . . . 0.0 110.376 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.69 -34.21 77.35 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.39 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -87.77 0.57 55.58 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.768 0.827 . . . . 0.0 112.551 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 44' ' ' ASP . 91.6 t -72.09 127.22 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.73 132.57 53.68 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.091 0.956 . . . . 0.0 111.358 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.23 -47.4 1.11 Allowed Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.617 -173.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.72 135.88 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 124.305 1.042 . . . . 0.0 112.243 -171.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -113.21 -47.03 3.04 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.811 1.244 . . . . 0.0 110.09 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 12.6 m -146.35 157.68 43.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.239 0.542 . . . . 0.0 111.007 -174.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 82.0 mt -123.09 82.68 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 173.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.438 ' HD1' ' HB ' ' A' ' 30' ' ' THR . 32.2 t80 -82.98 88.04 6.86 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 5.5 t60 -84.5 87.95 7.28 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 p -92.62 105.8 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.712 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.581 ' SD ' ' HA ' ' A' ' 24' ' ' GLU . 44.5 tpp 65.45 -91.19 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.916 1.287 . . . . 0.0 111.276 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.575 ' HB3' ' HA ' ' A' ' 23' ' ' ARG . 6.7 p-10 -116.2 -7.36 11.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.734 0.814 . . . . 0.0 111.933 -170.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -133.61 136.78 45.07 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.071 0.548 . . . . 0.0 111.011 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 56' ' ' HIS . 43.5 mt -94.06 106.65 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.787 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 15' ' ' MET . 10.7 t -81.99 90.98 6.53 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 172.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.82 98.18 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.16 0.584 . . . . 0.0 109.647 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 53' ' ' SER . 3.2 m-20 -79.78 150.12 30.85 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.505 0.722 . . . . 0.0 110.567 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -152.99 -159.49 1.01 Allowed 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.717 0.807 . . . . 0.0 109.091 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -63.11 -175.88 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.147 0.979 . . . . 0.0 111.947 168.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -51.33 -43.45 61.75 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.966 0.906 . . . . 0.0 111.828 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -158.3 -46.72 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.434 0.694 . . . . 0.0 110.467 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 51.68 -97.05 0.05 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.995 0.918 . . . . 0.0 109.171 -169.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -158.73 127.53 5.41 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 160.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.436 ' CH2' ' HG2' ' A' ' 15' ' ' MET . 94.3 m95 -80.72 -13.52 58.92 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.979 -0.451 . . . . 0.0 110.295 171.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -50.99 -45.19 60.96 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.397 1.079 . . . . 0.0 111.854 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -75.64 -41.72 53.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.631 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.29 -50.78 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.917 0.887 . . . . 0.0 113.359 -166.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.36 -50.4 85.17 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-O 117.772 -1.109 . . . . 0.0 113.135 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -43.9 -41.0 11.98 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.867 2.378 . . . . 0.0 114.83 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.61 -46.45 26.02 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.939 0.496 . . . . 0.0 110.874 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.528 HG22 HG23 ' A' ' 45' ' ' ILE . 89.2 t -64.53 -52.85 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.661 0.784 . . . . 0.0 110.768 -175.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.527 ' HG2' HD12 ' A' ' 3' ' ' ILE . 49.5 mt-10 -58.9 -34.66 71.92 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.53 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.68 -34.04 72.36 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.878 0.871 . . . . 0.0 112.005 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.84 -42.13 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.672 0.789 . . . . 0.0 110.679 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -84.61 7.63 19.53 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.617 0.767 . . . . 0.0 112.927 173.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -133.28 52.97 2.04 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.191 0.996 . . . . 0.0 109.172 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.487 1.38 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.326 -178.644 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -88.7 41.01 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.367 0.667 . . . . 0.0 112.295 -173.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 17' ' ' ILE . 43.3 mt 53.79 103.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 124.57 1.148 . . . . 0.0 112.061 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.0 mm -82.66 -49.59 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.678 0.791 . . . . 0.0 110.677 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 t -149.3 148.17 29.22 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 120.88 0.371 . . . . 0.0 110.586 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.8 mm -96.01 106.86 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.481 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.475 0.824 0 C-N-CA 126.093 1.757 . . . . 0.0 115.537 168.967 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -64.95 -56.47 13.03 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 9.8 t -115.66 126.78 54.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.804 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.6 ' HE1' HD11 ' A' ' 75' ' ' LEU . 34.2 mtm -110.69 136.57 49.58 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.253 0.549 . . . . 0.0 110.857 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.506 ' NZ ' ' HB3' ' A' ' 60' ' ' PHE . 6.4 tmtm? -79.22 94.56 5.44 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.059 174.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 3' ' ' ILE . 58.3 mt -77.8 96.33 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 m -63.03 129.89 42.33 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.964 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.2 mt -116.15 149.18 39.47 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -75.37 -13.75 60.42 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.06 0.544 . . . . 0.0 110.54 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -92.05 63.08 4.34 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.564 1.146 . . . . 0.0 108.712 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.53 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 26.5 m -78.43 -172.93 3.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.611 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 72.39 171.63 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.562 1.145 . . . . 0.0 110.398 -172.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 68.36 -75.84 0.06 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.309 1.443 . . . . 0.0 111.966 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.7 -25.2 0.21 Allowed Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.009 -175.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 43.5 tpp 41.56 66.46 0.69 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.579 1.552 . . . . 0.0 111.444 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.5 p 48.44 100.57 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.976 1.71 . . . . 0.0 112.883 -171.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.5 p -88.48 70.75 8.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.823 0.821 . . . . 0.0 108.985 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.64 168.52 11.68 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.039 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.487 ' HG1' ' HD1' ' A' ' 55' ' ' PHE . 7.4 m -126.36 97.11 4.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.283 -1.326 . . . . 0.0 107.864 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.491 ' HB3' HD11 ' A' ' 46' ' ' LEU . 44.0 m-85 -83.25 98.43 9.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.933 0.893 . . . . 0.0 108.842 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.447 HG23 HG22 ' A' ' 30' ' ' THR . 28.6 p -124.34 -64.47 1.12 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.733 0.813 . . . . 0.0 110.102 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -79.88 -4.09 50.77 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -168.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 t 63.88 164.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 C-N-CA 125.161 1.384 . . . . 0.0 110.599 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 65.54 96.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.285 1.034 . . . . 0.0 110.892 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -152.99 -74.95 0.13 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.6 t -165.62 23.44 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.495 0.718 . . . . 0.0 109.46 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.56 140.95 22.04 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.141 0.577 . . . . 0.0 109.668 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.22 148.42 3.13 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.934 3.089 . . . . 0.0 114.563 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.06 -32.96 62.31 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.996 0.918 . . . . 0.0 110.714 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.619 ' HB3' HG13 ' A' ' 81' ' ' VAL . 82.3 m-85 -52.69 -48.65 66.42 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.704 1.201 . . . . 0.0 111.037 172.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -71.42 -31.05 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.254 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.81 -37.71 82.33 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.441 ' O ' HG23 ' A' ' 48' ' ' VAL . 25.0 t70 -65.1 -41.82 94.58 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.635 0.774 . . . . 0.0 110.1 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.462 HD11 HG21 ' A' ' 81' ' ' VAL . 64.3 mt -57.26 -47.32 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 123.891 0.744 . . . . 0.0 109.831 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 31' ' ' TYR . 88.8 mt -60.47 -36.92 79.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.212 0.605 . . . . 0.0 111.178 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.92 -8.93 59.52 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.6 0.76 . . . . 0.0 112.094 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 44' ' ' ASP . 97.2 t -65.17 107.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 171.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.56 107.19 0.31 Allowed 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.983 0.802 . . . . 0.0 110.398 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.5 -45.38 0.86 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.183 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.517 HG13 HG13 ' A' ' 63' ' ' VAL . 40.2 t -60.55 -40.51 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 125.085 1.354 . . . . 0.0 113.655 -171.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 38.5 ttmt 64.13 -72.25 0.06 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.389 1.876 . . . . 0.0 111.587 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 p -144.95 156.33 43.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.157 0.583 . . . . 0.0 111.156 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.1 mt -131.64 131.48 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.463 1.105 . . . . 0.0 108.245 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.487 ' HD1' ' HG1' ' A' ' 30' ' ' THR . 67.3 t80 -118.14 104.77 11.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -96.62 128.08 43.22 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 p -163.9 151.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 56.6 tpp 68.46 -69.77 0.14 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.367 1.467 . . . . 0.0 110.692 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.53 ' HB3' ' HA ' ' A' ' 22' ' ' SER . 8.7 p-10 -148.16 -36.41 0.2 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.591 1.157 . . . . 0.0 110.401 173.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.506 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . 55.3 p90 -87.47 149.69 24.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -158.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 66.8 mt -98.77 97.17 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 113.616 -1.629 . . . . 0.0 107.921 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.1 t -83.94 86.97 7.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.116 0.566 . . . . 0.0 109.625 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.517 HG13 HG13 ' A' ' 51' ' ' VAL . 44.2 t -80.87 103.55 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 36.3 t70 -95.01 95.53 8.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.971 0.908 . . . . 0.0 109.875 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.613 ' HD2' ' HB3' ' A' ' 69' ' ' ALA . 17.3 pttp -86.05 -172.17 3.94 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.904 0.881 . . . . 0.0 112.359 -175.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.45 167.56 1.88 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.768 0.827 . . . . 0.0 111.45 167.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -51.25 -68.76 0.14 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.219 1.007 . . . . 0.0 111.496 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -94.35 -57.23 2.56 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.35 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.613 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . 40.39 -157.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.309 1.443 . . . . 0.0 113.578 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -141.68 108.59 5.42 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.478 0.711 . . . . 0.0 109.477 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -61.18 -32.86 72.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.038 0.535 . . . . 0.0 110.041 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -62.91 -22.04 66.46 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.977 0.911 . . . . 0.0 111.614 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.3 m -92.36 -44.86 8.48 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.619 0.767 . . . . 0.0 110.962 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.3 t -72.69 -51.6 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.834 0.854 . . . . 0.0 112.398 -172.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.6 HD11 ' HE1' ' A' ' 15' ' ' MET . 91.3 mt -56.44 -41.34 90.68 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-O 117.368 -1.301 . . . . 0.0 114.389 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -40.33 -41.83 3.5 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.067 2.511 . . . . 0.0 114.596 170.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 36.6 mtpt -75.92 -43.04 47.01 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.683 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.08 -50.18 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.261 0.624 . . . . 0.0 110.042 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.447 ' HG2' HD12 ' A' ' 3' ' ' ILE . 42.9 mt-10 -57.21 -44.18 83.45 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.342 1.057 . . . . 0.0 110.968 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.08 67.76 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.48 1.112 . . . . 0.0 112.703 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 41' ' ' PHE . 52.6 t -61.55 -49.4 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.267 0.627 . . . . 0.0 110.977 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -78.54 -27.71 45.99 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.967 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.46 71.34 4.35 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.476 0.846 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.849 173.522 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.586 ' HG2' HD13 ' A' ' 19' ' ' LEU . 3.3 mpp? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.069 0.461 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -116.81 -175.57 2.8 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.83 1.252 . . . . 0.0 109.766 174.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.6 mt -102.49 109.66 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 170.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mm -84.19 -46.02 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.0 m -146.53 127.27 14.32 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.172 0.589 . . . . 0.0 110.272 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -86.78 75.35 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 165.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 CA--C 1.541 0.608 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.352 -178.841 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -59.21 -36.81 76.05 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.904 0.881 . . . . 0.0 109.542 163.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -123.78 159.25 29.92 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.796 0.839 . . . . 0.0 110.966 -177.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 37.7 mtm -136.45 143.06 43.68 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.553 1.141 . . . . 0.0 108.569 169.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -95.25 116.68 29.07 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.411 0.685 . . . . 0.0 109.597 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 64.6 mt -90.58 96.11 6.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 172.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 m -66.29 120.53 13.44 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.476 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.586 HD13 ' HG2' ' A' ' 1' ' ' MET . 77.0 mt -87.8 -160.56 0.63 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.216 0.607 . . . . 0.0 110.238 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -68.97 8.26 0.56 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 66.33 106.62 0.04 OUTLIER 'General case' 0 C--N 1.362 1.115 0 C-N-CA 125.352 1.461 . . . . 0.0 110.742 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -140.49 174.24 10.71 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.364 0.666 . . . . 0.0 110.827 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -56.48 133.04 52.96 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.222 0.609 . . . . 0.0 109.711 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -54.37 91.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.807 1.317 . . . . 0.0 112.519 -170.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.459 ' N ' ' HA ' ' A' ' 58' ' ' MET . . . -164.65 -73.2 0.03 OUTLIER Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 60.4 tpp 51.29 21.6 1.18 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.304 1.442 . . . . 0.0 112.381 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m 67.61 135.17 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.503 1.521 . . . . 0.0 110.513 -168.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 p -102.32 114.46 28.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.009 0.923 . . . . 0.0 108.746 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' A' ' 56' ' ' HIS . 15.7 m-20 -138.21 158.57 44.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.198 0.999 . . . . 0.0 110.194 -170.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 t -151.21 93.96 1.98 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -95.56 92.34 6.59 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.876 0.87 . . . . 0.0 110.566 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 53' ' ' SER . 81.3 p -92.31 -23.47 19.26 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.219 0.533 . . . . 0.0 109.585 174.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.649 ' HG2' ' H ' ' A' ' 34' ' ' VAL . 20.6 ttmm -106.58 -161.91 0.82 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.78 1.232 . . . . 0.0 108.272 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.649 ' H ' ' HG2' ' A' ' 33' ' ' LYS . 58.4 t -149.01 83.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 105.645 -1.984 . . . . 0.0 105.645 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -164.74 -138.0 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.694 -170.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 64.01 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.359 1.019 0 C-N-CA 124.891 1.276 . . . . 0.0 110.527 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.1 p -172.9 20.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.11 1.364 . . . . 0.0 109.386 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -65.1 142.86 98.73 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.028 0.931 . . . . 0.0 110.369 -176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.82 141.18 28.92 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.597 2.865 . . . . 0.0 113.347 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -58.97 -31.81 69.07 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.981 0.912 . . . . 0.0 111.74 -178.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.523 ' HB3' HG13 ' A' ' 81' ' ' VAL . 62.5 m-85 -65.4 -36.49 84.13 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.268 0.627 . . . . 0.0 110.911 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.3 mm -73.66 -27.1 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.525 0.73 . . . . 0.0 110.136 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 4.3 m-20 -62.27 -41.79 98.77 Favored 'General case' 0 C--N 1.368 1.392 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -57.72 -46.12 84.83 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.502 1.126 . . . . 0.0 111.418 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.539 HG23 HG22 ' A' ' 78' ' ' VAL . 57.4 mt -55.42 -49.27 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 123.801 0.688 . . . . 0.0 110.064 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.4 mt -65.15 -32.69 74.51 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.51 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -72.04 -18.94 61.91 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.764 0.826 . . . . 0.0 112.278 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.05 117.94 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -57.05 99.99 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.229 0.956 . . . . 0.0 109.168 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.52 -56.09 0.48 Allowed Glycine 0 C--O 1.225 -0.437 0 N-CA-C 110.071 -1.211 . . . . 0.0 110.071 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.73 127.71 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.844 0.858 . . . . 0.0 111.719 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.532 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 8.0 ttpm? -92.2 -46.56 7.68 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.063 0.945 . . . . 0.0 108.48 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 32' ' ' THR . 20.1 p -166.43 178.89 5.86 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 123.702 0.626 . . . . 0.0 111.599 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.4 mt -131.63 111.25 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.178 0.991 . . . . 0.0 109.377 176.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -90.35 125.79 35.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 169.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 29' ' ' ASP . 11.1 t-160 -132.78 123.38 26.06 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.61 0.764 . . . . 0.0 109.233 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -168.03 161.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 123.164 0.29 . . . . 0.0 110.458 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.459 ' HA ' ' N ' ' A' ' 25' ' ' GLY 0.27 27.2 ptm 56.64 -61.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 128.412 2.685 . . . . 0.0 114.973 175.251 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -150.88 -31.54 0.17 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.584 0.753 . . . . 0.0 111.0 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -95.51 155.38 16.77 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.337 0.589 . . . . 0.0 112.205 -167.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 42.7 mt -108.89 94.2 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 t -82.82 88.96 6.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.7 t -80.15 122.2 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.27 156.47 23.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.896 0.478 . . . . 0.0 110.006 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.532 ' HA ' ' H ' ' A' ' 52' ' ' LYS . 16.8 pttm -132.11 -162.09 1.2 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.109 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.94 165.64 2.32 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.535 0.734 . . . . 0.0 111.403 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -39.2 -44.82 1.26 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.539 1.536 . . . . 0.0 114.692 -164.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -133.36 -59.04 0.88 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 173.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . . . 49.91 -163.08 0.05 OUTLIER 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 125.782 1.633 . . . . 0.0 113.79 171.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -131.39 120.85 23.65 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.159 0.584 . . . . 0.0 111.536 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -73.81 -10.78 60.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.302 0.641 . . . . 0.0 110.935 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -61.93 -26.92 68.48 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.76 0.824 . . . . 0.0 110.575 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 m -91.84 -43.91 9.24 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.506 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.9 t -80.3 -50.21 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.631 0.772 . . . . 0.0 112.793 -172.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.25 -46.98 83.45 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-O 117.29 -1.338 . . . . 0.0 113.093 -171.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.19 -38.52 81.35 Favored 'Trans proline' 0 C--N 1.4 3.278 0 C-N-CA 122.232 1.955 . . . . 0.0 112.979 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.26 -40.56 70.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.067 0.547 . . . . 0.0 111.337 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 45' ' ' ILE . 41.4 t -65.47 -40.14 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.022 0.529 . . . . 0.0 109.97 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.15 -45.5 87.29 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.804 1.242 . . . . 0.0 110.463 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.0 -31.73 51.95 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.642 1.177 . . . . 0.0 112.708 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.523 HG13 ' HB3' ' A' ' 41' ' ' PHE . 56.0 t -65.77 -51.68 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 124.068 0.947 . . . . 0.0 111.279 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -72.66 -25.53 61.3 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -79.67 -69.76 0.56 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.375 0.27 . . . . 0.0 111.321 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 N--CA 1.495 1.824 0 C-N-CA 125.976 1.71 . . . . 0.0 111.813 -175.07 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -160.99 167.28 26.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.636 0.774 . . . . 0.0 109.981 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.3 mt -65.21 96.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 20' ' ' SER . 33.3 mm -93.26 -40.98 12.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 C-N-CA 123.889 0.876 . . . . 0.0 109.786 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.589 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 10.9 t -150.5 158.74 44.49 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.428 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -117.06 134.13 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.118 0.967 . . . . 0.0 109.087 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 7.3 m . . . . . 0 C--O 1.245 0.84 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.7 m170 . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 17.0 m120 76.82 -66.42 0.25 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.988 1.715 . . . . 0.0 110.363 -176.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 10.0 t -105.15 135.47 46.44 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.847 0.356 . . . . 0.0 111.573 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 62' ' ' SER . 13.0 ptp -133.24 149.29 51.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.723 169.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 84.3 tttt -91.06 100.26 13.14 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.534 1.134 . . . . 0.0 110.58 -175.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.86 111.15 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.589 ' HB ' ' HB3' ' A' ' 5' ' ' SER . 86.2 m -75.35 131.27 40.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.601 0.76 . . . . 0.0 110.98 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.5 mt -102.35 166.56 10.5 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.764 0.825 . . . . 0.0 109.239 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.516 ' HB2' HG13 ' A' ' 4' ' ' ILE . 29.4 t -76.19 -26.77 56.5 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.702 0.401 . . . . 0.0 111.501 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -82.0 76.67 8.88 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.28 0.562 . . . . 0.0 109.976 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -87.5 166.53 14.7 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.996 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 68.92 173.44 0.29 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.506 1.122 . . . . 0.0 110.586 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 57.05 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.702 1.201 . . . . 0.0 111.061 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.72 143.43 5.71 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.8 mtt -92.35 -165.93 1.44 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.525 0.73 . . . . 0.0 109.7 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.1 m -90.65 153.27 20.43 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.039 0.447 . . . . 0.0 110.048 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 p -87.09 104.71 16.6 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.26 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -123.55 97.5 5.41 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.88 0.872 . . . . 0.0 110.49 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 m -89.45 83.49 6.37 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.631 ' HB3' HD11 ' A' ' 46' ' ' LEU . 25.0 m-85 -81.87 110.46 17.18 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.477 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.3 p -121.55 -39.91 2.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.969 0.908 . . . . 0.0 110.472 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.658 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -141.14 40.0 1.78 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.883 -176.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.7 t 65.86 126.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 125.003 1.321 . . . . 0.0 113.133 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -93.69 -88.31 0.23 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 171.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 t70 169.51 -42.3 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.362 1.065 . . . . 0.0 109.294 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.5 p -63.42 -38.27 90.51 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.412 1.085 . . . . 0.0 111.806 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -60.51 141.9 91.44 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.945 0.898 . . . . 0.0 111.598 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.93 154.47 7.11 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.225 2.617 . . . . 0.0 113.815 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.14 67.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.973 0.909 . . . . 0.0 111.095 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.497 ' HB3' HG13 ' A' ' 81' ' ' VAL . 55.3 m-85 -62.3 -34.31 76.36 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.217 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.605 HD13 HG11 ' A' ' 81' ' ' VAL . 13.0 mm -79.76 -23.17 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 122.906 0.482 . . . . 0.0 110.52 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -68.27 -36.26 79.14 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.87 -41.84 92.4 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.71 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.586 HG22 HG11 ' A' ' 51' ' ' VAL . 54.3 mt -56.45 -46.6 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 123.994 0.809 . . . . 0.0 110.416 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 31' ' ' TYR . 96.7 mt -64.04 -36.4 83.88 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -79.34 -1.93 39.16 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.163 0.585 . . . . 0.0 112.059 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.6 t -70.87 115.52 10.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 165.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -62.96 89.06 0.03 OUTLIER 'General case' 0 C--N 1.348 0.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.28 -52.48 0.25 Allowed Glycine 0 C--O 1.218 -0.872 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.056 -172.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.586 HG11 HG22 ' A' ' 45' ' ' ILE . 74.2 t -69.9 -40.83 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -168.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 19.6 ttmt 65.63 -72.69 0.07 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.857 1.663 . . . . 0.0 111.823 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 35.9 t -133.29 151.86 51.91 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.641 0.776 . . . . 0.0 111.24 -174.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 75.1 mt -129.68 107.01 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.469 1.508 . . . . 0.0 107.401 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 72.0 t80 -99.59 91.44 4.89 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -94.13 134.49 36.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.138 0.975 . . . . 0.0 109.649 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 p -171.02 153.32 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.433 0.693 . . . . 0.0 109.48 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.498 ' HG3' ' H ' ' A' ' 59' ' ' ASP 0.269 18.3 ptp 43.93 -84.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 126.698 1.999 . . . . 0.0 115.231 -175.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.498 ' H ' ' HG3' ' A' ' 58' ' ' MET . 9.5 p-10 -138.82 20.88 2.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.022 -1.049 . . . . 0.0 111.853 -172.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -147.54 167.37 24.68 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.443 HG23 HG23 ' A' ' 54' ' ' ILE . 68.4 mt -132.14 101.89 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.406 1.483 . . . . 0.0 108.118 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.517 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 68.4 m -82.78 94.65 7.68 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.764 0.426 . . . . 0.0 110.121 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.49 HG13 HG13 ' A' ' 51' ' ' VAL . 97.5 t -79.15 105.21 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 18.7 t0 -93.71 85.57 4.88 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.273 1.029 . . . . 0.0 109.966 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 13' ' ' ASN . 16.8 pttp -75.73 174.09 10.26 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.074 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -75.54 176.25 7.76 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.946 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -70.46 -66.02 0.66 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.521 0.328 . . . . 0.0 110.531 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -69.81 -44.22 70.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.021 0.528 . . . . 0.0 111.348 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.53 121.48 8.48 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.244 0.965 . . . . 0.0 110.476 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -94.94 154.9 16.98 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.752 0.821 . . . . 0.0 111.311 -168.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -62.88 -20.11 64.81 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.094 0.558 . . . . 0.0 112.459 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -70.07 -19.34 63.27 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.565 0.346 . . . . 0.0 111.311 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.2 m -95.28 -47.18 6.43 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.409 0.683 . . . . 0.0 110.469 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.504 HG13 HG22 ' A' ' 51' ' ' VAL . 93.5 t -70.32 -59.99 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.934 0.893 . . . . 0.0 112.364 -171.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.3 tt -56.78 -50.27 88.97 Favored Pre-proline 0 CA--C 1.57 1.725 0 CA-C-O 117.773 -1.108 . . . . 0.0 112.902 -171.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -59.2 -31.25 94.96 Favored 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.409 2.072 . . . . 0.0 112.894 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -71.9 -41.25 68.16 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.659 0.784 . . . . 0.0 111.227 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.64 -48.51 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.96 -38.38 85.72 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.228 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.92 -29.1 70.31 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.13 0.972 . . . . 0.0 111.844 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.605 HG11 HD13 ' A' ' 42' ' ' ILE . 38.0 t -68.32 -39.4 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.686 0.394 . . . . 0.0 110.991 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -70.9 -40.79 71.97 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.469 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.0 79.14 1.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 124.658 1.183 . . . . 0.0 111.854 -177.682 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.464 0.649 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 10.8 mtmp? -137.55 -175.72 4.16 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.258 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -92.27 93.83 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.605 HG13 ' HB3' ' A' ' 20' ' ' SER . 49.1 mm -90.41 -42.13 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.364 0.666 . . . . 0.0 110.027 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -142.84 156.29 44.92 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.15 0.98 . . . . 0.0 108.87 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -111.51 -75.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.462 0.705 . . . . 0.0 110.196 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.6 t . . . . . 0 N--CA 1.484 1.25 0 C-N-CA 124.813 1.245 . . . . 0.0 110.79 -176.858 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.2 m80 . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.19 -48.27 18.05 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -128.04 141.65 51.45 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.472 0.653 . . . . 0.0 111.863 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.609 ' SD ' HD21 ' A' ' 75' ' ' LEU . 13.2 ptp -130.63 148.79 52.47 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 108.765 167.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 59.3 mttp -94.42 158.26 15.64 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.319 0.648 . . . . 0.0 109.538 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.1 mt -132.66 94.87 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.1 m -60.11 109.46 0.97 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.767 0.827 . . . . 0.0 109.983 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.9 mt -79.38 -26.76 41.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.939 0.496 . . . . 0.0 111.625 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.605 ' HB3' HG13 ' A' ' 4' ' ' ILE . 54.5 p 98.82 -6.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 127.876 2.47 . . . . 0.0 112.849 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -89.86 62.94 5.88 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.139 0.427 . . . . 0.0 109.887 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.3 m -65.22 84.47 0.05 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.586 0.707 . . . . 0.0 111.024 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -104.73 5.23 33.21 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.324 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 66.74 -71.1 0.1 Allowed 'General case' 0 C--N 1.37 1.497 0 C-N-CA 125.823 1.649 . . . . 0.0 111.075 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.29 56.34 4.25 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.288 -0.414 . . . . 0.0 112.246 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.9 ttt -94.92 46.95 1.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 m 68.47 155.2 0.12 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 125.752 1.621 . . . . 0.0 111.997 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.1 p -135.27 78.87 1.75 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.85 1.26 . . . . 0.0 108.309 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -124.52 144.68 49.98 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.434 0.694 . . . . 0.0 111.329 -165.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -99.92 149.73 23.12 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.989 0.916 . . . . 0.0 109.978 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.541 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 59.5 m-85 -141.35 113.99 8.32 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.156 1.383 . . . . 0.0 107.782 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.4 p -136.71 -43.06 0.59 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.564 0.746 . . . . 0.0 110.262 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -106.61 32.76 4.28 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.983 0.913 . . . . 0.0 112.076 -164.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 43' ' ' ASN . 58.9 t 55.58 64.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 122.756 1.265 . . . . 0.0 109.194 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.3 135.21 42.57 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.481 -1.69 . . . . 0.0 111.321 -170.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -77.09 91.89 3.72 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 p -177.96 -61.83 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.685 1.194 . . . . 0.0 108.662 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.478 ' HG3' ' ND2' ' A' ' 43' ' ' ASN . 25.2 pt20 -60.08 149.69 73.56 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.904 1.282 . . . . 0.0 111.91 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.6 150.93 11.18 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.262 2.642 . . . . 0.0 112.542 168.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.87 -37.33 63.58 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 123.687 0.617 . . . . 0.0 111.253 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -55.69 -40.31 72.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.89 1.276 . . . . 0.0 111.937 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.4 mm -75.63 -28.96 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.435 0.694 . . . . 0.0 110.304 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.478 ' ND2' ' HG3' ' A' ' 38' ' ' GLN . 55.5 m-80 -70.86 -34.94 72.15 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -64.61 -34.89 79.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.071 0.548 . . . . 0.0 110.93 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.9 mt -60.55 -45.24 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 123.728 0.642 . . . . 0.0 110.091 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.2 -35.74 78.01 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.921 0.488 . . . . 0.0 111.883 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.58 -14.12 60.38 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.212 0.605 . . . . 0.0 111.647 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.39 109.77 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -59.12 104.64 0.26 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.041 0.838 . . . . 0.0 111.003 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 146.88 -45.3 0.78 Allowed Glycine 0 C--N 1.344 1.015 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.5 121.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.791 0.836 . . . . 0.0 109.897 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.438 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 26.2 ttpp -104.96 -32.58 8.69 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.84 0.856 . . . . 0.0 110.965 -172.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 t -151.99 161.62 42.35 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.73 0.412 . . . . 0.0 111.062 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 79.1 mt -148.02 116.84 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.658 1.583 . . . . 0.0 107.252 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -119.59 110.23 16.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.798 0.439 . . . . 0.0 110.083 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -95.16 119.94 34.52 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.29 147.81 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.074 0.55 . . . . 0.0 110.336 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 67.55 -68.46 0.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.529 1.532 . . . . 0.0 110.883 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.404 ' H ' ' H ' ' A' ' 60' ' ' PHE . 6.2 p-10 -160.06 -25.44 0.06 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.87 1.268 . . . . 0.0 110.234 169.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.404 ' H ' ' H ' ' A' ' 59' ' ' ASP . 45.7 p90 -81.27 143.11 32.51 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-O 120.922 0.391 . . . . 0.0 111.259 -170.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.16 103.18 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 15.0 t -83.32 89.25 6.98 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.6 t -77.48 126.13 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -120.21 149.4 42.32 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.275 1.03 . . . . 0.0 110.457 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HA ' ' H ' ' A' ' 52' ' ' LYS . 17.8 pttp -140.22 179.88 6.38 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.681 1.192 . . . . 0.0 109.441 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.9 167.04 22.51 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.828 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.11 -48.38 71.07 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.976 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.96 -32.88 74.57 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.507 -172.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.83 161.99 27.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.705 0.802 . . . . 0.0 111.933 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -118.25 146.23 44.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.679 0.792 . . . . 0.0 110.074 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.538 ' HB3' HD23 ' A' ' 75' ' ' LEU . 66.1 m95 -69.66 -17.14 63.48 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.048 0.539 . . . . 0.0 111.031 172.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.59 -24.81 67.76 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.969 0.908 . . . . 0.0 111.792 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.7 m -84.75 -45.3 12.53 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.019 0.928 . . . . 0.0 110.397 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.8 t -73.5 -60.92 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.068 -169.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.609 HD21 ' SD ' ' A' ' 15' ' ' MET . 3.9 mm? -49.32 -47.62 76.33 Favored Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -172.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -55.51 -33.85 87.69 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.078 1.852 . . . . 0.0 113.876 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -80.96 -41.98 21.99 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.696 0.798 . . . . 0.0 110.5 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.1 t -74.42 -31.77 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.331 1.052 . . . . 0.0 111.523 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.5 -41.35 80.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.872 0.869 . . . . 0.0 110.987 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.33 -32.34 71.15 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.045 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -63.11 -40.19 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.901 0.88 . . . . 0.0 111.663 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.665 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 27.2 m-85 -91.2 25.08 2.63 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -145.62 -58.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.055 0.455 . . . . 0.0 109.904 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.487 1.381 0 C-N-CA 125.397 1.479 . . . . 0.0 111.091 -174.38 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.644 0.259 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -167.27 179.35 5.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.78 0.832 . . . . 0.0 111.125 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.9 mt -72.41 115.84 13.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.107 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.2 mm -84.74 -45.65 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.3 p -154.65 133.44 12.19 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.12 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.7 mm -78.37 105.6 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 169.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.538 ' HB3' ' HG3' ' A' ' 16' ' ' LYS . 38.2 t -77.97 160.56 28.11 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 122.956 0.502 . . . . 0.0 110.804 -176.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -72.79 163.27 28.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.357 0.663 . . . . 0.0 111.607 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -154.27 144.17 15.47 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.709 0.804 . . . . 0.0 109.761 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.93 -11.6 8.81 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.465 2.11 . . . . 0.0 112.523 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -117.32 115.79 25.95 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -67.71 -19.83 65.2 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.85 0.86 . . . . 0.0 111.81 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.447 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 25.6 t-20 -66.59 -64.76 0.79 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.536 0.734 . . . . 0.0 110.618 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.4 t -106.84 126.9 52.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.532 0.333 . . . . 0.0 110.121 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -122.35 143.33 49.71 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.29 0.567 . . . . 0.0 110.457 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HG3' ' HB3' ' A' ' 7' ' ' SER . 20.3 ptmt -88.38 140.53 29.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.84 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.1 mt -130.0 114.93 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.499 1.12 . . . . 0.0 109.317 -172.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.8 m -71.66 119.96 16.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.645 0.778 . . . . 0.0 110.322 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.9 mt -87.41 169.88 11.86 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.222 0.609 . . . . 0.0 110.696 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 p -74.7 -26.72 60.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.399 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HB2' ' SD ' ' A' ' 26' ' ' MET . 24.5 mm-40 -84.2 128.42 34.55 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.267 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.6 p -153.37 166.8 31.51 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.216 0.606 . . . . 0.0 111.334 -174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 71.04 156.13 0.15 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.875 1.67 . . . . 0.0 112.437 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 69.28 -75.97 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.803 1.641 . . . . 0.0 110.853 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.02 116.45 1.06 Allowed Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.535 -0.302 . . . . 0.0 112.505 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 21' ' ' GLU . 82.5 mtp -75.32 -167.59 0.67 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.302 1.041 . . . . 0.0 109.748 170.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.0 p -59.19 112.9 1.88 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.298 0.639 . . . . 0.0 110.991 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.1 p -94.59 84.87 4.36 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -144.78 141.74 29.44 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.828 0.851 . . . . 0.0 111.237 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.469 ' HG1' ' HD1' ' A' ' 55' ' ' PHE . 23.2 m -89.29 106.41 18.42 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -80.21 101.17 8.69 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -146.01 -33.7 0.32 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.948 0.499 . . . . 0.0 111.874 -171.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.427 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 46.9 pttt -88.85 4.87 46.26 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -169.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.4 t 65.02 126.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 125.448 1.499 . . . . 0.0 110.533 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 t70 72.01 47.34 0.31 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.927 1.291 . . . . 0.0 109.26 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' A' ' 33' ' ' LYS . 2.7 m-20 -84.31 47.91 1.41 Allowed 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.882 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.0 p 58.05 19.29 5.85 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.843 1.657 . . . . 0.0 113.249 -174.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.32 147.01 34.12 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 123.789 0.836 . . . . 0.0 109.966 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -52.43 155.19 10.15 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.739 2.959 . . . . 0.0 113.809 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.86 -31.35 49.29 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.253 1.021 . . . . 0.0 112.107 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -56.73 -44.98 82.19 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.216 1.006 . . . . 0.0 111.257 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mm -71.55 -28.86 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.381 0.672 . . . . 0.0 109.958 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.417 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 28.8 m-80 -72.07 -32.93 67.52 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.91 0.484 . . . . 0.0 110.068 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 48' ' ' VAL . 28.0 t70 -63.43 -41.78 98.7 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 124.145 0.903 . . . . 0.0 109.8 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.0 mt -59.74 -44.84 94.69 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 O-C-N 124.267 0.979 . . . . 0.0 109.882 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.48 -36.68 74.12 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.132 0.573 . . . . 0.0 111.223 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 43' ' ' ASN . 96.2 mttt -79.45 -19.72 49.2 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.658 0.783 . . . . 0.0 112.09 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 44' ' ' ASP . 55.9 t -60.44 121.83 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.65 89.47 0.05 OUTLIER 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.353 1.033 . . . . 0.0 109.581 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.15 -32.07 0.45 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.184 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.89 131.4 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.476 0.71 . . . . 0.0 109.7 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -87.05 -52.05 5.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.331 0.652 . . . . 0.0 109.26 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.6 p -163.31 173.0 13.84 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.584 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.461 HG23 HG22 ' A' ' 63' ' ' VAL . 74.0 mt -132.03 101.04 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.469 ' HD1' ' HG1' ' A' ' 30' ' ' THR . 28.8 t80 -81.98 146.27 29.83 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -135.54 135.03 40.04 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.12 124.64 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.538 0.735 . . . . 0.0 110.241 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 45.6 ttm 55.78 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.263 1.425 . . . . 0.0 112.821 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -120.31 -39.32 2.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.131 0.572 . . . . 0.0 110.6 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -98.26 138.79 35.01 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.644 0.735 . . . . 0.0 110.807 -167.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 53.5 mt -85.61 163.78 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.801 173.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -143.44 86.31 1.89 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.461 HG22 HG23 ' A' ' 54' ' ' ILE . 40.7 t -80.01 114.63 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.27 131.15 34.32 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.097 0.959 . . . . 0.0 108.69 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 13' ' ' ASN . 21.5 pttp -101.72 -173.86 2.45 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 173.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -89.39 162.71 15.64 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -59.13 -48.19 82.51 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.295 0.638 . . . . 0.0 112.631 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -80.55 -33.8 35.94 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.36 0.664 . . . . 0.0 111.597 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.35 140.94 12.59 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.591 1.156 . . . . 0.0 112.666 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -110.24 130.47 55.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.799 0.84 . . . . 0.0 110.302 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -60.35 -18.32 49.25 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.448 0.699 . . . . 0.0 112.027 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -56.73 -35.31 68.44 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.537 0.735 . . . . 0.0 110.732 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 t -101.06 -42.59 6.33 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.012 0.525 . . . . 0.0 110.884 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.1 t -70.73 -45.87 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.312 1.045 . . . . 0.0 113.358 -170.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.6 tp -60.64 -43.74 93.22 Favored Pre-proline 0 N--CA 1.492 1.66 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.65 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -46.45 -34.31 14.32 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.415 2.077 . . . . 0.0 114.38 170.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -75.1 -41.45 58.64 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.337 0.655 . . . . 0.0 111.118 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -65.02 -58.12 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-O 121.638 0.732 . . . . 0.0 109.237 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.67 -31.17 67.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.73 1.612 . . . . 0.0 112.26 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.14 55.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.383 1.073 . . . . 0.0 112.876 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.3 -49.54 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.203 0.601 . . . . 0.0 110.816 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -69.28 -25.22 64.15 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.351 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -122.49 77.16 1.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.726 0.81 . . . . 0.0 109.534 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -142.87 168.75 18.97 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.097 0.959 . . . . 0.0 108.565 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -68.38 98.07 0.8 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.23 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -82.68 104.93 13.3 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.92 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -136.31 155.82 49.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.093 0.957 . . . . 0.0 109.044 167.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -78.13 143.96 36.84 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.528 0.731 . . . . 0.0 110.068 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -123.72 119.76 30.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.044 0.938 . . . . 0.0 109.333 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -152.25 -48.5 0.11 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.388 0.675 . . . . 0.0 110.215 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 CA--C 1.561 1.374 0 O-C-N 124.763 1.289 . . . . 0.0 110.244 -172.974 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -145.28 144.45 30.78 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.452 0.701 . . . . 0.0 110.424 -175.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.5 mt -73.58 95.04 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.4 0.68 . . . . 0.0 109.728 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 mm -83.54 -35.51 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.698 0.799 . . . . 0.0 110.138 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.7 t -134.31 146.75 50.28 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.824 0.45 . . . . 0.0 111.123 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.422 HG23 ' HG2' ' A' ' 15' ' ' MET . 72.6 mt -128.76 133.95 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.775 1.63 . . . . 0.0 108.252 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.4 p -98.64 53.67 1.02 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.226 0.536 . . . . 0.0 111.285 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -103.2 -17.4 15.37 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.098 0.559 . . . . 0.0 112.388 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.408 ' HB ' ' HD3' ' A' ' 10' ' ' PRO . 18.2 m -89.21 -53.23 0.34 Allowed Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 123.721 0.809 . . . . 0.0 110.009 175.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD3' ' HB ' ' A' ' 9' ' ' THR . 64.7 Cg_endo -82.86 -10.69 10.42 Favored 'Trans proline' 0 C--N 1.395 2.991 0 C-N-CA 121.773 1.649 . . . . 0.0 113.288 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -145.65 -161.86 1.39 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -168.33 148.87 4.8 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.828 0.74 . . . . 0.0 109.736 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 69.64 20.29 7.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.553 1.141 . . . . 0.0 111.912 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 13.2 t -161.01 143.1 12.29 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.097 0.959 . . . . 0.0 108.832 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 62' ' ' SER . 57.7 mtm -115.68 110.76 19.61 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -75.74 85.89 2.75 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 165.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.2 mt -77.31 93.29 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.0 m -77.94 116.89 18.77 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.1 mt -84.88 -150.49 0.12 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 p -76.65 15.17 0.67 Allowed 'General case' 0 CA--C 1.558 1.269 0 O-C-N 121.93 -0.481 . . . . 0.0 112.114 173.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 42.4 mt-10 67.82 92.4 0.08 Allowed 'General case' 0 C--N 1.358 0.944 0 C-N-CA 125.903 1.681 . . . . 0.0 110.798 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -73.07 131.92 42.69 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -76.11 78.91 2.94 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.549 0.531 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 62.17 13.27 5.7 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.497 1.119 . . . . 0.0 111.874 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.12 -26.7 61.43 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.156 -173.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.0 mmt -80.46 107.13 13.01 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.5 p -75.12 154.54 37.74 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.579 0.352 . . . . 0.0 110.916 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.0 p -69.48 96.06 0.88 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.241 0.543 . . . . 0.0 110.815 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -119.2 111.06 17.76 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.258 1.023 . . . . 0.0 109.565 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.3 m -91.1 97.23 11.03 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -81.98 103.78 11.87 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.0 p -99.47 49.81 0.94 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.753 1.221 . . . . 0.0 109.307 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.463 ' HA ' HD13 ' A' ' 46' ' ' LEU 0.298 0.9 OUTLIER 56.72 99.55 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 127.427 2.291 . . . . 0.0 113.727 179.372 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t 50.54 80.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 125.53 1.532 . . . . 0.0 111.215 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -151.78 -50.08 0.11 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -164.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -105.07 -96.64 0.33 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.856 0.462 . . . . 0.0 110.783 -169.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.6 t -161.81 87.54 0.67 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.1 pm0 -139.77 144.36 38.56 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.627 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -53.34 150.65 25.42 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.837 2.358 . . . . 0.0 112.326 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.33 -34.43 57.41 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.581 0.753 . . . . 0.0 111.057 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.468 ' HB3' HG13 ' A' ' 81' ' ' VAL . 91.0 m-85 -56.82 -46.94 81.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.422 1.089 . . . . 0.0 111.499 176.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.0 mm -67.31 -32.35 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.202 0.601 . . . . 0.0 110.296 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.455 ' HA ' HD12 ' A' ' 46' ' ' LEU . 64.6 m-20 -70.5 -32.01 69.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.509 0.724 . . . . 0.0 110.702 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 48' ' ' VAL . 1.1 m-20 -65.63 -38.11 88.47 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.237 0.615 . . . . 0.0 111.221 175.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 78' ' ' VAL . 59.7 mt -61.99 -44.6 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.794 0.807 . . . . 0.0 109.931 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 33' ' ' LYS . 58.7 mt -61.89 -34.55 76.23 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.725 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -82.32 -8.67 59.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.559 0.744 . . . . 0.0 112.562 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.498 HG11 HG13 ' A' ' 74' ' ' VAL . 65.9 t -70.5 105.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 171.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.69 94.31 0.2 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.694 0.798 . . . . 0.0 110.451 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 161.44 -35.81 0.39 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.0 129.73 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.825 0.85 . . . . 0.0 109.024 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -78.6 -57.04 3.97 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 p -163.61 178.49 7.92 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.975 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.403 HG12 HG13 ' A' ' 63' ' ' VAL . 75.5 mt -132.27 117.64 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.084 0.954 . . . . 0.0 109.221 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -103.67 97.54 7.54 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.697 0.76 . . . . 0.0 109.621 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -87.86 131.35 34.59 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.652 1.181 . . . . 0.0 109.88 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.4 p -172.52 155.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 118.433 0.56 . . . . 0.0 111.715 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 27.5 ttt 65.09 -83.81 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.5 1.92 . . . . 0.0 112.918 171.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 7.1 p-10 -132.71 -16.19 2.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.977 0.911 . . . . 0.0 110.561 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.408 ' HE2' ' HB2' ' A' ' 62' ' ' SER . 37.6 p90 -122.54 171.13 9.33 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 122.129 0.966 . . . . 0.0 112.446 -162.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -126.06 103.67 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.616 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 15' ' ' MET . 28.5 t -86.0 89.08 7.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.403 HG13 HG12 ' A' ' 54' ' ' ILE . 26.3 t -88.54 107.72 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 4.8 p-10 -106.58 158.19 17.12 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.894 0.478 . . . . 0.0 111.035 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -139.44 -167.97 2.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.815 0.846 . . . . 0.0 111.889 -165.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -88.19 161.13 17.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.33 1.052 . . . . 0.0 110.826 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.87 -27.02 67.91 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.731 0.812 . . . . 0.0 113.048 -172.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -97.1 -28.26 14.21 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.813 0.845 . . . . 0.0 111.734 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.28 130.89 23.74 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.817 0.847 . . . . 0.0 112.282 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -104.6 127.43 52.33 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.242 0.617 . . . . 0.0 110.443 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.425 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 63.3 m95 -71.87 -16.72 62.15 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.531 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.92 -34.54 71.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.083 0.468 . . . . 0.0 110.787 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.1 m -82.96 -44.7 14.99 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.74 0.816 . . . . 0.0 110.536 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.498 HG13 HG11 ' A' ' 48' ' ' VAL . 48.2 t -74.61 -39.51 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.944 0.898 . . . . 0.0 112.538 -170.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 71' ' ' TRP . 3.0 tt -59.14 -44.25 98.29 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-O 117.125 -1.417 . . . . 0.0 112.509 -168.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -48.96 -31.21 19.69 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.441 2.094 . . . . 0.0 114.676 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -82.08 -40.81 21.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.515 0.726 . . . . 0.0 110.029 -179.391 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 45' ' ' ILE . 56.2 t -63.81 -38.45 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 123.914 0.885 . . . . 0.0 109.936 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.68 -47.64 82.77 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.73 1.612 . . . . 0.0 109.868 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.51 -31.1 61.78 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.854 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 41' ' ' PHE . 56.1 t -68.34 -55.48 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.41 0.684 . . . . 0.0 110.683 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 1' ' ' MET . 17.9 m-85 -65.04 -29.05 69.92 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -80.14 -38.59 31.12 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.029 0.532 . . . . 0.0 112.07 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 84.0 mt 55.27 37.58 29.11 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.055 0.942 . . . . 0.0 109.504 -164.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 53.17 -136.61 1.34 Allowed 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.242 -168.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -117.76 51.38 1.05 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 165.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -83.31 -166.56 1.4 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.135 172.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -71.57 79.82 0.81 Allowed 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.474 1.131 . . . . 0.0 109.947 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -102.69 21.87 14.66 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.984 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 65.84 6.32 3.91 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.534 1.533 . . . . 0.0 112.31 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.1 t60 . . . . . 0 C--O 1.25 1.081 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -174.498 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 mtm . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -127.94 -174.75 3.28 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.9 mt -76.1 108.1 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -82.16 -51.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -162.79 147.88 11.93 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.558 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mt -89.74 97.29 6.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 168.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -83.74 -166.16 1.32 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.531 0.732 . . . . 0.0 111.782 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -58.01 154.69 12.11 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.034 0.933 . . . . 0.0 113.424 -168.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 t -155.61 64.63 4.05 Favored Pre-proline 0 CA--C 1.556 1.187 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.003 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.5 -13.01 32.42 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.534 2.156 . . . . 0.0 112.663 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -85.3 -32.82 22.31 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.192 0.597 . . . . 0.0 110.052 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 71.03 165.57 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.971 1.308 . . . . 0.0 109.974 -171.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 77.56 -51.22 0.53 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.234 1.414 . . . . 0.0 111.254 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.4 t -105.71 112.04 24.96 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.866 0.466 . . . . 0.0 110.635 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.9 mtm -98.98 142.85 29.95 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.187 0.518 . . . . 0.0 110.048 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -89.59 113.73 25.2 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.936 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.8 mt -93.32 111.39 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.4 m -76.59 122.89 25.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.579 0.752 . . . . 0.0 109.832 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.2 mt -101.99 -171.3 1.95 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.489 0.715 . . . . 0.0 109.727 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 p -76.72 6.76 5.48 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 63.86 -171.29 0.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.427 1.091 . . . . 0.0 112.122 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 t -151.28 -162.81 1.62 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -69.68 89.56 0.55 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.244 0.618 . . . . 0.0 109.576 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 65.49 -74.0 0.06 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.453 1.501 . . . . 0.0 110.482 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.85 148.68 20.43 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.034 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -131.64 127.53 37.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.236 1.014 . . . . 0.0 109.447 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 t 46.64 176.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 126.609 1.964 . . . . 0.0 115.365 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 p -155.61 98.37 1.94 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.624 0.769 . . . . 0.0 109.46 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.49 164.24 14.86 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.108 0.963 . . . . 0.0 110.866 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 m -141.41 98.02 3.28 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 161.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 40.4 m-85 -82.16 111.97 18.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 p -122.38 -71.29 0.73 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.079 0.552 . . . . 0.0 110.134 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -110.02 46.88 0.99 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.683 0.793 . . . . 0.0 108.994 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.4 t 67.6 120.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 125.139 1.376 . . . . 0.0 111.704 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.17 -81.41 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.903 1.281 . . . . 0.0 110.4 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 166.06 -66.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.299 1.44 . . . . 0.0 108.611 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t -90.98 -2.4 57.71 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.117 0.967 . . . . 0.0 111.802 -169.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -63.08 149.84 89.86 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 123.693 0.797 . . . . 0.0 111.257 173.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -53.61 148.21 36.31 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.556 2.837 . . . . 0.0 113.731 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.02 69.81 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.029 0.931 . . . . 0.0 111.364 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.505 ' HB3' HG13 ' A' ' 81' ' ' VAL . 31.5 m-85 -61.48 -36.69 81.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.983 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.3 mm -75.69 -25.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -69.1 -37.26 78.3 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.15 -39.17 92.62 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.6 0.76 . . . . 0.0 110.358 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.523 HG22 HG11 ' A' ' 51' ' ' VAL . 29.2 mt -66.42 -34.55 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 123.533 0.521 . . . . 0.0 110.04 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 31' ' ' TYR . 88.9 mt -64.32 -35.54 81.19 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.838 0.455 . . . . 0.0 111.804 174.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.36 -15.37 61.87 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.896 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.49 97.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.82 87.48 0.06 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 109.904 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.46 -17.22 0.08 OUTLIER Glycine 0 C--O 1.221 -0.714 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.881 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.523 HG11 HG22 ' A' ' 45' ' ' ILE . 35.6 m -85.77 -27.86 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 22.2 ttmm 48.59 -77.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.94 2.096 . . . . 0.0 113.217 -173.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 49.9 m -122.89 98.06 5.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.945 0.898 . . . . 0.0 110.172 -171.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 66.0 mt -83.93 84.08 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.447 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 92.5 t80 -81.49 140.32 34.65 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.429 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -137.02 134.41 36.56 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.15 143.32 9.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 171.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.2 ttt 62.31 -80.45 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 O-C-N 124.651 1.22 . . . . 0.0 111.837 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.59 -38.01 1.55 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.636 0.774 . . . . 0.0 111.327 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -103.44 165.14 11.21 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.305 0.642 . . . . 0.0 112.625 -163.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.3 mt -120.19 111.53 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.989 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 50.1 m -85.83 95.37 9.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.358 0.663 . . . . 0.0 109.61 173.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 14' ' ' THR . 52.4 t -85.07 99.95 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.571 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 1.8 m-20 -84.7 98.3 10.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.683 1.193 . . . . 0.0 108.58 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.631 ' HD2' ' HB3' ' A' ' 69' ' ' ALA . 57.9 pttt -66.25 177.09 1.54 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -175.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 47.7 mm-40 -64.09 -177.39 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.499 0.719 . . . . 0.0 112.274 174.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -61.0 -25.1 66.65 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.528 0.731 . . . . 0.0 111.732 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.13 -58.27 0.9 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.412 0.685 . . . . 0.0 109.772 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.631 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . 49.6 -164.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.85 1.26 . . . . 0.0 113.053 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -156.8 114.21 3.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -68.69 -28.07 66.53 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.064 0.546 . . . . 0.0 111.832 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.63 -21.65 64.46 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 120.982 0.42 . . . . 0.0 110.505 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.7 m -86.0 -45.14 11.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.115 0.566 . . . . 0.0 110.396 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.44 -58.14 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.845 0.858 . . . . 0.0 112.571 -173.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.36 -47.01 99.73 Favored Pre-proline 0 N--CA 1.491 1.599 0 CA-C-O 117.362 -1.304 . . . . 0.0 114.321 -170.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.49 -33.99 60.03 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 122.14 1.893 . . . . 0.0 113.974 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -77.25 -39.02 49.82 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.811 0.844 . . . . 0.0 110.435 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.94 -41.23 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.765 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.93 -36.88 84.87 Favored 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 123.75 0.82 . . . . 0.0 110.837 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.71 -30.49 67.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.415 0.686 . . . . 0.0 111.917 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 41' ' ' PHE . 40.6 t -65.83 -58.96 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.848 0.859 . . . . 0.0 111.928 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -73.75 -42.93 60.41 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.261 0.624 . . . . 0.0 110.914 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.5 70.36 2.26 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.18 -32.17 64.09 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.558 0.743 . . . . 0.0 110.915 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.68 164.12 28.98 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.721 1.209 . . . . 0.0 109.682 174.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -78.0 109.24 11.89 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -57.16 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.209 1.004 . . . . 0.0 112.01 -170.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -172.2 66.04 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.7 0.8 . . . . 0.0 109.218 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -86.47 -42.97 13.14 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -138.29 161.46 36.84 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.626 1.17 . . . . 0.0 108.865 169.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 71.1 t60 . . . . . 0 CA--C 1.557 1.246 0 C-N-CA 123.915 0.886 . . . . 0.0 109.776 -174.518 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 121.132 0.491 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.602 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 50.9 pttt -145.14 -170.72 3.49 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.195 0.998 . . . . 0.0 108.984 173.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 6' ' ' ILE . 59.5 mt -78.12 116.65 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 163.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 19' ' ' LEU . 1.6 mp -83.43 -52.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 t -159.32 124.39 4.13 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.432 0.458 . . . . 0.0 110.881 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.632 HG21 ' HE2' ' A' ' 15' ' ' MET . 59.8 mt -92.25 90.6 3.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m 55.99 -160.93 0.19 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.959 0.904 . . . . 0.0 112.532 171.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -83.98 -32.66 24.87 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.402 0.62 . . . . 0.0 110.892 170.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 t -130.8 134.49 26.05 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.449 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HB3' HD11 ' A' ' 75' ' ' LEU . 52.1 Cg_exo -56.07 -52.49 7.19 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.91 2.407 . . . . 0.0 113.044 172.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.483 ' HA ' ' HD1' ' A' ' 71' ' ' TRP . 63.2 t30 -83.88 124.55 31.09 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.121 0.486 . . . . 0.0 110.837 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -172.69 171.01 4.57 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.572 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 1.6 m120 -72.28 -22.29 61.23 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.03 1.287 . . . . 0.0 111.469 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 11.9 t -140.31 162.44 35.29 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.225 1.01 . . . . 0.0 109.292 171.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.632 ' HE2' HG21 ' A' ' 6' ' ' ILE . 6.9 ptp -136.36 125.49 24.55 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.285 0.564 . . . . 0.0 110.929 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -80.32 92.39 5.77 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.008 0.923 . . . . 0.0 109.356 170.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 6' ' ' ILE . 71.1 mt -80.04 95.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 m -82.75 141.32 32.47 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.519 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.682 ' HA ' HD13 ' A' ' 4' ' ' ILE . 75.5 mt -111.98 160.85 17.06 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.141 0.976 . . . . 0.0 110.069 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.4 p -76.31 -15.81 59.91 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.205 1.002 . . . . 0.0 111.886 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.39 61.62 6.72 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 122.078 0.942 . . . . 0.0 110.244 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.3 m -90.12 66.41 6.71 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.768 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -154.25 -56.43 0.11 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.882 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.57 -19.89 66.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -170.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.7 63.15 4.44 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.491 0.494 . . . . 0.0 112.457 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.9 mtt -48.7 149.55 1.7 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.28 1.432 . . . . 0.0 112.821 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.7 p -66.08 148.6 51.56 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.024 0.93 . . . . 0.0 111.926 -174.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 p -89.05 105.3 17.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.655 0.782 . . . . 0.0 110.223 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -138.39 138.23 38.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.471 0.708 . . . . 0.0 111.193 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.4 m -103.31 98.91 8.75 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.1 0.96 . . . . 0.0 109.552 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -83.98 116.08 22.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.465 1.106 . . . . 0.0 109.683 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.3 p -137.42 -75.79 0.41 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.365 0.666 . . . . 0.0 112.514 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -91.47 18.66 6.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -164.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t 61.86 90.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.369 1.068 . . . . 0.0 109.485 -170.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -163.0 155.68 18.89 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.563 0.745 . . . . 0.0 110.347 -171.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.8 t70 67.17 -80.56 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.471 1.509 . . . . 0.0 112.129 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.5 t -154.28 69.99 0.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.295 0.569 . . . . 0.0 110.006 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -108.74 104.74 55.47 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.485 0.714 . . . . 0.0 109.358 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.79 152.34 42.93 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.765 2.31 . . . . 0.0 112.221 173.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.46 -37.91 51.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.928 0.891 . . . . 0.0 111.612 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.632 ' HB3' HG13 ' A' ' 81' ' ' VAL . 59.1 m-85 -62.91 -39.48 94.64 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.126 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -74.73 -29.69 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.127 0.971 . . . . 0.0 110.587 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -41.12 91.87 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 22.1 t70 -56.92 -49.23 76.24 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.297 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.481 HG23 HG22 ' A' ' 78' ' ' VAL . 61.1 mt -57.27 -46.26 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 124.148 0.905 . . . . 0.0 110.278 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.74 -36.91 82.37 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.719 0.808 . . . . 0.0 111.856 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -77.49 -13.36 59.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.405 0.682 . . . . 0.0 111.536 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 44' ' ' ASP . 96.9 t -71.0 125.9 30.27 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -61.97 92.11 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.109 1.364 . . . . 0.0 111.367 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.52 -52.13 0.38 Allowed Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.098 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.98 120.88 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.53 0.732 . . . . 0.0 110.985 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -95.55 -50.86 4.79 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.373 0.669 . . . . 0.0 110.074 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.3 t -143.06 152.68 42.14 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.79 0.436 . . . . 0.0 111.286 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.422 HG12 HG13 ' A' ' 63' ' ' VAL . 46.7 mt -125.2 94.59 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.773 1.229 . . . . 0.0 108.615 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -96.18 100.11 11.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.893 -0.504 . . . . 0.0 110.088 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.33 129.71 35.83 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 p -161.59 141.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.445 0.698 . . . . 0.0 111.086 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 65.08 -73.25 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.976 1.71 . . . . 0.0 113.594 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -155.16 8.84 0.29 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.78 0.432 . . . . 0.0 111.166 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -142.52 165.97 25.96 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.1 0.56 . . . . 0.0 110.213 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.59 102.27 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 15' ' ' MET . 19.3 p -81.98 89.07 6.37 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.422 HG13 HG12 ' A' ' 54' ' ' ILE . 43.8 t -89.27 116.04 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.244 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 4.1 p30 -99.75 163.72 12.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.941 0.496 . . . . 0.0 111.293 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -136.37 173.07 12.1 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.342 -175.348 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.07 125.06 32.45 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 166.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -54.68 -21.18 9.95 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.715 1.206 . . . . 0.0 113.347 -167.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -51.76 -47.9 63.95 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.598 1.159 . . . . 0.0 112.159 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.09 130.54 35.52 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.61 0.764 . . . . 0.0 111.389 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -84.94 155.94 21.41 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.103 0.561 . . . . 0.0 109.56 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.483 ' HD1' ' HA ' ' A' ' 11' ' ' ASN . 49.4 m95 -76.58 -31.38 57.48 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -28.62 44.14 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -171.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -81.12 -39.59 25.36 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.889 0.876 . . . . 0.0 110.011 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.65 -36.04 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 124.93 1.292 . . . . 0.0 111.703 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.43 HD11 ' HB3' ' A' ' 10' ' ' PRO . 77.0 mt -50.12 -49.12 77.4 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 125.194 1.398 . . . . 0.0 114.59 -172.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.85 -31.16 88.04 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.885 1.723 . . . . 0.0 113.555 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -80.13 -40.18 27.96 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.862 0.865 . . . . 0.0 110.387 -176.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 45' ' ' ILE . 59.8 t -65.81 -48.91 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.22 -31.26 72.38 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.966 0.906 . . . . 0.0 111.339 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.67 -34.83 69.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.892 0.877 . . . . 0.0 111.119 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 41' ' ' PHE . 43.2 t -57.82 -46.99 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.914 0.886 . . . . 0.0 111.059 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.602 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 18.1 m-85 -87.69 19.56 3.38 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.693 0.797 . . . . 0.0 112.684 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -157.05 5.75 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.89 -31.44 66.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 111.306 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 53.39 43.55 31.22 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.45 1.094 . . . . 0.0 112.791 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -80.53 73.25 7.46 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.461 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -171.54 115.04 0.38 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.549 1.54 . . . . 0.0 107.378 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -68.99 -33.03 73.01 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.564 0.746 . . . . 0.0 111.184 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -70.75 152.27 43.98 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 167.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -87.13 139.92 30.08 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.2 m170 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 124.882 1.273 . . . . 0.0 110.481 -178.64 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.609 0.242 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.75 157.8 16.71 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.451 HG21 HG13 ' A' ' 6' ' ' ILE . 32.8 mt -76.93 129.85 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.983 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.4 mm -87.56 -48.02 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.935 0.894 . . . . 0.0 109.849 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 p -142.25 128.73 20.15 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.369 0.667 . . . . 0.0 109.673 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.451 HG13 HG21 ' A' ' 3' ' ' ILE . 3.8 mp -90.53 86.92 2.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.648 ' HB2' HD21 ' A' ' 11' ' ' ASN . 97.5 p 60.52 176.57 0.1 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.531 1.533 . . . . 0.0 113.901 171.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.441 ' HB2' ' OD1' ' A' ' 11' ' ' ASN . 40.8 mt-10 -115.1 -166.01 1.08 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.332 1.053 . . . . 0.0 108.335 168.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.4 p -87.13 -48.97 0.47 Allowed Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 118.275 -0.869 . . . . 0.0 113.232 -176.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.67 -9.9 21.48 Favored 'Trans proline' 0 C--N 1.396 3.031 0 CA-C-N 121.374 1.526 . . . . 0.0 112.817 -166.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.648 HD21 ' HB2' ' A' ' 7' ' ' SER . 3.7 p-10 -99.03 50.62 0.95 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.629 1.171 . . . . 0.0 110.156 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -64.25 -27.38 69.01 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.977 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.602 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 76.9 m-20 -102.82 8.79 39.25 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.161 0.584 . . . . 0.0 112.191 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 3.1 t -159.89 95.07 1.16 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.545 0.738 . . . . 0.0 110.135 176.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.1 mtp -82.65 125.77 31.57 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 121.713 -0.617 . . . . 0.0 111.802 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 7' ' ' SER . 23.0 ttmm -79.92 89.73 5.31 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.743 1.217 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.494 HD12 HG21 ' A' ' 63' ' ' VAL . 70.9 mt -85.6 95.63 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 174.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 60' ' ' PHE . 49.3 m -77.06 124.16 27.4 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.265 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.3 mt -87.55 164.52 16.06 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.118 0.485 . . . . 0.0 110.785 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -76.02 -19.89 58.28 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.872 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -96.73 101.57 13.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 109.664 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.778 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 29.3 t -79.41 107.94 12.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.536 0.734 . . . . 0.0 109.291 173.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 46.08 -154.94 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.712 1.605 . . . . 0.0 113.326 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.22 40.88 32.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.137 0.975 . . . . 0.0 112.078 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.79 -32.29 1.45 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.804 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.8 mmt -90.34 101.91 14.64 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.547 0.739 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.7 m -80.11 166.82 21.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.016 0.926 . . . . 0.0 111.057 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 67.8 p -80.87 74.35 7.85 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.937 0.895 . . . . 0.0 109.784 170.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -87.15 153.99 21.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.584 1.154 . . . . 0.0 110.387 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -128.54 101.25 6.09 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.453 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 37.4 m-85 -88.01 119.62 28.56 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.2 p -118.19 -62.44 1.54 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.52 0.6 . . . . 0.0 112.132 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.65 26.97 7.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -157.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.459 ' H ' HD13 ' A' ' 46' ' ' LEU . 87.5 t 62.11 83.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -166.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.76 -77.21 0.26 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.567 -162.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -169.31 -77.2 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.02 0.373 . . . . 0.0 111.337 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 m -89.15 68.48 8.18 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.089 0.956 . . . . 0.0 110.727 -171.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.444 HE22 HD11 ' A' ' 46' ' ' LEU . 4.1 pt20 -151.65 154.22 32.91 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.594 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.488 ' HB2' ' HB2' ' A' ' 41' ' ' PHE . 21.5 Cg_exo -66.2 150.89 84.68 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 122.669 2.246 . . . . 0.0 112.215 169.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HA ' HD21 ' A' ' 43' ' ' ASN . . . -60.02 -23.76 63.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.865 0.866 . . . . 0.0 111.389 171.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.591 ' HB3' HG13 ' A' ' 81' ' ' VAL . 25.3 m-85 -46.97 -51.4 17.16 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.374 1.47 . . . . 0.0 110.82 170.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.1 mm -72.62 -29.25 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.625 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.474 HD21 ' HA ' ' A' ' 40' ' ' ALA . 93.7 m-20 -67.97 -32.94 73.71 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.362 0.665 . . . . 0.0 111.945 -175.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -59.08 -46.8 87.35 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.492 0.495 . . . . 0.0 110.22 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.8 mt -66.07 -38.75 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.609 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.459 HD13 ' H ' ' A' ' 34' ' ' VAL . 76.7 mt -60.71 -39.53 88.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.36 0.664 . . . . 0.0 111.709 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -85.62 4.13 37.69 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.267 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.2 t -78.84 123.53 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 169.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.13 130.39 34.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.571 0.748 . . . . 0.0 110.931 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.63 -32.67 7.3 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.644 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.37 109.36 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 24.3 ttmm -78.94 -55.24 5.29 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.427 0.691 . . . . 0.0 110.568 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.1 t -158.88 157.29 31.19 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.567 0.698 . . . . 0.0 110.716 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 67.6 mt -114.4 87.26 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.442 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 58.3 t80 -84.26 90.75 7.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.546 0.689 . . . . 0.0 109.841 -175.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -80.75 117.37 21.36 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 2.5 p -140.97 125.25 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.129 0.422 . . . . 0.0 110.556 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 62.84 -71.98 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.446 1.498 . . . . 0.0 110.59 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.778 ' HB3' ' HA ' ' A' ' 22' ' ' SER . 2.0 p30 -148.46 -33.08 0.24 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.849 1.259 . . . . 0.0 110.08 172.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 29.0 p90 -83.86 129.31 34.93 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -174.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.26 113.78 39.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -176.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 10.9 m -82.37 81.84 8.07 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.643 0.777 . . . . 0.0 109.64 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.494 HG21 HD12 ' A' ' 17' ' ' ILE . 48.7 t -78.85 92.89 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -82.41 151.2 26.71 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.265 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.602 ' HE2' ' HA ' ' A' ' 13' ' ' ASN . 39.0 pttt -137.17 -178.2 5.1 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.746 -173.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.84 140.88 30.85 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.95 -38.57 62.16 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.708 0.803 . . . . 0.0 112.163 -169.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.52 -32.62 72.7 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.702 0.801 . . . . 0.0 112.956 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.497 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . -56.31 111.33 0.94 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.936 0.894 . . . . 0.0 111.945 -175.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.512 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 15.8 m120 -82.47 126.4 32.19 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -70.59 -13.99 62.31 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.821 0.448 . . . . 0.0 112.101 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 70' ' ' ASN . 12.6 pt-20 -60.65 -28.4 68.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.302 0.641 . . . . 0.0 111.549 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.2 t -96.49 -40.68 8.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.761 0.824 . . . . 0.0 111.307 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.6 t -66.1 -47.23 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.094 0.958 . . . . 0.0 111.659 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.84 -43.33 97.59 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.858 -171.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.12 -39.51 20.49 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.732 2.288 . . . . 0.0 113.742 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -75.59 -41.32 54.92 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.036 0.534 . . . . 0.0 111.391 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.421 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 76.0 t -60.01 -55.52 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.317 0.647 . . . . 0.0 110.643 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -60.12 -39.11 85.08 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.035 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.59 -33.12 72.27 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.53 0.732 . . . . 0.0 111.655 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 41' ' ' PHE . 8.2 t -58.85 -48.56 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.295 0.638 . . . . 0.0 110.88 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -74.44 -30.48 61.91 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.932 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -107.0 20.39 19.11 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 81' ' ' VAL . 4.5 pp -84.38 5.92 25.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 122.176 -0.328 . . . . 0.0 111.417 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -52.41 150.8 4.52 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 123.698 0.799 . . . . 0.0 110.332 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -49.56 110.54 0.39 Allowed 'General case' 0 N--CA 1.477 0.893 0 O-C-N 124.585 1.178 . . . . 0.0 110.087 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -60.49 -48.28 82.46 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.546 0.738 . . . . 0.0 111.603 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 66.74 150.78 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.752 1.221 . . . . 0.0 111.644 -175.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -80.35 -11.18 59.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.222 167.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -75.5 75.4 2.55 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 164.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 . . . . . 0 C--O 1.252 1.191 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.282 -175.76 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -122.76 179.31 4.67 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.607 0.763 . . . . 0.0 109.969 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.527 HD12 ' HG2' ' A' ' 79' ' ' GLU . 27.6 mt -71.92 104.11 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.1 mm -84.23 -48.73 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.185 0.594 . . . . 0.0 109.808 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.1 p -155.81 125.99 6.63 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.017 0.527 . . . . 0.0 110.243 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.92 153.01 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.611 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 47.6 t -66.52 171.72 4.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.141 0.576 . . . . 0.0 112.369 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -59.54 -23.52 62.93 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.021 1.328 . . . . 0.0 111.35 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -104.99 96.33 10.74 Favored Pre-proline 0 CA--C 1.56 1.338 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.135 169.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -88.93 10.24 3.36 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.825 2.35 . . . . 0.0 112.239 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.412 ' HA ' ' NE1' ' A' ' 71' ' ' TRP . 12.1 p30 -149.15 -158.14 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.519 1.127 . . . . 0.0 109.873 -174.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 42.6 m170 65.14 73.97 0.4 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.567 1.147 . . . . 0.0 110.182 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 72.63 -61.4 0.5 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.136 1.774 . . . . 0.0 112.237 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.448 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 6.7 t -140.92 136.75 32.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.996 0.426 . . . . 0.0 111.201 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.448 ' O ' ' HA ' ' A' ' 62' ' ' SER . 6.7 ptp -104.49 153.35 21.24 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.533 174.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 32.2 ttmt -95.47 125.01 39.78 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 171.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.21 97.1 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.1 m -70.37 113.0 7.09 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.298 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 86.9 mt -81.71 -178.67 7.07 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.029 0.532 . . . . 0.0 111.081 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.434 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 7.4 m -73.63 0.8 11.68 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.203 0.601 . . . . 0.0 111.537 172.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.94 130.72 48.13 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.199 1.4 . . . . 0.0 110.121 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -61.98 -30.58 71.04 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.113 1.365 . . . . 0.0 112.327 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.575 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 44.4 ttt85 103.9 132.96 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 129.067 2.947 . . . . 0.0 109.186 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.581 ' HA ' ' SD ' ' A' ' 58' ' ' MET . 28.4 tt0 80.62 -4.53 1.79 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.064 1.746 . . . . 0.0 111.788 175.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.18 -33.73 53.4 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 58' ' ' MET . 64.4 mtt -107.42 -179.6 3.97 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.268 1.027 . . . . 0.0 109.635 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 t -124.56 179.2 5.05 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.297 0.639 . . . . 0.0 111.276 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 33.9 p -89.43 132.93 34.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.667 1.187 . . . . 0.0 110.709 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -155.57 158.19 38.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.438 ' HB ' ' HD1' ' A' ' 55' ' ' PHE . 5.7 t -129.17 102.68 6.57 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.709 0.766 . . . . 0.0 109.38 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 68.6 m-85 -83.11 109.39 17.11 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.7 p -113.17 -69.64 0.85 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.531 0.732 . . . . 0.0 111.145 -172.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -100.23 22.94 10.73 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.244 0.618 . . . . 0.0 112.106 -168.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.9 t 69.23 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 124.718 1.207 . . . . 0.0 112.509 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 66.26 90.3 0.09 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.028 1.731 . . . . 0.0 112.065 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -168.7 74.07 0.1 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 0.0 109.039 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.1 p 46.89 46.63 15.56 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.112 1.365 . . . . 0.0 112.508 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.07 125.04 17.85 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 123.992 0.917 . . . . 0.0 109.22 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.97 155.07 6.33 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 124.05 3.167 . . . . 0.0 114.412 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.5 -33.1 43.4 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.403 1.081 . . . . 0.0 112.519 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -60.87 -40.72 94.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.095 0.958 . . . . 0.0 111.479 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.1 mm -70.98 -27.6 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.787 0.835 . . . . 0.0 110.024 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.79 -34.75 74.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.293 0.637 . . . . 0.0 110.391 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -64.62 -43.64 93.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.538 0.735 . . . . 0.0 111.105 175.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.528 HG23 HG22 ' A' ' 78' ' ' VAL . 54.9 mt -60.22 -37.63 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.038 0.447 . . . . 0.0 110.376 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.69 -34.21 77.35 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.39 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -87.77 0.57 55.58 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.768 0.827 . . . . 0.0 112.551 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 44' ' ' ASP . 91.6 t -72.09 127.22 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.73 132.57 53.68 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.091 0.956 . . . . 0.0 111.358 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.23 -47.4 1.11 Allowed Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.617 -173.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.72 135.88 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 124.305 1.042 . . . . 0.0 112.243 -171.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -113.21 -47.03 3.04 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.811 1.244 . . . . 0.0 110.09 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 12.6 m -146.35 157.68 43.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.239 0.542 . . . . 0.0 111.007 -174.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 82.0 mt -123.09 82.68 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 173.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.438 ' HD1' ' HB ' ' A' ' 30' ' ' THR . 32.2 t80 -82.98 88.04 6.86 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 5.5 t60 -84.5 87.95 7.28 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 p -92.62 105.8 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.712 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.581 ' SD ' ' HA ' ' A' ' 24' ' ' GLU . 44.5 tpp 65.45 -91.19 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.916 1.287 . . . . 0.0 111.276 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.575 ' HB3' ' HA ' ' A' ' 23' ' ' ARG . 6.7 p-10 -116.2 -7.36 11.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.734 0.814 . . . . 0.0 111.933 -170.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -133.61 136.78 45.07 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.071 0.548 . . . . 0.0 111.011 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 56' ' ' HIS . 43.5 mt -94.06 106.65 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.787 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 15' ' ' MET . 10.7 t -81.99 90.98 6.53 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 172.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.82 98.18 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.16 0.584 . . . . 0.0 109.647 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 53' ' ' SER . 3.2 m-20 -79.78 150.12 30.85 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.505 0.722 . . . . 0.0 110.567 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -152.99 -159.49 1.01 Allowed 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.717 0.807 . . . . 0.0 109.091 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -63.11 -175.88 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.147 0.979 . . . . 0.0 111.947 168.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -51.33 -43.45 61.75 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.966 0.906 . . . . 0.0 111.828 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -158.3 -46.72 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.434 0.694 . . . . 0.0 110.467 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 51.68 -97.05 0.05 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.995 0.918 . . . . 0.0 109.171 -169.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -158.73 127.53 5.41 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 160.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.436 ' CH2' ' HG2' ' A' ' 15' ' ' MET . 94.3 m95 -80.72 -13.52 58.92 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.979 -0.451 . . . . 0.0 110.295 171.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -50.99 -45.19 60.96 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.397 1.079 . . . . 0.0 111.854 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -75.64 -41.72 53.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.631 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.29 -50.78 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.917 0.887 . . . . 0.0 113.359 -166.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.36 -50.4 85.17 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-O 117.772 -1.109 . . . . 0.0 113.135 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -43.9 -41.0 11.98 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.867 2.378 . . . . 0.0 114.83 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.61 -46.45 26.02 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.939 0.496 . . . . 0.0 110.874 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.528 HG22 HG23 ' A' ' 45' ' ' ILE . 89.2 t -64.53 -52.85 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.661 0.784 . . . . 0.0 110.768 -175.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.527 ' HG2' HD12 ' A' ' 3' ' ' ILE . 49.5 mt-10 -58.9 -34.66 71.92 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.53 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.68 -34.04 72.36 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.878 0.871 . . . . 0.0 112.005 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.84 -42.13 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.672 0.789 . . . . 0.0 110.679 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -84.61 7.63 19.53 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.617 0.767 . . . . 0.0 112.927 173.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -133.28 52.97 2.04 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.191 0.996 . . . . 0.0 109.172 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.65 30.51 0.72 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.326 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -72.27 106.63 4.52 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 167.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -93.77 -39.74 10.58 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.222 0.609 . . . . 0.0 110.045 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -160.39 -42.92 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.899 0.88 . . . . 0.0 109.283 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -88.99 133.08 34.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.049 0.94 . . . . 0.0 109.614 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -74.57 150.44 39.71 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.408 0.683 . . . . 0.0 110.081 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -139.28 97.52 3.31 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.952 0.501 . . . . 0.0 109.784 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.245 0.837 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.084 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -88.7 41.01 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.367 0.667 . . . . 0.0 112.295 -173.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 17' ' ' ILE . 43.3 mt 53.79 103.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 124.57 1.148 . . . . 0.0 112.061 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.0 mm -82.66 -49.59 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.678 0.791 . . . . 0.0 110.677 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 t -149.3 148.17 29.22 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 120.88 0.371 . . . . 0.0 110.586 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.8 mm -96.01 106.86 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.481 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 t 66.63 140.23 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.093 1.757 . . . . 0.0 115.537 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.521 ' H ' ' HB3' ' A' ' 16' ' ' LYS . 21.4 mm-40 -115.25 -6.91 12.41 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.948 1.299 . . . . 0.0 110.555 168.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 11' ' ' ASN . 7.7 m -104.94 129.75 24.32 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 125.384 1.474 . . . . 0.0 108.975 -174.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.0 -4.64 15.53 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.137 1.891 . . . . 0.0 113.014 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.442 ' H ' HG22 ' A' ' 9' ' ' THR . 42.1 t30 -78.38 121.09 24.04 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.526 0.73 . . . . 0.0 109.624 176.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -74.92 -18.63 60.37 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.609 0.764 . . . . 0.0 112.024 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -64.95 -56.47 13.03 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 9.8 t -115.66 126.78 54.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.804 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.6 ' HE1' HD11 ' A' ' 75' ' ' LEU . 34.2 mtm -110.69 136.57 49.58 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.253 0.549 . . . . 0.0 110.857 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' HB3' ' H ' ' A' ' 8' ' ' GLU . 6.4 tmtm? -79.22 94.56 5.44 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.059 174.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 3' ' ' ILE . 58.3 mt -77.8 96.33 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 m -63.03 129.89 42.33 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.964 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.2 mt -116.15 149.18 39.47 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -75.37 -13.75 60.42 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.06 0.544 . . . . 0.0 110.54 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -92.05 63.08 4.34 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.564 1.146 . . . . 0.0 108.712 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.53 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 26.5 m -78.43 -172.93 3.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.611 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 72.39 171.63 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.562 1.145 . . . . 0.0 110.398 -172.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 68.36 -75.84 0.06 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.309 1.443 . . . . 0.0 111.966 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.7 -25.2 0.21 Allowed Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.009 -175.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 43.5 tpp 41.56 66.46 0.69 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.579 1.552 . . . . 0.0 111.444 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.5 p 48.44 100.57 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.976 1.71 . . . . 0.0 112.883 -171.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.5 p -88.48 70.75 8.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.823 0.821 . . . . 0.0 108.985 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.64 168.52 11.68 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.039 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.487 ' HG1' ' HD1' ' A' ' 55' ' ' PHE . 7.4 m -126.36 97.11 4.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.283 -1.326 . . . . 0.0 107.864 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.491 ' HB3' HD11 ' A' ' 46' ' ' LEU . 44.0 m-85 -83.25 98.43 9.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.933 0.893 . . . . 0.0 108.842 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.447 HG23 HG22 ' A' ' 30' ' ' THR . 28.6 p -124.34 -64.47 1.12 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.733 0.813 . . . . 0.0 110.102 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -79.88 -4.09 50.77 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -168.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 t 63.88 164.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 C-N-CA 125.161 1.384 . . . . 0.0 110.599 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 65.54 96.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.285 1.034 . . . . 0.0 110.892 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -152.99 -74.95 0.13 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.6 t -165.62 23.44 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.495 0.718 . . . . 0.0 109.46 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.56 140.95 22.04 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.141 0.577 . . . . 0.0 109.668 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.22 148.42 3.13 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.934 3.089 . . . . 0.0 114.563 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.06 -32.96 62.31 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.996 0.918 . . . . 0.0 110.714 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.619 ' HB3' HG13 ' A' ' 81' ' ' VAL . 82.3 m-85 -52.69 -48.65 66.42 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.704 1.201 . . . . 0.0 111.037 172.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -71.42 -31.05 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.254 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.81 -37.71 82.33 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.441 ' O ' HG23 ' A' ' 48' ' ' VAL . 25.0 t70 -65.1 -41.82 94.58 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.635 0.774 . . . . 0.0 110.1 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.462 HD11 HG21 ' A' ' 81' ' ' VAL . 64.3 mt -57.26 -47.32 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 123.891 0.744 . . . . 0.0 109.831 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 31' ' ' TYR . 88.8 mt -60.47 -36.92 79.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.212 0.605 . . . . 0.0 111.178 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.92 -8.93 59.52 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.6 0.76 . . . . 0.0 112.094 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 44' ' ' ASP . 97.2 t -65.17 107.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 171.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.56 107.19 0.31 Allowed 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.983 0.802 . . . . 0.0 110.398 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.5 -45.38 0.86 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.183 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.517 HG13 HG13 ' A' ' 63' ' ' VAL . 40.2 t -60.55 -40.51 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 125.085 1.354 . . . . 0.0 113.655 -171.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 38.5 ttmt 64.13 -72.25 0.06 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.389 1.876 . . . . 0.0 111.587 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 p -144.95 156.33 43.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.157 0.583 . . . . 0.0 111.156 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.1 mt -131.64 131.48 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.463 1.105 . . . . 0.0 108.245 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.487 ' HD1' ' HG1' ' A' ' 30' ' ' THR . 67.3 t80 -118.14 104.77 11.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -96.62 128.08 43.22 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 p -163.9 151.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 56.6 tpp 68.46 -69.77 0.14 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.367 1.467 . . . . 0.0 110.692 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.53 ' HB3' ' HA ' ' A' ' 22' ' ' SER . 8.7 p-10 -148.16 -36.41 0.2 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.591 1.157 . . . . 0.0 110.401 173.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.506 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . 55.3 p90 -87.47 149.69 24.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -158.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 66.8 mt -98.77 97.17 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 113.616 -1.629 . . . . 0.0 107.921 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.1 t -83.94 86.97 7.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.116 0.566 . . . . 0.0 109.625 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.517 HG13 HG13 ' A' ' 51' ' ' VAL . 44.2 t -80.87 103.55 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 36.3 t70 -95.01 95.53 8.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.971 0.908 . . . . 0.0 109.875 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.613 ' HD2' ' HB3' ' A' ' 69' ' ' ALA . 17.3 pttp -86.05 -172.17 3.94 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.904 0.881 . . . . 0.0 112.359 -175.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.45 167.56 1.88 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.768 0.827 . . . . 0.0 111.45 167.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -51.25 -68.76 0.14 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.219 1.007 . . . . 0.0 111.496 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -94.35 -57.23 2.56 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.35 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.613 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . 40.39 -157.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.309 1.443 . . . . 0.0 113.578 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -141.68 108.59 5.42 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.478 0.711 . . . . 0.0 109.477 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -61.18 -32.86 72.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.038 0.535 . . . . 0.0 110.041 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -62.91 -22.04 66.46 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.977 0.911 . . . . 0.0 111.614 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.3 m -92.36 -44.86 8.48 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.619 0.767 . . . . 0.0 110.962 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.3 t -72.69 -51.6 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.834 0.854 . . . . 0.0 112.398 -172.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.6 HD11 ' HE1' ' A' ' 15' ' ' MET . 91.3 mt -56.44 -41.34 90.68 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-O 117.368 -1.301 . . . . 0.0 114.389 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -40.33 -41.83 3.5 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.067 2.511 . . . . 0.0 114.596 170.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 36.6 mtpt -75.92 -43.04 47.01 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.683 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.08 -50.18 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.261 0.624 . . . . 0.0 110.042 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.447 ' HG2' HD12 ' A' ' 3' ' ' ILE . 42.9 mt-10 -57.21 -44.18 83.45 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.342 1.057 . . . . 0.0 110.968 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.08 67.76 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.48 1.112 . . . . 0.0 112.703 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 41' ' ' PHE . 52.6 t -61.55 -49.4 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.267 0.627 . . . . 0.0 110.977 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -78.54 -27.71 45.99 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.967 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.46 71.34 4.35 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.6 mt -85.12 51.19 2.11 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.849 173.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 23.68 76.37 0.02 OUTLIER 'General case' 0 C--N 1.374 1.644 0 C-N-CA 126.539 1.936 . . . . 0.0 113.352 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -60.79 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.444 1.097 . . . . 0.0 111.582 -169.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -109.13 -42.17 4.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.03 0.932 . . . . 0.0 109.299 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -65.18 161.15 19.77 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 171.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -74.6 -160.2 0.1 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.072 0.549 . . . . 0.0 110.22 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -65.74 137.81 57.52 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.369 -0.832 . . . . 0.0 110.064 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 . . . . . 0 CA--C 1.553 1.096 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.417 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.586 ' HG2' HD13 ' A' ' 19' ' ' LEU . 3.3 mpp? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.069 0.461 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -116.81 -175.57 2.8 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.83 1.252 . . . . 0.0 109.766 174.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.6 mt -102.49 109.66 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 170.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mm -84.19 -46.02 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.0 m -146.53 127.27 14.32 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.172 0.589 . . . . 0.0 110.272 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -86.78 75.35 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 165.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 p -77.6 90.69 3.94 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.352 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.45 -179.17 2.85 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.404 1.081 . . . . 0.0 111.047 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 p -137.64 151.65 71.23 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.591 1.157 . . . . 0.0 108.463 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.7 -37.95 84.21 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.745 2.297 . . . . 0.0 111.024 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -79.56 73.74 6.24 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 166.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -77.44 25.53 0.18 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.177 -167.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -59.21 -36.81 76.05 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.904 0.881 . . . . 0.0 109.542 163.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -123.78 159.25 29.92 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.796 0.839 . . . . 0.0 110.966 -177.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 37.7 mtm -136.45 143.06 43.68 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.553 1.141 . . . . 0.0 108.569 169.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -95.25 116.68 29.07 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.411 0.685 . . . . 0.0 109.597 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 64.6 mt -90.58 96.11 6.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 172.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 m -66.29 120.53 13.44 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.476 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.586 HD13 ' HG2' ' A' ' 1' ' ' MET . 77.0 mt -87.8 -160.56 0.63 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.216 0.607 . . . . 0.0 110.238 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -68.97 8.26 0.56 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 66.33 106.62 0.04 OUTLIER 'General case' 0 C--N 1.362 1.115 0 C-N-CA 125.352 1.461 . . . . 0.0 110.742 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -140.49 174.24 10.71 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.364 0.666 . . . . 0.0 110.827 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -56.48 133.04 52.96 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.222 0.609 . . . . 0.0 109.711 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -54.37 91.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.807 1.317 . . . . 0.0 112.519 -170.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.459 ' N ' ' HA ' ' A' ' 58' ' ' MET . . . -164.65 -73.2 0.03 OUTLIER Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 60.4 tpp 51.29 21.6 1.18 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.304 1.442 . . . . 0.0 112.381 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m 67.61 135.17 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.503 1.521 . . . . 0.0 110.513 -168.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 p -102.32 114.46 28.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.009 0.923 . . . . 0.0 108.746 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' A' ' 56' ' ' HIS . 15.7 m-20 -138.21 158.57 44.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.198 0.999 . . . . 0.0 110.194 -170.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 t -151.21 93.96 1.98 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -95.56 92.34 6.59 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.876 0.87 . . . . 0.0 110.566 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 53' ' ' SER . 81.3 p -92.31 -23.47 19.26 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.219 0.533 . . . . 0.0 109.585 174.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.649 ' HG2' ' H ' ' A' ' 34' ' ' VAL . 20.6 ttmm -106.58 -161.91 0.82 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.78 1.232 . . . . 0.0 108.272 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.649 ' H ' ' HG2' ' A' ' 33' ' ' LYS . 58.4 t -149.01 83.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 105.645 -1.984 . . . . 0.0 105.645 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -164.74 -138.0 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.694 -170.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 64.01 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.359 1.019 0 C-N-CA 124.891 1.276 . . . . 0.0 110.527 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.1 p -172.9 20.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.11 1.364 . . . . 0.0 109.386 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -65.1 142.86 98.73 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.028 0.931 . . . . 0.0 110.369 -176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.82 141.18 28.92 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.597 2.865 . . . . 0.0 113.347 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -58.97 -31.81 69.07 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.981 0.912 . . . . 0.0 111.74 -178.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.523 ' HB3' HG13 ' A' ' 81' ' ' VAL . 62.5 m-85 -65.4 -36.49 84.13 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.268 0.627 . . . . 0.0 110.911 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.3 mm -73.66 -27.1 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.525 0.73 . . . . 0.0 110.136 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 4.3 m-20 -62.27 -41.79 98.77 Favored 'General case' 0 C--N 1.368 1.392 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -57.72 -46.12 84.83 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.502 1.126 . . . . 0.0 111.418 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.539 HG23 HG22 ' A' ' 78' ' ' VAL . 57.4 mt -55.42 -49.27 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 123.801 0.688 . . . . 0.0 110.064 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.4 mt -65.15 -32.69 74.51 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.51 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -72.04 -18.94 61.91 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.764 0.826 . . . . 0.0 112.278 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.05 117.94 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -57.05 99.99 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.229 0.956 . . . . 0.0 109.168 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.52 -56.09 0.48 Allowed Glycine 0 C--O 1.225 -0.437 0 N-CA-C 110.071 -1.211 . . . . 0.0 110.071 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.73 127.71 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.844 0.858 . . . . 0.0 111.719 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.532 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 8.0 ttpm? -92.2 -46.56 7.68 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.063 0.945 . . . . 0.0 108.48 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 32' ' ' THR . 20.1 p -166.43 178.89 5.86 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 123.702 0.626 . . . . 0.0 111.599 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.4 mt -131.63 111.25 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.178 0.991 . . . . 0.0 109.377 176.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -90.35 125.79 35.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 169.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 29' ' ' ASP . 11.1 t-160 -132.78 123.38 26.06 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.61 0.764 . . . . 0.0 109.233 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -168.03 161.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 123.164 0.29 . . . . 0.0 110.458 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.459 ' HA ' ' N ' ' A' ' 25' ' ' GLY 0.27 27.2 ptm 56.64 -61.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 128.412 2.685 . . . . 0.0 114.973 175.251 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -150.88 -31.54 0.17 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.584 0.753 . . . . 0.0 111.0 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -95.51 155.38 16.77 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.337 0.589 . . . . 0.0 112.205 -167.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 42.7 mt -108.89 94.2 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 t -82.82 88.96 6.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.7 t -80.15 122.2 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.27 156.47 23.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.896 0.478 . . . . 0.0 110.006 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.532 ' HA ' ' H ' ' A' ' 52' ' ' LYS . 16.8 pttm -132.11 -162.09 1.2 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.109 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.94 165.64 2.32 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.535 0.734 . . . . 0.0 111.403 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -39.2 -44.82 1.26 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.539 1.536 . . . . 0.0 114.692 -164.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -133.36 -59.04 0.88 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 173.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . . . 49.91 -163.08 0.05 OUTLIER 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 125.782 1.633 . . . . 0.0 113.79 171.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -131.39 120.85 23.65 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.159 0.584 . . . . 0.0 111.536 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -73.81 -10.78 60.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.302 0.641 . . . . 0.0 110.935 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -61.93 -26.92 68.48 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.76 0.824 . . . . 0.0 110.575 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 m -91.84 -43.91 9.24 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.506 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.9 t -80.3 -50.21 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.631 0.772 . . . . 0.0 112.793 -172.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.25 -46.98 83.45 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-O 117.29 -1.338 . . . . 0.0 113.093 -171.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.19 -38.52 81.35 Favored 'Trans proline' 0 C--N 1.4 3.278 0 C-N-CA 122.232 1.955 . . . . 0.0 112.979 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.26 -40.56 70.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.067 0.547 . . . . 0.0 111.337 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 45' ' ' ILE . 41.4 t -65.47 -40.14 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.022 0.529 . . . . 0.0 109.97 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.15 -45.5 87.29 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.804 1.242 . . . . 0.0 110.463 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.0 -31.73 51.95 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.642 1.177 . . . . 0.0 112.708 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.523 HG13 ' HB3' ' A' ' 41' ' ' PHE . 56.0 t -65.77 -51.68 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 124.068 0.947 . . . . 0.0 111.279 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -72.66 -25.53 61.3 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -79.67 -69.76 0.56 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.375 0.27 . . . . 0.0 111.321 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.3 mt 73.38 -45.57 0.62 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.976 1.71 . . . . 0.0 111.813 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.59 144.54 42.57 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.627 1.171 . . . . 0.0 109.184 170.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -70.3 73.21 0.49 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.742 0.782 . . . . 0.0 110.409 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -67.92 108.4 3.02 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.6 0.76 . . . . 0.0 110.36 -173.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -103.67 149.87 24.54 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.515 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -67.55 -25.47 65.82 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.319 0.647 . . . . 0.0 111.113 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -117.36 154.24 31.63 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.435 0.694 . . . . 0.0 109.236 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 . . . . . 0 C--O 1.249 1.076 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 172.65 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -160.99 167.28 26.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.636 0.774 . . . . 0.0 109.981 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.3 mt -65.21 96.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 20' ' ' SER . 33.3 mm -93.26 -40.98 12.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 C-N-CA 123.889 0.876 . . . . 0.0 109.786 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.589 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 10.9 t -150.5 158.74 44.49 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.428 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -117.06 134.13 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.118 0.967 . . . . 0.0 109.087 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 7.3 m -118.06 81.52 1.69 Allowed 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.75 -179.13 6.75 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.22 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 11' ' ' ASN . 2.0 t -160.11 154.77 20.62 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.778 0.831 . . . . 0.0 109.417 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.22 -18.95 65.05 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 122.529 2.153 . . . . 0.0 111.818 171.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.502 ' O ' HG23 ' A' ' 9' ' ' THR . 49.8 t30 -78.21 148.03 34.18 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 169.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -116.51 -171.71 2.05 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 122.116 -0.365 . . . . 0.0 111.413 -168.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 17.0 m120 76.82 -66.42 0.25 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.988 1.715 . . . . 0.0 110.363 -176.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 10.0 t -105.15 135.47 46.44 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.847 0.356 . . . . 0.0 111.573 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 62' ' ' SER . 13.0 ptp -133.24 149.29 51.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.723 169.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 84.3 tttt -91.06 100.26 13.14 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.534 1.134 . . . . 0.0 110.58 -175.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.86 111.15 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.589 ' HB ' ' HB3' ' A' ' 5' ' ' SER . 86.2 m -75.35 131.27 40.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.601 0.76 . . . . 0.0 110.98 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.5 mt -102.35 166.56 10.5 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.764 0.825 . . . . 0.0 109.239 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.516 ' HB2' HG13 ' A' ' 4' ' ' ILE . 29.4 t -76.19 -26.77 56.5 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.702 0.401 . . . . 0.0 111.501 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -82.0 76.67 8.88 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.28 0.562 . . . . 0.0 109.976 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -87.5 166.53 14.7 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.996 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 68.92 173.44 0.29 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.506 1.122 . . . . 0.0 110.586 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 57.05 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.702 1.201 . . . . 0.0 111.061 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.72 143.43 5.71 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.8 mtt -92.35 -165.93 1.44 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.525 0.73 . . . . 0.0 109.7 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.1 m -90.65 153.27 20.43 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.039 0.447 . . . . 0.0 110.048 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 p -87.09 104.71 16.6 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.26 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -123.55 97.5 5.41 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.88 0.872 . . . . 0.0 110.49 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 m -89.45 83.49 6.37 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.631 ' HB3' HD11 ' A' ' 46' ' ' LEU . 25.0 m-85 -81.87 110.46 17.18 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.477 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.3 p -121.55 -39.91 2.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.969 0.908 . . . . 0.0 110.472 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.658 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -141.14 40.0 1.78 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.883 -176.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.7 t 65.86 126.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 125.003 1.321 . . . . 0.0 113.133 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -93.69 -88.31 0.23 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 171.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 t70 169.51 -42.3 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.362 1.065 . . . . 0.0 109.294 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.5 p -63.42 -38.27 90.51 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.412 1.085 . . . . 0.0 111.806 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -60.51 141.9 91.44 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.945 0.898 . . . . 0.0 111.598 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.93 154.47 7.11 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.225 2.617 . . . . 0.0 113.815 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.14 67.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.973 0.909 . . . . 0.0 111.095 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.497 ' HB3' HG13 ' A' ' 81' ' ' VAL . 55.3 m-85 -62.3 -34.31 76.36 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.217 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.605 HD13 HG11 ' A' ' 81' ' ' VAL . 13.0 mm -79.76 -23.17 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 122.906 0.482 . . . . 0.0 110.52 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -68.27 -36.26 79.14 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.87 -41.84 92.4 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.71 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.586 HG22 HG11 ' A' ' 51' ' ' VAL . 54.3 mt -56.45 -46.6 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 123.994 0.809 . . . . 0.0 110.416 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 31' ' ' TYR . 96.7 mt -64.04 -36.4 83.88 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -79.34 -1.93 39.16 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.163 0.585 . . . . 0.0 112.059 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.6 t -70.87 115.52 10.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 165.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -62.96 89.06 0.03 OUTLIER 'General case' 0 C--N 1.348 0.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.28 -52.48 0.25 Allowed Glycine 0 C--O 1.218 -0.872 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.056 -172.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.586 HG11 HG22 ' A' ' 45' ' ' ILE . 74.2 t -69.9 -40.83 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -168.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 19.6 ttmt 65.63 -72.69 0.07 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.857 1.663 . . . . 0.0 111.823 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 35.9 t -133.29 151.86 51.91 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.641 0.776 . . . . 0.0 111.24 -174.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 75.1 mt -129.68 107.01 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.469 1.508 . . . . 0.0 107.401 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 72.0 t80 -99.59 91.44 4.89 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -94.13 134.49 36.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.138 0.975 . . . . 0.0 109.649 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 p -171.02 153.32 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.433 0.693 . . . . 0.0 109.48 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.498 ' HG3' ' H ' ' A' ' 59' ' ' ASP 0.269 18.3 ptp 43.93 -84.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 126.698 1.999 . . . . 0.0 115.231 -175.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.498 ' H ' ' HG3' ' A' ' 58' ' ' MET . 9.5 p-10 -138.82 20.88 2.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.022 -1.049 . . . . 0.0 111.853 -172.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -147.54 167.37 24.68 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.443 HG23 HG23 ' A' ' 54' ' ' ILE . 68.4 mt -132.14 101.89 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.406 1.483 . . . . 0.0 108.118 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.517 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 68.4 m -82.78 94.65 7.68 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.764 0.426 . . . . 0.0 110.121 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.49 HG13 HG13 ' A' ' 51' ' ' VAL . 97.5 t -79.15 105.21 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 18.7 t0 -93.71 85.57 4.88 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.273 1.029 . . . . 0.0 109.966 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 13' ' ' ASN . 16.8 pttp -75.73 174.09 10.26 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.074 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -75.54 176.25 7.76 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.946 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -70.46 -66.02 0.66 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.521 0.328 . . . . 0.0 110.531 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -69.81 -44.22 70.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.021 0.528 . . . . 0.0 111.348 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.53 121.48 8.48 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.244 0.965 . . . . 0.0 110.476 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -94.94 154.9 16.98 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.752 0.821 . . . . 0.0 111.311 -168.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -62.88 -20.11 64.81 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.094 0.558 . . . . 0.0 112.459 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -70.07 -19.34 63.27 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.565 0.346 . . . . 0.0 111.311 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.2 m -95.28 -47.18 6.43 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.409 0.683 . . . . 0.0 110.469 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.504 HG13 HG22 ' A' ' 51' ' ' VAL . 93.5 t -70.32 -59.99 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.934 0.893 . . . . 0.0 112.364 -171.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.3 tt -56.78 -50.27 88.97 Favored Pre-proline 0 CA--C 1.57 1.725 0 CA-C-O 117.773 -1.108 . . . . 0.0 112.902 -171.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -59.2 -31.25 94.96 Favored 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.409 2.072 . . . . 0.0 112.894 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -71.9 -41.25 68.16 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.659 0.784 . . . . 0.0 111.227 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.64 -48.51 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.96 -38.38 85.72 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.228 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.92 -29.1 70.31 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.13 0.972 . . . . 0.0 111.844 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.605 HG11 HD13 ' A' ' 42' ' ' ILE . 38.0 t -68.32 -39.4 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.686 0.394 . . . . 0.0 110.991 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -70.9 -40.79 71.97 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.469 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.0 79.14 1.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.9 mt -80.04 40.04 0.46 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.658 1.183 . . . . 0.0 111.854 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 66.93 172.31 0.25 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.06 0.944 . . . . 0.0 109.164 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -80.07 62.36 4.23 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.997 -1.064 . . . . 0.0 108.157 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -169.66 91.25 0.21 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.568 1.547 . . . . 0.0 107.309 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -69.43 -12.17 61.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.853 0.861 . . . . 0.0 111.766 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 80.99 -61.34 0.22 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.048 1.739 . . . . 0.0 111.827 173.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 50.43 -165.03 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.517 1.527 . . . . 0.0 112.53 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 28.8 p80 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 123.181 0.592 . . . . 0.0 109.479 170.903 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.464 0.649 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 10.8 mtmp? -137.55 -175.72 4.16 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.258 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -92.27 93.83 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.605 HG13 ' HB3' ' A' ' 20' ' ' SER . 49.1 mm -90.41 -42.13 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.364 0.666 . . . . 0.0 110.027 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -142.84 156.29 44.92 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.15 0.98 . . . . 0.0 108.87 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -111.51 -75.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.462 0.705 . . . . 0.0 110.196 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.6 t 57.12 84.06 0.1 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.813 1.245 . . . . 0.0 110.79 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -85.14 -168.7 2.32 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.029 -179.299 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.2 p -112.65 149.39 41.09 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.2 -33.79 97.89 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.912 2.408 . . . . 0.0 113.836 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -78.61 -11.71 59.98 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.694 0.797 . . . . 0.0 111.124 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.2 m80 64.98 29.94 12.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.133 1.373 . . . . 0.0 112.423 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.19 -48.27 18.05 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -128.04 141.65 51.45 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.472 0.653 . . . . 0.0 111.863 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.609 ' SD ' HD21 ' A' ' 75' ' ' LEU . 13.2 ptp -130.63 148.79 52.47 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 108.765 167.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 59.3 mttp -94.42 158.26 15.64 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.319 0.648 . . . . 0.0 109.538 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.1 mt -132.66 94.87 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.1 m -60.11 109.46 0.97 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.767 0.827 . . . . 0.0 109.983 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.9 mt -79.38 -26.76 41.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.939 0.496 . . . . 0.0 111.625 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.605 ' HB3' HG13 ' A' ' 4' ' ' ILE . 54.5 p 98.82 -6.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 127.876 2.47 . . . . 0.0 112.849 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -89.86 62.94 5.88 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.139 0.427 . . . . 0.0 109.887 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.3 m -65.22 84.47 0.05 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.586 0.707 . . . . 0.0 111.024 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -104.73 5.23 33.21 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.324 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 66.74 -71.1 0.1 Allowed 'General case' 0 C--N 1.37 1.497 0 C-N-CA 125.823 1.649 . . . . 0.0 111.075 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.29 56.34 4.25 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.288 -0.414 . . . . 0.0 112.246 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.9 ttt -94.92 46.95 1.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 m 68.47 155.2 0.12 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 125.752 1.621 . . . . 0.0 111.997 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.1 p -135.27 78.87 1.75 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.85 1.26 . . . . 0.0 108.309 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -124.52 144.68 49.98 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.434 0.694 . . . . 0.0 111.329 -165.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -99.92 149.73 23.12 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.989 0.916 . . . . 0.0 109.978 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.541 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 59.5 m-85 -141.35 113.99 8.32 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.156 1.383 . . . . 0.0 107.782 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.4 p -136.71 -43.06 0.59 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.564 0.746 . . . . 0.0 110.262 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -106.61 32.76 4.28 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.983 0.913 . . . . 0.0 112.076 -164.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 43' ' ' ASN . 58.9 t 55.58 64.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 122.756 1.265 . . . . 0.0 109.194 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.3 135.21 42.57 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.481 -1.69 . . . . 0.0 111.321 -170.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -77.09 91.89 3.72 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 p -177.96 -61.83 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.685 1.194 . . . . 0.0 108.662 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.478 ' HG3' ' ND2' ' A' ' 43' ' ' ASN . 25.2 pt20 -60.08 149.69 73.56 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.904 1.282 . . . . 0.0 111.91 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.6 150.93 11.18 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.262 2.642 . . . . 0.0 112.542 168.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.87 -37.33 63.58 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 123.687 0.617 . . . . 0.0 111.253 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -55.69 -40.31 72.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.89 1.276 . . . . 0.0 111.937 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.4 mm -75.63 -28.96 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.435 0.694 . . . . 0.0 110.304 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.478 ' ND2' ' HG3' ' A' ' 38' ' ' GLN . 55.5 m-80 -70.86 -34.94 72.15 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -64.61 -34.89 79.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.071 0.548 . . . . 0.0 110.93 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.9 mt -60.55 -45.24 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 123.728 0.642 . . . . 0.0 110.091 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.2 -35.74 78.01 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.921 0.488 . . . . 0.0 111.883 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.58 -14.12 60.38 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.212 0.605 . . . . 0.0 111.647 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.39 109.77 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -59.12 104.64 0.26 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.041 0.838 . . . . 0.0 111.003 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 146.88 -45.3 0.78 Allowed Glycine 0 C--N 1.344 1.015 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.5 121.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.791 0.836 . . . . 0.0 109.897 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 26.2 ttpp -104.96 -32.58 8.69 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.84 0.856 . . . . 0.0 110.965 -172.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 t -151.99 161.62 42.35 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.73 0.412 . . . . 0.0 111.062 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 79.1 mt -148.02 116.84 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.658 1.583 . . . . 0.0 107.252 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -119.59 110.23 16.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.798 0.439 . . . . 0.0 110.083 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -95.16 119.94 34.52 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.29 147.81 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.074 0.55 . . . . 0.0 110.336 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 67.55 -68.46 0.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.529 1.532 . . . . 0.0 110.883 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.404 ' H ' ' H ' ' A' ' 60' ' ' PHE . 6.2 p-10 -160.06 -25.44 0.06 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.87 1.268 . . . . 0.0 110.234 169.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.404 ' H ' ' H ' ' A' ' 59' ' ' ASP . 45.7 p90 -81.27 143.11 32.51 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-O 120.922 0.391 . . . . 0.0 111.259 -170.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.16 103.18 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 15.0 t -83.32 89.25 6.98 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.6 t -77.48 126.13 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -120.21 149.4 42.32 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.275 1.03 . . . . 0.0 110.457 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HA ' ' H ' ' A' ' 52' ' ' LYS . 17.8 pttp -140.22 179.88 6.38 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.681 1.192 . . . . 0.0 109.441 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.9 167.04 22.51 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.828 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.11 -48.38 71.07 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.976 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.96 -32.88 74.57 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.507 -172.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.83 161.99 27.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.705 0.802 . . . . 0.0 111.933 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -118.25 146.23 44.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.679 0.792 . . . . 0.0 110.074 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.538 ' HB3' HD23 ' A' ' 75' ' ' LEU . 66.1 m95 -69.66 -17.14 63.48 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.048 0.539 . . . . 0.0 111.031 172.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.59 -24.81 67.76 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.969 0.908 . . . . 0.0 111.792 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.7 m -84.75 -45.3 12.53 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.019 0.928 . . . . 0.0 110.397 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.8 t -73.5 -60.92 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.068 -169.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.609 HD21 ' SD ' ' A' ' 15' ' ' MET . 3.9 mm? -49.32 -47.62 76.33 Favored Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -172.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -55.51 -33.85 87.69 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.078 1.852 . . . . 0.0 113.876 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -80.96 -41.98 21.99 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.696 0.798 . . . . 0.0 110.5 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.1 t -74.42 -31.77 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.331 1.052 . . . . 0.0 111.523 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.5 -41.35 80.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.872 0.869 . . . . 0.0 110.987 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.33 -32.34 71.15 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.045 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -63.11 -40.19 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.901 0.88 . . . . 0.0 111.663 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.665 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 27.2 m-85 -91.2 25.08 2.63 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.428 ' HB3' ' HG2' ' A' ' 85' ' ' GLU . 57.8 mt-10 -145.62 -58.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.055 0.455 . . . . 0.0 109.904 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 62.82 30.73 16.66 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.397 1.479 . . . . 0.0 111.091 -174.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 83' ' ' GLU . 10.2 mm-40 -72.89 93.71 1.75 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.633 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -116.37 125.3 51.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.273 1.029 . . . . 0.0 108.988 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 60.35 27.18 16.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.028 0.931 . . . . 0.0 111.566 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.33 124.41 27.47 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.778 0.831 . . . . 0.0 110.988 -173.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -125.61 91.56 3.43 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.238 1.015 . . . . 0.0 108.67 175.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -93.39 -68.99 0.77 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.9 p80 . . . . . 0 CA--C 1.557 1.24 0 C-N-CA 123.778 0.831 . . . . 0.0 109.584 178.455 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.644 0.259 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -167.27 179.35 5.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.78 0.832 . . . . 0.0 111.125 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.9 mt -72.41 115.84 13.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.107 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.2 mm -84.74 -45.65 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.3 p -154.65 133.44 12.19 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.12 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.7 mm -78.37 105.6 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 169.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.538 ' HB3' ' HG3' ' A' ' 16' ' ' LYS . 38.2 t . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 122.956 0.502 . . . . 0.0 110.804 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.447 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 25.6 t-20 -66.59 -64.76 0.79 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.536 0.734 . . . . 0.0 110.618 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.4 t -106.84 126.9 52.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.532 0.333 . . . . 0.0 110.121 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -122.35 143.33 49.71 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.29 0.567 . . . . 0.0 110.457 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HG3' ' HB3' ' A' ' 7' ' ' SER . 20.3 ptmt -88.38 140.53 29.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.84 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.1 mt -130.0 114.93 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.499 1.12 . . . . 0.0 109.317 -172.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.8 m -71.66 119.96 16.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.645 0.778 . . . . 0.0 110.322 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.9 mt -87.41 169.88 11.86 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.222 0.609 . . . . 0.0 110.696 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 p -74.7 -26.72 60.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.399 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HB2' ' SD ' ' A' ' 26' ' ' MET . 24.5 mm-40 -84.2 128.42 34.55 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.267 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.6 p -153.37 166.8 31.51 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.216 0.606 . . . . 0.0 111.334 -174.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 71.04 156.13 0.15 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.875 1.67 . . . . 0.0 112.437 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 69.28 -75.97 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.803 1.641 . . . . 0.0 110.853 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.02 116.45 1.06 Allowed Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.535 -0.302 . . . . 0.0 112.505 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 21' ' ' GLU . 82.5 mtp -75.32 -167.59 0.67 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.302 1.041 . . . . 0.0 109.748 170.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.0 p -59.19 112.9 1.88 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.298 0.639 . . . . 0.0 110.991 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.1 p -94.59 84.87 4.36 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -144.78 141.74 29.44 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.828 0.851 . . . . 0.0 111.237 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.469 ' HG1' ' HD1' ' A' ' 55' ' ' PHE . 23.2 m -89.29 106.41 18.42 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -80.21 101.17 8.69 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -146.01 -33.7 0.32 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.948 0.499 . . . . 0.0 111.874 -171.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.427 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 46.9 pttt -88.85 4.87 46.26 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -169.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.4 t 65.02 126.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 125.448 1.499 . . . . 0.0 110.533 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 t70 72.01 47.34 0.31 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.927 1.291 . . . . 0.0 109.26 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' A' ' 33' ' ' LYS . 2.7 m-20 -84.31 47.91 1.41 Allowed 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.882 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.0 p 58.05 19.29 5.85 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.843 1.657 . . . . 0.0 113.249 -174.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.32 147.01 34.12 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 123.789 0.836 . . . . 0.0 109.966 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -52.43 155.19 10.15 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.739 2.959 . . . . 0.0 113.809 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.86 -31.35 49.29 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.253 1.021 . . . . 0.0 112.107 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -56.73 -44.98 82.19 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.216 1.006 . . . . 0.0 111.257 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mm -71.55 -28.86 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.381 0.672 . . . . 0.0 109.958 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.417 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 28.8 m-80 -72.07 -32.93 67.52 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.91 0.484 . . . . 0.0 110.068 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 48' ' ' VAL . 28.0 t70 -63.43 -41.78 98.7 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 124.145 0.903 . . . . 0.0 109.8 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.0 mt -59.74 -44.84 94.69 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 O-C-N 124.267 0.979 . . . . 0.0 109.882 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.48 -36.68 74.12 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.132 0.573 . . . . 0.0 111.223 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 43' ' ' ASN . 96.2 mttt -79.45 -19.72 49.2 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.658 0.783 . . . . 0.0 112.09 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 44' ' ' ASP . 55.9 t -60.44 121.83 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.65 89.47 0.05 OUTLIER 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.353 1.033 . . . . 0.0 109.581 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.15 -32.07 0.45 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.184 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.89 131.4 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.476 0.71 . . . . 0.0 109.7 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -87.05 -52.05 5.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.331 0.652 . . . . 0.0 109.26 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.6 p -163.31 173.0 13.84 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.584 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.461 HG23 HG22 ' A' ' 63' ' ' VAL . 74.0 mt -132.03 101.04 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.469 ' HD1' ' HG1' ' A' ' 30' ' ' THR . 28.8 t80 -81.98 146.27 29.83 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -135.54 135.03 40.04 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.12 124.64 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.538 0.735 . . . . 0.0 110.241 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 45.6 ttm 55.78 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.263 1.425 . . . . 0.0 112.821 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -120.31 -39.32 2.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.131 0.572 . . . . 0.0 110.6 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -98.26 138.79 35.01 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.644 0.735 . . . . 0.0 110.807 -167.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 53.5 mt -85.61 163.78 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.801 173.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -143.44 86.31 1.89 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.461 HG22 HG23 ' A' ' 54' ' ' ILE . 40.7 t -80.01 114.63 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.27 131.15 34.32 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.097 0.959 . . . . 0.0 108.69 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 13' ' ' ASN . 21.5 pttp -101.72 -173.86 2.45 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 173.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -89.39 162.71 15.64 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -59.13 -48.19 82.51 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.295 0.638 . . . . 0.0 112.631 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -80.55 -33.8 35.94 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.36 0.664 . . . . 0.0 111.597 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.35 140.94 12.59 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.591 1.156 . . . . 0.0 112.666 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -110.24 130.47 55.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.799 0.84 . . . . 0.0 110.302 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -60.35 -18.32 49.25 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.448 0.699 . . . . 0.0 112.027 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -56.73 -35.31 68.44 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.537 0.735 . . . . 0.0 110.732 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 t -101.06 -42.59 6.33 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.012 0.525 . . . . 0.0 110.884 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.1 t -70.73 -45.87 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.312 1.045 . . . . 0.0 113.358 -170.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.6 tp -60.64 -43.74 93.22 Favored Pre-proline 0 N--CA 1.492 1.66 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.65 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -46.45 -34.31 14.32 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.415 2.077 . . . . 0.0 114.38 170.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -75.1 -41.45 58.64 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.337 0.655 . . . . 0.0 111.118 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -65.02 -58.12 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-O 121.638 0.732 . . . . 0.0 109.237 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.67 -31.17 67.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.73 1.612 . . . . 0.0 112.26 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.14 55.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.383 1.073 . . . . 0.0 112.876 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.3 -49.54 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.203 0.601 . . . . 0.0 110.816 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -69.28 -25.22 64.15 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.351 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -122.49 77.16 1.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.726 0.81 . . . . 0.0 109.534 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--O 1.243 0.754 0 C-N-CA 124.097 0.959 . . . . 0.0 108.565 171.01 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -145.28 144.45 30.78 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.452 0.701 . . . . 0.0 110.424 -175.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.5 mt -73.58 95.04 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.4 0.68 . . . . 0.0 109.728 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 mm -83.54 -35.51 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.698 0.799 . . . . 0.0 110.138 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.7 t -134.31 146.75 50.28 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.824 0.45 . . . . 0.0 111.123 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.422 HG23 ' HG2' ' A' ' 15' ' ' MET . 72.6 mt -128.76 133.95 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.775 1.63 . . . . 0.0 108.252 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 121.226 0.536 . . . . 0.0 111.285 -179.279 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 69.64 20.29 7.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.553 1.141 . . . . 0.0 111.912 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 13.2 t -161.01 143.1 12.29 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.097 0.959 . . . . 0.0 108.832 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 62' ' ' SER . 57.7 mtm -115.68 110.76 19.61 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -75.74 85.89 2.75 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 165.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.2 mt -77.31 93.29 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.0 m -77.94 116.89 18.77 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.1 mt -84.88 -150.49 0.12 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 p -76.65 15.17 0.67 Allowed 'General case' 0 CA--C 1.558 1.269 0 O-C-N 121.93 -0.481 . . . . 0.0 112.114 173.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 42.4 mt-10 67.82 92.4 0.08 Allowed 'General case' 0 C--N 1.358 0.944 0 C-N-CA 125.903 1.681 . . . . 0.0 110.798 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -73.07 131.92 42.69 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -76.11 78.91 2.94 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.549 0.531 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 62.17 13.27 5.7 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.497 1.119 . . . . 0.0 111.874 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.12 -26.7 61.43 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.156 -173.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.0 mmt -80.46 107.13 13.01 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.5 p -75.12 154.54 37.74 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.579 0.352 . . . . 0.0 110.916 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.0 p -69.48 96.06 0.88 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.241 0.543 . . . . 0.0 110.815 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -119.2 111.06 17.76 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.258 1.023 . . . . 0.0 109.565 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.3 m -91.1 97.23 11.03 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -81.98 103.78 11.87 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.0 p -99.47 49.81 0.94 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.753 1.221 . . . . 0.0 109.307 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.463 ' HA ' HD13 ' A' ' 46' ' ' LEU 0.298 0.9 OUTLIER 56.72 99.55 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 127.427 2.291 . . . . 0.0 113.727 179.372 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t 50.54 80.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 125.53 1.532 . . . . 0.0 111.215 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -151.78 -50.08 0.11 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -164.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -105.07 -96.64 0.33 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.856 0.462 . . . . 0.0 110.783 -169.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.6 t -161.81 87.54 0.67 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.1 pm0 -139.77 144.36 38.56 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.627 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -53.34 150.65 25.42 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.837 2.358 . . . . 0.0 112.326 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.33 -34.43 57.41 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.581 0.753 . . . . 0.0 111.057 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.468 ' HB3' HG13 ' A' ' 81' ' ' VAL . 91.0 m-85 -56.82 -46.94 81.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.422 1.089 . . . . 0.0 111.499 176.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.0 mm -67.31 -32.35 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.202 0.601 . . . . 0.0 110.296 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.455 ' HA ' HD12 ' A' ' 46' ' ' LEU . 64.6 m-20 -70.5 -32.01 69.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.509 0.724 . . . . 0.0 110.702 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 48' ' ' VAL . 1.1 m-20 -65.63 -38.11 88.47 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.237 0.615 . . . . 0.0 111.221 175.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 78' ' ' VAL . 59.7 mt -61.99 -44.6 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.794 0.807 . . . . 0.0 109.931 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 33' ' ' LYS . 58.7 mt -61.89 -34.55 76.23 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.725 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -82.32 -8.67 59.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.559 0.744 . . . . 0.0 112.562 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.498 HG11 HG13 ' A' ' 74' ' ' VAL . 65.9 t -70.5 105.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 171.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.69 94.31 0.2 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.694 0.798 . . . . 0.0 110.451 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 161.44 -35.81 0.39 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.0 129.73 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.825 0.85 . . . . 0.0 109.024 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -78.6 -57.04 3.97 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 p -163.61 178.49 7.92 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.975 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.403 HG12 HG13 ' A' ' 63' ' ' VAL . 75.5 mt -132.27 117.64 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.084 0.954 . . . . 0.0 109.221 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -103.67 97.54 7.54 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.697 0.76 . . . . 0.0 109.621 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -87.86 131.35 34.59 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.652 1.181 . . . . 0.0 109.88 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.4 p -172.52 155.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 118.433 0.56 . . . . 0.0 111.715 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 27.5 ttt 65.09 -83.81 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.5 1.92 . . . . 0.0 112.918 171.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 7.1 p-10 -132.71 -16.19 2.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.977 0.911 . . . . 0.0 110.561 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.408 ' HE2' ' HB2' ' A' ' 62' ' ' SER . 37.6 p90 -122.54 171.13 9.33 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 122.129 0.966 . . . . 0.0 112.446 -162.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -126.06 103.67 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.616 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 15' ' ' MET . 28.5 t -86.0 89.08 7.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.403 HG13 HG12 ' A' ' 54' ' ' ILE . 26.3 t -88.54 107.72 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 4.8 p-10 -106.58 158.19 17.12 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.894 0.478 . . . . 0.0 111.035 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -139.44 -167.97 2.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.815 0.846 . . . . 0.0 111.889 -165.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -88.19 161.13 17.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.33 1.052 . . . . 0.0 110.826 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.87 -27.02 67.91 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.731 0.812 . . . . 0.0 113.048 -172.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -97.1 -28.26 14.21 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.813 0.845 . . . . 0.0 111.734 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.28 130.89 23.74 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.817 0.847 . . . . 0.0 112.282 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -104.6 127.43 52.33 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.242 0.617 . . . . 0.0 110.443 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.425 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 63.3 m95 -71.87 -16.72 62.15 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.531 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.92 -34.54 71.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.083 0.468 . . . . 0.0 110.787 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.1 m -82.96 -44.7 14.99 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.74 0.816 . . . . 0.0 110.536 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.498 HG13 HG11 ' A' ' 48' ' ' VAL . 48.2 t -74.61 -39.51 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.944 0.898 . . . . 0.0 112.538 -170.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 71' ' ' TRP . 3.0 tt -59.14 -44.25 98.29 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-O 117.125 -1.417 . . . . 0.0 112.509 -168.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -48.96 -31.21 19.69 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.441 2.094 . . . . 0.0 114.676 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -82.08 -40.81 21.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.515 0.726 . . . . 0.0 110.029 -179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 45' ' ' ILE . 56.2 t -63.81 -38.45 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 123.914 0.885 . . . . 0.0 109.936 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.68 -47.64 82.77 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.73 1.612 . . . . 0.0 109.868 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.51 -31.1 61.78 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.854 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 41' ' ' PHE . 56.1 t -68.34 -55.48 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.41 0.684 . . . . 0.0 110.683 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 1' ' ' MET . 17.9 m-85 -65.04 -29.05 69.92 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -80.14 -38.59 31.12 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.029 0.532 . . . . 0.0 112.07 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 124.055 0.942 . . . . 0.0 109.504 -164.676 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 mtm . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -127.94 -174.75 3.28 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.9 mt -76.1 108.1 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -82.16 -51.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -162.79 147.88 11.93 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.558 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mt -89.74 97.29 6.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 168.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.549 0.911 0 C-N-CA 123.531 0.732 . . . . 0.0 111.782 -174.489 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.2 t60 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 77.56 -51.22 0.53 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.234 1.414 . . . . 0.0 111.254 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.4 t -105.71 112.04 24.96 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.866 0.466 . . . . 0.0 110.635 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.9 mtm -98.98 142.85 29.95 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.187 0.518 . . . . 0.0 110.048 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -89.59 113.73 25.2 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.936 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.8 mt -93.32 111.39 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.4 m -76.59 122.89 25.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.579 0.752 . . . . 0.0 109.832 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.2 mt -101.99 -171.3 1.95 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.489 0.715 . . . . 0.0 109.727 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 p -76.72 6.76 5.48 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 63.86 -171.29 0.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.427 1.091 . . . . 0.0 112.122 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 t -151.28 -162.81 1.62 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -69.68 89.56 0.55 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.244 0.618 . . . . 0.0 109.576 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 65.49 -74.0 0.06 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.453 1.501 . . . . 0.0 110.482 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.85 148.68 20.43 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.034 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -131.64 127.53 37.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.236 1.014 . . . . 0.0 109.447 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 t 46.64 176.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 126.609 1.964 . . . . 0.0 115.365 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 p -155.61 98.37 1.94 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.624 0.769 . . . . 0.0 109.46 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.49 164.24 14.86 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.108 0.963 . . . . 0.0 110.866 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 m -141.41 98.02 3.28 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 161.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 40.4 m-85 -82.16 111.97 18.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 p -122.38 -71.29 0.73 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.079 0.552 . . . . 0.0 110.134 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -110.02 46.88 0.99 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.683 0.793 . . . . 0.0 108.994 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.4 t 67.6 120.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 125.139 1.376 . . . . 0.0 111.704 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.17 -81.41 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.903 1.281 . . . . 0.0 110.4 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 166.06 -66.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.299 1.44 . . . . 0.0 108.611 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t -90.98 -2.4 57.71 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.117 0.967 . . . . 0.0 111.802 -169.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -63.08 149.84 89.86 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 123.693 0.797 . . . . 0.0 111.257 173.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -53.61 148.21 36.31 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.556 2.837 . . . . 0.0 113.731 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.02 69.81 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.029 0.931 . . . . 0.0 111.364 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.505 ' HB3' HG13 ' A' ' 81' ' ' VAL . 31.5 m-85 -61.48 -36.69 81.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.983 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.3 mm -75.69 -25.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -69.1 -37.26 78.3 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.15 -39.17 92.62 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.6 0.76 . . . . 0.0 110.358 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.523 HG22 HG11 ' A' ' 51' ' ' VAL . 29.2 mt -66.42 -34.55 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 123.533 0.521 . . . . 0.0 110.04 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 31' ' ' TYR . 88.9 mt -64.32 -35.54 81.19 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.838 0.455 . . . . 0.0 111.804 174.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.36 -15.37 61.87 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.896 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.49 97.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.82 87.48 0.06 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 109.904 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.46 -17.22 0.08 OUTLIER Glycine 0 C--O 1.221 -0.714 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.881 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.523 HG11 HG22 ' A' ' 45' ' ' ILE . 35.6 m -85.77 -27.86 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 22.2 ttmm 48.59 -77.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.94 2.096 . . . . 0.0 113.217 -173.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 49.9 m -122.89 98.06 5.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.945 0.898 . . . . 0.0 110.172 -171.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 66.0 mt -83.93 84.08 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.447 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 92.5 t80 -81.49 140.32 34.65 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.429 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -137.02 134.41 36.56 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.15 143.32 9.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 171.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.2 ttt 62.31 -80.45 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 O-C-N 124.651 1.22 . . . . 0.0 111.837 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.59 -38.01 1.55 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.636 0.774 . . . . 0.0 111.327 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -103.44 165.14 11.21 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.305 0.642 . . . . 0.0 112.625 -163.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.3 mt -120.19 111.53 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.989 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 50.1 m -85.83 95.37 9.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.358 0.663 . . . . 0.0 109.61 173.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 14' ' ' THR . 52.4 t -85.07 99.95 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.571 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 1.8 m-20 -84.7 98.3 10.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.683 1.193 . . . . 0.0 108.58 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.631 ' HD2' ' HB3' ' A' ' 69' ' ' ALA . 57.9 pttt -66.25 177.09 1.54 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -175.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 47.7 mm-40 -64.09 -177.39 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.499 0.719 . . . . 0.0 112.274 174.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -61.0 -25.1 66.65 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.528 0.731 . . . . 0.0 111.732 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.13 -58.27 0.9 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.412 0.685 . . . . 0.0 109.772 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.631 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . 49.6 -164.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.85 1.26 . . . . 0.0 113.053 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -156.8 114.21 3.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -68.69 -28.07 66.53 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.064 0.546 . . . . 0.0 111.832 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.63 -21.65 64.46 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 120.982 0.42 . . . . 0.0 110.505 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.7 m -86.0 -45.14 11.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.115 0.566 . . . . 0.0 110.396 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.44 -58.14 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.845 0.858 . . . . 0.0 112.571 -173.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.36 -47.01 99.73 Favored Pre-proline 0 N--CA 1.491 1.599 0 CA-C-O 117.362 -1.304 . . . . 0.0 114.321 -170.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.49 -33.99 60.03 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 122.14 1.893 . . . . 0.0 113.974 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -77.25 -39.02 49.82 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.811 0.844 . . . . 0.0 110.435 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.94 -41.23 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.765 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.93 -36.88 84.87 Favored 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 123.75 0.82 . . . . 0.0 110.837 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.71 -30.49 67.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.415 0.686 . . . . 0.0 111.917 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 41' ' ' PHE . 40.6 t -65.83 -58.96 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.848 0.859 . . . . 0.0 111.928 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -73.75 -42.93 60.41 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.261 0.624 . . . . 0.0 110.914 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.5 70.36 2.26 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.483 1.191 0 C-N-CA 123.558 0.743 . . . . 0.0 110.915 175.72 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 121.132 0.491 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.602 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 50.9 pttt -145.14 -170.72 3.49 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.195 0.998 . . . . 0.0 108.984 173.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 6' ' ' ILE . 59.5 mt -78.12 116.65 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 163.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 19' ' ' LEU . 1.6 mp -83.43 -52.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 t -159.32 124.39 4.13 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.432 0.458 . . . . 0.0 110.881 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.632 HG21 ' HE2' ' A' ' 15' ' ' MET . 59.8 mt -92.25 90.6 3.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 123.959 0.904 . . . . 0.0 112.532 171.075 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.402 ' HD2' ' H ' ' A' ' 14' ' ' THR . 22.9 t60 . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.572 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 1.6 m120 -72.28 -22.29 61.23 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.03 1.287 . . . . 0.0 111.469 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 11.9 t -140.31 162.44 35.29 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.225 1.01 . . . . 0.0 109.292 171.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.632 ' HE2' HG21 ' A' ' 6' ' ' ILE . 6.9 ptp -136.36 125.49 24.55 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.285 0.564 . . . . 0.0 110.929 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -80.32 92.39 5.77 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.008 0.923 . . . . 0.0 109.356 170.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 6' ' ' ILE . 71.1 mt -80.04 95.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 m -82.75 141.32 32.47 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.519 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.682 ' HA ' HD13 ' A' ' 4' ' ' ILE . 75.5 mt -111.98 160.85 17.06 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.141 0.976 . . . . 0.0 110.069 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.4 p -76.31 -15.81 59.91 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.205 1.002 . . . . 0.0 111.886 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.39 61.62 6.72 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 122.078 0.942 . . . . 0.0 110.244 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.3 m -90.12 66.41 6.71 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.768 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -154.25 -56.43 0.11 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.882 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.57 -19.89 66.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -170.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.7 63.15 4.44 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.491 0.494 . . . . 0.0 112.457 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.9 mtt -48.7 149.55 1.7 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.28 1.432 . . . . 0.0 112.821 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.7 p -66.08 148.6 51.56 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.024 0.93 . . . . 0.0 111.926 -174.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 p -89.05 105.3 17.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.655 0.782 . . . . 0.0 110.223 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -138.39 138.23 38.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.471 0.708 . . . . 0.0 111.193 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.4 m -103.31 98.91 8.75 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.1 0.96 . . . . 0.0 109.552 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -83.98 116.08 22.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.465 1.106 . . . . 0.0 109.683 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.3 p -137.42 -75.79 0.41 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.365 0.666 . . . . 0.0 112.514 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -91.47 18.66 6.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -164.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t 61.86 90.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.369 1.068 . . . . 0.0 109.485 -170.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -163.0 155.68 18.89 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.563 0.745 . . . . 0.0 110.347 -171.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.8 t70 67.17 -80.56 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.471 1.509 . . . . 0.0 112.129 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.5 t -154.28 69.99 0.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.295 0.569 . . . . 0.0 110.006 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -108.74 104.74 55.47 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.485 0.714 . . . . 0.0 109.358 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.79 152.34 42.93 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.765 2.31 . . . . 0.0 112.221 173.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.46 -37.91 51.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.928 0.891 . . . . 0.0 111.612 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.632 ' HB3' HG13 ' A' ' 81' ' ' VAL . 59.1 m-85 -62.91 -39.48 94.64 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.126 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -74.73 -29.69 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.127 0.971 . . . . 0.0 110.587 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -41.12 91.87 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 22.1 t70 -56.92 -49.23 76.24 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.297 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.481 HG23 HG22 ' A' ' 78' ' ' VAL . 61.1 mt -57.27 -46.26 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 124.148 0.905 . . . . 0.0 110.278 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.74 -36.91 82.37 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.719 0.808 . . . . 0.0 111.856 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -77.49 -13.36 59.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.405 0.682 . . . . 0.0 111.536 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 44' ' ' ASP . 96.9 t -71.0 125.9 30.27 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -61.97 92.11 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.109 1.364 . . . . 0.0 111.367 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.52 -52.13 0.38 Allowed Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.098 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.98 120.88 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.53 0.732 . . . . 0.0 110.985 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -95.55 -50.86 4.79 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.373 0.669 . . . . 0.0 110.074 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.3 t -143.06 152.68 42.14 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.79 0.436 . . . . 0.0 111.286 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.422 HG12 HG13 ' A' ' 63' ' ' VAL . 46.7 mt -125.2 94.59 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.773 1.229 . . . . 0.0 108.615 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -96.18 100.11 11.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.893 -0.504 . . . . 0.0 110.088 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.33 129.71 35.83 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 p -161.59 141.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.445 0.698 . . . . 0.0 111.086 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 65.08 -73.25 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.976 1.71 . . . . 0.0 113.594 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -155.16 8.84 0.29 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.78 0.432 . . . . 0.0 111.166 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -142.52 165.97 25.96 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.1 0.56 . . . . 0.0 110.213 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.59 102.27 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 15' ' ' MET . 19.3 p -81.98 89.07 6.37 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.422 HG13 HG12 ' A' ' 54' ' ' ILE . 43.8 t -89.27 116.04 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.244 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 4.1 p30 -99.75 163.72 12.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.941 0.496 . . . . 0.0 111.293 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -136.37 173.07 12.1 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.342 -175.348 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.07 125.06 32.45 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 166.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -54.68 -21.18 9.95 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.715 1.206 . . . . 0.0 113.347 -167.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -51.76 -47.9 63.95 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.598 1.159 . . . . 0.0 112.159 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.09 130.54 35.52 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.61 0.764 . . . . 0.0 111.389 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -84.94 155.94 21.41 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.103 0.561 . . . . 0.0 109.56 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.41 ' HH2' HG12 ' A' ' 63' ' ' VAL . 49.4 m95 -76.58 -31.38 57.48 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -28.62 44.14 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -171.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -81.12 -39.59 25.36 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.889 0.876 . . . . 0.0 110.011 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.65 -36.04 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 124.93 1.292 . . . . 0.0 111.703 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 77.0 mt -50.12 -49.12 77.4 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 125.194 1.398 . . . . 0.0 114.59 -172.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.85 -31.16 88.04 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.885 1.723 . . . . 0.0 113.555 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -80.13 -40.18 27.96 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.862 0.865 . . . . 0.0 110.387 -176.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 45' ' ' ILE . 59.8 t -65.81 -48.91 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.22 -31.26 72.38 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.966 0.906 . . . . 0.0 111.339 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.67 -34.83 69.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.892 0.877 . . . . 0.0 111.119 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 41' ' ' PHE . 43.2 t -57.82 -46.99 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.914 0.886 . . . . 0.0 111.059 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.602 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 18.1 m-85 -87.69 19.56 3.38 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.693 0.797 . . . . 0.0 112.684 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -157.05 5.75 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 111.306 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.609 0.242 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.75 157.8 16.71 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.451 HG21 HG13 ' A' ' 6' ' ' ILE . 32.8 mt -76.93 129.85 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.983 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.4 mm -87.56 -48.02 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.935 0.894 . . . . 0.0 109.849 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 p -142.25 128.73 20.15 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.369 0.667 . . . . 0.0 109.673 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.451 HG13 HG21 ' A' ' 3' ' ' ILE . 3.8 mp -90.53 86.92 2.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.552 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 97.5 p . . . . . 0 N--CA 1.484 1.266 0 C-N-CA 125.531 1.533 . . . . 0.0 113.901 171.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.602 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 76.9 m-20 -102.82 8.79 39.25 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.161 0.584 . . . . 0.0 112.191 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 t -159.89 95.07 1.16 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.545 0.738 . . . . 0.0 110.135 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.1 mtp -82.65 125.77 31.57 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 121.713 -0.617 . . . . 0.0 111.802 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 7' ' ' SER . 23.0 ttmm -79.92 89.73 5.31 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.743 1.217 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.494 HD12 HG21 ' A' ' 63' ' ' VAL . 70.9 mt -85.6 95.63 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 174.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 60' ' ' PHE . 49.3 m -77.06 124.16 27.4 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.265 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.3 mt -87.55 164.52 16.06 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.118 0.485 . . . . 0.0 110.785 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -76.02 -19.89 58.28 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.872 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -96.73 101.57 13.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 109.664 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.778 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 29.3 t -79.41 107.94 12.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.536 0.734 . . . . 0.0 109.291 173.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 46.08 -154.94 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.712 1.605 . . . . 0.0 113.326 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.22 40.88 32.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.137 0.975 . . . . 0.0 112.078 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.79 -32.29 1.45 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.804 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.8 mmt -90.34 101.91 14.64 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.547 0.739 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.7 m -80.11 166.82 21.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.016 0.926 . . . . 0.0 111.057 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 67.8 p -80.87 74.35 7.85 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.937 0.895 . . . . 0.0 109.784 170.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -87.15 153.99 21.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.584 1.154 . . . . 0.0 110.387 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -128.54 101.25 6.09 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.453 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 37.4 m-85 -88.01 119.62 28.56 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.2 p -118.19 -62.44 1.54 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.52 0.6 . . . . 0.0 112.132 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.65 26.97 7.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -157.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.459 ' H ' HD13 ' A' ' 46' ' ' LEU . 87.5 t 62.11 83.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -166.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.76 -77.21 0.26 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.567 -162.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -169.31 -77.2 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.02 0.373 . . . . 0.0 111.337 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 m -89.15 68.48 8.18 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.089 0.956 . . . . 0.0 110.727 -171.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.444 HE22 HD11 ' A' ' 46' ' ' LEU . 4.1 pt20 -151.65 154.22 32.91 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.594 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.488 ' HB2' ' HB2' ' A' ' 41' ' ' PHE . 21.5 Cg_exo -66.2 150.89 84.68 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 122.669 2.246 . . . . 0.0 112.215 169.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.02 -23.76 63.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.865 0.866 . . . . 0.0 111.389 171.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.591 ' HB3' HG13 ' A' ' 81' ' ' VAL . 25.3 m-85 -46.97 -51.4 17.16 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.374 1.47 . . . . 0.0 110.82 170.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.1 mm -72.62 -29.25 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.625 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.478 HD22 HD12 ' A' ' 46' ' ' LEU . 14.0 m120 -67.97 -32.94 73.71 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.362 0.665 . . . . 0.0 111.945 -175.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -59.08 -46.8 87.35 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.492 0.495 . . . . 0.0 110.22 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.8 mt -66.07 -38.75 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.609 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.478 HD12 HD22 ' A' ' 43' ' ' ASN . 76.7 mt -60.71 -39.53 88.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.36 0.664 . . . . 0.0 111.709 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -85.62 4.13 37.69 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.267 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.2 t -78.84 123.53 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 169.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.13 130.39 34.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.571 0.748 . . . . 0.0 110.931 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.63 -32.67 7.3 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.644 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.37 109.36 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 24.3 ttmm -78.94 -55.24 5.29 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.427 0.691 . . . . 0.0 110.568 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.1 t -158.88 157.29 31.19 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.567 0.698 . . . . 0.0 110.716 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 67.6 mt -114.4 87.26 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.442 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 58.3 t80 -84.26 90.75 7.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.546 0.689 . . . . 0.0 109.841 -175.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -80.75 117.37 21.36 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 2.5 p -140.97 125.25 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.129 0.422 . . . . 0.0 110.556 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 62.84 -71.98 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.446 1.498 . . . . 0.0 110.59 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.778 ' HB3' ' HA ' ' A' ' 22' ' ' SER . 2.0 p30 -148.46 -33.08 0.24 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.849 1.259 . . . . 0.0 110.08 172.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 29.0 p90 -83.86 129.31 34.93 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -174.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.26 113.78 39.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -176.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 10.9 m -82.37 81.84 8.07 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.643 0.777 . . . . 0.0 109.64 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.494 HG21 HD12 ' A' ' 17' ' ' ILE . 48.7 t -78.85 92.89 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -82.41 151.2 26.71 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.265 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.602 ' HE2' ' HA ' ' A' ' 13' ' ' ASN . 39.0 pttt -137.17 -178.2 5.1 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.746 -173.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.84 140.88 30.85 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.95 -38.57 62.16 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.708 0.803 . . . . 0.0 112.163 -169.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.52 -32.62 72.7 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.702 0.801 . . . . 0.0 112.956 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.497 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . -56.31 111.33 0.94 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.936 0.894 . . . . 0.0 111.945 -175.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.512 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 15.8 m120 -82.47 126.4 32.19 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -70.59 -13.99 62.31 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.821 0.448 . . . . 0.0 112.101 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 70' ' ' ASN . 12.6 pt-20 -60.65 -28.4 68.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.302 0.641 . . . . 0.0 111.549 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.2 t -96.49 -40.68 8.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.761 0.824 . . . . 0.0 111.307 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.6 t -66.1 -47.23 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.094 0.958 . . . . 0.0 111.659 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.84 -43.33 97.59 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.858 -171.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.12 -39.51 20.49 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.732 2.288 . . . . 0.0 113.742 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -75.59 -41.32 54.92 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.036 0.534 . . . . 0.0 111.391 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.421 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 76.0 t -60.01 -55.52 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.317 0.647 . . . . 0.0 110.643 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -60.12 -39.11 85.08 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.035 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.59 -33.12 72.27 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.53 0.732 . . . . 0.0 111.655 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 41' ' ' PHE . 8.2 t -58.85 -48.56 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.295 0.638 . . . . 0.0 110.88 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -74.44 -30.48 61.91 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.932 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -107.0 20.39 19.11 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 81' ' ' VAL . 4.5 pp . . . . . 0 N--CA 1.493 1.698 0 O-C-N 122.176 -0.328 . . . . 0.0 111.417 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.488 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -122.76 179.31 4.67 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.607 0.763 . . . . 0.0 109.969 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.527 HD12 ' HG2' ' A' ' 79' ' ' GLU . 27.6 mt -71.92 104.11 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.1 mm -84.23 -48.73 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.185 0.594 . . . . 0.0 109.808 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.1 p -155.81 125.99 6.63 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.017 0.527 . . . . 0.0 110.243 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.92 153.01 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.611 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 47.6 t . . . . . 0 N--CA 1.48 1.033 0 C-N-CA 123.141 0.576 . . . . 0.0 112.369 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 42.6 m170 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.0 m120 72.63 -61.4 0.5 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.136 1.774 . . . . 0.0 112.237 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.448 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 6.7 t -140.92 136.75 32.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.996 0.426 . . . . 0.0 111.201 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.448 ' O ' ' HA ' ' A' ' 62' ' ' SER . 6.7 ptp -104.49 153.35 21.24 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.533 174.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 32.2 ttmt -95.47 125.01 39.78 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 171.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.21 97.1 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.1 m -70.37 113.0 7.09 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.298 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 86.9 mt -81.71 -178.67 7.07 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.029 0.532 . . . . 0.0 111.081 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.434 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 7.4 m -73.63 0.8 11.68 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.203 0.601 . . . . 0.0 111.537 172.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.94 130.72 48.13 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.199 1.4 . . . . 0.0 110.121 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -61.98 -30.58 71.04 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.113 1.365 . . . . 0.0 112.327 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.575 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 44.4 ttt85 103.9 132.96 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 129.067 2.947 . . . . 0.0 109.186 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.581 ' HA ' ' SD ' ' A' ' 58' ' ' MET . 28.4 tt0 80.62 -4.53 1.79 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.064 1.746 . . . . 0.0 111.788 175.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.18 -33.73 53.4 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 58' ' ' MET . 64.4 mtt -107.42 -179.6 3.97 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.268 1.027 . . . . 0.0 109.635 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 t -124.56 179.2 5.05 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.297 0.639 . . . . 0.0 111.276 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 33.9 p -89.43 132.93 34.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.667 1.187 . . . . 0.0 110.709 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -155.57 158.19 38.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.438 ' HB ' ' HD1' ' A' ' 55' ' ' PHE . 5.7 t -129.17 102.68 6.57 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.709 0.766 . . . . 0.0 109.38 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.514 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 68.6 m-85 -83.11 109.39 17.11 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.7 p -113.17 -69.64 0.85 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.531 0.732 . . . . 0.0 111.145 -172.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -100.23 22.94 10.73 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.244 0.618 . . . . 0.0 112.106 -168.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.9 t 69.23 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 124.718 1.207 . . . . 0.0 112.509 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 66.26 90.3 0.09 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.028 1.731 . . . . 0.0 112.065 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -168.7 74.07 0.1 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 0.0 109.039 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.1 p 46.89 46.63 15.56 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.112 1.365 . . . . 0.0 112.508 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.07 125.04 17.85 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 123.992 0.917 . . . . 0.0 109.22 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.97 155.07 6.33 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 124.05 3.167 . . . . 0.0 114.412 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.5 -33.1 43.4 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.403 1.081 . . . . 0.0 112.519 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -60.87 -40.72 94.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.095 0.958 . . . . 0.0 111.479 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.1 mm -70.98 -27.6 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.787 0.835 . . . . 0.0 110.024 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.448 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -69.79 -34.75 74.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.293 0.637 . . . . 0.0 110.391 177.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -64.62 -43.64 93.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.538 0.735 . . . . 0.0 111.105 175.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.528 HG23 HG22 ' A' ' 78' ' ' VAL . 54.9 mt -60.22 -37.63 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.038 0.447 . . . . 0.0 110.376 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.69 -34.21 77.35 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.39 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -87.77 0.57 55.58 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.768 0.827 . . . . 0.0 112.551 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 44' ' ' ASP . 91.6 t -72.09 127.22 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.73 132.57 53.68 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.091 0.956 . . . . 0.0 111.358 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.23 -47.4 1.11 Allowed Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.617 -173.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.72 135.88 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 124.305 1.042 . . . . 0.0 112.243 -171.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -113.21 -47.03 3.04 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.811 1.244 . . . . 0.0 110.09 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 12.6 m -146.35 157.68 43.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.239 0.542 . . . . 0.0 111.007 -174.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 82.0 mt -123.09 82.68 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 173.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.438 ' HD1' ' HB ' ' A' ' 30' ' ' THR . 32.2 t80 -82.98 88.04 6.86 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 9.6 t-160 -84.5 87.95 7.28 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 p -92.62 105.8 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.712 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.581 ' SD ' ' HA ' ' A' ' 24' ' ' GLU . 44.5 tpp 65.45 -91.19 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.916 1.287 . . . . 0.0 111.276 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.575 ' HB3' ' HA ' ' A' ' 23' ' ' ARG . 6.7 p-10 -116.2 -7.36 11.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.734 0.814 . . . . 0.0 111.933 -170.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -133.61 136.78 45.07 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.071 0.548 . . . . 0.0 111.011 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 56' ' ' HIS . 43.5 mt -94.06 106.65 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.787 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 15' ' ' MET . 10.7 t -81.99 90.98 6.53 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 172.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.82 98.18 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.16 0.584 . . . . 0.0 109.647 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 53' ' ' SER . 3.2 m-20 -79.78 150.12 30.85 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.505 0.722 . . . . 0.0 110.567 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -152.99 -159.49 1.01 Allowed 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.717 0.807 . . . . 0.0 109.091 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -63.11 -175.88 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.147 0.979 . . . . 0.0 111.947 168.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -51.33 -43.45 61.75 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.966 0.906 . . . . 0.0 111.828 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -158.3 -46.72 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.434 0.694 . . . . 0.0 110.467 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 51.68 -97.05 0.05 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.995 0.918 . . . . 0.0 109.171 -169.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -158.73 127.53 5.41 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 160.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.436 ' CH2' ' HG2' ' A' ' 15' ' ' MET . 94.3 m95 -80.72 -13.52 58.92 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.979 -0.451 . . . . 0.0 110.295 171.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -50.99 -45.19 60.96 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.397 1.079 . . . . 0.0 111.854 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -75.64 -41.72 53.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.631 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.29 -50.78 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.917 0.887 . . . . 0.0 113.359 -166.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.36 -50.4 85.17 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-O 117.772 -1.109 . . . . 0.0 113.135 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -43.9 -41.0 11.98 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.867 2.378 . . . . 0.0 114.83 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.61 -46.45 26.02 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.939 0.496 . . . . 0.0 110.874 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.528 HG22 HG23 ' A' ' 45' ' ' ILE . 89.2 t -64.53 -52.85 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.661 0.784 . . . . 0.0 110.768 -175.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.527 ' HG2' HD12 ' A' ' 3' ' ' ILE . 49.5 mt-10 -58.9 -34.66 71.92 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.53 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.68 -34.04 72.36 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.878 0.871 . . . . 0.0 112.005 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.84 -42.13 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.672 0.789 . . . . 0.0 110.679 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -84.61 7.63 19.53 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.617 0.767 . . . . 0.0 112.927 173.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -133.28 52.97 2.04 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.191 0.996 . . . . 0.0 109.172 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.487 1.38 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.326 -178.644 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -88.7 41.01 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.367 0.667 . . . . 0.0 112.295 -173.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 17' ' ' ILE . 43.3 mt 53.79 103.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 124.57 1.148 . . . . 0.0 112.061 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.0 mm -82.66 -49.59 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.678 0.791 . . . . 0.0 110.677 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 t -149.3 148.17 29.22 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 120.88 0.371 . . . . 0.0 110.586 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.8 mm -96.01 106.86 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.481 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.475 0.824 0 C-N-CA 126.093 1.757 . . . . 0.0 115.537 168.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -64.95 -56.47 13.03 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 9.8 t -115.66 126.78 54.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.804 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.6 ' HE1' HD11 ' A' ' 75' ' ' LEU . 34.2 mtm -110.69 136.57 49.58 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.253 0.549 . . . . 0.0 110.857 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.506 ' NZ ' ' HB3' ' A' ' 60' ' ' PHE . 6.4 tmtm? -79.22 94.56 5.44 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.059 174.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 3' ' ' ILE . 58.3 mt -77.8 96.33 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 m -63.03 129.89 42.33 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.964 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.2 mt -116.15 149.18 39.47 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -75.37 -13.75 60.42 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.06 0.544 . . . . 0.0 110.54 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -92.05 63.08 4.34 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.564 1.146 . . . . 0.0 108.712 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.53 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 26.5 m -78.43 -172.93 3.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.611 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 72.39 171.63 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.562 1.145 . . . . 0.0 110.398 -172.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 68.36 -75.84 0.06 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.309 1.443 . . . . 0.0 111.966 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.7 -25.2 0.21 Allowed Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.009 -175.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 43.5 tpp 41.56 66.46 0.69 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.579 1.552 . . . . 0.0 111.444 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.5 p 48.44 100.57 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.976 1.71 . . . . 0.0 112.883 -171.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.5 p -88.48 70.75 8.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.823 0.821 . . . . 0.0 108.985 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.64 168.52 11.68 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.039 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.487 ' HG1' ' HD1' ' A' ' 55' ' ' PHE . 7.4 m -126.36 97.11 4.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.283 -1.326 . . . . 0.0 107.864 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.491 ' HB3' HD11 ' A' ' 46' ' ' LEU . 44.0 m-85 -83.25 98.43 9.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.933 0.893 . . . . 0.0 108.842 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.447 HG23 HG22 ' A' ' 30' ' ' THR . 28.6 p -124.34 -64.47 1.12 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.733 0.813 . . . . 0.0 110.102 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -79.88 -4.09 50.77 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -168.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 t 63.88 164.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 C-N-CA 125.161 1.384 . . . . 0.0 110.599 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 65.54 96.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.285 1.034 . . . . 0.0 110.892 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -152.99 -74.95 0.13 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.6 t -165.62 23.44 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.495 0.718 . . . . 0.0 109.46 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.536 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -107.56 140.95 22.04 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.141 0.577 . . . . 0.0 109.668 -177.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.22 148.42 3.13 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.934 3.089 . . . . 0.0 114.563 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.06 -32.96 62.31 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.996 0.918 . . . . 0.0 110.714 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.619 ' HB3' HG13 ' A' ' 81' ' ' VAL . 82.3 m-85 -52.69 -48.65 66.42 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.704 1.201 . . . . 0.0 111.037 172.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -71.42 -31.05 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.254 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.536 ' ND2' ' HG2' ' A' ' 38' ' ' GLN . 0.9 OUTLIER -67.81 -37.71 82.33 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.441 ' O ' HG23 ' A' ' 48' ' ' VAL . 25.0 t70 -65.1 -41.82 94.58 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.635 0.774 . . . . 0.0 110.1 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.462 HD11 HG21 ' A' ' 81' ' ' VAL . 64.3 mt -57.26 -47.32 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 123.891 0.744 . . . . 0.0 109.831 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 31' ' ' TYR . 88.8 mt -60.47 -36.92 79.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.212 0.605 . . . . 0.0 111.178 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.92 -8.93 59.52 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.6 0.76 . . . . 0.0 112.094 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 44' ' ' ASP . 97.2 t -65.17 107.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 171.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.56 107.19 0.31 Allowed 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.983 0.802 . . . . 0.0 110.398 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.5 -45.38 0.86 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.183 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.517 HG13 HG13 ' A' ' 63' ' ' VAL . 40.2 t -60.55 -40.51 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 125.085 1.354 . . . . 0.0 113.655 -171.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 38.5 ttmt 64.13 -72.25 0.06 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.389 1.876 . . . . 0.0 111.587 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 p -144.95 156.33 43.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.157 0.583 . . . . 0.0 111.156 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.1 mt -131.64 131.48 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.463 1.105 . . . . 0.0 108.245 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.487 ' HD1' ' HG1' ' A' ' 30' ' ' THR . 67.3 t80 -118.14 104.77 11.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -96.62 128.08 43.22 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 p -163.9 151.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 56.6 tpp 68.46 -69.77 0.14 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.367 1.467 . . . . 0.0 110.692 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.53 ' HB3' ' HA ' ' A' ' 22' ' ' SER . 8.7 p-10 -148.16 -36.41 0.2 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.591 1.157 . . . . 0.0 110.401 173.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.506 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . 55.3 p90 -87.47 149.69 24.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -158.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 66.8 mt -98.77 97.17 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 113.616 -1.629 . . . . 0.0 107.921 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.1 t -83.94 86.97 7.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.116 0.566 . . . . 0.0 109.625 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.517 HG13 HG13 ' A' ' 51' ' ' VAL . 44.2 t -80.87 103.55 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 36.3 t70 -95.01 95.53 8.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.971 0.908 . . . . 0.0 109.875 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.613 ' HD2' ' HB3' ' A' ' 69' ' ' ALA . 17.3 pttp -86.05 -172.17 3.94 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.904 0.881 . . . . 0.0 112.359 -175.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.45 167.56 1.88 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.768 0.827 . . . . 0.0 111.45 167.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -51.25 -68.76 0.14 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.219 1.007 . . . . 0.0 111.496 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -94.35 -57.23 2.56 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.35 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.613 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . 40.39 -157.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.309 1.443 . . . . 0.0 113.578 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -141.68 108.59 5.42 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.478 0.711 . . . . 0.0 109.477 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -61.18 -32.86 72.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.038 0.535 . . . . 0.0 110.041 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -62.91 -22.04 66.46 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.977 0.911 . . . . 0.0 111.614 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.3 m -92.36 -44.86 8.48 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.619 0.767 . . . . 0.0 110.962 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.3 t -72.69 -51.6 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.834 0.854 . . . . 0.0 112.398 -172.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.6 HD11 ' HE1' ' A' ' 15' ' ' MET . 91.3 mt -56.44 -41.34 90.68 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-O 117.368 -1.301 . . . . 0.0 114.389 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -40.33 -41.83 3.5 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.067 2.511 . . . . 0.0 114.596 170.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 36.6 mtpt -75.92 -43.04 47.01 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.683 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.08 -50.18 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.261 0.624 . . . . 0.0 110.042 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.447 ' HG2' HD12 ' A' ' 3' ' ' ILE . 42.9 mt-10 -57.21 -44.18 83.45 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.342 1.057 . . . . 0.0 110.968 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.08 67.76 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.48 1.112 . . . . 0.0 112.703 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 41' ' ' PHE . 52.6 t -61.55 -49.4 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.267 0.627 . . . . 0.0 110.977 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -78.54 -27.71 45.99 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.967 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.46 71.34 4.35 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.476 0.846 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.849 173.522 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.586 ' HG2' HD13 ' A' ' 19' ' ' LEU . 3.3 mpp? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.069 0.461 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -116.81 -175.57 2.8 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.83 1.252 . . . . 0.0 109.766 174.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.6 mt -102.49 109.66 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 170.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mm -84.19 -46.02 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.0 m -146.53 127.27 14.32 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.172 0.589 . . . . 0.0 110.272 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -86.78 75.35 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 165.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 CA--C 1.541 0.608 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.352 -178.841 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -59.21 -36.81 76.05 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.904 0.881 . . . . 0.0 109.542 163.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -123.78 159.25 29.92 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.796 0.839 . . . . 0.0 110.966 -177.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 37.7 mtm -136.45 143.06 43.68 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.553 1.141 . . . . 0.0 108.569 169.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -95.25 116.68 29.07 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.411 0.685 . . . . 0.0 109.597 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 64.6 mt -90.58 96.11 6.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 172.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 m -66.29 120.53 13.44 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.476 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.586 HD13 ' HG2' ' A' ' 1' ' ' MET . 77.0 mt -87.8 -160.56 0.63 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.216 0.607 . . . . 0.0 110.238 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -68.97 8.26 0.56 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 66.33 106.62 0.04 OUTLIER 'General case' 0 C--N 1.362 1.115 0 C-N-CA 125.352 1.461 . . . . 0.0 110.742 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -140.49 174.24 10.71 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.364 0.666 . . . . 0.0 110.827 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -56.48 133.04 52.96 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.222 0.609 . . . . 0.0 109.711 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -54.37 91.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.807 1.317 . . . . 0.0 112.519 -170.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.459 ' N ' ' HA ' ' A' ' 58' ' ' MET . . . -164.65 -73.2 0.03 OUTLIER Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 60.4 tpp 51.29 21.6 1.18 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.304 1.442 . . . . 0.0 112.381 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m 67.61 135.17 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.503 1.521 . . . . 0.0 110.513 -168.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 p -102.32 114.46 28.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.009 0.923 . . . . 0.0 108.746 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' A' ' 56' ' ' HIS . 15.7 m-20 -138.21 158.57 44.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.198 0.999 . . . . 0.0 110.194 -170.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 t -151.21 93.96 1.98 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -95.56 92.34 6.59 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.876 0.87 . . . . 0.0 110.566 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 53' ' ' SER . 81.3 p -92.31 -23.47 19.26 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.219 0.533 . . . . 0.0 109.585 174.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.649 ' HG2' ' H ' ' A' ' 34' ' ' VAL . 20.6 ttmm -106.58 -161.91 0.82 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.78 1.232 . . . . 0.0 108.272 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.649 ' H ' ' HG2' ' A' ' 33' ' ' LYS . 58.4 t -149.01 83.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 105.645 -1.984 . . . . 0.0 105.645 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -164.74 -138.0 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.694 -170.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 64.01 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.359 1.019 0 C-N-CA 124.891 1.276 . . . . 0.0 110.527 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.1 p -172.9 20.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.11 1.364 . . . . 0.0 109.386 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.521 ' HG3' ' ND2' ' A' ' 43' ' ' ASN . 12.9 pt20 -65.1 142.86 98.73 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.028 0.931 . . . . 0.0 110.369 -176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.82 141.18 28.92 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.597 2.865 . . . . 0.0 113.347 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -58.97 -31.81 69.07 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.981 0.912 . . . . 0.0 111.74 -178.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.523 ' HB3' HG13 ' A' ' 81' ' ' VAL . 62.5 m-85 -65.4 -36.49 84.13 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.268 0.627 . . . . 0.0 110.911 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.3 mm -73.66 -27.1 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.525 0.73 . . . . 0.0 110.136 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.521 ' ND2' ' HG3' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -62.27 -41.79 98.77 Favored 'General case' 0 C--N 1.368 1.392 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.265 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -57.72 -46.12 84.83 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.502 1.126 . . . . 0.0 111.418 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.539 HG23 HG22 ' A' ' 78' ' ' VAL . 57.4 mt -55.42 -49.27 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 123.801 0.688 . . . . 0.0 110.064 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.4 mt -65.15 -32.69 74.51 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.51 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -72.04 -18.94 61.91 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.764 0.826 . . . . 0.0 112.278 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.05 117.94 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -57.05 99.99 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.229 0.956 . . . . 0.0 109.168 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.52 -56.09 0.48 Allowed Glycine 0 C--O 1.225 -0.437 0 N-CA-C 110.071 -1.211 . . . . 0.0 110.071 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.73 127.71 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.844 0.858 . . . . 0.0 111.719 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.532 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 8.0 ttpm? -92.2 -46.56 7.68 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.063 0.945 . . . . 0.0 108.48 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 32' ' ' THR . 20.1 p -166.43 178.89 5.86 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 123.702 0.626 . . . . 0.0 111.599 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.4 mt -131.63 111.25 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.178 0.991 . . . . 0.0 109.377 176.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -90.35 125.79 35.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 169.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 29' ' ' ASP . 11.1 t-160 -132.78 123.38 26.06 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.61 0.764 . . . . 0.0 109.233 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -168.03 161.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 123.164 0.29 . . . . 0.0 110.458 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.459 ' HA ' ' N ' ' A' ' 25' ' ' GLY 0.27 27.2 ptm 56.64 -61.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 128.412 2.685 . . . . 0.0 114.973 175.251 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -150.88 -31.54 0.17 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.584 0.753 . . . . 0.0 111.0 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -95.51 155.38 16.77 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.337 0.589 . . . . 0.0 112.205 -167.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 42.7 mt -108.89 94.2 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 t -82.82 88.96 6.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.7 t -80.15 122.2 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.27 156.47 23.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.896 0.478 . . . . 0.0 110.006 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.532 ' HA ' ' H ' ' A' ' 52' ' ' LYS . 16.8 pttm -132.11 -162.09 1.2 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.109 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.94 165.64 2.32 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.535 0.734 . . . . 0.0 111.403 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -39.2 -44.82 1.26 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.539 1.536 . . . . 0.0 114.692 -164.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -133.36 -59.04 0.88 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 173.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . . . 49.91 -163.08 0.05 OUTLIER 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 125.782 1.633 . . . . 0.0 113.79 171.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -131.39 120.85 23.65 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.159 0.584 . . . . 0.0 111.536 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -73.81 -10.78 60.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.302 0.641 . . . . 0.0 110.935 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -61.93 -26.92 68.48 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.76 0.824 . . . . 0.0 110.575 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 m -91.84 -43.91 9.24 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.506 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.9 t -80.3 -50.21 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.631 0.772 . . . . 0.0 112.793 -172.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.25 -46.98 83.45 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-O 117.29 -1.338 . . . . 0.0 113.093 -171.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.19 -38.52 81.35 Favored 'Trans proline' 0 C--N 1.4 3.278 0 C-N-CA 122.232 1.955 . . . . 0.0 112.979 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.26 -40.56 70.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.067 0.547 . . . . 0.0 111.337 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 45' ' ' ILE . 41.4 t -65.47 -40.14 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.022 0.529 . . . . 0.0 109.97 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.15 -45.5 87.29 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.804 1.242 . . . . 0.0 110.463 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.0 -31.73 51.95 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.642 1.177 . . . . 0.0 112.708 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.523 HG13 ' HB3' ' A' ' 41' ' ' PHE . 56.0 t -65.77 -51.68 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 124.068 0.947 . . . . 0.0 111.279 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -72.66 -25.53 61.3 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -79.67 -69.76 0.56 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.375 0.27 . . . . 0.0 111.321 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 N--CA 1.495 1.824 0 C-N-CA 125.976 1.71 . . . . 0.0 111.813 -175.07 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -160.99 167.28 26.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.636 0.774 . . . . 0.0 109.981 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.3 mt -65.21 96.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 20' ' ' SER . 33.3 mm -93.26 -40.98 12.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 C-N-CA 123.889 0.876 . . . . 0.0 109.786 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.589 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 10.9 t -150.5 158.74 44.49 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.428 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -117.06 134.13 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.118 0.967 . . . . 0.0 109.087 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 7.3 m . . . . . 0 C--O 1.245 0.84 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.7 m170 . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 17.0 m120 76.82 -66.42 0.25 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.988 1.715 . . . . 0.0 110.363 -176.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 10.0 t -105.15 135.47 46.44 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.847 0.356 . . . . 0.0 111.573 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 62' ' ' SER . 13.0 ptp -133.24 149.29 51.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.723 169.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 84.3 tttt -91.06 100.26 13.14 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.534 1.134 . . . . 0.0 110.58 -175.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.86 111.15 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.589 ' HB ' ' HB3' ' A' ' 5' ' ' SER . 86.2 m -75.35 131.27 40.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.601 0.76 . . . . 0.0 110.98 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.5 mt -102.35 166.56 10.5 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.764 0.825 . . . . 0.0 109.239 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.516 ' HB2' HG13 ' A' ' 4' ' ' ILE . 29.4 t -76.19 -26.77 56.5 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.702 0.401 . . . . 0.0 111.501 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -82.0 76.67 8.88 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.28 0.562 . . . . 0.0 109.976 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -87.5 166.53 14.7 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.996 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 68.92 173.44 0.29 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.506 1.122 . . . . 0.0 110.586 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 57.05 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.702 1.201 . . . . 0.0 111.061 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.72 143.43 5.71 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.8 mtt -92.35 -165.93 1.44 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.525 0.73 . . . . 0.0 109.7 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.1 m -90.65 153.27 20.43 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.039 0.447 . . . . 0.0 110.048 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 p -87.09 104.71 16.6 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.26 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -123.55 97.5 5.41 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.88 0.872 . . . . 0.0 110.49 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 m -89.45 83.49 6.37 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.631 ' HB3' HD11 ' A' ' 46' ' ' LEU . 25.0 m-85 -81.87 110.46 17.18 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.477 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.3 p -121.55 -39.91 2.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.969 0.908 . . . . 0.0 110.472 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.658 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -141.14 40.0 1.78 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.883 -176.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.7 t 65.86 126.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 125.003 1.321 . . . . 0.0 113.133 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -93.69 -88.31 0.23 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 171.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 t70 169.51 -42.3 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.362 1.065 . . . . 0.0 109.294 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.5 p -63.42 -38.27 90.51 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.412 1.085 . . . . 0.0 111.806 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -60.51 141.9 91.44 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.945 0.898 . . . . 0.0 111.598 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.93 154.47 7.11 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.225 2.617 . . . . 0.0 113.815 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.14 67.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.973 0.909 . . . . 0.0 111.095 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.497 ' HB3' HG13 ' A' ' 81' ' ' VAL . 55.3 m-85 -62.3 -34.31 76.36 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.217 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.605 HD13 HG11 ' A' ' 81' ' ' VAL . 13.0 mm -79.76 -23.17 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 122.906 0.482 . . . . 0.0 110.52 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -68.27 -36.26 79.14 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.87 -41.84 92.4 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.71 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.586 HG22 HG11 ' A' ' 51' ' ' VAL . 54.3 mt -56.45 -46.6 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 123.994 0.809 . . . . 0.0 110.416 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 31' ' ' TYR . 96.7 mt -64.04 -36.4 83.88 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -79.34 -1.93 39.16 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.163 0.585 . . . . 0.0 112.059 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.6 t -70.87 115.52 10.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 165.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -62.96 89.06 0.03 OUTLIER 'General case' 0 C--N 1.348 0.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.28 -52.48 0.25 Allowed Glycine 0 C--O 1.218 -0.872 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.056 -172.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.586 HG11 HG22 ' A' ' 45' ' ' ILE . 74.2 t -69.9 -40.83 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -168.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 19.6 ttmt 65.63 -72.69 0.07 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.857 1.663 . . . . 0.0 111.823 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 35.9 t -133.29 151.86 51.91 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.641 0.776 . . . . 0.0 111.24 -174.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 75.1 mt -129.68 107.01 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.469 1.508 . . . . 0.0 107.401 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 72.0 t80 -99.59 91.44 4.89 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -94.13 134.49 36.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.138 0.975 . . . . 0.0 109.649 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 p -171.02 153.32 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.433 0.693 . . . . 0.0 109.48 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.498 ' HG3' ' H ' ' A' ' 59' ' ' ASP 0.269 18.3 ptp 43.93 -84.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 126.698 1.999 . . . . 0.0 115.231 -175.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.498 ' H ' ' HG3' ' A' ' 58' ' ' MET . 9.5 p-10 -138.82 20.88 2.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.022 -1.049 . . . . 0.0 111.853 -172.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -147.54 167.37 24.68 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.443 HG23 HG23 ' A' ' 54' ' ' ILE . 68.4 mt -132.14 101.89 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.406 1.483 . . . . 0.0 108.118 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.517 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 68.4 m -82.78 94.65 7.68 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.764 0.426 . . . . 0.0 110.121 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.49 HG13 HG13 ' A' ' 51' ' ' VAL . 97.5 t -79.15 105.21 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 18.7 t0 -93.71 85.57 4.88 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.273 1.029 . . . . 0.0 109.966 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 13' ' ' ASN . 16.8 pttp -75.73 174.09 10.26 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.074 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -75.54 176.25 7.76 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.946 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -70.46 -66.02 0.66 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.521 0.328 . . . . 0.0 110.531 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -69.81 -44.22 70.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.021 0.528 . . . . 0.0 111.348 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.53 121.48 8.48 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.244 0.965 . . . . 0.0 110.476 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -94.94 154.9 16.98 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.752 0.821 . . . . 0.0 111.311 -168.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -62.88 -20.11 64.81 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.094 0.558 . . . . 0.0 112.459 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -70.07 -19.34 63.27 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.565 0.346 . . . . 0.0 111.311 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.2 m -95.28 -47.18 6.43 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.409 0.683 . . . . 0.0 110.469 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.504 HG13 HG22 ' A' ' 51' ' ' VAL . 93.5 t -70.32 -59.99 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.934 0.893 . . . . 0.0 112.364 -171.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.3 tt -56.78 -50.27 88.97 Favored Pre-proline 0 CA--C 1.57 1.725 0 CA-C-O 117.773 -1.108 . . . . 0.0 112.902 -171.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -59.2 -31.25 94.96 Favored 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.409 2.072 . . . . 0.0 112.894 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -71.9 -41.25 68.16 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.659 0.784 . . . . 0.0 111.227 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.64 -48.51 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.96 -38.38 85.72 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.228 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.92 -29.1 70.31 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.13 0.972 . . . . 0.0 111.844 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.605 HG11 HD13 ' A' ' 42' ' ' ILE . 38.0 t -68.32 -39.4 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.686 0.394 . . . . 0.0 110.991 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -70.9 -40.79 71.97 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.469 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.0 79.14 1.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 124.658 1.183 . . . . 0.0 111.854 -177.682 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.464 0.649 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 10.8 mtmp? -137.55 -175.72 4.16 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.258 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -92.27 93.83 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.605 HG13 ' HB3' ' A' ' 20' ' ' SER . 49.1 mm -90.41 -42.13 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.364 0.666 . . . . 0.0 110.027 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -142.84 156.29 44.92 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.15 0.98 . . . . 0.0 108.87 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -111.51 -75.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.462 0.705 . . . . 0.0 110.196 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.6 t . . . . . 0 N--CA 1.484 1.25 0 C-N-CA 124.813 1.245 . . . . 0.0 110.79 -176.858 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.2 m80 . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.19 -48.27 18.05 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -128.04 141.65 51.45 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.472 0.653 . . . . 0.0 111.863 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.609 ' SD ' HD21 ' A' ' 75' ' ' LEU . 13.2 ptp -130.63 148.79 52.47 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 108.765 167.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 59.3 mttp -94.42 158.26 15.64 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.319 0.648 . . . . 0.0 109.538 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.1 mt -132.66 94.87 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.1 m -60.11 109.46 0.97 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.767 0.827 . . . . 0.0 109.983 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.9 mt -79.38 -26.76 41.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.939 0.496 . . . . 0.0 111.625 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.605 ' HB3' HG13 ' A' ' 4' ' ' ILE . 54.5 p 98.82 -6.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 127.876 2.47 . . . . 0.0 112.849 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -89.86 62.94 5.88 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.139 0.427 . . . . 0.0 109.887 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.3 m -65.22 84.47 0.05 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.586 0.707 . . . . 0.0 111.024 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -104.73 5.23 33.21 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.324 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 66.74 -71.1 0.1 Allowed 'General case' 0 C--N 1.37 1.497 0 C-N-CA 125.823 1.649 . . . . 0.0 111.075 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.29 56.34 4.25 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.288 -0.414 . . . . 0.0 112.246 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.9 ttt -94.92 46.95 1.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 m 68.47 155.2 0.12 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 125.752 1.621 . . . . 0.0 111.997 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.1 p -135.27 78.87 1.75 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.85 1.26 . . . . 0.0 108.309 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -124.52 144.68 49.98 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.434 0.694 . . . . 0.0 111.329 -165.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -99.92 149.73 23.12 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.989 0.916 . . . . 0.0 109.978 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.541 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 59.5 m-85 -141.35 113.99 8.32 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.156 1.383 . . . . 0.0 107.782 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.4 p -136.71 -43.06 0.59 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.564 0.746 . . . . 0.0 110.262 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -106.61 32.76 4.28 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.983 0.913 . . . . 0.0 112.076 -164.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 43' ' ' ASN . 58.9 t 55.58 64.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 122.756 1.265 . . . . 0.0 109.194 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.3 135.21 42.57 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.481 -1.69 . . . . 0.0 111.321 -170.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -77.09 91.89 3.72 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 p -177.96 -61.83 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.685 1.194 . . . . 0.0 108.662 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.478 ' HG3' ' ND2' ' A' ' 43' ' ' ASN . 25.2 pt20 -60.08 149.69 73.56 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.904 1.282 . . . . 0.0 111.91 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.6 150.93 11.18 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.262 2.642 . . . . 0.0 112.542 168.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.87 -37.33 63.58 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 123.687 0.617 . . . . 0.0 111.253 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -55.69 -40.31 72.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.89 1.276 . . . . 0.0 111.937 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.4 mm -75.63 -28.96 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.435 0.694 . . . . 0.0 110.304 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.478 ' ND2' ' HG3' ' A' ' 38' ' ' GLN . 55.5 m-80 -70.86 -34.94 72.15 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -64.61 -34.89 79.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.071 0.548 . . . . 0.0 110.93 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.9 mt -60.55 -45.24 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 123.728 0.642 . . . . 0.0 110.091 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.2 -35.74 78.01 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.921 0.488 . . . . 0.0 111.883 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.58 -14.12 60.38 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.212 0.605 . . . . 0.0 111.647 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.39 109.77 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -59.12 104.64 0.26 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.041 0.838 . . . . 0.0 111.003 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 146.88 -45.3 0.78 Allowed Glycine 0 C--N 1.344 1.015 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.5 121.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.791 0.836 . . . . 0.0 109.897 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.438 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 26.2 ttpp -104.96 -32.58 8.69 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.84 0.856 . . . . 0.0 110.965 -172.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 t -151.99 161.62 42.35 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.73 0.412 . . . . 0.0 111.062 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 79.1 mt -148.02 116.84 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.658 1.583 . . . . 0.0 107.252 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -119.59 110.23 16.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.798 0.439 . . . . 0.0 110.083 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -95.16 119.94 34.52 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.29 147.81 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.074 0.55 . . . . 0.0 110.336 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 67.55 -68.46 0.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.529 1.532 . . . . 0.0 110.883 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.404 ' H ' ' H ' ' A' ' 60' ' ' PHE . 6.2 p-10 -160.06 -25.44 0.06 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.87 1.268 . . . . 0.0 110.234 169.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.404 ' H ' ' H ' ' A' ' 59' ' ' ASP . 45.7 p90 -81.27 143.11 32.51 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-O 120.922 0.391 . . . . 0.0 111.259 -170.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.16 103.18 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 15.0 t -83.32 89.25 6.98 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.6 t -77.48 126.13 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -120.21 149.4 42.32 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.275 1.03 . . . . 0.0 110.457 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HA ' ' H ' ' A' ' 52' ' ' LYS . 17.8 pttp -140.22 179.88 6.38 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.681 1.192 . . . . 0.0 109.441 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.9 167.04 22.51 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.828 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.11 -48.38 71.07 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.976 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.96 -32.88 74.57 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.507 -172.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.83 161.99 27.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.705 0.802 . . . . 0.0 111.933 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -118.25 146.23 44.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.679 0.792 . . . . 0.0 110.074 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.538 ' HB3' HD23 ' A' ' 75' ' ' LEU . 66.1 m95 -69.66 -17.14 63.48 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.048 0.539 . . . . 0.0 111.031 172.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.59 -24.81 67.76 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.969 0.908 . . . . 0.0 111.792 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.7 m -84.75 -45.3 12.53 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.019 0.928 . . . . 0.0 110.397 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.8 t -73.5 -60.92 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.068 -169.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.609 HD21 ' SD ' ' A' ' 15' ' ' MET . 3.9 mm? -49.32 -47.62 76.33 Favored Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -172.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -55.51 -33.85 87.69 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.078 1.852 . . . . 0.0 113.876 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -80.96 -41.98 21.99 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.696 0.798 . . . . 0.0 110.5 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.1 t -74.42 -31.77 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.331 1.052 . . . . 0.0 111.523 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.5 -41.35 80.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.872 0.869 . . . . 0.0 110.987 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.33 -32.34 71.15 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.045 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -63.11 -40.19 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.901 0.88 . . . . 0.0 111.663 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.665 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 27.2 m-85 -91.2 25.08 2.63 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -145.62 -58.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.055 0.455 . . . . 0.0 109.904 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.487 1.381 0 C-N-CA 125.397 1.479 . . . . 0.0 111.091 -174.38 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.644 0.259 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -167.27 179.35 5.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.78 0.832 . . . . 0.0 111.125 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.9 mt -72.41 115.84 13.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.107 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.2 mm -84.74 -45.65 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.3 p -154.65 133.44 12.19 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.12 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.7 mm -78.37 105.6 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 169.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.538 ' HB3' ' HG3' ' A' ' 16' ' ' LYS . 38.2 t -77.97 160.56 28.11 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 122.956 0.502 . . . . 0.0 110.804 -176.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -72.79 163.27 28.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.357 0.663 . . . . 0.0 111.607 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -154.27 144.17 15.47 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.709 0.804 . . . . 0.0 109.761 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.93 -11.6 8.81 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.465 2.11 . . . . 0.0 112.523 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -117.32 115.79 25.95 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -67.71 -19.83 65.2 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.85 0.86 . . . . 0.0 111.81 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.447 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 25.6 t-20 -66.59 -64.76 0.79 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.536 0.734 . . . . 0.0 110.618 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.4 t -106.84 126.9 52.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.532 0.333 . . . . 0.0 110.121 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -122.35 143.33 49.71 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.29 0.567 . . . . 0.0 110.457 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HG3' ' HB3' ' A' ' 7' ' ' SER . 20.3 ptmt -88.38 140.53 29.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.84 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.1 mt -130.0 114.93 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.499 1.12 . . . . 0.0 109.317 -172.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.8 m -71.66 119.96 16.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.645 0.778 . . . . 0.0 110.322 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.9 mt -87.41 169.88 11.86 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.222 0.609 . . . . 0.0 110.696 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 p -74.7 -26.72 60.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.399 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HB2' ' SD ' ' A' ' 26' ' ' MET . 24.5 mm-40 -84.2 128.42 34.55 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.267 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.6 p -153.37 166.8 31.51 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.216 0.606 . . . . 0.0 111.334 -174.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 71.04 156.13 0.15 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.875 1.67 . . . . 0.0 112.437 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 69.28 -75.97 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.803 1.641 . . . . 0.0 110.853 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.02 116.45 1.06 Allowed Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.535 -0.302 . . . . 0.0 112.505 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 21' ' ' GLU . 82.5 mtp -75.32 -167.59 0.67 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.302 1.041 . . . . 0.0 109.748 170.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.0 p -59.19 112.9 1.88 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.298 0.639 . . . . 0.0 110.991 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.1 p -94.59 84.87 4.36 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -144.78 141.74 29.44 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.828 0.851 . . . . 0.0 111.237 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.469 ' HG1' ' HD1' ' A' ' 55' ' ' PHE . 23.2 m -89.29 106.41 18.42 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -80.21 101.17 8.69 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -146.01 -33.7 0.32 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.948 0.499 . . . . 0.0 111.874 -171.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.427 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 46.9 pttt -88.85 4.87 46.26 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -169.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.4 t 65.02 126.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 125.448 1.499 . . . . 0.0 110.533 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 t70 72.01 47.34 0.31 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.927 1.291 . . . . 0.0 109.26 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' A' ' 33' ' ' LYS . 2.7 m-20 -84.31 47.91 1.41 Allowed 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.882 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.0 p 58.05 19.29 5.85 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.843 1.657 . . . . 0.0 113.249 -174.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.32 147.01 34.12 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 123.789 0.836 . . . . 0.0 109.966 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -52.43 155.19 10.15 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.739 2.959 . . . . 0.0 113.809 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.86 -31.35 49.29 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.253 1.021 . . . . 0.0 112.107 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -56.73 -44.98 82.19 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.216 1.006 . . . . 0.0 111.257 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.6 mm -71.55 -28.86 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.381 0.672 . . . . 0.0 109.958 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.417 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 28.8 m-80 -72.07 -32.93 67.52 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.91 0.484 . . . . 0.0 110.068 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 48' ' ' VAL . 28.0 t70 -63.43 -41.78 98.7 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 124.145 0.903 . . . . 0.0 109.8 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.0 mt -59.74 -44.84 94.69 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 O-C-N 124.267 0.979 . . . . 0.0 109.882 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.48 -36.68 74.12 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.132 0.573 . . . . 0.0 111.223 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 43' ' ' ASN . 96.2 mttt -79.45 -19.72 49.2 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.658 0.783 . . . . 0.0 112.09 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 44' ' ' ASP . 55.9 t -60.44 121.83 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.65 89.47 0.05 OUTLIER 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.353 1.033 . . . . 0.0 109.581 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.15 -32.07 0.45 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.184 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.89 131.4 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.476 0.71 . . . . 0.0 109.7 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -87.05 -52.05 5.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.331 0.652 . . . . 0.0 109.26 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.6 p -163.31 173.0 13.84 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.584 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.461 HG23 HG22 ' A' ' 63' ' ' VAL . 74.0 mt -132.03 101.04 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.469 ' HD1' ' HG1' ' A' ' 30' ' ' THR . 28.8 t80 -81.98 146.27 29.83 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -135.54 135.03 40.04 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.12 124.64 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.538 0.735 . . . . 0.0 110.241 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 45.6 ttm 55.78 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.263 1.425 . . . . 0.0 112.821 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -120.31 -39.32 2.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.131 0.572 . . . . 0.0 110.6 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -98.26 138.79 35.01 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.644 0.735 . . . . 0.0 110.807 -167.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 53.5 mt -85.61 163.78 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.801 173.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -143.44 86.31 1.89 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.461 HG22 HG23 ' A' ' 54' ' ' ILE . 40.7 t -80.01 114.63 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.27 131.15 34.32 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.097 0.959 . . . . 0.0 108.69 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 13' ' ' ASN . 21.5 pttp -101.72 -173.86 2.45 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 173.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -89.39 162.71 15.64 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -59.13 -48.19 82.51 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.295 0.638 . . . . 0.0 112.631 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -80.55 -33.8 35.94 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.36 0.664 . . . . 0.0 111.597 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.35 140.94 12.59 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.591 1.156 . . . . 0.0 112.666 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -110.24 130.47 55.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.799 0.84 . . . . 0.0 110.302 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -60.35 -18.32 49.25 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.448 0.699 . . . . 0.0 112.027 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -56.73 -35.31 68.44 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.537 0.735 . . . . 0.0 110.732 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 t -101.06 -42.59 6.33 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.012 0.525 . . . . 0.0 110.884 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.1 t -70.73 -45.87 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.312 1.045 . . . . 0.0 113.358 -170.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.6 tp -60.64 -43.74 93.22 Favored Pre-proline 0 N--CA 1.492 1.66 0 CA-C-O 117.568 -1.206 . . . . 0.0 112.65 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -46.45 -34.31 14.32 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.415 2.077 . . . . 0.0 114.38 170.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -75.1 -41.45 58.64 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.337 0.655 . . . . 0.0 111.118 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -65.02 -58.12 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-O 121.638 0.732 . . . . 0.0 109.237 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.67 -31.17 67.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.73 1.612 . . . . 0.0 112.26 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.14 55.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.383 1.073 . . . . 0.0 112.876 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.3 -49.54 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.203 0.601 . . . . 0.0 110.816 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -69.28 -25.22 64.15 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.351 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -122.49 77.16 1.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.726 0.81 . . . . 0.0 109.534 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -142.87 168.75 18.97 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.097 0.959 . . . . 0.0 108.565 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -68.38 98.07 0.8 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.23 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -82.68 104.93 13.3 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.92 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -136.31 155.82 49.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.093 0.957 . . . . 0.0 109.044 167.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -78.13 143.96 36.84 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.528 0.731 . . . . 0.0 110.068 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -123.72 119.76 30.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.044 0.938 . . . . 0.0 109.333 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -152.25 -48.5 0.11 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.388 0.675 . . . . 0.0 110.215 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 CA--C 1.561 1.374 0 O-C-N 124.763 1.289 . . . . 0.0 110.244 -172.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -145.28 144.45 30.78 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.452 0.701 . . . . 0.0 110.424 -175.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.5 mt -73.58 95.04 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.4 0.68 . . . . 0.0 109.728 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 mm -83.54 -35.51 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.698 0.799 . . . . 0.0 110.138 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.7 t -134.31 146.75 50.28 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.824 0.45 . . . . 0.0 111.123 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.422 HG23 ' HG2' ' A' ' 15' ' ' MET . 72.6 mt -128.76 133.95 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.775 1.63 . . . . 0.0 108.252 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.4 p -98.64 53.67 1.02 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.226 0.536 . . . . 0.0 111.285 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -103.2 -17.4 15.37 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.098 0.559 . . . . 0.0 112.388 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.408 ' HB ' ' HD3' ' A' ' 10' ' ' PRO . 18.2 m -89.21 -53.23 0.34 Allowed Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 123.721 0.809 . . . . 0.0 110.009 175.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD3' ' HB ' ' A' ' 9' ' ' THR . 64.7 Cg_endo -82.86 -10.69 10.42 Favored 'Trans proline' 0 C--N 1.395 2.991 0 C-N-CA 121.773 1.649 . . . . 0.0 113.288 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -145.65 -161.86 1.39 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -168.33 148.87 4.8 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.828 0.74 . . . . 0.0 109.736 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 69.64 20.29 7.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.553 1.141 . . . . 0.0 111.912 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 13.2 t -161.01 143.1 12.29 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.097 0.959 . . . . 0.0 108.832 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 62' ' ' SER . 57.7 mtm -115.68 110.76 19.61 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -75.74 85.89 2.75 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 165.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.2 mt -77.31 93.29 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.0 m -77.94 116.89 18.77 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.1 mt -84.88 -150.49 0.12 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 p -76.65 15.17 0.67 Allowed 'General case' 0 CA--C 1.558 1.269 0 O-C-N 121.93 -0.481 . . . . 0.0 112.114 173.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 42.4 mt-10 67.82 92.4 0.08 Allowed 'General case' 0 C--N 1.358 0.944 0 C-N-CA 125.903 1.681 . . . . 0.0 110.798 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -73.07 131.92 42.69 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 171.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -76.11 78.91 2.94 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.549 0.531 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 62.17 13.27 5.7 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.497 1.119 . . . . 0.0 111.874 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.12 -26.7 61.43 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.156 -173.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.0 mmt -80.46 107.13 13.01 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.5 p -75.12 154.54 37.74 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.579 0.352 . . . . 0.0 110.916 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.0 p -69.48 96.06 0.88 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.241 0.543 . . . . 0.0 110.815 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -119.2 111.06 17.76 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.258 1.023 . . . . 0.0 109.565 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.3 m -91.1 97.23 11.03 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -81.98 103.78 11.87 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.0 p -99.47 49.81 0.94 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.753 1.221 . . . . 0.0 109.307 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.463 ' HA ' HD13 ' A' ' 46' ' ' LEU 0.298 0.9 OUTLIER 56.72 99.55 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 127.427 2.291 . . . . 0.0 113.727 179.372 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t 50.54 80.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 125.53 1.532 . . . . 0.0 111.215 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -151.78 -50.08 0.11 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -164.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -105.07 -96.64 0.33 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.856 0.462 . . . . 0.0 110.783 -169.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.6 t -161.81 87.54 0.67 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.1 pm0 -139.77 144.36 38.56 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.627 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -53.34 150.65 25.42 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.837 2.358 . . . . 0.0 112.326 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.33 -34.43 57.41 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.581 0.753 . . . . 0.0 111.057 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.468 ' HB3' HG13 ' A' ' 81' ' ' VAL . 91.0 m-85 -56.82 -46.94 81.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.422 1.089 . . . . 0.0 111.499 176.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.0 mm -67.31 -32.35 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.202 0.601 . . . . 0.0 110.296 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.455 ' HA ' HD12 ' A' ' 46' ' ' LEU . 64.6 m-20 -70.5 -32.01 69.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.509 0.724 . . . . 0.0 110.702 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 48' ' ' VAL . 1.1 m-20 -65.63 -38.11 88.47 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.237 0.615 . . . . 0.0 111.221 175.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 78' ' ' VAL . 59.7 mt -61.99 -44.6 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.794 0.807 . . . . 0.0 109.931 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 33' ' ' LYS . 58.7 mt -61.89 -34.55 76.23 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.725 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -82.32 -8.67 59.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.559 0.744 . . . . 0.0 112.562 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.498 HG11 HG13 ' A' ' 74' ' ' VAL . 65.9 t -70.5 105.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 171.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.69 94.31 0.2 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.694 0.798 . . . . 0.0 110.451 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 161.44 -35.81 0.39 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.0 129.73 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.825 0.85 . . . . 0.0 109.024 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -78.6 -57.04 3.97 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 p -163.61 178.49 7.92 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.975 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.403 HG12 HG13 ' A' ' 63' ' ' VAL . 75.5 mt -132.27 117.64 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.084 0.954 . . . . 0.0 109.221 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -103.67 97.54 7.54 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.697 0.76 . . . . 0.0 109.621 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -87.86 131.35 34.59 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.652 1.181 . . . . 0.0 109.88 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.4 p -172.52 155.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 118.433 0.56 . . . . 0.0 111.715 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 27.5 ttt 65.09 -83.81 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.5 1.92 . . . . 0.0 112.918 171.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 7.1 p-10 -132.71 -16.19 2.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.977 0.911 . . . . 0.0 110.561 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.408 ' HE2' ' HB2' ' A' ' 62' ' ' SER . 37.6 p90 -122.54 171.13 9.33 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 122.129 0.966 . . . . 0.0 112.446 -162.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -126.06 103.67 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.616 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 15' ' ' MET . 28.5 t -86.0 89.08 7.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.403 HG13 HG12 ' A' ' 54' ' ' ILE . 26.3 t -88.54 107.72 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 4.8 p-10 -106.58 158.19 17.12 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.894 0.478 . . . . 0.0 111.035 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -139.44 -167.97 2.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.815 0.846 . . . . 0.0 111.889 -165.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -88.19 161.13 17.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.33 1.052 . . . . 0.0 110.826 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.87 -27.02 67.91 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.731 0.812 . . . . 0.0 113.048 -172.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -97.1 -28.26 14.21 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.813 0.845 . . . . 0.0 111.734 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.28 130.89 23.74 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.817 0.847 . . . . 0.0 112.282 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -104.6 127.43 52.33 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.242 0.617 . . . . 0.0 110.443 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.425 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 63.3 m95 -71.87 -16.72 62.15 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.531 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.92 -34.54 71.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.083 0.468 . . . . 0.0 110.787 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.1 m -82.96 -44.7 14.99 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.74 0.816 . . . . 0.0 110.536 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.498 HG13 HG11 ' A' ' 48' ' ' VAL . 48.2 t -74.61 -39.51 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.944 0.898 . . . . 0.0 112.538 -170.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 71' ' ' TRP . 3.0 tt -59.14 -44.25 98.29 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-O 117.125 -1.417 . . . . 0.0 112.509 -168.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -48.96 -31.21 19.69 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.441 2.094 . . . . 0.0 114.676 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -82.08 -40.81 21.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.515 0.726 . . . . 0.0 110.029 -179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 45' ' ' ILE . 56.2 t -63.81 -38.45 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 123.914 0.885 . . . . 0.0 109.936 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.68 -47.64 82.77 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.73 1.612 . . . . 0.0 109.868 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.51 -31.1 61.78 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.854 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 41' ' ' PHE . 56.1 t -68.34 -55.48 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.41 0.684 . . . . 0.0 110.683 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 1' ' ' MET . 17.9 m-85 -65.04 -29.05 69.92 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -80.14 -38.59 31.12 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.029 0.532 . . . . 0.0 112.07 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 84.0 mt 55.27 37.58 29.11 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.055 0.942 . . . . 0.0 109.504 -164.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 87' ' ' HIS . 2.3 mp0 53.17 -136.61 1.34 Allowed 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.242 -168.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -117.76 51.38 1.05 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 165.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.445 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 89.0 m-70 -83.31 -166.56 1.4 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.135 172.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -71.57 79.82 0.81 Allowed 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.474 1.131 . . . . 0.0 109.947 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -102.69 21.87 14.66 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.984 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 65.84 6.32 3.91 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.534 1.533 . . . . 0.0 112.31 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.1 t60 . . . . . 0 C--O 1.25 1.081 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -174.498 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 mtm . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -127.94 -174.75 3.28 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.9 mt -76.1 108.1 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -82.16 -51.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 p -162.79 147.88 11.93 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.558 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mt -89.74 97.29 6.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 168.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -83.74 -166.16 1.32 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.531 0.732 . . . . 0.0 111.782 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -58.01 154.69 12.11 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.034 0.933 . . . . 0.0 113.424 -168.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 t -155.61 64.63 4.05 Favored Pre-proline 0 CA--C 1.556 1.187 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.003 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.5 -13.01 32.42 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.534 2.156 . . . . 0.0 112.663 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -85.3 -32.82 22.31 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.192 0.597 . . . . 0.0 110.052 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.2 t60 71.03 165.57 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.971 1.308 . . . . 0.0 109.974 -171.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 77.56 -51.22 0.53 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.234 1.414 . . . . 0.0 111.254 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.4 t -105.71 112.04 24.96 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.866 0.466 . . . . 0.0 110.635 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.9 mtm -98.98 142.85 29.95 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.187 0.518 . . . . 0.0 110.048 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -89.59 113.73 25.2 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.936 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.8 mt -93.32 111.39 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.4 m -76.59 122.89 25.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.579 0.752 . . . . 0.0 109.832 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.2 mt -101.99 -171.3 1.95 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.489 0.715 . . . . 0.0 109.727 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 p -76.72 6.76 5.48 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 63.86 -171.29 0.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.427 1.091 . . . . 0.0 112.122 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 t -151.28 -162.81 1.62 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -69.68 89.56 0.55 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.244 0.618 . . . . 0.0 109.576 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 65.49 -74.0 0.06 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.453 1.501 . . . . 0.0 110.482 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.85 148.68 20.43 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.034 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -131.64 127.53 37.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.236 1.014 . . . . 0.0 109.447 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 t 46.64 176.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 126.609 1.964 . . . . 0.0 115.365 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 p -155.61 98.37 1.94 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.624 0.769 . . . . 0.0 109.46 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.49 164.24 14.86 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.108 0.963 . . . . 0.0 110.866 -172.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 m -141.41 98.02 3.28 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 161.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 40.4 m-85 -82.16 111.97 18.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 p -122.38 -71.29 0.73 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.079 0.552 . . . . 0.0 110.134 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -110.02 46.88 0.99 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.683 0.793 . . . . 0.0 108.994 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.4 t 67.6 120.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 125.139 1.376 . . . . 0.0 111.704 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -59.17 -81.41 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.903 1.281 . . . . 0.0 110.4 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 166.06 -66.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.299 1.44 . . . . 0.0 108.611 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t -90.98 -2.4 57.71 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.117 0.967 . . . . 0.0 111.802 -169.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -63.08 149.84 89.86 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 123.693 0.797 . . . . 0.0 111.257 173.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -53.61 148.21 36.31 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.556 2.837 . . . . 0.0 113.731 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.02 69.81 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.029 0.931 . . . . 0.0 111.364 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.505 ' HB3' HG13 ' A' ' 81' ' ' VAL . 31.5 m-85 -61.48 -36.69 81.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.983 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.3 mm -75.69 -25.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -69.1 -37.26 78.3 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.15 -39.17 92.62 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.6 0.76 . . . . 0.0 110.358 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.523 HG22 HG11 ' A' ' 51' ' ' VAL . 29.2 mt -66.42 -34.55 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 123.533 0.521 . . . . 0.0 110.04 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 31' ' ' TYR . 88.9 mt -64.32 -35.54 81.19 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.838 0.455 . . . . 0.0 111.804 174.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.36 -15.37 61.87 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.896 177.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.49 97.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.82 87.48 0.06 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 109.904 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.46 -17.22 0.08 OUTLIER Glycine 0 C--O 1.221 -0.714 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.881 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.523 HG11 HG22 ' A' ' 45' ' ' ILE . 35.6 m -85.77 -27.86 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 22.2 ttmm 48.59 -77.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.94 2.096 . . . . 0.0 113.217 -173.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 49.9 m -122.89 98.06 5.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.945 0.898 . . . . 0.0 110.172 -171.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 66.0 mt -83.93 84.08 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.447 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 92.5 t80 -81.49 140.32 34.65 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.429 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -137.02 134.41 36.56 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.15 143.32 9.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 171.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.2 ttt 62.31 -80.45 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 O-C-N 124.651 1.22 . . . . 0.0 111.837 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.59 -38.01 1.55 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.636 0.774 . . . . 0.0 111.327 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -103.44 165.14 11.21 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.305 0.642 . . . . 0.0 112.625 -163.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.3 mt -120.19 111.53 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.989 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 50.1 m -85.83 95.37 9.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.358 0.663 . . . . 0.0 109.61 173.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 14' ' ' THR . 52.4 t -85.07 99.95 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.571 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 1.8 m-20 -84.7 98.3 10.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.683 1.193 . . . . 0.0 108.58 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.631 ' HD2' ' HB3' ' A' ' 69' ' ' ALA . 57.9 pttt -66.25 177.09 1.54 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -175.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 47.7 mm-40 -64.09 -177.39 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.499 0.719 . . . . 0.0 112.274 174.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -61.0 -25.1 66.65 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.528 0.731 . . . . 0.0 111.732 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.13 -58.27 0.9 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.412 0.685 . . . . 0.0 109.772 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.631 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . 49.6 -164.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.85 1.26 . . . . 0.0 113.053 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -156.8 114.21 3.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -68.69 -28.07 66.53 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.064 0.546 . . . . 0.0 111.832 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.63 -21.65 64.46 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 120.982 0.42 . . . . 0.0 110.505 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.7 m -86.0 -45.14 11.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.115 0.566 . . . . 0.0 110.396 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.44 -58.14 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.845 0.858 . . . . 0.0 112.571 -173.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.36 -47.01 99.73 Favored Pre-proline 0 N--CA 1.491 1.599 0 CA-C-O 117.362 -1.304 . . . . 0.0 114.321 -170.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.49 -33.99 60.03 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 122.14 1.893 . . . . 0.0 113.974 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -77.25 -39.02 49.82 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.811 0.844 . . . . 0.0 110.435 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.94 -41.23 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.765 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.93 -36.88 84.87 Favored 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 123.75 0.82 . . . . 0.0 110.837 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.71 -30.49 67.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.415 0.686 . . . . 0.0 111.917 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 41' ' ' PHE . 40.6 t -65.83 -58.96 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.848 0.859 . . . . 0.0 111.928 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -73.75 -42.93 60.41 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.261 0.624 . . . . 0.0 110.914 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.5 70.36 2.26 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.18 -32.17 64.09 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.558 0.743 . . . . 0.0 110.915 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.68 164.12 28.98 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.721 1.209 . . . . 0.0 109.682 174.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -78.0 109.24 11.89 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -57.16 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.209 1.004 . . . . 0.0 112.01 -170.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -172.2 66.04 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.7 0.8 . . . . 0.0 109.218 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -86.47 -42.97 13.14 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -138.29 161.46 36.84 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.626 1.17 . . . . 0.0 108.865 169.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 71.1 t60 . . . . . 0 CA--C 1.557 1.246 0 C-N-CA 123.915 0.886 . . . . 0.0 109.776 -174.518 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 121.132 0.491 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.602 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 50.9 pttt -145.14 -170.72 3.49 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.195 0.998 . . . . 0.0 108.984 173.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 6' ' ' ILE . 59.5 mt -78.12 116.65 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 163.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 19' ' ' LEU . 1.6 mp -83.43 -52.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 t -159.32 124.39 4.13 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.432 0.458 . . . . 0.0 110.881 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.632 HG21 ' HE2' ' A' ' 15' ' ' MET . 59.8 mt -92.25 90.6 3.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m 55.99 -160.93 0.19 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.959 0.904 . . . . 0.0 112.532 171.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -83.98 -32.66 24.87 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.402 0.62 . . . . 0.0 110.892 170.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 t -130.8 134.49 26.05 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.449 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HB3' HD11 ' A' ' 75' ' ' LEU . 52.1 Cg_exo -56.07 -52.49 7.19 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.91 2.407 . . . . 0.0 113.044 172.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.483 ' HA ' ' HD1' ' A' ' 71' ' ' TRP . 63.2 t30 -83.88 124.55 31.09 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.121 0.486 . . . . 0.0 110.837 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.402 ' HD2' ' H ' ' A' ' 14' ' ' THR . 22.9 t60 -172.69 171.01 4.57 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.572 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 1.6 m120 -72.28 -22.29 61.23 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.03 1.287 . . . . 0.0 111.469 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 11.9 t -140.31 162.44 35.29 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.225 1.01 . . . . 0.0 109.292 171.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.632 ' HE2' HG21 ' A' ' 6' ' ' ILE . 6.9 ptp -136.36 125.49 24.55 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.285 0.564 . . . . 0.0 110.929 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -80.32 92.39 5.77 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.008 0.923 . . . . 0.0 109.356 170.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 6' ' ' ILE . 71.1 mt -80.04 95.45 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 m -82.75 141.32 32.47 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.519 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.682 ' HA ' HD13 ' A' ' 4' ' ' ILE . 75.5 mt -111.98 160.85 17.06 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.141 0.976 . . . . 0.0 110.069 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.4 p -76.31 -15.81 59.91 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.205 1.002 . . . . 0.0 111.886 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.39 61.62 6.72 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 122.078 0.942 . . . . 0.0 110.244 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.3 m -90.12 66.41 6.71 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.768 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -154.25 -56.43 0.11 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.882 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.57 -19.89 66.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -170.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.7 63.15 4.44 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.491 0.494 . . . . 0.0 112.457 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.9 mtt -48.7 149.55 1.7 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.28 1.432 . . . . 0.0 112.821 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.7 p -66.08 148.6 51.56 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.024 0.93 . . . . 0.0 111.926 -174.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 p -89.05 105.3 17.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.655 0.782 . . . . 0.0 110.223 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -138.39 138.23 38.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.471 0.708 . . . . 0.0 111.193 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.4 m -103.31 98.91 8.75 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.1 0.96 . . . . 0.0 109.552 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -83.98 116.08 22.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.465 1.106 . . . . 0.0 109.683 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.3 p -137.42 -75.79 0.41 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.365 0.666 . . . . 0.0 112.514 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -91.47 18.66 6.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -164.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t 61.86 90.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.369 1.068 . . . . 0.0 109.485 -170.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -163.0 155.68 18.89 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.563 0.745 . . . . 0.0 110.347 -171.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.8 t70 67.17 -80.56 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.471 1.509 . . . . 0.0 112.129 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.5 t -154.28 69.99 0.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.295 0.569 . . . . 0.0 110.006 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -108.74 104.74 55.47 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.485 0.714 . . . . 0.0 109.358 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.79 152.34 42.93 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.765 2.31 . . . . 0.0 112.221 173.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.46 -37.91 51.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.928 0.891 . . . . 0.0 111.612 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.632 ' HB3' HG13 ' A' ' 81' ' ' VAL . 59.1 m-85 -62.91 -39.48 94.64 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.126 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -74.73 -29.69 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 124.127 0.971 . . . . 0.0 110.587 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -41.12 91.87 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 22.1 t70 -56.92 -49.23 76.24 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.297 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.481 HG23 HG22 ' A' ' 78' ' ' VAL . 61.1 mt -57.27 -46.26 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 124.148 0.905 . . . . 0.0 110.278 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.74 -36.91 82.37 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.719 0.808 . . . . 0.0 111.856 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -77.49 -13.36 59.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.405 0.682 . . . . 0.0 111.536 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 44' ' ' ASP . 96.9 t -71.0 125.9 30.27 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -61.97 92.11 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.109 1.364 . . . . 0.0 111.367 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.52 -52.13 0.38 Allowed Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.098 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.98 120.88 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.53 0.732 . . . . 0.0 110.985 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -95.55 -50.86 4.79 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.373 0.669 . . . . 0.0 110.074 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.3 t -143.06 152.68 42.14 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.79 0.436 . . . . 0.0 111.286 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.422 HG12 HG13 ' A' ' 63' ' ' VAL . 46.7 mt -125.2 94.59 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.773 1.229 . . . . 0.0 108.615 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -96.18 100.11 11.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.893 -0.504 . . . . 0.0 110.088 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.33 129.71 35.83 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 p -161.59 141.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.445 0.698 . . . . 0.0 111.086 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 65.08 -73.25 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.976 1.71 . . . . 0.0 113.594 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -155.16 8.84 0.29 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.78 0.432 . . . . 0.0 111.166 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -142.52 165.97 25.96 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.1 0.56 . . . . 0.0 110.213 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.59 102.27 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 15' ' ' MET . 19.3 p -81.98 89.07 6.37 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.422 HG13 HG12 ' A' ' 54' ' ' ILE . 43.8 t -89.27 116.04 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.244 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 4.1 p30 -99.75 163.72 12.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.941 0.496 . . . . 0.0 111.293 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -136.37 173.07 12.1 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.342 -175.348 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.07 125.06 32.45 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 166.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -54.68 -21.18 9.95 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.715 1.206 . . . . 0.0 113.347 -167.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -51.76 -47.9 63.95 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.598 1.159 . . . . 0.0 112.159 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.09 130.54 35.52 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.61 0.764 . . . . 0.0 111.389 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -84.94 155.94 21.41 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.103 0.561 . . . . 0.0 109.56 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.483 ' HD1' ' HA ' ' A' ' 11' ' ' ASN . 49.4 m95 -76.58 -31.38 57.48 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -28.62 44.14 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -171.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -81.12 -39.59 25.36 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.889 0.876 . . . . 0.0 110.011 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.65 -36.04 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 124.93 1.292 . . . . 0.0 111.703 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.43 HD11 ' HB3' ' A' ' 10' ' ' PRO . 77.0 mt -50.12 -49.12 77.4 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 125.194 1.398 . . . . 0.0 114.59 -172.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.85 -31.16 88.04 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.885 1.723 . . . . 0.0 113.555 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -80.13 -40.18 27.96 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.862 0.865 . . . . 0.0 110.387 -176.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 45' ' ' ILE . 59.8 t -65.81 -48.91 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.22 -31.26 72.38 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.966 0.906 . . . . 0.0 111.339 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.67 -34.83 69.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.892 0.877 . . . . 0.0 111.119 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 41' ' ' PHE . 43.2 t -57.82 -46.99 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.914 0.886 . . . . 0.0 111.059 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.602 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 18.1 m-85 -87.69 19.56 3.38 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.693 0.797 . . . . 0.0 112.684 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -157.05 5.75 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.89 -31.44 66.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 111.306 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 53.39 43.55 31.22 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.45 1.094 . . . . 0.0 112.791 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -80.53 73.25 7.46 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.461 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -171.54 115.04 0.38 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.549 1.54 . . . . 0.0 107.378 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -68.99 -33.03 73.01 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.564 0.746 . . . . 0.0 111.184 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -70.75 152.27 43.98 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 167.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -87.13 139.92 30.08 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.2 m170 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 124.882 1.273 . . . . 0.0 110.481 -178.64 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.609 0.242 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.75 157.8 16.71 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.451 HG21 HG13 ' A' ' 6' ' ' ILE . 32.8 mt -76.93 129.85 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.983 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.4 mm -87.56 -48.02 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.935 0.894 . . . . 0.0 109.849 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.4 p -142.25 128.73 20.15 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.369 0.667 . . . . 0.0 109.673 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.451 HG13 HG21 ' A' ' 3' ' ' ILE . 3.8 mp -90.53 86.92 2.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.648 ' HB2' HD21 ' A' ' 11' ' ' ASN . 97.5 p 60.52 176.57 0.1 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.531 1.533 . . . . 0.0 113.901 171.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.441 ' HB2' ' OD1' ' A' ' 11' ' ' ASN . 40.8 mt-10 -115.1 -166.01 1.08 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.332 1.053 . . . . 0.0 108.335 168.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.4 p -87.13 -48.97 0.47 Allowed Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 118.275 -0.869 . . . . 0.0 113.232 -176.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.67 -9.9 21.48 Favored 'Trans proline' 0 C--N 1.396 3.031 0 CA-C-N 121.374 1.526 . . . . 0.0 112.817 -166.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.648 HD21 ' HB2' ' A' ' 7' ' ' SER . 3.7 p-10 -99.03 50.62 0.95 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.629 1.171 . . . . 0.0 110.156 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -64.25 -27.38 69.01 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.977 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.602 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 76.9 m-20 -102.82 8.79 39.25 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.161 0.584 . . . . 0.0 112.191 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 3.1 t -159.89 95.07 1.16 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.545 0.738 . . . . 0.0 110.135 176.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.1 mtp -82.65 125.77 31.57 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 121.713 -0.617 . . . . 0.0 111.802 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 7' ' ' SER . 23.0 ttmm -79.92 89.73 5.31 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.743 1.217 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.494 HD12 HG21 ' A' ' 63' ' ' VAL . 70.9 mt -85.6 95.63 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 174.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 60' ' ' PHE . 49.3 m -77.06 124.16 27.4 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.265 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.3 mt -87.55 164.52 16.06 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.118 0.485 . . . . 0.0 110.785 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -76.02 -19.89 58.28 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.872 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -96.73 101.57 13.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 109.664 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.778 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 29.3 t -79.41 107.94 12.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.536 0.734 . . . . 0.0 109.291 173.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 46.08 -154.94 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.712 1.605 . . . . 0.0 113.326 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.22 40.88 32.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.137 0.975 . . . . 0.0 112.078 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.79 -32.29 1.45 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.804 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.8 mmt -90.34 101.91 14.64 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.547 0.739 . . . . 0.0 110.313 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.7 m -80.11 166.82 21.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.016 0.926 . . . . 0.0 111.057 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 67.8 p -80.87 74.35 7.85 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.937 0.895 . . . . 0.0 109.784 170.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -87.15 153.99 21.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.584 1.154 . . . . 0.0 110.387 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -128.54 101.25 6.09 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.453 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 37.4 m-85 -88.01 119.62 28.56 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.2 p -118.19 -62.44 1.54 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.52 0.6 . . . . 0.0 112.132 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.65 26.97 7.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -157.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.459 ' H ' HD13 ' A' ' 46' ' ' LEU . 87.5 t 62.11 83.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -166.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.76 -77.21 0.26 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-N 113.365 -1.743 . . . . 0.0 111.567 -162.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -169.31 -77.2 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.02 0.373 . . . . 0.0 111.337 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 m -89.15 68.48 8.18 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.089 0.956 . . . . 0.0 110.727 -171.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.444 HE22 HD11 ' A' ' 46' ' ' LEU . 4.1 pt20 -151.65 154.22 32.91 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.594 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.488 ' HB2' ' HB2' ' A' ' 41' ' ' PHE . 21.5 Cg_exo -66.2 150.89 84.68 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 122.669 2.246 . . . . 0.0 112.215 169.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.02 -23.76 63.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.865 0.866 . . . . 0.0 111.389 171.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.591 ' HB3' HG13 ' A' ' 81' ' ' VAL . 25.3 m-85 -46.97 -51.4 17.16 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.374 1.47 . . . . 0.0 110.82 170.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.1 mm -72.62 -29.25 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.625 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.478 HD22 HD12 ' A' ' 46' ' ' LEU . 14.0 m120 -67.97 -32.94 73.71 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.362 0.665 . . . . 0.0 111.945 -175.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -59.08 -46.8 87.35 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.492 0.495 . . . . 0.0 110.22 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.8 mt -66.07 -38.75 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.609 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.478 HD12 HD22 ' A' ' 43' ' ' ASN . 76.7 mt -60.71 -39.53 88.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.36 0.664 . . . . 0.0 111.709 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -85.62 4.13 37.69 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.267 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.2 t -78.84 123.53 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 169.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.13 130.39 34.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.571 0.748 . . . . 0.0 110.931 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.63 -32.67 7.3 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.644 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.37 109.36 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 24.3 ttmm -78.94 -55.24 5.29 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.427 0.691 . . . . 0.0 110.568 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.1 t -158.88 157.29 31.19 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.567 0.698 . . . . 0.0 110.716 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 67.6 mt -114.4 87.26 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.442 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 58.3 t80 -84.26 90.75 7.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.546 0.689 . . . . 0.0 109.841 -175.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -80.75 117.37 21.36 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 2.5 p -140.97 125.25 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.129 0.422 . . . . 0.0 110.556 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 62.84 -71.98 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.446 1.498 . . . . 0.0 110.59 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.778 ' HB3' ' HA ' ' A' ' 22' ' ' SER . 2.0 p30 -148.46 -33.08 0.24 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.849 1.259 . . . . 0.0 110.08 172.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 29.0 p90 -83.86 129.31 34.93 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -174.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -102.26 113.78 39.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -176.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 10.9 m -82.37 81.84 8.07 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.643 0.777 . . . . 0.0 109.64 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.494 HG21 HD12 ' A' ' 17' ' ' ILE . 48.7 t -78.85 92.89 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -82.41 151.2 26.71 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.265 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.602 ' HE2' ' HA ' ' A' ' 13' ' ' ASN . 39.0 pttt -137.17 -178.2 5.1 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.746 -173.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.84 140.88 30.85 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.95 -38.57 62.16 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.708 0.803 . . . . 0.0 112.163 -169.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.52 -32.62 72.7 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.702 0.801 . . . . 0.0 112.956 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.497 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . -56.31 111.33 0.94 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.936 0.894 . . . . 0.0 111.945 -175.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.512 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 15.8 m120 -82.47 126.4 32.19 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -70.59 -13.99 62.31 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.821 0.448 . . . . 0.0 112.101 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 70' ' ' ASN . 12.6 pt-20 -60.65 -28.4 68.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.302 0.641 . . . . 0.0 111.549 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.2 t -96.49 -40.68 8.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.761 0.824 . . . . 0.0 111.307 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.6 t -66.1 -47.23 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.094 0.958 . . . . 0.0 111.659 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.84 -43.33 97.59 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.858 -171.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.12 -39.51 20.49 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.732 2.288 . . . . 0.0 113.742 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -75.59 -41.32 54.92 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.036 0.534 . . . . 0.0 111.391 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.421 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 76.0 t -60.01 -55.52 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.317 0.647 . . . . 0.0 110.643 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -60.12 -39.11 85.08 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.035 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.59 -33.12 72.27 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.53 0.732 . . . . 0.0 111.655 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 41' ' ' PHE . 8.2 t -58.85 -48.56 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.295 0.638 . . . . 0.0 110.88 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -74.44 -30.48 61.91 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.932 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -107.0 20.39 19.11 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 81' ' ' VAL . 4.5 pp -84.38 5.92 25.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 122.176 -0.328 . . . . 0.0 111.417 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -52.41 150.8 4.52 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 123.698 0.799 . . . . 0.0 110.332 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -49.56 110.54 0.39 Allowed 'General case' 0 N--CA 1.477 0.893 0 O-C-N 124.585 1.178 . . . . 0.0 110.087 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -60.49 -48.28 82.46 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.546 0.738 . . . . 0.0 111.603 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 66.74 150.78 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.752 1.221 . . . . 0.0 111.644 -175.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -80.35 -11.18 59.73 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.222 167.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -75.5 75.4 2.55 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 164.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 . . . . . 0 C--O 1.252 1.191 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.282 -175.76 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -122.76 179.31 4.67 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.607 0.763 . . . . 0.0 109.969 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.527 HD12 ' HG2' ' A' ' 79' ' ' GLU . 27.6 mt -71.92 104.11 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.1 mm -84.23 -48.73 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.185 0.594 . . . . 0.0 109.808 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.1 p -155.81 125.99 6.63 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.017 0.527 . . . . 0.0 110.243 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.92 153.01 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.611 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 47.6 t -66.52 171.72 4.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.141 0.576 . . . . 0.0 112.369 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -59.54 -23.52 62.93 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.021 1.328 . . . . 0.0 111.35 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -104.99 96.33 10.74 Favored Pre-proline 0 CA--C 1.56 1.338 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.135 169.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -88.93 10.24 3.36 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.825 2.35 . . . . 0.0 112.239 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.412 ' HA ' ' NE1' ' A' ' 71' ' ' TRP . 12.1 p30 -149.15 -158.14 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.519 1.127 . . . . 0.0 109.873 -174.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 42.6 m170 65.14 73.97 0.4 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.567 1.147 . . . . 0.0 110.182 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.0 m120 72.63 -61.4 0.5 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.136 1.774 . . . . 0.0 112.237 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.448 ' HB ' ' HA ' ' A' ' 64' ' ' ASP . 6.7 t -140.92 136.75 32.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.996 0.426 . . . . 0.0 111.201 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.448 ' O ' ' HA ' ' A' ' 62' ' ' SER . 6.7 ptp -104.49 153.35 21.24 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.533 174.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 32.2 ttmt -95.47 125.01 39.78 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 171.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.21 97.1 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.1 m -70.37 113.0 7.09 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.298 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 86.9 mt -81.71 -178.67 7.07 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.029 0.532 . . . . 0.0 111.081 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.434 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 7.4 m -73.63 0.8 11.68 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.203 0.601 . . . . 0.0 111.537 172.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.94 130.72 48.13 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.199 1.4 . . . . 0.0 110.121 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -61.98 -30.58 71.04 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.113 1.365 . . . . 0.0 112.327 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.575 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 44.4 ttt85 103.9 132.96 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 129.067 2.947 . . . . 0.0 109.186 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.581 ' HA ' ' SD ' ' A' ' 58' ' ' MET . 28.4 tt0 80.62 -4.53 1.79 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.064 1.746 . . . . 0.0 111.788 175.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.18 -33.73 53.4 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 58' ' ' MET . 64.4 mtt -107.42 -179.6 3.97 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.268 1.027 . . . . 0.0 109.635 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 t -124.56 179.2 5.05 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.297 0.639 . . . . 0.0 111.276 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 33.9 p -89.43 132.93 34.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.667 1.187 . . . . 0.0 110.709 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -155.57 158.19 38.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.438 ' HB ' ' HD1' ' A' ' 55' ' ' PHE . 5.7 t -129.17 102.68 6.57 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.709 0.766 . . . . 0.0 109.38 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 68.6 m-85 -83.11 109.39 17.11 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.7 p -113.17 -69.64 0.85 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.531 0.732 . . . . 0.0 111.145 -172.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -100.23 22.94 10.73 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.244 0.618 . . . . 0.0 112.106 -168.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.9 t 69.23 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 124.718 1.207 . . . . 0.0 112.509 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 66.26 90.3 0.09 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.028 1.731 . . . . 0.0 112.065 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -168.7 74.07 0.1 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 0.0 109.039 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.1 p 46.89 46.63 15.56 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.112 1.365 . . . . 0.0 112.508 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.07 125.04 17.85 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 123.992 0.917 . . . . 0.0 109.22 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.97 155.07 6.33 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 124.05 3.167 . . . . 0.0 114.412 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.5 -33.1 43.4 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.403 1.081 . . . . 0.0 112.519 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -60.87 -40.72 94.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.095 0.958 . . . . 0.0 111.479 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.1 mm -70.98 -27.6 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.787 0.835 . . . . 0.0 110.024 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.448 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -69.79 -34.75 74.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.293 0.637 . . . . 0.0 110.391 177.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -64.62 -43.64 93.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.538 0.735 . . . . 0.0 111.105 175.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.528 HG23 HG22 ' A' ' 78' ' ' VAL . 54.9 mt -60.22 -37.63 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.038 0.447 . . . . 0.0 110.376 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.69 -34.21 77.35 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.39 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -87.77 0.57 55.58 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.768 0.827 . . . . 0.0 112.551 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 44' ' ' ASP . 91.6 t -72.09 127.22 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.73 132.57 53.68 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.091 0.956 . . . . 0.0 111.358 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.23 -47.4 1.11 Allowed Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.617 -173.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.72 135.88 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 124.305 1.042 . . . . 0.0 112.243 -171.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -113.21 -47.03 3.04 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.811 1.244 . . . . 0.0 110.09 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 12.6 m -146.35 157.68 43.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.239 0.542 . . . . 0.0 111.007 -174.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 82.0 mt -123.09 82.68 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 173.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.438 ' HD1' ' HB ' ' A' ' 30' ' ' THR . 32.2 t80 -82.98 88.04 6.86 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 9.6 t-160 -84.5 87.95 7.28 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 p -92.62 105.8 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.712 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.581 ' SD ' ' HA ' ' A' ' 24' ' ' GLU . 44.5 tpp 65.45 -91.19 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.916 1.287 . . . . 0.0 111.276 171.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.575 ' HB3' ' HA ' ' A' ' 23' ' ' ARG . 6.7 p-10 -116.2 -7.36 11.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.734 0.814 . . . . 0.0 111.933 -170.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -133.61 136.78 45.07 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.071 0.548 . . . . 0.0 111.011 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 56' ' ' HIS . 43.5 mt -94.06 106.65 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.787 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 15' ' ' MET . 10.7 t -81.99 90.98 6.53 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 172.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.82 98.18 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.16 0.584 . . . . 0.0 109.647 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 53' ' ' SER . 3.2 m-20 -79.78 150.12 30.85 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.505 0.722 . . . . 0.0 110.567 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -152.99 -159.49 1.01 Allowed 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.717 0.807 . . . . 0.0 109.091 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -63.11 -175.88 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.147 0.979 . . . . 0.0 111.947 168.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -51.33 -43.45 61.75 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.966 0.906 . . . . 0.0 111.828 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -158.3 -46.72 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.434 0.694 . . . . 0.0 110.467 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 51.68 -97.05 0.05 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.995 0.918 . . . . 0.0 109.171 -169.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -158.73 127.53 5.41 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 160.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.436 ' CH2' ' HG2' ' A' ' 15' ' ' MET . 94.3 m95 -80.72 -13.52 58.92 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.979 -0.451 . . . . 0.0 110.295 171.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -50.99 -45.19 60.96 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.397 1.079 . . . . 0.0 111.854 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -75.64 -41.72 53.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.631 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.29 -50.78 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.917 0.887 . . . . 0.0 113.359 -166.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.36 -50.4 85.17 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-O 117.772 -1.109 . . . . 0.0 113.135 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -43.9 -41.0 11.98 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.867 2.378 . . . . 0.0 114.83 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.61 -46.45 26.02 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.939 0.496 . . . . 0.0 110.874 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.528 HG22 HG23 ' A' ' 45' ' ' ILE . 89.2 t -64.53 -52.85 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.661 0.784 . . . . 0.0 110.768 -175.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.527 ' HG2' HD12 ' A' ' 3' ' ' ILE . 49.5 mt-10 -58.9 -34.66 71.92 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.53 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.68 -34.04 72.36 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.878 0.871 . . . . 0.0 112.005 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.84 -42.13 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.672 0.789 . . . . 0.0 110.679 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -84.61 7.63 19.53 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.617 0.767 . . . . 0.0 112.927 173.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -133.28 52.97 2.04 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.191 0.996 . . . . 0.0 109.172 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.65 30.51 0.72 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.326 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -72.27 106.63 4.52 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 167.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -93.77 -39.74 10.58 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.222 0.609 . . . . 0.0 110.045 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -160.39 -42.92 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.899 0.88 . . . . 0.0 109.283 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -88.99 133.08 34.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.049 0.94 . . . . 0.0 109.614 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -74.57 150.44 39.71 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.408 0.683 . . . . 0.0 110.081 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -139.28 97.52 3.31 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.952 0.501 . . . . 0.0 109.784 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.245 0.837 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.084 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -88.7 41.01 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.367 0.667 . . . . 0.0 112.295 -173.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 17' ' ' ILE . 43.3 mt 53.79 103.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 124.57 1.148 . . . . 0.0 112.061 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.0 mm -82.66 -49.59 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.678 0.791 . . . . 0.0 110.677 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 t -149.3 148.17 29.22 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 120.88 0.371 . . . . 0.0 110.586 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.8 mm -96.01 106.86 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.481 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 t 66.63 140.23 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.093 1.757 . . . . 0.0 115.537 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.521 ' H ' ' HB3' ' A' ' 16' ' ' LYS . 21.4 mm-40 -115.25 -6.91 12.41 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.948 1.299 . . . . 0.0 110.555 168.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 11' ' ' ASN . 7.7 m -104.94 129.75 24.32 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 125.384 1.474 . . . . 0.0 108.975 -174.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.0 -4.64 15.53 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.137 1.891 . . . . 0.0 113.014 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.442 ' H ' HG22 ' A' ' 9' ' ' THR . 42.1 t30 -78.38 121.09 24.04 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.526 0.73 . . . . 0.0 109.624 176.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -74.92 -18.63 60.37 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.609 0.764 . . . . 0.0 112.024 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -64.95 -56.47 13.03 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 9.8 t -115.66 126.78 54.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.804 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.6 ' HE1' HD11 ' A' ' 75' ' ' LEU . 34.2 mtm -110.69 136.57 49.58 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.253 0.549 . . . . 0.0 110.857 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' HB3' ' H ' ' A' ' 8' ' ' GLU . 6.4 tmtm? -79.22 94.56 5.44 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.059 174.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 3' ' ' ILE . 58.3 mt -77.8 96.33 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 m -63.03 129.89 42.33 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.964 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.2 mt -116.15 149.18 39.47 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -75.37 -13.75 60.42 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.06 0.544 . . . . 0.0 110.54 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -92.05 63.08 4.34 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.564 1.146 . . . . 0.0 108.712 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.53 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 26.5 m -78.43 -172.93 3.09 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.611 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 72.39 171.63 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.562 1.145 . . . . 0.0 110.398 -172.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 68.36 -75.84 0.06 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.309 1.443 . . . . 0.0 111.966 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.7 -25.2 0.21 Allowed Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.009 -175.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 43.5 tpp 41.56 66.46 0.69 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.579 1.552 . . . . 0.0 111.444 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.5 p 48.44 100.57 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.976 1.71 . . . . 0.0 112.883 -171.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.5 p -88.48 70.75 8.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.823 0.821 . . . . 0.0 108.985 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.64 168.52 11.68 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.039 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.487 ' HG1' ' HD1' ' A' ' 55' ' ' PHE . 7.4 m -126.36 97.11 4.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.283 -1.326 . . . . 0.0 107.864 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.491 ' HB3' HD11 ' A' ' 46' ' ' LEU . 44.0 m-85 -83.25 98.43 9.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.933 0.893 . . . . 0.0 108.842 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.447 HG23 HG22 ' A' ' 30' ' ' THR . 28.6 p -124.34 -64.47 1.12 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.733 0.813 . . . . 0.0 110.102 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -79.88 -4.09 50.77 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -168.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 t 63.88 164.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 C-N-CA 125.161 1.384 . . . . 0.0 110.599 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 65.54 96.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.285 1.034 . . . . 0.0 110.892 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -152.99 -74.95 0.13 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.6 t -165.62 23.44 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.495 0.718 . . . . 0.0 109.46 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.536 ' HG2' ' ND2' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -107.56 140.95 22.04 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.141 0.577 . . . . 0.0 109.668 -177.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.22 148.42 3.13 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.934 3.089 . . . . 0.0 114.563 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.06 -32.96 62.31 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.996 0.918 . . . . 0.0 110.714 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.619 ' HB3' HG13 ' A' ' 81' ' ' VAL . 82.3 m-85 -52.69 -48.65 66.42 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.704 1.201 . . . . 0.0 111.037 172.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -71.42 -31.05 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.254 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.536 ' ND2' ' HG2' ' A' ' 38' ' ' GLN . 0.9 OUTLIER -67.81 -37.71 82.33 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.441 ' O ' HG23 ' A' ' 48' ' ' VAL . 25.0 t70 -65.1 -41.82 94.58 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.635 0.774 . . . . 0.0 110.1 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.462 HD11 HG21 ' A' ' 81' ' ' VAL . 64.3 mt -57.26 -47.32 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 123.891 0.744 . . . . 0.0 109.831 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 31' ' ' TYR . 88.8 mt -60.47 -36.92 79.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.212 0.605 . . . . 0.0 111.178 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.92 -8.93 59.52 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.6 0.76 . . . . 0.0 112.094 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 44' ' ' ASP . 97.2 t -65.17 107.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 171.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.56 107.19 0.31 Allowed 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.983 0.802 . . . . 0.0 110.398 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.5 -45.38 0.86 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.183 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.517 HG13 HG13 ' A' ' 63' ' ' VAL . 40.2 t -60.55 -40.51 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 125.085 1.354 . . . . 0.0 113.655 -171.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 38.5 ttmt 64.13 -72.25 0.06 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.389 1.876 . . . . 0.0 111.587 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 p -144.95 156.33 43.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.157 0.583 . . . . 0.0 111.156 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.1 mt -131.64 131.48 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.463 1.105 . . . . 0.0 108.245 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.487 ' HD1' ' HG1' ' A' ' 30' ' ' THR . 67.3 t80 -118.14 104.77 11.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -96.62 128.08 43.22 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.4 p -163.9 151.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 56.6 tpp 68.46 -69.77 0.14 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.367 1.467 . . . . 0.0 110.692 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.53 ' HB3' ' HA ' ' A' ' 22' ' ' SER . 8.7 p-10 -148.16 -36.41 0.2 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.591 1.157 . . . . 0.0 110.401 173.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.506 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . 55.3 p90 -87.47 149.69 24.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -158.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 66.8 mt -98.77 97.17 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 113.616 -1.629 . . . . 0.0 107.921 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.1 t -83.94 86.97 7.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.116 0.566 . . . . 0.0 109.625 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.517 HG13 HG13 ' A' ' 51' ' ' VAL . 44.2 t -80.87 103.55 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 36.3 t70 -95.01 95.53 8.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.971 0.908 . . . . 0.0 109.875 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.613 ' HD2' ' HB3' ' A' ' 69' ' ' ALA . 17.3 pttp -86.05 -172.17 3.94 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.904 0.881 . . . . 0.0 112.359 -175.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.45 167.56 1.88 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.768 0.827 . . . . 0.0 111.45 167.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -51.25 -68.76 0.14 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.219 1.007 . . . . 0.0 111.496 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -94.35 -57.23 2.56 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.35 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.613 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . . . 40.39 -157.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.309 1.443 . . . . 0.0 113.578 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -141.68 108.59 5.42 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.478 0.711 . . . . 0.0 109.477 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -61.18 -32.86 72.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.038 0.535 . . . . 0.0 110.041 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -62.91 -22.04 66.46 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.977 0.911 . . . . 0.0 111.614 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.3 m -92.36 -44.86 8.48 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.619 0.767 . . . . 0.0 110.962 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.3 t -72.69 -51.6 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.834 0.854 . . . . 0.0 112.398 -172.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.6 HD11 ' HE1' ' A' ' 15' ' ' MET . 91.3 mt -56.44 -41.34 90.68 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-O 117.368 -1.301 . . . . 0.0 114.389 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -40.33 -41.83 3.5 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.067 2.511 . . . . 0.0 114.596 170.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 77' ' ' LYS . 36.6 mtpt -75.92 -43.04 47.01 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.683 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.08 -50.18 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.261 0.624 . . . . 0.0 110.042 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.447 ' HG2' HD12 ' A' ' 3' ' ' ILE . 42.9 mt-10 -57.21 -44.18 83.45 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.342 1.057 . . . . 0.0 110.968 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.08 67.76 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.48 1.112 . . . . 0.0 112.703 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 41' ' ' PHE . 52.6 t -61.55 -49.4 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.267 0.627 . . . . 0.0 110.977 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -78.54 -27.71 45.99 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.967 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.46 71.34 4.35 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.6 mt -85.12 51.19 2.11 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.849 173.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 23.68 76.37 0.02 OUTLIER 'General case' 0 C--N 1.374 1.644 0 C-N-CA 126.539 1.936 . . . . 0.0 113.352 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -60.79 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.444 1.097 . . . . 0.0 111.582 -169.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -109.13 -42.17 4.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.03 0.932 . . . . 0.0 109.299 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -65.18 161.15 19.77 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 171.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -74.6 -160.2 0.1 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.072 0.549 . . . . 0.0 110.22 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -65.74 137.81 57.52 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.369 -0.832 . . . . 0.0 110.064 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 . . . . . 0 CA--C 1.553 1.096 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.417 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.586 ' HG2' HD13 ' A' ' 19' ' ' LEU . 3.3 mpp? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.069 0.461 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -116.81 -175.57 2.8 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.83 1.252 . . . . 0.0 109.766 174.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.6 mt -102.49 109.66 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 170.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mm -84.19 -46.02 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.0 m -146.53 127.27 14.32 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.172 0.589 . . . . 0.0 110.272 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -86.78 75.35 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 165.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 p -77.6 90.69 3.94 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.352 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.45 -179.17 2.85 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.404 1.081 . . . . 0.0 111.047 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 p -137.64 151.65 71.23 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.591 1.157 . . . . 0.0 108.463 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.7 -37.95 84.21 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.745 2.297 . . . . 0.0 111.024 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -79.56 73.74 6.24 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 166.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -77.44 25.53 0.18 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.177 -167.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -59.21 -36.81 76.05 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.904 0.881 . . . . 0.0 109.542 163.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -123.78 159.25 29.92 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.796 0.839 . . . . 0.0 110.966 -177.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 37.7 mtm -136.45 143.06 43.68 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.553 1.141 . . . . 0.0 108.569 169.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -95.25 116.68 29.07 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.411 0.685 . . . . 0.0 109.597 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 64.6 mt -90.58 96.11 6.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 172.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 m -66.29 120.53 13.44 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.476 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.586 HD13 ' HG2' ' A' ' 1' ' ' MET . 77.0 mt -87.8 -160.56 0.63 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.216 0.607 . . . . 0.0 110.238 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -68.97 8.26 0.56 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -168.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 66.33 106.62 0.04 OUTLIER 'General case' 0 C--N 1.362 1.115 0 C-N-CA 125.352 1.461 . . . . 0.0 110.742 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -140.49 174.24 10.71 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.364 0.666 . . . . 0.0 110.827 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -56.48 133.04 52.96 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.222 0.609 . . . . 0.0 109.711 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -54.37 91.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.807 1.317 . . . . 0.0 112.519 -170.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.459 ' N ' ' HA ' ' A' ' 58' ' ' MET . . . -164.65 -73.2 0.03 OUTLIER Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 60.4 tpp 51.29 21.6 1.18 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.304 1.442 . . . . 0.0 112.381 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m 67.61 135.17 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.503 1.521 . . . . 0.0 110.513 -168.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 p -102.32 114.46 28.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.009 0.923 . . . . 0.0 108.746 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' A' ' 56' ' ' HIS . 15.7 m-20 -138.21 158.57 44.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.198 0.999 . . . . 0.0 110.194 -170.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 t -151.21 93.96 1.98 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -95.56 92.34 6.59 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.876 0.87 . . . . 0.0 110.566 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 53' ' ' SER . 81.3 p -92.31 -23.47 19.26 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.219 0.533 . . . . 0.0 109.585 174.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.649 ' HG2' ' H ' ' A' ' 34' ' ' VAL . 20.6 ttmm -106.58 -161.91 0.82 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.78 1.232 . . . . 0.0 108.272 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.649 ' H ' ' HG2' ' A' ' 33' ' ' LYS . 58.4 t -149.01 83.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 105.645 -1.984 . . . . 0.0 105.645 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -164.74 -138.0 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.694 -170.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 64.01 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.359 1.019 0 C-N-CA 124.891 1.276 . . . . 0.0 110.527 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.1 p -172.9 20.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.11 1.364 . . . . 0.0 109.386 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.521 ' HG3' ' ND2' ' A' ' 43' ' ' ASN . 12.9 pt20 -65.1 142.86 98.73 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.028 0.931 . . . . 0.0 110.369 -176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.82 141.18 28.92 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.597 2.865 . . . . 0.0 113.347 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -58.97 -31.81 69.07 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.981 0.912 . . . . 0.0 111.74 -178.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.523 ' HB3' HG13 ' A' ' 81' ' ' VAL . 62.5 m-85 -65.4 -36.49 84.13 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.268 0.627 . . . . 0.0 110.911 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.3 mm -73.66 -27.1 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.525 0.73 . . . . 0.0 110.136 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.521 ' ND2' ' HG3' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -62.27 -41.79 98.77 Favored 'General case' 0 C--N 1.368 1.392 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.265 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -57.72 -46.12 84.83 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.502 1.126 . . . . 0.0 111.418 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.539 HG23 HG22 ' A' ' 78' ' ' VAL . 57.4 mt -55.42 -49.27 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 123.801 0.688 . . . . 0.0 110.064 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.4 mt -65.15 -32.69 74.51 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.51 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -72.04 -18.94 61.91 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.764 0.826 . . . . 0.0 112.278 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.05 117.94 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -57.05 99.99 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.229 0.956 . . . . 0.0 109.168 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.52 -56.09 0.48 Allowed Glycine 0 C--O 1.225 -0.437 0 N-CA-C 110.071 -1.211 . . . . 0.0 110.071 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.73 127.71 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.844 0.858 . . . . 0.0 111.719 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.532 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 8.0 ttpm? -92.2 -46.56 7.68 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.063 0.945 . . . . 0.0 108.48 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 32' ' ' THR . 20.1 p -166.43 178.89 5.86 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 123.702 0.626 . . . . 0.0 111.599 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.4 mt -131.63 111.25 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.178 0.991 . . . . 0.0 109.377 176.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -90.35 125.79 35.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 169.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 29' ' ' ASP . 11.1 t-160 -132.78 123.38 26.06 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.61 0.764 . . . . 0.0 109.233 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -168.03 161.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 123.164 0.29 . . . . 0.0 110.458 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.459 ' HA ' ' N ' ' A' ' 25' ' ' GLY 0.27 27.2 ptm 56.64 -61.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 128.412 2.685 . . . . 0.0 114.973 175.251 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -150.88 -31.54 0.17 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.584 0.753 . . . . 0.0 111.0 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -95.51 155.38 16.77 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.337 0.589 . . . . 0.0 112.205 -167.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 42.7 mt -108.89 94.2 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 t -82.82 88.96 6.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.7 t -80.15 122.2 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.27 156.47 23.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.896 0.478 . . . . 0.0 110.006 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.532 ' HA ' ' H ' ' A' ' 52' ' ' LYS . 16.8 pttm -132.11 -162.09 1.2 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.109 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.94 165.64 2.32 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.535 0.734 . . . . 0.0 111.403 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -39.2 -44.82 1.26 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.539 1.536 . . . . 0.0 114.692 -164.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -133.36 -59.04 0.88 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 173.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . . . 49.91 -163.08 0.05 OUTLIER 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 125.782 1.633 . . . . 0.0 113.79 171.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -131.39 120.85 23.65 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.159 0.584 . . . . 0.0 111.536 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -73.81 -10.78 60.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.302 0.641 . . . . 0.0 110.935 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -61.93 -26.92 68.48 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.76 0.824 . . . . 0.0 110.575 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 m -91.84 -43.91 9.24 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.506 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.9 t -80.3 -50.21 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.631 0.772 . . . . 0.0 112.793 -172.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.25 -46.98 83.45 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-O 117.29 -1.338 . . . . 0.0 113.093 -171.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.19 -38.52 81.35 Favored 'Trans proline' 0 C--N 1.4 3.278 0 C-N-CA 122.232 1.955 . . . . 0.0 112.979 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.26 -40.56 70.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.067 0.547 . . . . 0.0 111.337 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 45' ' ' ILE . 41.4 t -65.47 -40.14 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.022 0.529 . . . . 0.0 109.97 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.15 -45.5 87.29 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.804 1.242 . . . . 0.0 110.463 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.0 -31.73 51.95 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.642 1.177 . . . . 0.0 112.708 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.523 HG13 ' HB3' ' A' ' 41' ' ' PHE . 56.0 t -65.77 -51.68 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 124.068 0.947 . . . . 0.0 111.279 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -72.66 -25.53 61.3 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -79.67 -69.76 0.56 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.375 0.27 . . . . 0.0 111.321 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.3 mt 73.38 -45.57 0.62 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.976 1.71 . . . . 0.0 111.813 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.59 144.54 42.57 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.627 1.171 . . . . 0.0 109.184 170.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -70.3 73.21 0.49 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.742 0.782 . . . . 0.0 110.409 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -67.92 108.4 3.02 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.6 0.76 . . . . 0.0 110.36 -173.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -103.67 149.87 24.54 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.515 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -67.55 -25.47 65.82 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.319 0.647 . . . . 0.0 111.113 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -117.36 154.24 31.63 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.435 0.694 . . . . 0.0 109.236 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 . . . . . 0 C--O 1.249 1.076 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 172.65 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -160.99 167.28 26.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.636 0.774 . . . . 0.0 109.981 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.3 mt -65.21 96.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 20' ' ' SER . 33.3 mm -93.26 -40.98 12.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 C-N-CA 123.889 0.876 . . . . 0.0 109.786 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.589 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 10.9 t -150.5 158.74 44.49 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.428 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -117.06 134.13 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.118 0.967 . . . . 0.0 109.087 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 7.3 m -118.06 81.52 1.69 Allowed 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 173.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.75 -179.13 6.75 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.22 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 11' ' ' ASN . 2.0 t -160.11 154.77 20.62 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.778 0.831 . . . . 0.0 109.417 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.22 -18.95 65.05 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 122.529 2.153 . . . . 0.0 111.818 171.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.502 ' O ' HG23 ' A' ' 9' ' ' THR . 49.8 t30 -78.21 148.03 34.18 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 169.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -116.51 -171.71 2.05 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 122.116 -0.365 . . . . 0.0 111.413 -168.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 17.0 m120 76.82 -66.42 0.25 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.988 1.715 . . . . 0.0 110.363 -176.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 10.0 t -105.15 135.47 46.44 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 120.847 0.356 . . . . 0.0 111.573 -175.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 62' ' ' SER . 13.0 ptp -133.24 149.29 51.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.723 169.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 84.3 tttt -91.06 100.26 13.14 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.534 1.134 . . . . 0.0 110.58 -175.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.86 111.15 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.589 ' HB ' ' HB3' ' A' ' 5' ' ' SER . 86.2 m -75.35 131.27 40.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.601 0.76 . . . . 0.0 110.98 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.5 mt -102.35 166.56 10.5 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.764 0.825 . . . . 0.0 109.239 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.516 ' HB2' HG13 ' A' ' 4' ' ' ILE . 29.4 t -76.19 -26.77 56.5 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.702 0.401 . . . . 0.0 111.501 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -82.0 76.67 8.88 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.28 0.562 . . . . 0.0 109.976 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -87.5 166.53 14.7 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.996 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 68.92 173.44 0.29 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.506 1.122 . . . . 0.0 110.586 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 57.05 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.702 1.201 . . . . 0.0 111.061 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.72 143.43 5.71 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.8 mtt -92.35 -165.93 1.44 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.525 0.73 . . . . 0.0 109.7 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.1 m -90.65 153.27 20.43 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.039 0.447 . . . . 0.0 110.048 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 p -87.09 104.71 16.6 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.26 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -123.55 97.5 5.41 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.88 0.872 . . . . 0.0 110.49 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 m -89.45 83.49 6.37 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.631 ' HB3' HD11 ' A' ' 46' ' ' LEU . 25.0 m-85 -81.87 110.46 17.18 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.477 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.3 p -121.55 -39.91 2.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.969 0.908 . . . . 0.0 110.472 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.658 ' HE3' ' HA ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -141.14 40.0 1.78 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.883 -176.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.7 t 65.86 126.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 125.003 1.321 . . . . 0.0 113.133 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -93.69 -88.31 0.23 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 171.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 t70 169.51 -42.3 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.362 1.065 . . . . 0.0 109.294 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.5 p -63.42 -38.27 90.51 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.412 1.085 . . . . 0.0 111.806 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -60.51 141.9 91.44 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.945 0.898 . . . . 0.0 111.598 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.93 154.47 7.11 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.225 2.617 . . . . 0.0 113.815 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.14 67.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.973 0.909 . . . . 0.0 111.095 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.497 ' HB3' HG13 ' A' ' 81' ' ' VAL . 55.3 m-85 -62.3 -34.31 76.36 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.217 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.605 HD13 HG11 ' A' ' 81' ' ' VAL . 13.0 mm -79.76 -23.17 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 122.906 0.482 . . . . 0.0 110.52 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -68.27 -36.26 79.14 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.87 -41.84 92.4 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.71 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.586 HG22 HG11 ' A' ' 51' ' ' VAL . 54.3 mt -56.45 -46.6 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 123.994 0.809 . . . . 0.0 110.416 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 31' ' ' TYR . 96.7 mt -64.04 -36.4 83.88 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -79.34 -1.93 39.16 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.163 0.585 . . . . 0.0 112.059 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.6 t -70.87 115.52 10.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 165.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -62.96 89.06 0.03 OUTLIER 'General case' 0 C--N 1.348 0.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.28 -52.48 0.25 Allowed Glycine 0 C--O 1.218 -0.872 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.056 -172.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.586 HG11 HG22 ' A' ' 45' ' ' ILE . 74.2 t -69.9 -40.83 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -168.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 19.6 ttmt 65.63 -72.69 0.07 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.857 1.663 . . . . 0.0 111.823 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 35.9 t -133.29 151.86 51.91 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.641 0.776 . . . . 0.0 111.24 -174.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 75.1 mt -129.68 107.01 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.469 1.508 . . . . 0.0 107.401 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 72.0 t80 -99.59 91.44 4.89 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -94.13 134.49 36.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.138 0.975 . . . . 0.0 109.649 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 p -171.02 153.32 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.433 0.693 . . . . 0.0 109.48 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.498 ' HG3' ' H ' ' A' ' 59' ' ' ASP 0.269 18.3 ptp 43.93 -84.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 126.698 1.999 . . . . 0.0 115.231 -175.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.498 ' H ' ' HG3' ' A' ' 58' ' ' MET . 9.5 p-10 -138.82 20.88 2.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.022 -1.049 . . . . 0.0 111.853 -172.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -147.54 167.37 24.68 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.443 HG23 HG23 ' A' ' 54' ' ' ILE . 68.4 mt -132.14 101.89 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.406 1.483 . . . . 0.0 108.118 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.517 ' HB2' ' HB3' ' A' ' 55' ' ' PHE . 68.4 m -82.78 94.65 7.68 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.764 0.426 . . . . 0.0 110.121 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.49 HG13 HG13 ' A' ' 51' ' ' VAL . 97.5 t -79.15 105.21 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 18.7 t0 -93.71 85.57 4.88 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.273 1.029 . . . . 0.0 109.966 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 13' ' ' ASN . 16.8 pttp -75.73 174.09 10.26 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.074 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -75.54 176.25 7.76 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.946 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -70.46 -66.02 0.66 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.521 0.328 . . . . 0.0 110.531 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -69.81 -44.22 70.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.021 0.528 . . . . 0.0 111.348 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.53 121.48 8.48 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.244 0.965 . . . . 0.0 110.476 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -94.94 154.9 16.98 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.752 0.821 . . . . 0.0 111.311 -168.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -62.88 -20.11 64.81 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.094 0.558 . . . . 0.0 112.459 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -70.07 -19.34 63.27 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.565 0.346 . . . . 0.0 111.311 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.2 m -95.28 -47.18 6.43 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.409 0.683 . . . . 0.0 110.469 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.504 HG13 HG22 ' A' ' 51' ' ' VAL . 93.5 t -70.32 -59.99 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.934 0.893 . . . . 0.0 112.364 -171.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.3 tt -56.78 -50.27 88.97 Favored Pre-proline 0 CA--C 1.57 1.725 0 CA-C-O 117.773 -1.108 . . . . 0.0 112.902 -171.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -59.2 -31.25 94.96 Favored 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.409 2.072 . . . . 0.0 112.894 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -71.9 -41.25 68.16 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.659 0.784 . . . . 0.0 111.227 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.64 -48.51 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -60.96 -38.38 85.72 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.228 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.92 -29.1 70.31 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.13 0.972 . . . . 0.0 111.844 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.605 HG11 HD13 ' A' ' 42' ' ' ILE . 38.0 t -68.32 -39.4 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.686 0.394 . . . . 0.0 110.991 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -70.9 -40.79 71.97 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.469 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.0 79.14 1.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.9 mt -80.04 40.04 0.46 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.658 1.183 . . . . 0.0 111.854 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 66.93 172.31 0.25 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.06 0.944 . . . . 0.0 109.164 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -80.07 62.36 4.23 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.997 -1.064 . . . . 0.0 108.157 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -169.66 91.25 0.21 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.568 1.547 . . . . 0.0 107.309 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -69.43 -12.17 61.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.853 0.861 . . . . 0.0 111.766 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 80.99 -61.34 0.22 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.048 1.739 . . . . 0.0 111.827 173.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 50.43 -165.03 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.517 1.527 . . . . 0.0 112.53 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 28.8 p80 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 123.181 0.592 . . . . 0.0 109.479 170.903 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.464 0.649 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 10.8 mtmp? -137.55 -175.72 4.16 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.258 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -92.27 93.83 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.605 HG13 ' HB3' ' A' ' 20' ' ' SER . 49.1 mm -90.41 -42.13 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.364 0.666 . . . . 0.0 110.027 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -142.84 156.29 44.92 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.15 0.98 . . . . 0.0 108.87 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -111.51 -75.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.462 0.705 . . . . 0.0 110.196 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.6 t 57.12 84.06 0.1 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.813 1.245 . . . . 0.0 110.79 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -85.14 -168.7 2.32 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.029 -179.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.2 p -112.65 149.39 41.09 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.2 -33.79 97.89 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.912 2.408 . . . . 0.0 113.836 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -78.61 -11.71 59.98 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.694 0.797 . . . . 0.0 111.124 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.2 m80 64.98 29.94 12.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.133 1.373 . . . . 0.0 112.423 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.19 -48.27 18.05 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -128.04 141.65 51.45 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.472 0.653 . . . . 0.0 111.863 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.609 ' SD ' HD21 ' A' ' 75' ' ' LEU . 13.2 ptp -130.63 148.79 52.47 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 108.765 167.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 59.3 mttp -94.42 158.26 15.64 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.319 0.648 . . . . 0.0 109.538 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.1 mt -132.66 94.87 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.1 m -60.11 109.46 0.97 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.767 0.827 . . . . 0.0 109.983 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.9 mt -79.38 -26.76 41.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.939 0.496 . . . . 0.0 111.625 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.605 ' HB3' HG13 ' A' ' 4' ' ' ILE . 54.5 p 98.82 -6.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 127.876 2.47 . . . . 0.0 112.849 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -89.86 62.94 5.88 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.139 0.427 . . . . 0.0 109.887 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.3 m -65.22 84.47 0.05 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.586 0.707 . . . . 0.0 111.024 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -104.73 5.23 33.21 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.324 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 66.74 -71.1 0.1 Allowed 'General case' 0 C--N 1.37 1.497 0 C-N-CA 125.823 1.649 . . . . 0.0 111.075 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.29 56.34 4.25 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.288 -0.414 . . . . 0.0 112.246 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.9 ttt -94.92 46.95 1.14 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 m 68.47 155.2 0.12 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 125.752 1.621 . . . . 0.0 111.997 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.1 p -135.27 78.87 1.75 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.85 1.26 . . . . 0.0 108.309 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -124.52 144.68 49.98 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.434 0.694 . . . . 0.0 111.329 -165.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -99.92 149.73 23.12 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.989 0.916 . . . . 0.0 109.978 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.541 ' HB2' ' HB ' ' A' ' 54' ' ' ILE . 59.5 m-85 -141.35 113.99 8.32 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.156 1.383 . . . . 0.0 107.782 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.4 p -136.71 -43.06 0.59 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.564 0.746 . . . . 0.0 110.262 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -106.61 32.76 4.28 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.983 0.913 . . . . 0.0 112.076 -164.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 43' ' ' ASN . 58.9 t 55.58 64.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 122.756 1.265 . . . . 0.0 109.194 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.3 135.21 42.57 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.481 -1.69 . . . . 0.0 111.321 -170.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -77.09 91.89 3.72 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 p -177.96 -61.83 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.685 1.194 . . . . 0.0 108.662 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.478 ' HG3' ' ND2' ' A' ' 43' ' ' ASN . 25.2 pt20 -60.08 149.69 73.56 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.904 1.282 . . . . 0.0 111.91 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.6 150.93 11.18 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.262 2.642 . . . . 0.0 112.542 168.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.87 -37.33 63.58 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 123.687 0.617 . . . . 0.0 111.253 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -55.69 -40.31 72.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.89 1.276 . . . . 0.0 111.937 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.4 mm -75.63 -28.96 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.435 0.694 . . . . 0.0 110.304 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.478 ' ND2' ' HG3' ' A' ' 38' ' ' GLN . 55.5 m-80 -70.86 -34.94 72.15 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -64.61 -34.89 79.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.071 0.548 . . . . 0.0 110.93 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.9 mt -60.55 -45.24 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 123.728 0.642 . . . . 0.0 110.091 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.2 -35.74 78.01 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.921 0.488 . . . . 0.0 111.883 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.58 -14.12 60.38 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.212 0.605 . . . . 0.0 111.647 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.39 109.77 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -59.12 104.64 0.26 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.041 0.838 . . . . 0.0 111.003 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 146.88 -45.3 0.78 Allowed Glycine 0 C--N 1.344 1.015 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.5 121.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.791 0.836 . . . . 0.0 109.897 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 26.2 ttpp -104.96 -32.58 8.69 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.84 0.856 . . . . 0.0 110.965 -172.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 t -151.99 161.62 42.35 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.73 0.412 . . . . 0.0 111.062 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 79.1 mt -148.02 116.84 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.658 1.583 . . . . 0.0 107.252 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -119.59 110.23 16.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.798 0.439 . . . . 0.0 110.083 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -95.16 119.94 34.52 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.29 147.81 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.074 0.55 . . . . 0.0 110.336 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 28.0 ttt 67.55 -68.46 0.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.529 1.532 . . . . 0.0 110.883 -175.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.404 ' H ' ' H ' ' A' ' 60' ' ' PHE . 6.2 p-10 -160.06 -25.44 0.06 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.87 1.268 . . . . 0.0 110.234 169.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.404 ' H ' ' H ' ' A' ' 59' ' ' ASP . 45.7 p90 -81.27 143.11 32.51 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-O 120.922 0.391 . . . . 0.0 111.259 -170.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.16 103.18 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 15.0 t -83.32 89.25 6.98 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.6 t -77.48 126.13 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -120.21 149.4 42.32 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.275 1.03 . . . . 0.0 110.457 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HA ' ' H ' ' A' ' 52' ' ' LYS . 17.8 pttp -140.22 179.88 6.38 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.681 1.192 . . . . 0.0 109.441 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -76.9 167.04 22.51 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.828 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.11 -48.38 71.07 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.976 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.96 -32.88 74.57 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.507 -172.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.83 161.99 27.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.705 0.802 . . . . 0.0 111.933 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -118.25 146.23 44.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.679 0.792 . . . . 0.0 110.074 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.538 ' HB3' HD23 ' A' ' 75' ' ' LEU . 66.1 m95 -69.66 -17.14 63.48 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.048 0.539 . . . . 0.0 111.031 172.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.59 -24.81 67.76 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.969 0.908 . . . . 0.0 111.792 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.7 m -84.75 -45.3 12.53 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.019 0.928 . . . . 0.0 110.397 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.8 t -73.5 -60.92 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.068 -169.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.609 HD21 ' SD ' ' A' ' 15' ' ' MET . 3.9 mm? -49.32 -47.62 76.33 Favored Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -172.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -55.51 -33.85 87.69 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.078 1.852 . . . . 0.0 113.876 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -80.96 -41.98 21.99 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.696 0.798 . . . . 0.0 110.5 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.1 t -74.42 -31.77 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.331 1.052 . . . . 0.0 111.523 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -57.5 -41.35 80.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.872 0.869 . . . . 0.0 110.987 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.33 -32.34 71.15 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.045 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -63.11 -40.19 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.901 0.88 . . . . 0.0 111.663 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.665 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 27.2 m-85 -91.2 25.08 2.63 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.428 ' HB3' ' HG2' ' A' ' 85' ' ' GLU . 57.8 mt-10 -145.62 -58.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.055 0.455 . . . . 0.0 109.904 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 62.82 30.73 16.66 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.397 1.479 . . . . 0.0 111.091 -174.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 83' ' ' GLU . 10.2 mm-40 -72.89 93.71 1.75 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.633 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -116.37 125.3 51.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.273 1.029 . . . . 0.0 108.988 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 60.35 27.18 16.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.028 0.931 . . . . 0.0 111.566 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.33 124.41 27.47 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.778 0.831 . . . . 0.0 110.988 -173.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -125.61 91.56 3.43 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.238 1.015 . . . . 0.0 108.67 175.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -93.39 -68.99 0.77 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.9 p80 . . . . . 0 CA--C 1.557 1.24 0 C-N-CA 123.778 0.831 . . . . 0.0 109.584 178.455 . . . . . . . . 0 0 . 1 stop_ save_